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SUMMARY 
All the events of egg activation in mammalian eggs are triggered physiologically by 
transient increases in cytosolic free Ca²⁺ referred to as Ca²⁺ioscillations. These oscillations 
are initiated by the sperm derived PLC isoform, PLCζ. PLCζ releases Ca²⁺ by hydrolysing its 
substrate PI(4,5)P₂ to produce IP₃, however, many of the mechanisms by which PLCζ elicits 
Ca²⁺release in eggs are poorly understood. The results of this thesis confirm that whilstPLCζ 
cRNA and recombinant protein is able to cause Ca²⁺ioscillations in mouse eggs the sperm 
derived protein PAWP does not cause any Ca²⁺ release in any circumstances. It is shown 
that EF hand domain and XY linker of PLCζ are important in determining its Ca²⁺i releasing 
ability by enabling PLCζ binding to its substrate PI(4,5)P₂ through electrostatic interactions. 
The C2 domain of PLCζ was also found to play a crucial role in the Ca²⁺ releasing ability of 
PLCζ, possibly by binding to lipids or proteins in the target membrane. The Ca²⁺releasing 
ability of eggs is acquired during oocyte maturation and a dramatic increase in PLCζ 
sensitivity of oocytes occurs after germinal vesicle breakdown.A variety of markers for 
PLCζ’s substrate PI(4,5)P₂ including fluorescent PI(4,5)P₂ and gelsolin based fluorescent 
probes suggests that this PI(4,5)P₂ is localised to intracellular vesicles that could derive 
from Golgi apparatus. Attempts are made to measure PI turnover in these intracellular 
compartments of eggs during PLCζ induced Ca²⁺i oscillations using several probes. The 
results of this thesis suggest that PLCζ releases Ca²⁺ by a novel IP₃ based signalling pathway 
that involves an intracellular source of PI(4,5)P₂ .  
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1. INTRODUCTION 
During fertilisation calcium (Ca²⁺) signalling inside the egg is both necessary and sufficient 
for initiating all further developmental events (Stricker 1999). In mammals this Ca²⁺ 
signalling takes the form of transient repetitive increases in cytosolic Ca²⁺ concentrations 
(Ca²⁺i) called Ca²⁺i oscillations that occur as a result of the introduction of a sperm derived 
protein into the egg cytoplasm following sperm egg fusion (Cuthbertson et al. 1981; Swann 
1994). Despite many different “sperm factor” candidates being proposed the most 
evidence indicates a sperm specific Phospholipase C (PLCζ) is responsible for initiating Ca²⁺i 
oscillations in mammalian eggs (Saunders et al. 2002).  
The work presented in this thesis aims to investigate the mechanism of action for PLCζ in 
eliciting Ca²⁺i oscillations in mouse eggs. This introduction will provide an overview of 
previous research conducted within this field and within the areas relevant to it. Firstly, the 
physiological and cellular events of egg formation and maturation will be discussed 
including how the egg becomes receptive for fertilisation. The process of fertilisation will 
then be covered with particular focus on egg activation and the role of Ca²⁺i oscillations. 
Next, a summary will be provided on the sperm factor theory and possible sperm factor 
candidates with a full discussion on the evidence for PLCζ in this role. Finally the structure 
and function of PLCζ including what is already understood about its activity will be 
reviewed paying particular attention to the upstream and downstream signalling cascades 
involved in its activity and the initiation of Ca²⁺ release.  
Gametogenesis 
Sexual reproduction in all animal species requires the joining of two haploid gametes 
through a process of fertilisation to produce a diploid zygote. In order for this process to 
occur the specialised gametes must first be produced from an initial undifferentiated 
somatic germ cell. This process is known generally as gametogenesis and occurs very 
differently in males and females. Male gametogenesis, also referred to as spermatogenesis, 
results in the production of many small sperm produced throughout the whole adult life of 
the male. In contrast female gametogenesis, or oogenesis, results in relatively few large 
eggs which are produced prior to birth and stored within the ovaries. There is also 
considerable variation in how these processes occur between different species. Here the 
mechanisms of mammalian spermatogenesis and oogenesis will be discussed with 
particular focus on its relevance to events at fertilization. 
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Spermatogenesis 
Spermatogenesis is the general term used to describe the process by which a diploid germ 
cell forms specialised haploid sperm cells. However, this process can be split into two main 
stages, first the formation of haploid spermatid and then the differentiation of these 
spermatids into mature spermatozoa by the process of spermiogenesis (see fig 1.1).  
Like oocytes the precursor cells of spermatozoa are determined early on in development as 
undifferentiated primordial germ cells (PGCs) which must migrate to the developing gonad 
(see oocyte formation) (Chiquoine 1954). Once PGCs arrive at the developing testes the 
cells divide mitoticallyand are then referred to as spermatogonia (McLean et al. 2003). 
These cells remain connected to each other via cytoplasmic bridges through incomplete 
cytokinesis which allows the development of multiple sperm to be synchronised(Togawa 
1971). These bridges also allow sharing of gene products between developing sperm 
(Ventela et al. 2003). Spermatogonia also interact with specialised somatic cells of the 
testes called Sertoli cells which produce hormones to inhibit the development of female 
reproductive organs (Hai et al. 2014). Sertoli cells also respond to hormones produced by 
the pituitary gland and the interstitial cells within the testes (Rato et al. 2016). Futhermore 
Sertoli cells inhibit further proliferation of the spermatogonia. This spermatogonia enters a 
dormant state until puberty (Chen and Liu 2015).  
At puberty some of the spermatogonia enter meiosis initiating a cycle of spermatid 
formation and maturation (lasting approximately 60 days in humans) which occurs in waves 
throughout the life of the male (Heller and Clermont 1963). Sertoli cells associate with the 
germ cells during the process by providing nutrients, stimulating cell division and 
responding to hormonal stimuli (Griswold 1995). Once spermatogonia complete two 
rounds of meiosis, four haploid cells are produced which are referred to as round 
spermatids (Sá et al. 2012). It is at this point the differentiation process of spermiogenesis 
begins which results in the production of mature spermatozoa competent for fertilisation 
(Clermont 1993). Spermogenesis involves several key events with the first being the 
development of the Acrosome (Abou-Haila and Tulsiani 2000). The acrosome contains the 
enzymes necessary for breaking down the envelopes surrounding the egg and is formed 
from Golgi apparatus derived vesicles which conjugate to form a cap around the nucleus 
(Bedford and Nicander 1971). The dramatic growth of microtubules from the centriole 
gives rise to the flagellum which allows the sperm to propel itself through the female 
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reproductive tract (Afzelius et al. 1995). Finally the cytoplasmic bridges are broken as 
residual bodies are pinched off forming individual spermatozoa (mature sperm cells) 
(Dietert 1966). Sperm are stored in the seminiferous tubules until they are ejaculated 
during copulation.  
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A
B
Figure 1.1 Schematic showing the process of spermatogenesis and the structure of a sperm head 
A) Schematic showing the overall process of spermatogenesis. Primordial germ cells (PGCs) migrate 
to gonadal ridge where they proliferate. Following hormonal stimulation these cells become 
committed to form spermatozoa. At this point these cells are called spermatogonia. Spermatogonia 
undergo DNA replication followed by two rounds of meiosis whilst remaining joined by cytoplasmic 
bridges. These haploid spermatids then undergo a differentiation process of spermiogenesis to 
produce mature spermatozoa. B) Diagram showing the structure of a mature spermatozoa head as a 
cross section. 
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Oogenesis 
Oocyte Formation 
Oocytes are derived from diploid primordial germ cells (PGCs) which after production in the 
embryo, must migrate to the developing ovary for proliferation and differentiation (Monk 
and McLaren 1981). The precursors for PGCs are determined very early on in development 
before gastrulation (Jeon and Kennedy 1973). During this time the embryo consists of only 
three separate cell lineages, trophectoderm, epiblast and primitiveendoderm. It is from 
these layers which all embryonic and extra-embryonic cell types are differentiated (Kojima 
et al. 2014). The precursors for PGCs first form in the distal section of the epiblast sitting 
next to a differentiated section of trophectoderm called the extraembryonic ectoderm 
(Spiegelman and Bennett 1973; Lawson and Hage 1994). This differentiation occurs as a 
result of inductive cell signals produced by surrounding cells and includes proteins that are 
members of the transforming growth factor β (TGFβ) super-family, specifically bone 
morphogenetic proteins (BMPs) (Tam and Zhou 1996; Lawson et al. 1999; Ying et al. 2001). 
On the onset of gastrulation PGC precursors move through the primitive streak before 
residing in the extraembryonic mesoderm. At this point true PGCs become evident (Lawson 
and Hage 1994) 
Later, PGCs migrate to the genital ridge where the developing gonads are found, at which 
time sexual differentiation has only just begun (Sanchez and Smitz 2012). Here the PGCs 
proliferateby mitosis until they colonize the ovary (Monk and McLaren 1981). This occurs 
due to a combination of intracellular derived transcription factors and cellular signals from 
surrounding somatic cells (Pesce et al. 2002). At this point the PGCs are considered germ 
cells and referred to as oogonia. During this process of proliferation the oogonia aggregate 
to form clusters which are connected by intercellular bridges called Oogonium clusters 
(Gondos 1973). By this stage some of somatic cells of the ovary have differentiated to form 
epithelial pre-granulosa cells which will later form the somatic cells of primordial follicle. 
The oogonium clusters organise with the pre-granulosa cells to form an ovarian cord which 
is separated from the rest of the developing ovary which remains this way until the onset 
of meiosis (Byskov 1986). 
Oogoniain this state are still diploid and must undergo meiosis before haploid oocytes are 
produced. Before the oogonia enters the meiotic cell cycle, its DNA is replicated so each 
chromosome has two sister chromatids connected by axial proteins (Xu et al. 2005).Once 
the prophase stage of the first round of meiosis begins (Prophase I) the chromosomes 
6 
 
become visible and homologues pair along the equatorial plane (Hunt et al. 1995). The 
homologous chromosomes become intimately bound transversely by a selection of 
filamentous proteins collectively referred to as the synaptonemalcomplex (Sym et al. 
1993). The synapses formed between chromosomes by the synaptonemalcomplex assists in 
the process of “crossing-over” where sections of chromosomal DNA is spliced and 
exchanged with the homologous chromosome adjoined to it in a cross-wise fashion (Tung 
and Roeder 1998). The process of crossing over, along with the formation of the 
synaptonemal complex, is also thought to assist in the correct segregation of chromosomes 
during metaphase (Newnham et al. 2010). 
Before prophase I can be completed the cell cycle is arrested and the cell is now referred to 
as a primary oocyte. An oocyte can remain in this quiescent state for many years until it is 
ready to be ovulated (Baker and Franchi 1972). This extended period of arrest allows the 
oocyte to undergo massive hypertrophy and growth whilst accumulating many proteins 
and lipids that will later form an energy source for the early embryo (Kaplan et al. 1982). At 
this stage the oocyte still contains 4 chromatids so is ideally suited for producing high 
quantities of RNA (Lima-De-Faria and Borum 1962). As a result, the primary oocyte 
becomes very active in RNA synthesis (Kaplan et al. 1982). Furthermore the chromatids 
change structure as they elongate and de-condense in regions, this exacerbates their 
transcriptional power (Clarke and Masui 1983; Kleckner et al. 1991). This DNA is encased 
ina large nucleus called the germinal vesicle which is characteristic to this stage of 
oogenesis, therefore, a primary oocyte may also be referred to as a germinal vesicle (GV) 
oocyte (Clarke and Masui 1983). Towards the end of the growth phase transcription slows 
and much of this RNA produced is degraded or translated during oocyte maturation(Kaplan 
et al. 1982). 
During the growth phase the oocyte also becomes associated with the surrounding pre-
granulosa cells to form a structure known as the primordial follicle. This consists of one 
oocyte surrounded by layers of pre-granulosa cells which interact via intercellular signals 
(Pepling 2006).  As the oocyte grows the follicle surrounding it develops and different 
layers of the granulosa cells become apparent (Thibault et al. 1975). The cumulus cells of 
the follicle remain in physical contact with the oocyte through the whole of the growth 
phase and later maturation phase where they play an important role in driving both these 
processes (Gilula et al. 1978).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
The oocyte is surrounded by a glycoprotein envelope known as the zona pellucida. 
Projections from the cumulus cells form and penetrate through the zona pellucida so to 
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produce gap junctions (Sotelo and Porter 1959; Anderson and Albertini 1976; Bleil and 
Wassarman 1980b). This allows effective paracrine signalling between these cells which 
enable oogenesis and follicle development to be coordinated (Byskov et al. 1997).  
In order forcells to enter the next stage of the cell cycle sufficient levels of the M-phase 
kinase, maturation promoting factor (MPF), are crucial (Hashimoto and Kishimoto 1988). 
MPF is a heterodimer containing cyclin B and cyclin dependent kinase 1 (CDK1) where 
cyclin B acts the regulatory subunit for the catalytic CDK1 (Labbe et al. 1989; Jessus and 
Beach 1992). As a complex, MPF is able to regulate cell cycle progression through the 
phosphorylationof target proteins (Doree et al. 1983). To maintain the oocytes in cell cycle 
arrest the levels of MPF are kept low to prevent further cell cycle progression. This is done 
by increased levels of cyclic adenosine monophosphate (cAMP) (Hashimoto and Kishimoto 
1986). cAMP is able to activate protein kinase A (PKA) which in turn activates Wee2 which 
stimulates meiotic arrest via CDK1 inactivation (Bornslaeger et al. 1986; Han et al. 2005). 
The cumulus cells may play a role in maintaining meiotic arrest of the oocyteby producing 
cyclic guanosine monophosphate (cGMP) which enters the oocytethrough intercellular gap 
junctions(Hubbard and Terranova 1982). This maintains high cAMP levels by preventing its 
degradation (Norris et al. 2009). cGMP prevents cAMP degradation by inhibiting the 
enzymes that are responsible for hydrolysing cGMP, phosphodiesterases (PDE) (Norris et al. 
2009). In mouse oocytes it is the isoform PDE3A that is involved in this process however 
inrat oocytes it is PDE5 and PDE1 isoforms that hydrolyse cAMP (Norris et al. 2009; Egbert 
et al. 2016). Oocytes will remain in this arrested state until hormonal signals produced at 
puberty initiate the oocyte maturation process. When Lutenising hormone (LH) increases 
the gap junctions close as a result of epidermal growth factor receptor kinase (Norris et al. 
2010). This produces a decrease in cGMP in the oocyte which leads to an increase in PDE 
activity and therefore a decrease in cAMP levels (Norris et al. 2009).   
Oocyte maturation 
Through childhood all primary oocytes are maintained in prophase I of the first round of 
meiosis. These oocytes are encased within the primordial follicle where they undergo a 
period of hypertrophy and produce many of the proteins and machinery required for the 
zygote to develop post fertilisation. However, at this stage the oocyte still contains four 
times the genetic material than is necessary and is not yet receptive for fertilisation 
(Ducibella and Buetow 1994). During the onset of puberty, hormonal stimulus acts to 
trigger the maturation of a small selection of oocytes of which only one will be ovulated 
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(Channing et al. 1978). This hormonal cycle of ovulation occurs throughout the individual’s 
life until menopause is reached which in humans is approximately 40-60 years of age. The 
process by which the oocyte develops into a mature egg and becomes competent for 
fertilisation is known as oocyte maturation (Edwards 1965). Oocyte maturation involves 
nuclear maturation in the form of haploidisation and chromosome reduction as well as 
cytoplasmic maturation which involves translational, post-translational and organellular 
modifications (Donahue 1968) (see fig 1.2).  
During prophase I arrest the oocyte is prevented from progressing in the cell cycle and 
completing meiosis I by maintaining low levels of MPF (Hashimoto and Kishimoto 1986). 
When oocyte maturation begins due to the presence of gonadotrophins such as LH, levels 
of MPF increase dramatically and CDK1 becomes activated allowing it to phosphorylate 
target proteins (Channing et al. 1978; Motlik and Kubelka 1990). Interestingly, removing GV 
oocytes from the follicle leads to spontaneous maturation in the absence of LH which 
suggests that the granulosa cells must play a role in maintaining low levels of MPF and 
therefore preventing premature maturation (Thibault 1977).  
The first cellular change that occurs following the resumption of meiosis I is the 
condensation of the chromosomes and breakdown of the nuclear envelope, also known as 
germinal vesicle breakdown (GVBD), a process that could be caused by the phosphorylation 
of nuclear lamins (Calarco et al. 1972; Lenart and Ellenberg 2003). At this time the two 
chromatids of each chromosome become visible and can be seen held together at the 
centromere and crossed over at chiasmata (Holm 1986). The first meiotic spindle (MI 
spindle) forms around the chromosomes that are still fairly central within the oocyte. 
Unlike other cellular divisions the meiotic divisions of the oocyte are asymmetric, that is to 
say one large oocyte produced containing half of the genetic material of the mother cell 
and the other half of the DNA is extruded in a small cell referred to as the polar 
body(Brunet and Verlhac 2011). This process ensures that the majority of cytoplasm and 
cellular organelles that have been produced during the growth phase are conserved within 
a single oocyte of higher quality (Maro and Verlhac 2002). As the point of cytokinesis in a 
cell is dependent on the location of the spindle, in order for this asymmetric division to 
occur the MI spindle must migrate to the oocyte cortex (Longo and Chen 1985).  It is 
believed that this relocation of the spindle is dependent on transport along a meshwork of 
filamentous microtubule F-actinorganised by Formin 2 (Verlhac et al. 2000; Dumont et al. 
2007; Azoury et al. 2008; Schuh and Ellenberg 2008). The migration of the MI spindle 
stimulates the formation of a cortical actomyosin domain which is a F-actin rich region 
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within a ring of myosin II (Longo and Chen 1985). Anaphase is then initiated by activation of 
anaphase-promoting complex (APC/C) which stimulates Seperase activity through 
degradation of its inhibitor Securin (Terret et al. 2003). Seperase is responsible for pulling 
homologous chromosomes apart to opposite poles of the oocyte (Terret et al. 2003). 
Completion of meiosis I following cytokinesis leads to the formation of the first polar body 
(Sato 1979). Meiosis II begins immediately after this and as the chromosomes are already 
condensed the second meiotic spindle (MII spindle) and a second actomyosin domain can 
both form straight away at the cortex. The oocyte now contains only one chromosome 
from each homologous pair however each of these contains 2 sister chromatids which are 
allelic but not necessarily identical as they have recombined sections of their DNA through 
crossing over(Holm 1986). During Meiosis II these chromatids are separated through 
equatorial chromosome reduction, however, the oocyte does not complete meiosis at this 
time but instead arrests in metaphase of meiosis II (MII arrested) whilst it acquires the 
ability for activation (Kubiak 1989). The MII arrested oocyte is now referred to as a 
metaphase II (MII) oocyte or an egg.  The egg is arrested with the spindle fully formed and 
the chromosomes aligned however only once the egg has been fertilised by a sperm the 
egg will complete meiosis II and extrude the second polar body. As is the case for prophase 
I arrest, stabilising levels of MPF are essential for maintaining MII arrest, however in this 
case maintaining high levels of MPF is required (Hashimoto and Kishimoto 1988).This 
maintenance of MPF levels is as a result of a complex of proteins referred to as the 
cytostatic factor (CSF)(Kubiak et al. 1993). A main component of CSF has now been 
identified as high levels of active endogenous meiotic inhibitor 2 (Emi 2) (Shoji et al. 2006). 
Despite a high level of cyclin B degradation by the anaphase promoting complex a huge 
amount of cyclin B is also synthesised therefore preventing cell cycle progression to 
anaphase (Kubiak et al. 1993). Cdk1 is also maintained in an active state through 
phosphorylation by the phosphatase cell cycle division cycle 25 homologue A (Cdc25A) (Oh 
et al. 2013). 
Alongside these nuclear alterations, structural and organelle changes are also necessary to 
produce a mature oocyte that is competent for fertilisation (see fig 1.3).  This self-
organising process is termed cytoplasmic maturation and is essential in preparing the egg 
for fertilisation (Watson 2007). One such alteration is the reorganisation of mitochondria 
that is diffuse throughout the cytoplasm in an immature GV oocyte to a polarised 
distribution in a mature egg (Van Blerkom and Runner 1984).  Eggs and early embryos 
produce virtually all their ATP via oxidative phosphorylation prior to implantation therefore 
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require a huge  amount of mitochondria, more than 100,000 per egg in fact (Biggers et 
al.1967). At the onset of meiosis I during germinal vesicle breakdown (GVBD) mitochondria 
begin to localise around the forming MI spindle in the centre of the oocyte (Van Blerkom 
and Runner 1984). As the MI spindle migrates to the oocyte cortex the mitochondria move 
with it however are excluded from the polar body as it is extruded (Dalton and Carroll 
2013). As the egg enters meiosis II the mitochondria remain clustered around the spindle, 
however, no longer form a ring around the spindle (Dalton and Carroll 2013). By the time 
the egg is arrested in metaphase II the mitochondria remain concentrated within the 
spindle containing hemisphere of the egg they are somewhat more diffuse (Calarco 1995; 
Yu et al. 2010; Dalton and Carroll 2013).  
Other organelles become polarised in a similar way, for example the endoplasmic reticulum 
(ER), which acts to store Ca²⁺ that is required for signalling at fertilisation. Throughout 
maturation oocytes increase their capacity to release Ca²⁺ from the ER and part of this is 
dependent on their redistribution to the cortex during MII phase (FitzHarris et al. 2003). 
This reorganisation is cell cycle dependent and doesn’t begin until GVBD. The ER changes to 
form a dense network that is continuous with the nuclear envelope to surrounding the 
spindle and meiotic apparatus in a ring with the mitochondria packed against it (FitzHarris 
et al. 2007; Mann et al. 2010; Dalton and Carroll 2013). Like the mitochondria, the ER 
moves to the cortex with the spindle (FitzHarris et al. 2007; Mann et al. 2010). 
Microtubules specifically the microtubule associated motor protein dynein are responsible 
for locating the ER to the spindle whereas microfilaments are involved in forming and 
maintaining ER clusters at the cortex (FitzHarris et al. 2007).  As there is a close correlation 
between ER distribution and the eggs ability to release Ca²⁺ it is possible there is a spatio-
temporal connection between these (Shiraishi et al. 1995). Indeed levels of inositol 
trisphophate(IP3) receptors on the ER appear to increase in sensitivity, increase in number 
by approximately 2 fold and change in distribution during oocyte maturation (Mehlmann et 
al. 1996; Fissore et al. 1999; Lee et al. 2006).  
It has been reported that Golgi apparatus (Golgi) distribution also changes during oocyte 
maturation though it is debated whether the redistribution of Golgi is linked to that of the 
ER during meiosis (Payne and Schatten 2003). In a GV oocyte the Golgi appear conspicuous 
throughout the cytoplasm as small stacks called "mini-Golgi" which fragment during GVBD 
to form vesicular structures in the centre of the oocyte (Moreno et al. 2002). These Golgi 
fragments spread across the oocyte during MI and this distribution is maintained through 
MII arrest (Moreno et al. 2002). Despite this observation the true role of this Golgi 
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fragmentation in oocyte maturation and how it increases the egg's capacity for fertilisation 
is not yet fully understood. 
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Figure 1.2 Schematic showing the overall process of oogenesis 
Primordial germ cells (PGCs) migrate to gonadal ridge where they proliferate. Following hormonal stimulation these 
cells become committed to form oocytes and are therefore referred to as oogonia. The first round of meiosis then 
begins and the DNA is replicated. The oocyte is arrested in prophase of this first meiosis and possesses a visible GV. 
These GV oocytes enter a growth phase for many years until sexual maturity when a surge of LH resumes meiosis 
and the GV breaks down. The oocytes then enter the second round of meiosis however become arrested in 
metaphase until ovulation and fertilisation. At fertilisation meiosis II is completed resulting in the formation of male 
and female pronuclei (PN) and extrusion of the second polar body.  
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Figure 1.3 Schematic showing the change in structure and organelle distribution during 
cytoplasmic maturation of oocytes 
In GV oocytes mitochondria (purple) and ER (red) are spread throughout the cytoplasm. The Golgi 
(green) is in the form of small stack structures called “mini-Golgi”. As the GV breaks down the Golgi 
fragments further into vesicles and become concentrated towards the centre of the egg with the ER 
and mitochondria. Eventually the ER and mitochondria surround the newly formed spindle. These 
organelles follow the spindle as it migrates to the cortex and begin the form clusters of ER and 
mitochondria that are concentrated to the cortex of the egg. 
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Fertilisation 
In order for sexual reproduction to take place the gametes must first fuse so that the 
genetic material may be unified. Though there are many carefully orchestrated mating 
behaviours found in the animal kingdom to bring the egg and sperm together the actual 
joining of these two gametes is remarkably similar amongst species.  The term fertilisation 
can be considered as a collective phrase that encompasses all the events that occur during 
this union of gametes, as a result fertilisation could be considered to start with the sperm’s 
approach to towards the egg and end with the production of a fertilised zygote. 
Fertilisation therefore consists of 4 main stages the approach of the sperm towards the 
egg, the penetration of the vitelline layers, the fusion of the egg and sperm plasma 
membrane and finally ending in egg activation.  
Sperm physiological changes 
On its path towards the egg the sperm encounters many obstacles that reduce the chances 
of it fertilising the egg, however there are also many factors within the female reproductive 
tract that increase the chances of fertilisation. In order for the sperm and egg to effectively 
fuse they both must be biochemically competent for fertilisation. For the egg this process 
occurs prior to ovulation in the ovary during oocyte maturation (see above). Though the 
sperm undergoes a differentiation process within the testis, at ejaculation the sperm is 
actually not competent for fertilisation therefore freshly ejaculated sperm is not able to 
fertilise the egg.  Instead, the sperm resides in the female reproductive tract for many 
hours before fertilisation during which time sperm undergoes a series of biochemical 
changes which enable it to become competent in fertilising the egg (Austin 1951a; Chang 
1951). These changes are collectively referred to as capacitation and during this time the 
sperm switches from being in a relatively low state of metabolic activity to a much more 
active state (Austin 1952; Hicks et al. 1972; de Lamirande et al. 1997). Despite acquiring the 
ability to be motile during the maturation process in the testis, during its storage in the 
epididymis the sperm is maintained in an immotile state partly due to a low external and 
internal pH (Bishop and Mathews 1952). It isn’t until the sperm is exposed to the seminal 
fluid at ejaculation that it becomes motile as a result of high bicarbonate and Ca²⁺ 
conditions that increase cAMP and possibly intracellular pH (Okamura et al. 1985; Visconti 
2009). However, this first phase of motility is somewhat different from the movement of 
the sperm after capacitation. Initially the sperm flagellum moves in a slow, symmetrical, 
high frequency, low amplitude whiplash motion, however,  after capacitation the activity of 
the flagellum changes so it beats in high amplitude asymmetrical strokes (Yanagimachi 
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1970). This alteration is referred to ashyperactivation and is required in order for the sperm 
to reach the fertilisation site and penetrate of the zona pellucida (Yanagimachi 1970; Stauss 
et al. 1995; Ho et al. 2009).  
Both phases of sperm motility are a result of many biochemical alterations that take place 
in the sperm during the capacitation period. A number of signalling pathways are involved 
but theserevolve mainly around the activation of Protein Kinase A (PKA) (Visconti 2009).The 
early events of capacitationinvolve significant alterations to the permeability of the sperm 
plasma membrane (Harrison and Gadella 2005). As a result there is an influx of bicarbonate 
(HCO₃⁻ ) across the plasma membrane through the Sodium/ bicarbonate (Na²⁺/HCO₃⁻) co-
transporter which leads to an increase in intracellular pH (Demarco et al. 2003). A sperm 
specific HCO₃⁻/Ca²⁺ sensitive adenylylcyclase then becomes active and is able to catalyse 
the synthesis of cAMP which activates PKA which allows it to phosphorylate many target 
proteins (Okamura et al. 1985; Lefievre et al. 2002). The cellular alkalization and activation 
of PKA have several important effects. First of all, the increase in pH leads to the 
hyperpolarization of the plasma membrane specifically in the tail via the activation of 
potassium (K⁺) channels (Navarro et al. 2007). One such channel is Iksper which is responsible 
for the majority of K⁺ influx (Navarro et al. 2007). In mouse sperm this channel seems to be 
regulated strongly by intracellular pH, however in humans Iksper appears to be regulated 
more strongly in response to increases in Ca²⁺ influx (Brenker et al. 2014). The 
hyperpolarization of the plasma membrane leads to voltage dependent Ca²⁺ influx via the 
CatSper channel in a process which is thought to be modulated by PKA activation (Kirichok 
et al. 2006). This influx of Ca²⁺ is vital for capacitation and hyperactivation and if sperm is 
not exposed to external Ca²⁺ it is neither motile nor able to fully capacitate (Yanagimachi 
and Usui 1974).  
Initial PKA activation stimulates the sperm flagellum to increase its beat frequency and 
prolonged PKA activation induces hyperactivation (Morgan et al. 2008).PKA activation also 
has downstream effects that occur later in capacitation. For example, in the presence of 
extracellular (bovine serum albumin) BSA, HCO₃- and Ca²⁺ there is an increase in tyrosine 
phosphorylation (Visconti et al. 1995). During this process BSA is required as a cholesterol 
acceptor for depleting plasma membrane localised cholesterol on the sperm head 
therefore increasing membrane fluidity (Visconti et al. 1999). However, stimulation of an 
intracellular Ca²⁺i increase in the sperm can overcome the need for changes in cAMP or 
tyrosine kinase stimulation. For example sperm treated with Ca²⁺ ionophore is able to 
fertilise eggs despite the lack of cAMP signalling (Tateno et al. 2013). Following capacitation 
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the sperm undergoes one final stage of development which involves the release of the 
sperm’s acrosome contents. This occurs in response to an increase in sperm intracellular 
Ca²⁺ via Ca²⁺ influx through the CatSper channel as with hyperactivation (Kirichok et al. 
2006). The acrosome is an organelle located at the apex of the sperm head which forms a 
subcellular cap which contains a cocktail of enzymes and binding proteins (Srivastava et al. 
1965; Nicander and Bane 1966). During a process known as the acrosome reaction the 
plasma membrane fuses with acrosome outer membrane resulting the exocytosis of 
acrosomal contents extracellularly in the form of lots of small vesicles (Franklin et al. 1970). 
Many of these enzymes are necessary to enable the sperm to penetrate the zona pellucida 
(Huang et al. 1981). It was previously argued that the acrosome reaction was not initiated 
until the sperm came in contact with the zona pellucida where the enzymes that enable its 
penetration are released (Cherr et al. 1986). More significantly, it was believed that sperm 
that underwent the acrosome reaction before it reached the zona pellucida had lost the 
ability to bind and penetrate it and as a result unable to fertilise the egg (Bleil and 
Wassarman 1983).  However, it has now been shown that acrosome reacted sperm is able 
to penetrate the zona pellucida and fertilise the egg (Inoue et al. 2011). Contrary to 
previous beliefs it appears 95% of the sperm have already undergone the acrosome 
reaction by the time it reaches the site of fertilisation (La Spina et al. 2016). Therefore the 
acrosome reaction may occur independently of the presence of the zona pellucida and 
could be viewed as the last event to take place in a series of biochemical changes that 
occur in the sperm before it interacts with the egg.   
Sperm-Egg Interaction 
By the end of capacitation the number of sperm that gets within close proximity to the 
fertilisation site has been reduced to a few hundred (Ahlgren 1975). If ovulation has not yet 
taken place the motility of the remaining sperm is arrested in the oviduct just below the 
fertilisation site until ovulation (Suarez 1987). If ovulation has occurred sperm motility 
becomes guided in the response to chemical signals called chemo-attractants released by 
the egg and its surrounding cells (Eisenbach 1999). In fact in vitro experiments have shown 
that sperm motility is enhanced when it is exposed to follicular fluid (Falcone et al. 1991). 
The chemotactic response of sperm is suggested to act as a selection mechanism as not all 
sperm are responsive to the chemo-attractants at the same time and it may only be the 
sperm of the optimum state that responds (Eisenbach and Giojalas 2006). In humans for 
example cumulus cells surrounding the egg release progesterone (Oren-Benaroya et al. 
2008). Progesterone acts as a chemoattractant by opening the CatSper Ca²⁺ channel on the 
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sperm plasma membrane which causes Ca²⁺ influx and enhances sperm motility (Strunker 
et al. 2011). However, in other mammalian species such as mouse, progesterone doesn’t 
appear to function as a chemoattractant and does not stimulate CatSper channel activity 
(Strunker et al. 2011). Within humans many different molecules have been shown to have 
chemo-attractant properties and it is likely that many stages are involved. Other processes 
such as thermotaxis and rheotaxis may also be involved (Bahat and Eisenbach 2006; 
Eisenbach and Giojalas 2006; Miki and Clapham 2013).  
On approach to the egg the sperm faces two more obstacles before it is able to bind to the 
egg plasma membrane. First is the thick layer of cumulus cells surrounding the egg. The 
cumulus cells are held together in an extracellular matrix bound by hyaluronic acid (Talbot 
1984). Human sperm digests this matrix using a sperm plasma membrane enzyme called 
PH20 (Sabeur et al. 1997). This enzyme has hyaluronidase activity and is able to break 
down some of the hyaluronic acid which dissociates the cumulus cells from the egg. This, 
along with the burrowing action of the sperm is sufficient for the sperm to reach the 
surface of the egg’s zona pellucida (Lin et al. 1994).  
Sperm binding to the zona pellucida is mediated by the glycoproteins that make up the 
zona pellucida which act as receptors for the sperm (Bleil and Wassarman 1980a). The zona 
pellucida of mammals is made up of either three or four different glycoproteins depending 
on the species. For example humans, hamsters and pigs have 4 glycoproteins – ZP1, ZP2, 
ZP3 and ZP4 in their zona pellucida however mice only have three as the ZP4 gene acts as a 
pseudogene (Bleil and Wassarman 1980b; Hasegawa et al. 1991; Lefièvre et al. 2004; 
Izquierdo-Rico et al. 2009). There are species differences within these ZPs and human 
sperm is unable to recognise mouse derived ZPs. However, human sperm is able to bind to 
the zona pellucida of transgenic mouse eggs expressing human ZPs (Baibakov et al. 2012). 
In humans it appears all 4 ZPs bind to sperm in some way however is likely that there are 
different ligands on the sperm plasma membrane for these (Tsubamoto et al. 1999; 
Chakravarty et al. 2008; Chiu et al. 2008; Ganguly et al. 2010; Avella et al. 2014). Genetic 
knockout studies of these glycoproteins have also shown that they may not all be essential 
for fertilisation in the physiological situation (Avella et al. 2013). In mice ZP2 and ZP3 are 
the key glycoproteins responsible for sperm binding (Bleil and Wassarman 1988; Mortillo 
and Wassarman 1991; Avella et al. 2014). In humans some light has been shed on the 
possible sperm ligands that interact with the ZPs of the zona pellucida however it remains 
unclear the precise importance or interaction of these proteins with ZPs (Gupta 2015).  
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Once the sperm has penetrated the zona pellucida it enters the peri-vitelline space and 
comes in contact with the plasma membrane of the egg. In order for the sperm to 
successfully fuse with the egg plasma membrane and deliver its contents into the egg 
cytoplasm, the plasma membranes of the two cells must recognise and bind to each other. 
This occurs in a two-step binding process by a receptor mechanism. The sperm plasma 
membrane contains immunoglobulin IZUMO found in the equatorial region of the sperm 
surface which binds to its receptor JUNO on the egg plasma membrane (Inoue et al. 2005; 
Bianchi et al. 2014). IZUMO1 is found in the inner acrosomal membrane until the acrosome 
reaction, which highlights the importance of the acrosome reaction in producing sperm 
capable for fertilisation (Fukuda et al. 2016). When IZUMO binds to JUNO a complex is 
formed which causes a conformational change of JUNO (Aydin et al. 2016; Ohto et al. 
2016). JUNO is then shed from the membrane which could act as a plasma membrane block 
to polyspermy,however, it is unclear exactly how these membranes fuse following this 
process (Bianchi and Wright 2014).  
Following fusion of the egg and sperm plasma membranes the cytoplasmic contents of the 
sperm are released into the egg cytoplasm along with the genetic material of the sperm. 
This diffusion of sperm contents initiates a series of biochemical, cytoplasmic and nuclear 
events in the egg collectively termed “egg activation” which kick start the developmental 
process and signify successful fertilisation (Loeb 1914) 
 
Role of Ca²⁺ Signalling at Egg Activation 
Importance of Ca²⁺i signalling in egg activation 
Successful egg activation requires the careful co-ordination of many interconnecting 
signalling pathways which enables early development to begin. Despite the cellular 
complexity involved during egg activation all subsequent events are triggered by one 
simple ion signal, calcium (Ca²⁺) (Steinhardt and Epel 1974). In all known animal species a 
cytosolic increase in Ca²⁺ (known as Ca²⁺i) is both necessary and sufficient to initiate 
physiological egg activation (Stricker 1999). There is evidence to suggest that this is even 
the case in some higher flowering plant species (Digonnet et al. 1997). As a result Ca²⁺ is 
considered as the universal signalling molecule that initiates egg activation and has been 
proven necessary for this process in many species including mammals, sea urchins, frogs, 
medaka fish, ascidians, insects and bivalves (Steinhardt et al. 1974; Ridgway et al. 1977; 
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Cuthbertson et al. 1981; Eisen and Reynolds 1984; Speksnijder et al. 1989; Taylor et al. 
1993; Stricker 1999). Inhibiting Ca²⁺i using Ca²⁺ chelators such as ethylene glycol tetraacetic 
acid (EGTA) or 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA) inhibits 
egg activation (Kline 1988; Kline and Kline 1992; Xu et al. 1996). Likewise parthenogenetic 
egg activation can be initiated by injecting Ca²⁺ or the adding the Ca²⁺releasing agonist Ca²⁺ 
ionophore to eggs (Steinhardt et al. 1974). 
Despite its universality the profile of Ca²⁺i increase varies considerably between different 
species as does the mechanism by which it is initiated. For example, some species such as 
limpets rely solely on Ca²⁺ influx to increase Ca²⁺i uniformly through the cytosol (Deguchi 
2007). Other species use a combination of Ca²⁺ influx and Ca²⁺ release from intracellular 
Ca²⁺ stores for example bivalves such as mussels have an initial influx of Ca²⁺ into the egg 
following sperm egg fusion which stimulates Ca²⁺release from the stores which cross the 
egg as a wave (Deguchi et al. 1996). Sea urchin eggs also have an initial burst of Ca²⁺ influx 
however this is mediated by an action potential triggered by sperm-egg fusion and is 
distinct from the Ca²⁺i wave that initiates egg activation. The wave itself  is a propagating 
wave-front that is stimulated by the release of Ca²⁺ from intracellular Ca²⁺ stores (Whitaker 
and Steinhardt 1982). Similarly frog eggs (genus Xenopus) also release Ca²⁺ as a single wave 
from internal stores at fertilisation, however, as the egg is so large this wave takes several 
minutes (5 to 6) to cross the egg before returning to a basal level of Ca²⁺i (Busa and 
Nuccitelli 1985). Interestingly newt eggs which are relatively close evolutionarily to 
Xenopus are fertilised using physiological polyspermy therefore require an incremental 
increase in Ca²⁺i by the fusion of many sperm. Each of these sperm causes Ca²⁺ release from 
the stores which propagates as a localised wave (Harada et al. 2011; Iwao 2012). 
Mammalian eggs are unique as they release Ca²⁺ from internal Ca²⁺ stores however, unlike 
sea urchins and frogs; this release occurs as repetitive transient increases called Ca²⁺i 
oscillations that last for many hours (Igusa et al. 1983; Igusa and Miyazaki 1986). Ascidians 
also show an increase in Ca²⁺ias oscillations however these are very different in pattern to 
mammalian eggs. In ascidians a large, singular Ca²⁺i wave is triggered from the site of the 
sperm-egg fusion site and it isn’t until about 10 minutes later that high frequency Ca²⁺i 
waves begin to propagate from the vegetal hemisphere (Speksnijder et al. 1990). 
Mammalian eggs in contrast oscillate at a higher amplitude and a lot lower frequency with 
one Ca²⁺i wave about every 10 minutes for mouse eggs (Deguchi et al. 2000). Though Ca²⁺i 
increases as a wave-front in mammalian eggs unlike other species these Ca²⁺i waves can 
propagate relatively quickly and last approximately 1 minute each (Deguchi et al. 2000). 
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Furthermore the dynamics of Ca²⁺i in mammalian eggs change with time. For example in 
mouse and hamster eggs the first Ca²⁺i originates from the sperm entry site and spreads 
across the egg (Miyazaki et al. 1986; Deguchi et al. 2000). This increase is larger and takes 
longer to reach the Ca²⁺i peak compared to subsequent Ca²⁺i oscillations which occur much 
quicker and originate from indiscriminate areas of the egg (Miyazaki et al. 1986; Deguchi et 
al. 2000).  There is clear pacemaker activity in mammalian eggs where during the interval 
between oscillations the basal Ca²⁺ appears to increase gradually before reaching a 
threshold where it dramatically and quickly increases before the Ca²⁺i then returns to a 
basal level as the Ca²⁺stores refill (Swann and Yu 2008). 
Though mammalian egg activation is purely dependent on release of Ca²⁺ from the 
endoplasmic reticulum in practice Ca²⁺ influx is also required in order to maintain Ca²⁺i 
oscillations (Miao et al. 2012). The Ca²⁺ oscillations of fertilising eggs will terminate if the 
eggs are put Ca²⁺ free media (Kline and Kline 1992). This is because during each Ca²⁺i 
increase a small amount of Ca²⁺ leaves the egg via efflux therefore Ca²⁺ influx is needed to 
replenish this (Igusa and Miyazaki 1983).  As a result mouse eggs are not able to oscillate if 
they are kept in Ca²⁺ free media but can oscillate if both Ca²⁺ efflux and influx are 
prevented using the inhibitor Gadolinium (Gd³⁺) at millimolar concentrations (Bird and 
Putney 2005; Wakai et al. 2013). This means the frequency of Ca²⁺i oscillations may be 
influenced by the amount of Ca²⁺ influx. In pig eggs for example store operated Ca²⁺ influx 
across the plasma membrane in response to Ca²⁺ release from the ER plays a role in 
determining the frequency of Ca²⁺i oscillations at fertilisation (Wang et al. 2015). The 
evidence for this comes from experiments where the Ca²⁺ channels involved in store 
operated Ca²⁺ influx, Orai and Stim 1, have been downregulated at fertilisation (Wang et al. 
2015). This data shows that downregulation of Orai and Stim1 leads to a reduction in the 
number of Ca²⁺i oscillations in these eggs at fertilisation (Wang et al. 2015). Interestingly 
however too much Ca²⁺ influx may be disadvantageous as during oocyte maturation there 
is naturally a down regulation of Orai and Stim1 expression which leads to a reduction in 
the amount of Ca²⁺ influx in preparation of fertilisation (Cheon et al. 2013; Lee et al. 2013). 
This may be because too much Ca²⁺ influx can lead to an over stimulated Ca²⁺ response 
where the frequency of the Ca²⁺i oscillations at fertilisation are too high which could be 
detrimental to early embryo development (Lee et al. 2013). In mouse eggs store operated 
Ca²⁺ influx via Stim 1 and Orai doesn’t seem to play a role as inhibitors of these channels 
have no effect on the frequency of Ca²⁺i oscillations at fertilisation (Takahashi et al. 2013). 
Other Ca²⁺ influx channels may play a role however, for example the T-type Ca²⁺ channel 
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CaV 3.2 which has been found necessary to maintain Ca²⁺i oscillations (Bernhardt et al. 
2015).  
Much of the male factor infertility that is accounted for by sperm defects can be overcome 
with the use of intracytoplasmic sperm injection (ICSI) which allows the sperm to be 
directly injected into the cytoplasm of the egg (Palermo et al. 1992; Tesarik et al. 1994). 
However, despite the use of this technology, even with those sperm that have normal 
morphology in around 3% of cases a patient’s sperm sample is unable to fertilise any eggs 
following the use of ICSI resulting in a situation called “total fertilisation failure”(Flaherty et 
al. 1998). It has been suggested that this effect could be due to the sperm's inability to 
cause sufficient Ca²⁺release in order to trigger egg activation (Yoon et al. 2012). In fact 
fertilisation failure can be rescued with the addition of Ca²⁺ionophore which acts to 
dramatically increase Ca² i by causing Ca²⁺ influx (Tesarik and Testart 1994). It is important 
to note that the Ca²⁺i increase elicited by Ca²⁺ ionophore is not comparable to the Ca²⁺i 
oscillations seen at fertilisation as Ca²⁺ ionophore causes a large Ca²⁺i increase that is 
sustained for a long time (Tesarik and Testart 1994). Even though eggs can be activated in 
this way it is not yet been established whether the development of these embryos is 
impaired compared to those eggs that are activated with healthy sperm alone. This is 
especially relevant because the frequency of Ca²⁺i oscillations at fertilisation has been 
shown to be important for successful later development (Ducibella et al. 2002; Ozil et al. 
2006). However, the exact downstream effects of Ca²⁺i signalling on later development are 
yet to be determined.  
Ca²⁺ release at fertilisation is induced by IP₃ 
There are many pathways that are able to induce Ca²⁺release from internal stores in 
mammalian cells one of these is the IP₃ signalling cassette. The IP₃ pathway is part of the 
phosphoinositide metabolic pathway and centres on the production of IP₃ at membranes 
following the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PI(4,5)P₂) by 
phospholipase C (PLC) (Berridge et al. 1983; Berridge 1984; Berridge and Irvine 1984). IP₃ 
acts as a secondary messenger that diffuses through the cytoplasm and binds to the IP₃ 
receptor (IP₃R) on the endoplasmic reticulum (ER) (Supattapone et al. 1988; Snyder and 
Supattapone 1989). The IP₃R is a Ca²⁺ releasing channel consisting of 4 subunits with 3 
different isoforms (Snyder and Supattapone 1989; Danoff et al. 1991; Maeda et al. 1991; 
Nakagawa et al. 1991). IP₃ binds to the receptor’s IP₃ binding domain which causes a 
conformational change allowing cytosolic Ca²⁺ to bind also which opens the channel 
22 
 
allowing Ca²⁺ to be released from the lumen of the ER (Mignery and Sudhof 1990; Chan et 
al. 2007). This process is known as IP₃ induced Ca²⁺release (IICR) and was first characterised 
in rat pancreatic aciner cells (Streb et al. 1983) however has since been recorded in many 
other cell types (Bonis et al. 1986; Delfert et al. 1986; Muto et al. 1986).  IICR is also the 
mechanism by which the majority of Ca²⁺is released at fertilisation particularly in those 
eggs that experience Ca²⁺i increase as a wave (Miyazaki and Ito 2006). For example if IP₃ is 
injected into sea urchin eggs this causes a Ca²⁺i wave like that seen at fertilisation (Slack et 
al. 1986). Similar effects are seen when Xenopus (Larabell and Nuccitelli 1992), ascidian 
(Albrieux et al. 1997) and Medaka fish eggs (Iwamatsu et al. 1988) are injected with IP₃. 
Furthermore an increase in IP₃ quantity has been recorded at fertilisation in Xenopus eggs 
(Snow et al. 1996). IICR seems to have the samerole in mammalian eggs as Ca²⁺release is 
also recorded when IP₃ is injected into mouse (Kline and Kline 1994), bovine (Fissore et al. 
1992), rabbit (Fissore and Robl 1993) and hamster eggs (Miyazaki 1988). A single IP3 
injection causes a single large release of Ca²⁺ from the stores, that occurs within seconds 
(Miyazaki 1988). Ca²⁺i oscillations can be induced however only when IP₃ is repeatedly 
injected into eggs or a caged IP₃ is injected which can be photo-activated (Jones and Nixon 
2000). The type I IP₃R (IP₃R1) is the prominent isoform in mammalian and Xenopus eggs (Xu 
et al. 1994; Runft et al. 1999). Experiments inhibiting IICR by targeting this receptor activity 
have provided more evidence for its role in mammalian egg activation (Xu et al. 1994; 
Fissore et al. 1999). In hamster if the type I IP₃Rs are downregulated using a monoclonal 
antibody against the receptor no Ca²⁺i oscillations are seen at fertilisation (Miyazaki et al. 
1992). What’s more, during fertilisation IP₃R undergo proteolysis in response to IP₃ binding, 
an effect that is mimicked by the addition of the IP₃ analogue Adenophostin A (Jellerette et 
al. 2000). IP₃R can be depleted in immature oocytes using Adenophostin A prior to in vitro 
maturation to produce MII eggs lacking IP₃Rs however these eggs do not oscillate when 
they are fertilised by IVF (Brind et al. 2000). This suggests that IP₃ is the only signalling 
molecule necessary to initiate Ca²⁺ release in mammalians eggs at fertilisation.  
Interestingly the Ca²⁺released as a product of IICR acts to further activate the IP₃R in a 
positive feedback loop until a certain Ca²⁺i level (Iino and Endo 1992). In this model Ca²⁺i 
acts as a conventional agonist of the IP₃R at low levels of IP₃ (Mak et al. 1998). However, 
when the cytosolic IP₃ levels increase this reduces the affinity of Ca²⁺i for the inhibitory site 
of the IP₃R (Mak et al. 1998). If the IP₃ agonist Adenophostin A is injected into mouse eggs 
the Ca²⁺i oscillations stimulated are not low frequency like those seen at fertilisation 
(Jellerette et al. 2000). It is therefore possible that fluctuations in cytosolic IP₃ levels may 
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regulate the pace and pattern of the oscillations and enable eggs to oscillate at low 
frequency for many hours (Swann and Yu 2008).  
The IP₃R in eggs may be regulated by multiple pathways. Firstly its expression may be 
controlled at the transcriptional and post-transcriptional level. IP₃R activity can also be 
altered post-translationally as a result of protein phosphorylation which can either 
stimulate its activity or decrease its activity (Roderick and Bootman 2003). Due to the Ca²⁺ 
sensitivity of the channel it is also suspected that cytosolic Ca²⁺i aswell as the levels of 
available IP₃ may also play a role in regulating the channel activity and therefore a role in 
determining oscillation pattern (Iino and Endo 1992). However, dynamic measurements of 
cytosolic IP₃ are yet to be recorded in eggs.  
Soluble sperm factor theory 
Though it is clear that the fusion of the sperm to the egg is required in order to elicit 
mammalian Ca²⁺i oscillations by the production of IP₃, exactly how this signal is triggered 
was a matter of debate for some years. In most other cell types IP₃ is produced at the 
plasma membrane in response to external stimuli via stimulation of a receptor on the 
extracellular face of the plasma membrane (Streb et al. 1983). However, this does not seem 
to be the case in eggs during fertilisation in the vast majority of cases. In some species the 
initial Ca²⁺i signalling can be a result of the physical interaction between the egg and sperm 
for example in sea urchins sperm fusion to the egg causes a jump in capacitance which 
produces an inward current (McCulloh and Chambers 1991). This leads to a depolarization 
of the membrane which triggers an action potential and a transient increase in Ca²⁺i via 
influx (Shen and Steinhardt 1984). It is important to note however this Ca²⁺ influx is distinct 
from the larger Ca²⁺i wave that occurs around 15 seconds later that is responsible for egg 
activation (Shen and Buck 1993) . Mammalian eggs do also experience a jump in 
capacitance during sperm fusion however as the membrane is already very depolarized 
with a potential of -30 to -40 V  there is no action potential and therefore no Ca²⁺ influx 
occurs (Lee et al. 2001) . Injecting mouse eggs with dextran linked fluorescent dyes prior to 
sperm egg fusion has shown that the cytoplasm of the sperm diffuses into the egg and 
there is a delay of 1 to 2 minutes before Ca²⁺i oscillations begin (Lawrence et al. 1997; Lee 
et al. 2001). This provides evidence that the signal transduction for IICR is not a result of 
sperm-egg membrane interaction, instead is initiated by some factor present in the sperm 
(Swann 1990b). This is supported by the success of the clinical procedure ICSI where a 
sperm is injected directly into an egg to fertilise it therefore bypassing all membrane 
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interaction (Tesarik et al. 1994). Damaging the sperm head prior to its injection into the egg 
seems to be important in determining whether it can cause Ca²⁺i oscillations and fertilise 
the egg (Dozortsev et al. 1995). It has been suggested that this damage to the sperm 
plasma membrane is necessary to allow sufficient release of Ca²⁺release inducing “sperm 
factor” into the egg (Swann et al. 1994). Furthermore sperm-egg fusion defective mice are 
infertile even though sperm-egg binding is unimpaired (Kaji et al. 2000). This evidence 
suggests that the cytosolic components of the sperm must be released into the egg in order 
to cause Ca²⁺ release giving rise to the “sperm factor hypothesis” (Swann 1990b). This is the 
idea that in mammals the sperm head contains a soluble sperm factor that is released into 
egg cytoplasm following sperm-egg fusion and initiates the Ca²⁺ release by the production 
of IP₃ (Swann 1990b). There is now an overwhelming amount of evidence supporting this 
theory. For example if mammalian soluble sperm extracts from a range of species are 
injected into hamster, mouse, bovine and human eggs you see Ca²⁺i oscillations similar to 
that seen at fertilisation, with  these eggs activating fully even developing up to blastocyst 
(Swann 1990b; Homa and Swann 1994; Swann 1994; Wu et al. 1997). Furthermore these 
sperm extracts were shown to cause a mass increase in IP₃ in sea urchin egg homogenates 
like that seen at fertilisation (Jones et al. 1998). Interestingly sperm extracts are able to 
cause Ca²⁺release and oscillations in species other than that they are derived from and 
even work across animal phylum. For example sperm extracts from boars or pigs can even 
cause Ca²⁺release in marsupials, marine worms and sea urchin eggs (Parrington et al. 1999; 
Witton et al. 1999; Stricker et al. 2000). This would suggest that the Ca²⁺releasing sperm 
factor may be universal at least amongst mammals and possibly conserved in other animal 
groups also. 
Though the sperm factor was initially thought to be soluble in all mammalian species it 
seems in the sperm of some species, for example mouse, this is not the case and may only 
be extractable using reducing agents (Kimura et al. 1998). This insoluble fraction that was 
able to cause Ca²⁺i oscillations was termed sperm derived oocyte activating factor 
(SOAF)(Kimura et al. 1998). Due to the differences in solubility between the hamster 
derived sperm factor and the mouse derived SOAF it was suggested that these were 
distinct entities. However, it is now recognised that the SOAF and sperm factor as actually 
the same thing but just with different solubility properties (Fujimoto et al. 2004). It has also 
been established that the sperm factor is most likely to reside the perinuclear theca of the 
sperm head which is also the first part of the sperm to fuse with the egg plasma membrane 
(Kimura et al. 1998).  
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There has been several suggested sperm factor candidates. For example a truncated form 
of the tyrosine kinase receptor c-kit expressed in the testis called tr-kit was found to cause 
egg activation when injected into mouse eggs (Sette et al. 1997). It was proposed that tr-kit 
releases Ca²⁺ by activating egg derived PLCγ to produced IP3 (Sette et al. 1998). Tr-kit was 
thought to promote the formation of a multi-molecular complex of PLCγ, the protein-
tyrosine proto-oncogene Fyn and the RNA binding protein Sam 68 which subsequently 
enables PLCγ to release Ca²⁺ (Sette et al. 2002; Paronetto et al. 2003).  However, tr-kit has 
not yet been shown to cause Ca²⁺i oscillations in any mammalian eggs. Furthermore 
nucleotide sequencing has shown that tr-kit is only functionally expressed in mouse sperm 
and in many other mammalian species specifically rat, pig and human tr-kit is considered a 
pseudogene (Sakamoto et al. 2004). The sperm structural protein post-acrosomal sheath 
WW-domain binding protein (PAWP) has also recently been suggested as a potential sperm 
factor candidate however the effects of PAWP at causing egg activation are yet to be 
confirmed (Wu et al. 2007). The evidence for a role of PAWP in egg activation will be 
discussed in detail in the introduction to Chapter 3.  
PLCζ as a sperm factor in inducing Egg Activation 
Characterisation of a novel PLC that induces egg activation 
Due to the high levels of biochemical PLC activity in sperm extracts it was suggested that 
the sperm factor itself could be a PLC (Jones et al. 1998; Rice et al. 2000). However, the 
known PLC isoforms expressed in the sperm were not present in the fraction of sperm 
extract that has the ability to cause Ca²⁺i oscillations (Wu et al. 2001). Furthermore 
injection of recombinant protein of these isoforms into eggs or the addition to sea urchin 
egg homogenates is unable to cause Ca²⁺ release or the Ca²⁺i oscillations like that seen at 
fertilisation (Jones et al. 2000). This therefore led to the search for a novel PLC isoform that 
had the characteristics of a sperm factor. Indeed a search through the mouse expressed 
sequence tag (EST) database for a PLC like sequence that is expressed in the mouse 
spermatid lead to the discovery of a novel PLC (Saunders et al. 2002). This PLC  was coined 
PLCζ and is specific to the testis as expression tests using northern blots were unable to 
detect expression in any other mouse tissues (Saunders et al. 2002). Expression of PLCζ in 
the sperm has since been characterised in many other species including human, monkey, 
horse, hamster pig, chicken, medaka fish, rat and cows (Cox et al. 2002; Coward et al. 2005; 
Yoneda et al. 2006; Ito et al. 2008; Ross et al. 2008; Young et al. 2009; Bedford-Guaus et al. 
2011; Sato et al. 2013). 
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PLCζ has many key structural, biochemical and behavioural features which make it distinct 
from other PLCs (see fig 1.4) however the most critical of these is its ability to cause Ca²⁺i 
oscillations when introduced into eggs just in the way sperm extracts do (Saunders et al. 
2002). This is a vital characteristic in determining if PLCζ is the true physiological sperm 
factor, as the egg activating sperm factor must be-able to elicit Ca²⁺i oscillations and 
subsequent egg activation in eggs at the levels of protein found in the sperm. If PLCζ cRNA 
or recombinant protein is injected into mouse eggs a series of Ca²⁺i oscillations are 
triggered that look very similar to those seen at fertilisation (Cox et al. 2002; Saunders et al. 
2002; Kouchi et al. 2004) (see fig 1.5). These parthenogenetically activated eggs activate 
fully as indicated by resumption of meiosis, the formation of pronuclei and even develop 
normally up to blastocyst stage (Cox et al. 2002; Saunders et al. 2002). Similar 
developmental outcomes have also been recorded when PLCζ is injected into human and 
pig eggs (Rogers et al. 2004; Yoneda et al. 2006) . Furthermore, over expression of PLCζ in 
the mouse ovary results in spontaneous activation of oocytes within the ovary (Yoshida et 
al. 2007). Despite possessing these egg activating properties, for PLCζ to be considered a 
valid sperm factor candidate it is crucial that it elicits Ca²⁺i oscillations at physiological levels 
of protein present in the sperm and is able to enter the egg at sperm-egg fusion. 
Immunocytochemistry has shown that PLCζ resides in the equatorial region and perinuclear 
theca of the sperm head (Yoon et al. 2008; Heytens et al. 2009; Escoffier et al. 2015a). This 
is significant as the perinuclear theca is the first part of the sperm to fuse with the eggand 
therefore the sperm factor must reside here (Kimura et al. 1998). Importantly 
approximately 50 fg of mouse PLCζ protein is a sufficient amount to cause physiological like 
Ca²⁺i oscillations and this is within the physiological range found in a single mouse sperm 
(Saunders et al. 2002). In porcine sperm this amount of PLCζ is higher at 350 fg (Kurokawa 
et al. 2005). Other PLCs are not able to cause Ca²⁺ release or oscillations at this level. PLCδ1 
concentrations must exceed 1pg in order to cause any Ca²⁺i oscillations in mouse eggs 
(Kouchi et al. 2004) whereas PLCβ1 or PLCγ are not able to induce any Ca²⁺ release in 
mouse eggs even at 5pg (Jones et al. 2000). 
To determine if PLCζ is exclusively responsible for the Ca²⁺i oscillations elicited by the sperm 
it was important to establish what the egg activating activity of sperm is in the absence of 
PLCζ. To do this immuno-depletion experiments have been completed where PLCζ was 
depleted in sperm extracts using an anti-PLCζ antibody (Saunders et al. 2002). Immunoblot 
analysis comparing anti-PLCζ extracts with controls shows that when sperm extracts 
undergo this antibody treatment PLCζ is successfully removed from the supernatant 
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(Saunders et al. 2002). These PLCζ depleted extracts are not able to cause fertilisation-like 
Ca²⁺i oscillations like those elicited by the control antibody treated sperm extract following 
microinjection into mouse eggs (Saunders et al. 2002). Furthermore using a sea urchin egg 
homogenate assay it’s been shown that these PLCζ depleted sperm extracts do not possess 
any Ca²⁺releasing activity (Saunders et al. 2002). These results are further supported by 
sperm fractionation studies which have shown that only the sperm fraction containing PLCζ 
is able to elicit Ca²⁺i oscillations in eggs (Fujimoto et al. 2004; Kurokawa et al. 2004). It 
appears that PLCζ causes this Ca²⁺release through the production of IP₃ in the same way as 
sperm does at fertilisation because injection of PLCζ into mouse eggs causes a rapid down-
regulation of IP₃R just like that seen at IVF fertilisation (Lee et al. 2010). When eggs are 
fertilised by IVF using sperm from a RNA interference transgenic mice with a reduced 
amount of PLCζ the Ca²⁺i oscillations recorded terminate prematurely compared to IVF 
controls (Knott et al. 2005). When these transgenic mice were mated fertility was 
compromised indicated by a reduced litter size (Knott et al. 2005).  
The functional effects of PLCζ in model systems such as these are further strengthened by 
clinical data on male factor infertility. Immunoblots and immunofluorescence have shown 
reduced levels of PLCζ in the sperm and specifically in equatorial region can be correlated 
to a sperm’s failure to fertilise and activate the egg even following ICSI (Yoon et al. 2008; 
Heytens et al. 2009; Escoffier et al. 2015b). Furthermore, deficiencies in PLCζ can be 
rescued with the addition of Ca²⁺ ionophore following ICSI resulting in full egg activation 
(Taylor et al. 2010; Chithiwala et al. 2015). Using a mouse model of male infertility has 
shown that heat treated sperm which isn’t able to fertilise an egg by ICSI is able to fertile 
eggs if co-injected with recombinant PLCζ protein (Sanusi et al. 2015).  
Immunofluorescence has shown that sperm from patients suffering from recurrent failure 
for egg activationhas reduced overall levels of PLCζ however there is considerable variation 
in PLCζ levels amongst control sperm (Kashir et al. 2013). This suggests that in a fertile 
population there may be variance in sperm’s egg activating ability (Kashir et al. 2013). 
Taken together this data offers very strong evidence for PLCζ as the physiological sperm 
factor needed to trigger egg activation at fertilisation in mammals.  
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Figure 1.4 Schematics showing the structural domains of different PLC isoforms 
PH = Pleckstrin homology domain  
EF = EF hands domain 
X = X catalytic domain  
Y = Y catalytic domain 
C2 = PKC-homology type II 
SH2= Src homology 2 domain 
SH3 = Src homology 3 domain 
RA1 = Ras associated 1 domain  
RA2= Ras associated 2 domain  
CDC25= Ras guanine exchange factor domain  
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Figure 1.5 Diagram summarising how PLCζ releases Ca²⁺i in mammalian eggs and an example of Ca²⁺i 
oscillations initiated by PLCζ 
A) Diagram summarising how PLCζ releases Ca²⁺i in mammalian eggs and how this pathway is 
connected to other signalling pathway (red arrows). PLCζdiffuses into the egg at fertilisation and 
hydrolyses PI(4,5)P₂ (on unknown vesicles) to produce IP3 and DAG. IP3 diffuses through the cytoplasm 
and binds to the IP3R on the ER to release Ca²⁺. This leads to egg activation and also positively feeds 
back onto PLCζ activity to release more Ca²⁺.B) Trace showing Ca²⁺i oscillations in a mouse egg injected 
with PLCζ cRNA (0.02 μg/μl) and the Ca²⁺i indicator Rhod-2 dextran (pipette concentration= 1mM, Life 
technologies). 
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Structure of PLCζ 
There are 13 known isoforms of PLC found in mammals which can be classified depending 
on their structure and the mechanism by which they are activated (see fig 1.4) (Suh et al. 
2008). All PLCs have the same basic structure which enables them to catalyse PI(4,5)P₂  
hydrolysis and induce IP3 formation and Ca²⁺release (Majerus et al. 1986). The active site 
for this enzyme comprises of two catalytic domains named X and Y which are separated by 
a large lopped linker region (Hicks et al. 2008). These X and Y domains are highly conserved 
and essential for the catalytic activity to all PLCs however these isoforms can vary greatly 
depending on the additional regulatory subunits which can drastically alter their 
mechanism of action (Hicks et al. 2008). For example the SH domain of PLCγ allows 
activation by tyrosine kinases (Kadamur and Ross 2013). 
Though the enzymatic activity of PLCζ is very potent it possesses the most elementary 
domain structure of all PLC isoforms (Saunders et al. 2002). PLCζ is unique, as unlike all 
other PLC isoforms, it does not possess a pleckstrin homology (PH) domain which is able to 
bind phosphatidylinositols and therefore attach the enzyme to the plasma membrane 
where its substrate is located (Lemmon et al. 1995; Saunders et al. 2002). This makes PLCζ 
the smallest PLC isoform at only about 70 – 74 kDa in mammals depending on species (Cox 
et al. 2002; Saunders et al. 2002). Despite its elementary structure each domain has very 
specific structure and function which is vital for the activity of PLCζ in eggs. 
X and Y Catalytic Domains 
The active site for all PLCs is made up of the X and Y domains which consist of two barrel 
like structures comprising of alternating β sheets and α helices (Suh et al. 2008). This region 
is very well conserved between all PLC isoforms,in fact PLCζ has approximately 64% 
homology with its closest related PLC isoform PLCδ1 of which it shares many structural 
characteristics (Saunders et al. 2002). The residues responsible for the catalytic activity of 
the active site have been identified for PLCδ1 and all these residues (His311, Glu341, Asp343, 
His356 and Glu390) appear to be conserved or conservatively replaced in PLCζ (Ellis et al. 
1998; Nomikos et al. 2011a). For example the mutation in Asp343 residue in the catalytic 
domain of PLCδ1 renders the enzyme catalytically inactive and the same effect is seen if the 
analogous residue of PLCζ (D210R) is mutated which ablates its ability to elicit Ca²⁺i 
oscillations (Ellis et al. 1998; Nomikos et al. 2011a). The loss of Ca²⁺i inducing ability seen 
following this mutation confirms that the ability of PLCζ to elicit effective Ca²⁺ release by 
the hydrolysis of PI(4,5)P₂  is dependent on the active site (Swann et al. 2006). Several 
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mutations in the catalytic domain of PLCζ have also been associated with male infertility as 
they seem to reduce the sperms’ egg activating ability. A maternally inherited point 
mutation in the Y domain of PLCζ (H398P) has been discovered which is associated with 
male infertility (Heytens et al. 2009). This does not seem to affect the localisation of PLCζ in 
the sperm however it dramatically reduces its Ca²⁺releasing activity. For example injection 
of recombinant PLCζ protein containing this mutation is unable to cause Ca²⁺i oscillations 
(Heytens et al. 2009; Kashir et al. 2011).This mutation appears to be conserved across 
mammalian species as a homolog for this mutation (H435P) has been identified in mouse 
PLCζ (Nomikos et al. 2011a). This mutated PLCζ is not able to hydrolyse PI(4,5)P₂ in vitro or 
elicit Ca²⁺ release when injected into mouse eggs (Nomikos et al. 2011a). Another mutation 
in the catalytic domain of PLCζ (H233L) has also been identified in male fertility patients 
which is thought to affect the capability of PLCζ to interact with other proteins and 
therefore does not trigger normal Ca²⁺release in the egg (Kashir et al. 2012). Collectively 
these data show that the catalytic domain of PLCζ is crucial for its ability to hydrolyse 
PI(4,5)P₂ and trigger Ca²⁺release. 
X-Y linker 
The X and Y catalytic domains are joined by a long amino acid looped chain called the X-Y 
linker. This region is much less conserved between different PLC isoforms and can even 
vary between species (Swann et al. 2006). In most PLCs (β, γ, δ and η) the X-Y linker is 
negatively charged and acts to mediate auto-inhibition of enzymatic activity by preventing 
PI(4,5)P₂ access to the active site through steric hindrance and electrostatic repulsion 
however this does not appear to be the case with PLCζ (Hicks et al. 2008; Gresset et al. 
2010). In PLCζ the X-Y linker is longer in length and contains many more basic residues than 
PLCδ1 (Essen et al. 1996; Cox et al. 2002; Saunders et al. 2002). As a result the X-Y linker of 
PLCζ is positively charged which seems to give it a specific role in regulating the activity of 
PLCζ and in targeting it to its substrates (Nomikos et al. 2011c). The X-Y linker provides PLCζ 
with a novel enzymatic mechanism as deleting the X-Y linker decreases the capacity for 
PLCζ to hydrolyse PI(4,5)P₂ in vitro which subsequently decreases the enzymes Ca²⁺i 
inducing ability in vivo (Nomikos et al. 2011c). There is evidence to suggest that the basic 
residues in PLCζ’s X-Y linker are responsible for this enzymatic control as neutralising these 
positively charged residues in this region of mouse PLCζ depletes the Ca²⁺i inducing ability 
of PLCζ in eggs and decreases its ability to hydrolyse PI(4,5)P₂ in vitro (Nomikos et al. 
2011b). It has been suggested that the positive residues in the X-Y linker of PLCζ help target 
it to membrane bound PI(4,5)P₂  therefore anchoring it in place and increasing its 
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enzymatic function (Nomikos et al. 2011b; Nomikos et al. 2011c). Indeed the X-Y linker has 
been found to have a high affinity for PI(4,5)P₂ in vitro dependent on the presence of basic 
residues in the region (Nomikos et al. 2011b) . It is also possible that species differences in 
the X-Y linker of PLCζ could be account for the differences in potency and rate of activity 
seen between species (Saunders et al. 2007). Furthermore as the X-Y linker is found close 
to the active site it may play other roles in regulating the catalytic activity of PLCζ that are 
not yet understood (Nomikos et al. 2012). 
EF-hand Domains 
All PLCs contain a region of EF motifs that are primarily responsible for the enzymes Ca²⁺ 
sensitivity and activating the protein (Nomikos et al. 2005). For example the EF hands of 
PLCδ1 links the PH domain with the catalytic domain and mediates the enzymatic activity 
through binding Ca²⁺ (Essen et al. 1996). PLCζ is unique amongst PLCs as it is active at 
relatively low levels of Ca²⁺i (10-100 nM) with optimal activity around 1μM which means 
PLCζ operates at half its maximum enzymatic activity at egg basal levels of Ca²⁺i of around 
100 nM (Kouchi et al. 2004; Nomikos et al. 2005). This activity is further stimulated by the 
increase in Ca²⁺i which could form a positive feedback loop with IP₃ and sustainthe Ca²⁺i 
oscillations at fertilisation (Miyazaki and Ito 2006). This is in great contrast to PLCδ1 which 
is not activated until around 1 μM Ca²⁺i and has peak activity around 50 μM which makes 
PLCζ extremely more sensitive to Ca²⁺ than PLCδ1 (Nomikos et al. 2005). PLCζ has two pairs 
of EF hand pair-wise lobesconstructed of 4 helix loop helix motifs found at the N-terminus 
of the protein (Saunders et al. 2002). These motifs appear to be fundamental for PLCζ to 
elicit Ca²⁺ioscillations as deleting one or both of these EF hand domains ablates its Ca²⁺i 
inducing activity in eggs however the hydrolytic activity of PLCζ remains unaffected (Kouchi 
et al. 2005; Nomikos et al. 2005). It appears that this disruption of activity is at least in part 
due to a reduction in Ca²⁺ sensitivity. When the EF hands are removed the EC50 of PLCζ 
changes from 80 nM to 30 μM (Nomikos et al. 2005). This dramatic decrease in Ca²⁺ 
sensitivity means that PLCζ is no longer able to hydrolyse PI(4,5)P₂  at the basal levels of 
Ca²⁺i present in the egg (Nomikos et al. 2015). The EF hands may also have a role in 
targeting PLCζ to the intracellular membranes as, unlike PLCδ1, PLCζ lacks the PH domain 
which allows effective targeting of PLCs to PI(4,5)P₂ at the plasma membrane (Rebecchi and 
Pentyala 2000). The role that the EF hand domain plays in membrane targeting to PI(4,5)P₂ 
is still unclear. 
 
33 
 
C2 domain 
The final functional domain present in all PLCs is the PKC-homology type II (C2) domain 
which normally behaves in a Ca²⁺ dependent way to form Ca²⁺-phospholipid complexes 
which help mediate membrane association (Medkova and Cho 1999). The C2 domain of 
PLCδ1 consists of a sandwich of 8 well conserved B sheets linked by peptide loops and 
contains approximately 120 residues responsible for phospholipid binding, for example 
through its interaction with phosphatidylserine (Lomasney et al. 1999). Despite a lack of 
understanding regarding the role of C2 domain in PLCζ its role in eliciting Ca²⁺ release in 
eggs is undisputed as deletion of the C2 domain of PLCζ completely ablates itsCa²⁺i 
releasing activity with only a small effect on enzyme activity with no effect on Ca²⁺ 
sensitivity (Nomikos et al. 2005). It has been suggested that the C2 domain of PLCζ may 
help sequester it to the membrane through phospholipid binding like PLCδ1 which is able 
to bind to phosphatidylserine contained in the plasma membrane (Rizo and Südhof 1998). 
The C2 domain of PLCζ does bind to PI(3)P and PI(5)P in vitro however this binding is 
relatively low affinity and more work needs to be done to determine why C2 domain is so 
vital for the activity of PLCζ (Kouchi et al. 2005).  
PLCζ Mode and Mechanism of Action 
Signalling cascade for PLCζ 
All isoforms of phosphoinositide specific phospholipase C cause Ca²⁺release by the 
production of IP₃ via the hydrolysis of PI(4,5)P₂ and have an absolute requirement for Ca²⁺i 
in order to work (McDonald and Mamrack 1989).  These enzymes work as an integral part 
of the phosphoinositide and IP₃ signalling cassettes triggering the same signalling events 
(Putney 1987). However, the mechanism by which a particular PLC isoform becomes 
activated differs and is often determined by variations in molecular structure and 
regulatory units. For example PLCγ is activated by endogenous stimulation of tyrosine 
kinase receptors by growth factors (Margolis et al. 1990). This stimulation induces 
relocation of PLCγ to the plasma membrane and tyrosine phosphorylation of PLCγ via the 
SH2 and SH3 domains which is correlated with PI(4,5)P₂ turnover (Piiper et al. 1997; Kim et 
al. 1999).  PLCβ also requires endogenous receptor stimulation to become activated 
stimulation of heterotrimeric G-protein coupled receptors is necessary to activate G 
proteins which targets the plasma membrane so it may become activated (Taylor et al. 
1991; Jhon et al. 1993). Likewise PLCε also requires G-protein coupled receptor binding to 
become activated however possesses an additional downstream role as an exchange factor 
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through stimulation by small GTPases which could produce a feedback loop (Song et al. 
2001; Wing et al. 2001; Wing et al. 2003). PLCη may also be mediated by G-Protein coupled 
receptors as it activated in this way however even in the absence of endogenous signalling 
will still bind to the plasma membrane via its PH domain (Hwang et al. 2005; Nakahara et 
al. 2005; Stewart et al. 2007). This would suggest that not all PLCs need exogenous 
receptor binding in order to become active. This is certainly true for PLCδ which can be 
activated in response to Ca²⁺release by other PLCs such as PLCβ but does not itself require 
exogenous stimulation (Guo et al. 2010). It has been suggested that PLCδ may also be 
mediated by phosphatidic acid (PA) or guanine nucleotide exchange factors (GEFs) which 
could form an auto-amplification loop (Pawelczyk and Matecki 1999; Baek et al. 2001). PLCζ 
is unusual in the respect that until now no endogenous stimulation or G-protein signalling 
have been affiliated with its activation and despite the close structural relationship with 
PLCδ1, PLCζ is around 10 times more sensitive to Ca²⁺ (Nomikos et al. 2005). Therefore, on 
its introduction into the egg, PLCζ is able to hydrolyse PI(4,5)P₂ immediately without any 
further stimulation (Saunders et al. 2002). However, accessory proteins or binding proteins 
associated with PLCζ activity other than PI(4,5)P₂ have yet to be identified.  
All PLCs use PI(4,5)P₂ as their substrate to cause Ca²⁺release, albeit with varying affinities. 
This is significant as PI(4,5)P₂ has a particularly important role within the phosphoinositide 
pathway as it not only produces secondary signalling messengers it also acts as the 
metabolic precursor for other signalling phosphoinositides such as PI(3,4)P₂ and PI(3,4,5)P₃ 
(see fig 1.6) . Furthermore it is able to act as a lipid messenger as part of the PI(4,5)P₂ 
signalling cassette by regulating a variety of cellular processes such as membrane 
trafficking, cytokinesis, exocytosis and regulation of ion channels (Field et al. 2005; Klein et 
al. 2008; Tan et al. 2015).  
 The parent molecule for all phosphoinositide is known as Phosphatidylinositol (PI, PtdIns) 
(Thompson et al. 1963). This possesses free hydroxyl groups on its inositol ring that are 
available for phosphorylation through inositol lipid metabolism where the ring becomes 
phosphorylated at different positions to produce phosphatidylinositol intermediates 
(Thompson et al. 1963) (see fig 1.6). Inositol lipid metabolism is tightly regulated by a 
whole range of kinases and phosphatases which synthesise and degrade phosphoinositides 
continuously (Hsu and Mao 2015). An example of one such enzyme is a Rho-GAP-domain 
containing phosphatase called OCRL1 which is able to hydrolyse PI(4,5)P₂, PI(3,4,5)P₃  and 
inositol phosphates (Attree et al. 1992).  
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PI(4,5)P₂ is produced from PI via 2 metabolic stages which are carried out by lipid kinases 
and phosphatases (Toker 1998). First the hydroxyl group at 4’ position on the inositol ring 
of PI is phosphorylated by PI-4 kinases to produce PI(4)P, this is then phosphorylated 
further at the 5’ position by PIP-5 kinases to produce PI(4,5)P₂ (Toker 1998). This occurs 
either directly in the plasma membrane or PI(4,5)P₂ is synthesised in the ER where it is not 
available for PLC hydrolysis (Helms et al. 1991). Therefore PI(4,5)P₂  can  transported to 
cellular membranes, such as the plasma membrane, by specialist phosphatidylinositol 
transfer proteins (PITPs) (Cunningham et al. 1995).  PITPs also transport parent Ptdlns to 
the plasma membrane where it can metabolised to produce PI(4,5)P₂. This PI(4,5)P₂ is 
available then for hydrolysis following activation of PLC to release two second messengers 
(see fig 1.5). The phosphodiester bond is cleaved to produce IP₃ which contains the inositol 
head groups, and diacylglycerol (DAG) which consists of the glycerol backbone and acyl 
chains (Berridge 1984; Kirk et al. 1984). Whilst DAG continues to reside on the plasma 
membrane where it feeds into the DAG/ protein kinase C signalling pathway (see below), 
IP₃ is soluble and diffuses through the cytoplasm. It is this IP₃ that initiates Ca²⁺release via 
binding to IP₃R as part of the IP₃ signalling cassette (Berridge and Irvine 1984) (see above 
and fig 1.5).  The Ca²⁺ released then further stimulates the hydrolysing activity of PLCζ 
producing a positive feedback loop which allows the Ca²⁺ release to continue for prolonged 
periods of time (Nomikos et al. 2005). However, inositol phosphates such as IP₃ may enter 
back into the phosphoinositide pathway as they are metabolised to produce free inositol by 
entering the inositol phosphate metabolic pathway (Joseph and Williams 1985; Rubiera et 
al. 1988). Degradation of IP₃ in this way not only makes free inositol available for the 
synthesis of new phosphoinositides it also acts as an OFF mechanism for IP₃ induced Ca²⁺ 
release. There are two pathways by which IP₃ is metabolised either it is broken down by 
phosphatases to produce IP2 or phosphorylated in a Ca²⁺i dependent manner by kinases to 
produce IP4  (Hughes and Putney 1988). As Ca²⁺i oscillations at mammalian fertilisation are 
able to persist for many hours there must be a high turnover of phosphoinositide and 
continuous periodic production of IP₃ like that in sea urchin eggs (Berridge et al. 1983; 
Ciapa et al. 1992). It is quite probable that the rapid metabolism of phosphoinositide as 
well as synthesis and degradation of specific intermediates at discrete membrane domains 
may be crucial for regulating the oscillatory activity of eggs at fertilisation and strict 
regulation of the enzymes in this pathway are vital (Yu et al. 2012). In addition most 
phosphoinositides have characteristic binding domains, therefore it has been suggested the 
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regional localisation of specific phospholipids could provide membrane recognition sites for 
other proteins or lipids (Lemmon 2008).  
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Figure 1.6 Diagram summarising the phosphoinositide metabolism cycle 
A) Schematic showing how each phosphoinositide is connected by phosphorylation and de-
phosphorylation that is indicated by arrows. B) Schematic showing the phosphoinositol head 
structure of different phosphoinositides and how these are attached to the glycerol backbone and 
fatt acid tails. Taken from P.T. Hawkins et al. Biochm. Soc. Trans. 2006;34:647-662 ©2006 by 
Portland Press Ltd 
A 
B 
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Spatial and Temporal Dynamics of PLCζ 
In mammalian eggs PLCζ causes Ca²⁺i oscillations at basal levels of Ca²⁺i following no further 
exogenous stimulation (Saunders et al. 2002). These oscillations last several hours before 
they are abruptly cease after approximately 4 hours (Cox et al. 2002; Saunders et al. 2002). 
Even though PLCζ activity is so potent and enduring in eggs the same is not true for somatic 
cells. If CHO cells are transfected with PLCζ they do not experience Ca²⁺i oscillations, 
however if these cells are then introduced into mammalian eggs Ca²⁺i oscillations can be 
recorded in the eggs (Phillips et al. 2011). Furthermore transgenic mice that over-express 
PLCζ ectopically experience no alterations in their somatic cells however in female mice the 
oocytes within the ovaries are found to activate prematurely (Yoshida et al. 2007).  This 
would suggest that there must be something unique about the egg physiology and cell 
biology that allows PLCζ to be active at eliciting Ca²⁺ release in these cells. These 
differences are not surprising given that a mammalian egg is arrested in the metaphase of 
meiosis 2 and has undergone much organelle reorganisation compared to a somatic cell in 
interphase of mitosis (Kubiak 1989). What is surprising however, is the that the single 
substrate for PLCζ, PI(4,5)P₂ is abundant in most somatic cells as well as eggs even though 
PLCζ is unable to utilise this pool of PI(4,5)P₂ to produce IP₃ in somatic cells (Phillips et al. 
2011). This would suggest that PLCζ is temporally and spatially regulated by factors present 
in the egg in a cell dependent manner (Swann and Yu 2008).  
There is evidence that the spatial activity of PLCζ in eggs differs considerably to that of 
other PLCs. If Venus tagged PLCζ cRNA is injected into eggs its localisation appears diffuse 
within the cytoplasm in contrast to other PLC isoforms which hydrolyse PI(4,5)P₂ at the 
plasma membrane (Yoda et al. 2004). It is important to notethat in order to record a signal 
from a fluorescent protein there must be over 100 nM of it present in the cell, however 
PLCζ is physiologically active at 1-10 nM (Niswender et al. 1995; Saunders et al. 2002). This 
means that this fluorescently tagged PLCζ must be overexpressed by 10 to a 100 times 
physiological level in these experiments. This cytoplasmic localisation has been further 
supported using immunostaining for cMyc tagged PLCζ which is shown to localises to small 
vesicles throughout the cytoplasm (Yu et al. 2012). Immunostaining for endogenous 
PI(4,5)P₂  in the egg shows that PI(4,5)P₂ can also be found in a similar vesicular pattern in 
the egg with considerable overlap with PLCζ (Yu et al. 2012). Furthermore it appearsPLCζ 
hydrolysesthis vesicular PI(4,5)P₂  as oppose to PI(4,5)P₂  at the plasma membrane. 
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Depleting the levels of PI(4,5)P₂ at the plasma membrane does not affect Ca²⁺i oscillations 
at fertilisation or initiated by PLCζ injection. However, Ca²⁺i oscillations induced by high 
levels of PLCδ1 are prevented following this plasma membrane PI(4,5)P₂ depletion (Yu et al. 
2012). In addition fertilisation causes no detectable decrease in PI(4,5)P₂ levels at the 
plasma membrane which would be expected if PLCζ was hydrolysing this pool of PI(4,5)P₂ 
(Halet et al. 2002).  Furthermore when PLCζis injected into eggs, DAG is not produced at the 
plasma membrane like it is following injection of PLCδ1 (Yu et al. 2008).This would suggest 
that unlike other PLC isoforms PLCζ does not hydrolyse PI(4,5)P₂ at the plasma membrane 
but instead hydrolyses an intracellular pool of PI(4,5)P₂ (Yu et al. 2012). It is unclear 
however what enablesPLCζ to discriminate between PI(4,5)P₂  found at the plasma 
membrane and vesicular PI(4,5)P₂  or if this is a dependent on addition factors present in 
the egg. 
Approximately 4- 5 hours after fertilisation mouse Venus tagged PLCζ can be seen to 
translocate to the newly reformed pronucleus which coincides with the termination of the 
Ca²⁺i oscillations (Yoda et al. 2004). This translocation is reliant on a short basic motif found 
within the X-Y linker of mouse PLCζ called the nuclear localisation signal (NLS)(Larman et al. 
2004). If the basic residues within this motif are neutralised then PLCζ does not become 
localised to the nucleus and therefore continues to hydrolyse PI(4,5)P₂ for longer than it 
should do (Larman et al. 2004). Furthermore Ca²⁺i oscillations have been recorded during 
the 1st mitosis of a fertilised mouse zygote which could be a result of PLCζ re-entering the 
cytoplasm following nuclear envelope breakdown (Larman et al. 2004). 
It is likely that PLCζ activity is regulated in a combinatorial manner with the aid of addition 
“egg factors” and alterations in conformation as a result of interactions of the functional 
domains in the structure of PLCζ.  However, it is still unknown precisely which lipids or 
proteins within the egg regulate the activity of PLCζ and may determine its unique 
localisation. 
Downstream signalling events at Egg Activation 
Egg activation is a series of complex cellular changes orchestrated by a variety of signalling 
pathways. Ca²⁺i signalling is the initial event at egg activation which in turn triggers a whole 
series of downstream signalling events that may themselves be crucial for the later events 
of egg activation (Jones 2007). As a result many of the enzymes involved in these later 
events of egg activation are stimulated by an increase in Ca²⁺i in a dose dependent manner 
(Jones 2007). Therefore, due to the low frequency nature of the Ca²⁺i oscillations at 
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fertilisation many of the enzymes in these pathways are activated periodically along with 
each Ca²⁺i transient (Swann and Yu 2008). This section will discuss some of the pathways 
and enzymes that are involved in these later signalling events of egg activation and their 
importance in allowing the fertilised zygote to develop.  
Cortical Granule Exocytosis 
At fertilisation it is necessary that the sperm reaches the egg in order to successfully fuse 
with the egg and fertilise it. However, it is highly disadvantageous for more than one sperm 
fuses with a single egg as this can create a tetraploid zygote which has surplus genetic 
material and couldsubsequently be lethal (Bender et al. 1989). It is therefore crucial that 
protective mechanisms are put in place to ensure only one sperm fertilises a single egg and 
all other sperm are prevented from doing so in a series of processes collectively termed as 
blocks to polyspermy (Horvath et al. 1993). For some species, particularly those that have 
their eggs externally fertilised, for example marine based invertebrates, a fast block to 
polyspermy is required as many sperm will be surrounding the egg prior to fertilisation 
(Jaffe 1976; Goudeau and Goudeau 1989). Fast blocks to polyspermy normally take the 
form of a depolarization of the egg plasma membrane as a direct result of the first sperm 
plasma membrane fusing with the egg plasma membrane and therefore take effect 
immediately (Jaffe 1976; Goudeau and Goudeau 1989). However, no such fast block has 
been recorded in mammalian eggs (Jaffe et al. 1983). This may be because mammalian 
eggs are fertilised internally thereforeonly 100-200 reach the site of fertilisation where the 
egg resides (Ahlgren 1975). The reduction in the number of sperm greatly reduces the risk 
of polyspermy but a biochemical block to polyspermy is also required (Conrad et al. 1971). 
This block occurs relatively slowly and is mediated by the release of cortical granules into 
the peri-vitelline space (Fukuda and Chang 1978; Cherr et al. 1988; Raz et al. 1998). Cortical 
granules are small secretory vesicles of between 0.1 μm and 1μm that are bound to the 
plasma membrane prior to fertilisation and are formed from the Golgi apparatus during 
oocyte maturation (see above) (Gulyas 1980; Cherr et al. 1988; Ducibella et al. 1988).  
When a Ca²⁺i increase is induced during fertilisationcortical granules are exocytosed into 
the peri-vitelline space so their contents can be released (Kline and Stewart-Savage 1994). 
Measurements of the plasma membrane capacitance of hamster eggs immediately 
following sperm fusion have shown that the majority of cortical granules are exocytosed 
during the first Ca²⁺i increase and cease by the fourth Ca²⁺i oscillation (Kline and Stewart-
Savage 1994). This process causes many biochemical changes so no more sperm can fuse 
(Braden et al. 1954). The most understood of these is modifications to the ZPs known as 
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the zona reaction (Moller and Wassarman 1989; Dolci et al. 1991; Miller et al. 1993). 
Proteolytic cleavage of ZPs such as the cleavage ZP2 to ZPf2 by ZP2 proteinase prevents 
further binding of sperm and the penetration of already bound sperm through the matrix 
(Moller and Wassarman 1989).  
It is well established that cortical granule exocytosis is a Ca²⁺i dependent process and is 
closely coupled to the Ca²⁺i oscillations that occur at fertilisation (Kline and Kline 1992; 
Kline and Stewart-Savage 1994). Microinjection of IP₃ into unfertilised eggs leads to the 
zona reaction and can be blocked by antibodies against IP3Rs (Kurasawa et al. 1989; Xu et 
al. 1994). However, it still remains to be determined exactly how Ca²⁺release causes the 
release of cortical granules.  
The involvement of the protein kinase C (PKC) signalling cassette has been suggested as this 
has been found to translocate to the plasma membrane during fertilisation in response to 
Ca²⁺i (Eliyahu and Shalgi 2002). Cortical granule exocytosis induced by Ca²⁺ ionophore can 
be blocked by the addition of PKC inhibitors (Ducibella and LeFevre 1997). However, it 
appears PKC signalling may not be sufficient in causing cortical granule exocytosis in the 
physiological situation as phorbol ester produces a pattern of cortical granule exocytosis 
that is different from that seen at fertilisation (Ducibella and LeFevre 1997). Moreover, 
different PKC inhibitors do not inhibit fertilisation induced cortical granule exocytosis and 
stimulating Ca²⁺release using ionomycin which does not induce PKC signalling still causes 
cortical granule exocytosis (Ducibella and LeFevre 1997; Eliyahu and Shalgi 2002). 
Other Ca²⁺i activated proteins have also been suggested to play a role in cortical granule 
exocytosis. For example Calmodulin (CaM) and Calmodulin dependent kinase II (CaMKII) 
are both located in the cortical region of the egg and have key roles in egg activation events 
such as cell cycle resumption (Knott et al. 2006). However, the role of CaMKII in this 
process is far from clear. Introduction of constitutively active CaMKII into mouse eggs does 
cause some cortical granule exocytosis this is not to the extent seen at fertilisation 
(Gardner et al. 2007; Backs et al. 2010). It is possible that CaM/CaMKII is not required for 
cortical granule exocytosis but still plays a role in assisting the process via it’s interaction 
with other proteins. The mechanism by which cortical granules dock to the plasma 
membrane and become released appears to be dependent on a class of proteins known as 
soluble NSF-attachment protein receptors (SNAREs) (Ikebuchi et al. 1998). Cleavage of the 
t-SNARE SNAP-25 using botulinum neurotoxin A in mouse eggs prior to their fertilisation 
appears to inhibit cortical granule exocytosis (Ikebuchi et al. 1998).  
42 
 
CAMKII pathway and the resumption of Meiosis 
Prior to fertilisation, a mammalian egg is maintained in an arrested state within metaphase 
of the second round of meiosis (Borum 1967). Once the egg has been fertilised meiosis may 
be completed leading to the extrusion of a second polar body following cytokinesis and 
eventually the formation of a male and female pronuclei (Austin 1951b). This process relies 
on a complex of signalling pathways that are stimulated downstream of the Ca²⁺i 
oscillations (Jones 2007). As with meiotic arrest prior to fertilisation the resumption of the 
cell cycle is dependent on the levels of intracellular MPF (see above). During metaphase II 
arrest prior to fertilisation the levels of MPF are sustained due to presence of high levels of 
CSF components such as Emi2 (see above) which inhibits the APC/C (Madgwick and Jones 
2007). However, at fertilisation the increase in Ca²⁺i triggers a chain of events that alter the 
levels of MPF (see fig 1.7). The increase in cytosolic Ca²⁺i is detected by the Ca²⁺ sensing 
messenger protein CaM which binds to the free Ca²⁺ ions in the cytoplasm. This leads to 
the activation of the enzyme CaMKII through a process of autophosphorylation (Zhu et al. 
1996; Madgwick et al. 2005). CaMKII activation at fertilisation appears to be a shared 
feature among vertebrates however only CamKIIγ isoform is present in mouse eggs (Backs 
et al. 2010). Due to the low frequency pattern of Ca²⁺i oscillations, CaMKIIγ becomes 
activated with each Ca²⁺i transient producing peaks in CaMKII activity (Markoulaki et al. 
2004). It has been shown that CaMKII activity is directly correlated to the levels of cytosolic 
free Ca²⁺i and that CaMKII does not become activated at fertilisation in the absence of 
cytosolic Ca²⁺i increase (Markoulaki et al. 2004). In vertebrates the activity of CaMKII has 
been shown to be vital for meiotic resumption and injection of recombinant CaMKII protein 
into mouse eggs causes parthenogenetic egg activation (Knott et al. 2005; Backs et al. 
2010). This indicates that CaMKII is the key intermediate messenger linking Ca²⁺i increase 
and meiotic resumption.  
The mechanisms by which increased CaMKII causes cell cycle resumption are well 
understood in eggs. CaMKII inhibits Emi2, a component of CSF, by phosphorylating it and 
therefore allowing further phosphorylation by Polo-like kinase 1 (Plk1) which subsequently 
leads to the degradation of Emi2 (see fig 1.7) (Liu and Maller 2005; Hansen et al. 2006; 
Madgwick and Jones 2007).  The degradation of Emi2 frees the E3 ubiqutinligase APC/C so 
it may become activated (Sako et al. 2014). APC/C polyubiquinates cyclin B1 and Securin 
which makes them available for proteolysis by the proteasome (see fig 1.7) (Pesin and Orr-
Weaver 2008). As cyclin B1 is a component of the MPF, targeted destruction of cyclin B1 
leads to a reduction in MPF level (Marangos and Carroll 2004).Inactivating MPF in this way 
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allows the cell to leave metaphase and complete the cell cycle (Fulka et al. 1992).  The 
degradation of Securin leads to the activation of an enzyme called Separase which 
promotes separation of the chromatids (see fig 1.7) (Fulka et al. 1994; Hornig et al. 2002). 
CDK1 is also directly deactivated following phosphorylation by the kinase Wee1b (Oh et al. 
2011). The meiotic cell cycle is completed with cytokinesis leading to second polar body 
extrusion as CaMKII activity oscillates with the increase in Ca²⁺i so does cyclin B1 
destruction (Marangos and Carroll 2004). Each Ca²⁺i oscillations leads to further destruction 
of cyclin B1 in a prolonged manner which is necessary for full egg activation (Kubiak 1989; 
Marangos and Carroll 2004). However, destruction of cyclin B alone is not enough to 
transition the cell into interphase of the first mitosis of the zygote. For this to occur the 
pronuclei has to reform in a process driven by components of the mitogen activated 
protein kinase (MAPK) pathway, specifically MAPK3 (ERK1) and MAPK1 (ERK2) (Verlhac et 
al. 1994; Moos et al. 1995; Moos et al. 1996). Like MPF, MAPK levels are maintained at a 
high level during metaphase II arrest before fertilisation (Dupre et al. 2011). After 
fertilisation MAPK activity is maintained until just before pronuclear formation and does 
not cease completely until after pronuclear formation (Gonzalez-Garcia et al. 2014). 
Towards the end of the series of Ca²⁺i oscillations ERK1/ERK2 becomes dephosphorylated 
resulting in a conformational change leading to its inactivation which reduces MAPK 
signalling considerably  (see fig 1.7) (Gonzalez-Garcia et al. 2014). Unlike cell cycle 
resumption which in some instances requires only a small number of Ca²⁺i transients before 
cyclin B levels are low enough to allow cell cycle progression, MAPK inactivation requires 
prolonged Ca²⁺i oscillations that last for many hours (Vitullo and Ozil 1992). Therefore in 
most cases a sufficient number of Ca²⁺i oscillations are required before the egg can become 
fully activated in the physiological situation. There is also a suggestion that the frequency 
and amplitude of Ca²⁺i oscillations during fertilisation could affect further developmental 
pre-implantation events however this is yet to be investigated fully (Ozil et al. 2006).  
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Figure 1.7 Schematic showing the molecular triggers of egg activation in mammals 
PLCζ causes an increase in Ca²⁺i by producing IP3. This increase in cystosolic Ca²⁺ binds to 
and activates CAM/CAMKII. CAMKII phosohorylates Emi2 (a component of CSF), leading to 
its destruction which lifts the inhibition of APC/C. Once APC/C is activated this polyubinates 
cyclin B1 and Securin enabling their destruction. Cyclin B1 is a component of MPF so its 
destruction leads to a decrease in MPF which reduced MAPK signalling and promotes cell 
cycle resumption. The destruction of securin leads to the activation of separase which 
promotes chromatid segregation. CAMKII activation also stimulates Wee1B which directly 
phosphorylates and inactivates CDK1, another component of MPF. 
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DAG/PKC Pathway 
The hydrolysis of PI(4,5)P₂  by PLCζ not only produces IP₃ which triggers Ca²⁺ release but 
also produces the lipid diacylglycerol (DAG) (Yu et al. 2008). DAG is a small molecule 
consisting of a glycerol backbone and 2 fatty acyl chains at the 1’ and 2’ sn positions and 
despites its simple structure the successful production of DAG is essential for cell survival 
and homeostasis (Berridge 1984; Williamson et al. 1985). DAG has an exceptional array of 
functions in lipid metabolism, maintaining membrane integrity and cellular signalling as a 
result many different mechanisms have evolved to regulate the levels of intracellular DAG 
(Carrasco and Merida 2007). Its production as a result of PLC induced hydrolysis of PI(4,P)₂ 
is just one mechanism by which DAG is generated (Hughes and Putney 1988) (see fig 1.8). 
Unlike IP₃, DAG remains in membranes where it acts as a lipid second messenger central to 
the DAG/PKC pathway (Bell et al. 1986). In this pathway DAG stimulates the protein kinase 
C- family of enzymes (PKCs) through their translocation to the plasma membrane which are 
then able to modulate the activity of other proteins by altering their phosphorylation (Kraft 
et al. 1982; Kraft and Anderson 1983). The PKC family contains a number of 
isoformsdivided into 3 main subgroups that differ in both their structural characteristics 
and mechanisms of activation (Ohno and Nishizuka 2002). Conventional and novel PKCs 
both require DAG for their activation however conventional PKCs are also Ca²⁺ dependent 
(Oancea and Meyer 1998). On activation PKCs undergo a conformational change which 
dramatically increases their affinity for the membrane causing them to translocate to the 
plasma membrane and bind phospholipids via their C2 domain (Snoek et al. 1986; Orr and 
Newton 1992; Newton and Keranen 1994; Mosior and Newton 1995). The C1 domain then 
binds to the DAG present here thus anchoring PKC for activation (Burns and Bell 1991). The 
Ca²⁺ sensitivity of conventional PKCs makes this process much quicker when compared to 
novel PKCs (Mosior and Epand 1994).  
PKC has been found to be activated at fertilisation as assays indicate that the rate of 
phosphorylation of the substrates of PKC can be seen to increase following fertilisation 
induced Ca²⁺release (Gallicano et al. 1993; de Barry et al. 1997; Tatone et al. 2003). The 
activity of conventional PKCs has been recorded at fertilisation however the activity of the 
enzyme appears to be Ca²⁺i frequency dependent and PKC translocation to the membrane 
is reliant on the amount of Ca²⁺ release (Oancea and Meyer 1998; Violin et al. 2003). This is 
important as Ca²⁺i oscillations at fertilisation follow a characteristic pattern which begins 
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with a large initial Ca²⁺i transient with high frequency and low amplitude oscillations 
superimposed onto this transient (Swann and Yu 2008). If conventional PKC tagged to a 
GFP (cPKC-GFP) is injected into eggs prior to fertilisation then during the initial Ca²⁺i 
increase cPKC-GFP is found to translocate to the plasma membrane indicted by an increase 
in GFP signal in this region (Halet 2004). However, the following Ca²⁺i oscillations are much 
lower frequency which means that though conventional PKC is recruited to the plasma 
membrane following Ca²⁺ release, this recruitment is significantly reduced when compared 
to that during higher frequency Ca²⁺i transients. Because there is no additive effect of PKC 
enzyme activity is not sustained (Halet 2004). The PKC activity during these Ca²⁺i oscillations 
have been recorded dynamically using a fluorescence resonance energy transfer (FRET) 
probe for PKC (Gonzalez-Garcia et al. 2013). In these experiments the PKC FRET probe C-
kinase activity reporter (CKAR) was introduced into eggs by microinjection prior to 
fertilisation. Once the eggs had been fertilised the ratio of the 2 fluorophores in the FRET 
probe were recorded alongside the changes in Ca²⁺i (Gonzalez-Garcia et al. 2013). It was 
found that like Ca²⁺i increase,the activation of PKC was oscillatory however the rise 
occurred shortly after the Ca²⁺i transient and returned to basal level before the next 
Ca²⁺release (Gonzalez-Garcia et al. 2013). Interestingly the activation of PKC at the plasma 
membrane was much lower than that recorded in cytoplasm (Gonzalez-Garcia et al. 2013). 
This would suggest that novel PKCs may also be activated elsewhere in the egg and indeed 
un-conventional PKCs have been found to activate at fertilisation (Tatone et al. 2003). For 
example if PLCζ is hydrolysing PI(4,5)P₂ on vesicles throughout the cytoplasm then the DAG 
produced could recruit novel PKC so it becomes activated (Yu et al. 2008; Yu et al. 2012). It 
has been postulated that due to the relatively small amount of activation of conventional 
PKC that this is not necessarily required for egg activation however there is evidence that it 
may possess a role in Ca²⁺ influx, for example in the elicitation of high frequency secondary 
Ca²⁺i  oscillations that occur when PLCζ is over-expressed (Yu et al. 2008). Indeed this 
phenomenon is mimicked by the stimulation of PKC (Yu et al 2008). Despite the change in 
its dynamics it remains unclear precisely what the role of PKC is in the egg activation 
process.  
DAG not only acts as an activator for the PKC pathway but also feeds back into the 
phosphoinositide cycle via the DAG metabolic pathway (Hodgkin et al. 1998). This means 
that signalling DAG produced as a result of the hydrolysis of PI(4,5)P₂ must be broken down 
in order to terminate the messenger signal and be recycled for the resynthesis of 
phosphoinositides (Paulus and Kennedy 1960) (see fig 1.8). DAG may be metabolised two 
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ways, first following its phosphorylation by DAG kinase and secondly via its hydrolysis by 
DAG lipases both of which reside and operate within cell membranes (Call and Rubert 
1973; Morley et al. 1975). The latter is likely to be the most common form of DAG 
breakdown in cells and involves the removal of fatty acyl chains at the SN’1 position of DAG 
by DAG lipase resulting in production of a particular monoglycerol called 2-
arachidonoylglycerol (2-AG) (Hasegawa-Sasaki 1985; Gammon et al. 1989). 2-AG is further 
metabolised bythe serine hydrolase, monoglycerollipase (MAGL) to produce the by-
products glycerol and arachidonic acid (Ghafouri et al. 2004). DAG kinases in contrast 
phosphorylates DAG to form phosphatidic acid (PA) which can then be used to resynthesize 
phosphoinositides (Hokin and Hokin 1963). Some isoforms of DAG kinase (DAG kinase α 
class) possess EF hand domains making them sensitive to Ca²⁺ and therefore act as an OFF 
mechanism in response to Ca²⁺ release (Abe et al. 2003).  In this pathway PA is translocated 
from the cell membrane where it has been produced to the endoplasmic reticulum by class 
II PITPs (Garner et al. 2012). Here PA is available for condensation with 
cystidinetriphosphate (CTP) by the enzymephosphatidate cytidyl transferase (CDP-DAG 
synthase) leading to the production of CDP-DAG (Carter and Kennedy 1966; Icho et al. 
1985). CDP-DAG is then available to undergo head group exchange with free inositol 
following their condensation by the enzyme phosphatidylinositol synthase (Tanaka et al. 
1996). This results in the production of parent phosphatidylinositol (PI) available for 
phosphorylation and the synthesis of other phosphoinositides including PI(4,5)P₂ (Tanaka et 
al. 1996).  
To complicate the situation further PA and DAG may also be produced by other signalling 
pathways that do not require the stimulation of PLC (see fig 1.8). In fact there are over 50 
structurally distinct forms of DAG which possess variations in their fatty acyl chain 
constituents (Hodgkin et al. 1998). Though PA and DAG are inconvertible the two pathways 
can be considered as distinct (see fig 1.8). It has therefore been proposed that all these 
forms of lipid exist in the cell simultaneously however maintained in different pools 
(Hodgkin et al. 1998). For example, PA may also be produced from phosphatidylcholine 
(PC) following the hydrolysis of its P-O bond by the enzyme phospholipase D (PLD) with 
choline produced as a by-product (Billah and Anthes 1990). The PA produced by this 
reaction has the phosphate group of the parent PC and acyl chains which are mono-
saturated or saturated (Hodgkin et al. 1998) (see fig 1.8). This PA is then further 
metabolised by dephsophorylation to produce DAG by the enzyme 
phosphatidatephosphatase (PAP, LPP) (Martin 1988). However, as this form of DAG is 
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derived from PC the fatty acyl chains are mono-saturated or saturated therefore they do 
not serve the same function as PLC induced DAG which has polyunsaturated fatty 
acidchains (Hodgkin et al. 1998). This saturated DAG does not appear to possess much of a 
signalling role and is a poor activator of PKC so therefore could be referred to as 
“metabolic” DAG (Pettitt et al. 1997). However, before it is metabolised to DAG, the PA 
produced as a result of PLD stimulation does appear to possess a signalling role. For 
example this isoform of PA is able to activate the enzyme PIP5K which produces PI(4,5)P₂  
from PI(4)P (Loijens et al. 1996). This would suggest that functional PA and signalling DAG 
do not always operate in the same pathways and lipid binding sites within cellular 
membranes must have the ability to distinguish between different molecular species of 
DAG.  
 DAG and PA  production may be spatially regulated thus producing distinct localised pools 
of DAG that may determine its function (Hodgkin et al. 1998). For instance, DAG may also 
be produced in the Golgi apparatus as a by-product of the synthesis of the 
phospholipidsphingomyelin (Villani et al. 2008) (see fig 1.8). In this reaction 
phosphatidylcholine donates its phosphocholine moiety to ceramide by the enzymatic 
activity of sphingomyelin synthase (SMS) which produces sphingomyelin and DAG (Merrill 
and Jones 1990). Protein kinase C (PKC) has been found to translocate to the Golgi 
apparatus and becomes activated following binding to this DAG which suggests that the 
enzymatic activity of sphingomyelin synthase may regulate Golgi localised production of 
DAG and PKC activation (Villani et al. 2008). However, due to the strict control of this 
enzyme and the small specific pools of phosphatidylcholine that are likely to be 
metabolised during the process it is unclear how much DAG is produced via this pathway 
(Villani et al. 2008). It is also worth noting that different isofroms of sphingomyelin 
synthaseoperate in different cellular membranes including the plasma membrane so this 
form of DAG is not only produced in the Golgi (Yeang et al. 2011). It is clear that DAG is 
present in the Golgi apparatus of somatic cells as part of physiological metabolic pathways 
(Liu et al. 2009).  
In addition to its role as a second messenger DAG may also assist in maintaining the 
structure of membranes it is associated with, particularly the Golgi apparatus. For example 
the cone shape of DAG means it promotes negative curvature on membranes, a process 
that is vital for the early formation of COPI vesicles at the Golgi (Shemesh et al. 2003; 
Cooke and Deserno 2006; Carrasco and Merida 2007). Interestingly the DAG involved in this 
curvature is produced by the conversion of PA by PAPs where this PA is generated from the 
49 
 
acylation of lysophatidic acid (LPA) by lyso PA-acyltransferase (LPAAT) (Hishikawa et al. 
2008) (see fig 1.8). LPA has an inverted cone-shape which imposes positive curvature on 
the membranes it associates with (Kooijman et al. 2003).  As DAG, PA and LPA are inter-
convertible it is the correct balance between these lipids that determines the alterations in 
membrane curvature necessary for vesicle formation. If the enzyme PAP is inhibited using 
the drug propranolol thus preventing DAG production from PA, then membrane bud 
formation at Golgi is also inhibited (Asp et al. 2009). 
Despite the functional differences between different pools of polyunsaturated signalling 
DAG and PLD induced mono/saturated metabolic DAG these two signalling pathways can 
stimulate each other (Hodgkin et al. 1998). It has been shown that when DAG is produced 
following cell stimulation and activation of PLC it is produced in a bisphasic manner 
(Nakashima et al. 1991). That is, there is an initial rapid rise in DAG which has found to be 
mainly polyunsaturated followed by a slower increase in mono/saturated DAG  that is 
sustained for a longer time (Hodgkin et al. 1998). This is probably because the signalling 
polyunsaturated DAG produced as a result of PLC activity goes on to activate PKC (Hodgkin 
et al. 1998). PKC is able to further activate PLD through the PKC substrate myristoylated 
alanine-rich C-kinase substrate (MARCKS) in a number of different ways (Morash et al. 
2000).  The activation of PLD produces PC derived mono/saturated metabolic DAG which 
creates the second phase of DAG production (Hodgkin et al. 1998). It is unclear whether 
this biphasic response occurs during Ca²⁺i oscillations in mammalian eggs at fertilisation as 
DAG dynamics are yet to be measured successfully during fertilisation.  
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Figure 1.8 Schematic showing the different pathways of PA and DAG production 
Two main forms of DAG/PA are present in cells, those that have poly-unsaturated fatty acid acyl 
chains (poly) called signalling DAG/PA and those that have saturated fatty acid acyl chains (sat) 
called metabolic DAG/PA. These two pathways of DAG/ PA production are not inter-convertible 
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Using Fluorescent and bioluminescent based indicators in eggs  
Immunostaining is a useful tool for observing the specific localisation of proteins or 
markers within a cell using an antibody that specifically binds to the target of interest which 
becomes visible when a fluorescent conjugated secondary antibody binds it. However, this 
technique requires cells to be fixed and therefore does not provide a way to measure cell 
signalling pathways dynamically in live cells. To do this live cell indicators are required. One 
way to create such an indicator is to tag a targeting gene with a fluorescent protein. 
Fluorescent proteins emit light following the absorption of a specific excitation wavelength. 
The light that is emitted has a longer wavelength and lower energy than that absorbed. For 
example an indicator to measure IP3 at the plasma membrane has been developed by 
tagging the PH domain with GFP. This indicator has been used to measure PI turnover at 
the plasma membrane in eggs (Halet et al. 2002). Howeve, these probes require high 
resolution imaging to look at the translocation of these probes. One way to avoid this issue 
is to use probes based on “Fluorescence Resonance Energy Transfer” or FRET. FRET relies 
on energy transfer between two fluorophores. When these two fluorophores come in close 
contact fluorescent light emitted from the donor fluorophore, for example CFP, excites the 
acceptor fluorophore, for example CFP. This produces a change in CFP-YFP signal ratio. The 
FRET based probe CKAR have been used to measure PKC phosphorylation in mouse egg 
(Gonzalez-Garcia et al. 2013). However, in order to measure a fluorescent signal that 
fluorescent protein must be present at approximately 100 nM which makes it difficult to 
measure low levels of fluorescent protein (Niswender et al. 1995). 
Chemiluminescence on the other hand, requires no excitation light; instead light is 
produced as a by-product of a chemical reaction. This process can occur naturally in some 
species and is therefore known as bioluminescence for example in fireflies which produce 
bioluminescence by the enzyme luciferase. Luciferase uses ATP as an energy source to 
oxidise its substrate luciferin resulting in the production of electronically excited oxy-
luciferin which leads to the emission of energy in the form of a photon so oxy-luciferin may 
return to its ground state. Chemiluminescent (luminescent) probes can be created through 
the addition of a firefly luciferase tag to the protein of interest and the addition of luciferin 
to the media containing the cells. Using luminescence as a measure of protein expression in 
this way is a lot more advantageous compared to fluorescent tagged probes as 
luminescence is much more sensitive and avoids the issue of background light and 
autofluorescence. As a result using luminescent probes it is possible to measure very low 
amounts of protein expressed in the egg and detect small differences in expression. For 
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example PLCζ expression levels have been measured in mouse eggs by tagging PLCζ cRNA 
with a luciferase sequence and measuring the luminescence signal (Swann et al. 2014). 
Both fluorescent and luminescence based indictors will be used in experiments 
demonstrated in this thesis. 
 
Aims and Objectives 
This thesis will investigate the mechanisms by which sperm derived PLCζ induces 
Ca²⁺release in mouse eggs at fertilisation. This includes investigating both the structural 
factors of PLCζ itself that allow it to release Ca²⁺ by the IP3 signalling cassette, as well as 
cellular properties of the egg that enable PLCζ to release Ca²⁺ in only this cell type. The 
potential role of other sperm derived proteins that could be involved in Ca²⁺ release or PLCζ 
activity is also examined. Finally the live cell dynamics of crucial signalling messengers such 
as IP3 and DAG will attempt to be measured using a series of new genetic probes.  
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2. MATERIALS AND METHODS 
Mice 
All oocytes were collected from 6-8 week old female mice of the strain MF1 (Harlan UK 
Ltd). Sperm was collected from the epididymis of male C57/CBA F1 hybrid (Harlan UK Ltd) 
mice at approximately 10 weeks of age. All mice were kept in light/dark cycle condition 
with the free availability of food and water. All animal procedures were UK Home Office 
Licensed and approved by Cardiff University’s Ethics Committee.  
Collection and Handling of Gametes 
GV oocytes were collected directly from the ovaries of the female mice by tissue harvest 
following schedule one culling using CO₂ overexposure and cervical dislocation. The ovaries 
were immediately transferred to warm M2 media (Sigma Aldrich) containing 100 μM IBMX 
(3-isobutyl-1-methylxanthine) (Sigma Aldrich) following dissection. Under a dissection 
microscope (SMZ1000, Nikon) ovaries were then macerated in M2 media containing 100 
μM IBMX to release oocytes. The oocytes with a visible germinal vesicle were then selected 
and maintained in 100μM IBMX containing M2 media and incubated at 37°C until use. 
Where GV oocytes were in vitro matured (IVM) these oocytes were washed out of IBMX, 
transferred to a drop of clean M2 media under mineral oil (Sigma Aldrich), incubated at 
37°C and left to spontaneously mature.  
MII oocytes (eggs) were collected from the excised oviducts of female mice that had 
previously been super ovulated. For this protocol mice were primed with 10 IU 
(international units) of pregnant mare’s serum gonadotrophin (PMSG; Intervet) before 
being injected with 10 IUof Human chronic gonadotrophin (hCG; Intervet) approximately 50 
hours later. The eggs were then collected from the mice by tissue harvest 15 hours post 
hCG injection and the dissected oviducts placed directly into a warmed M2 media. The 
oviducts were then transferred to a petri dish of warmed M2 media containing 300 mg/ml 
hyaluronidase (Sigma Aldrich) under a dissection microscope. The cumulus masses 
containing the oocytes were torn from the oviduct using a thick needle and left in the 
hyaluronidasecontaining media until the oocytes dissociated from the cumulus cells. The 
free oocytes were then washed through 4 drops of M2 media to remove any 
hyaluronidase.  The eggs were incubated at 37°C in a drop of M2 media under embryo 
tested mineral oil (Sigma Aldrich) until use.   
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All oocytes were transported using glass pipettes that were controlled by mouth suction. 
Pipette suction devices were constructed from silicone tubing containing a cotton wool 
plug attached to the back end of a plastic pipette tip. A custom made glass Pasteur pipette 
pulled using a Bunsen burner to produce a diameter of about 100 μm was then fitted onto 
the tubing via the plastic pipette tip. The glass pipette was changed frequently. At the other 
end of the tubing a sterile mouth piece was constructed using a 1 ml plastic syringe with 
the plunger taken out.  
In Vitro Fertilisation 
Eggs were fertilised by IVF using fresh sperm expelled from the excised epididymis into T6 
media (1.42 mM KCL, 1.78 mM CaCl₂, 99 mM NaCl, 25 mM NaHCO₃, 0.47 mM MgCl₂, 0.36 
mM Na₂HPO₄, 5.56 mM glucose, 24.9 mM Na lactose, 0.47 mM Na pyruvate, 10 mg/l 
phenol red) that contained 16 μg/μl Bovine serum albumin (BSA) (Sigma Aldrich) in a plastic 
tube (Falcon). Sperm were incubated at 37 °C in this media and kept at a CO₂ level of 5% for 
approximately 3 hours to allow for capacitation. At the time of fertilisation approximately 
50μl of sperm suspended in the T6 was added to the dish containing the eggs that were 
being imaged. It was important that the zona pellucida of the eggs was removed prior to 
imaging in this instance to prevent the egg moving around during imaging. 
Use of Fluorescent/ Luminescent Probes 
Both fluorescent and chemiluminescent tagged constructs are useful tools as they allow 
quantification of the amount of a protein being expressed in a cell or determine the 
localization of a particular molecule within the cell. Fluorescent proteins such as GFP, YFP 
and CFP can be fused to specific proteins to provide a fluorescent construct. All molecular 
probes, proteins and cRNA were produced by Prof Tony Lai’s Lab (Cardiff University) or 
commercially available products. This was with exception of DAN20 probe which was kindly 
provided by Ankona Datta (Tata Institute of Fundamental Research, Mumbai, India) and 
Green “Upwards” DAG probe (Montana Molecular, US).  See Table 2.1 for the full list of 
fluorescent tags used.  
Molecular Biology 
Cloning of DNA expression constructs 
Original DNA was amplified by polymerase chain reaction (PCR) using Phusion DNA 
polymerase (Finnzymes, Fischer Scientific, UK) from a plasmid containing the gene of 
interest in the presences of the appropriate primers. If recombinant protein was to be 
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produced the PCR product was then cloned into a subsequent pETMM60 plasmid which 
allowed bacterial expression using the corresponding primers. For the synthesis of cRNA 
the DNA was amplified in the same way before being sub-cloned using the appropriate 
primers into a PCR3 vector or a PCR3 vector that contained a firefly (Photinus pyralis) 
luciferase tag at the c terminus. Dideoxynucleotide-sequencing (Sangar sequencing) was 
used to confirm the expression of these constructs using the Big-Dye Terminator V 3.1 cycle 
sequencing kit  (Applied Biosystems) and an automated capillary DNA analyser (model 
3730, DNA Sequencing and Services) 
cRNA synthesis 
Once the PCR3 plasmids had been linearised complementary RNA was synthesised using 
the mMessage mMachine T7 transcription kit (Ambion). To ensure faithful translation and 
stability inside the cell the cRNA was polyadenylated by means of aPoly(A) tailing kit 
(Ambion). Once produced cRNA was either stored at - 80°C or -20 °C.  
Production and purification of recombinant protein 
All recombinant protein produced possessed a N-utilization substance (NusA) to increase 
solubility and 6x-Histidine (6x-His) tag to allow purification. NusA is a bacterial tag which 
acts to stabilize proteins as they are translated by promoting hairpin folding and 
termination.  The relevant pETMM60 plasmid was transformed into Escherichia coli (BL21-
CodonPlus (DE3)-RILP, Stratagene, CA, USA). These bacteria were then cultured partly in 
the presence of isopropyl β-D-thiogalactopyranoside (0.2 mM; Formedium, UK). Once cells 
had been harvested they were re-suspended in an EDTA free protease inhibitor mix (Roche) 
diluted in PBS and then sonicated. The recombinant protein was then purified using nickel-
nitrilotriacetic affinity chromatography matrix (Ni-NTA Agrose; Qiagen) which selects for 
His tagged proteins. The protein was eluted and dialysed overnight before being 
concentrated. Recombinant protein was either used immediately, kept at 4°C for short 
term storage or snap froze and stored at -80°C for long term storage. 
Preparation for injection 
Recombinant protein and cRNA were diluted prior to microinjection in either RNase free 
molecular grade water (Sigma Aldrich) or HEPES buffered injection buffer (KCL HEPES) 
containing 120 mM KCL, 20 mM HEPES, at pH 7.4. Where Ca²⁺i was being measured this was 
mixed in equal parts with a Ca²⁺i indicator. Solution was mixed using a benchtop centrifuge 
(Spectrofuge 24D, Jencons) prior to microinjection.  
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Use of Peptides 
The PAWP derived PPXY peptide used (PPVRYGSPPPGYEAPT) was a 16 residue amino acid 
sequence synthesised by a commercial company and bought from Liftein LLC (South 
Plainsfield, New Jersey, USA).Where peptides were microinjected they were diluted prior 
to microinjection in the same way as cRNA and protein, in either KCL HEPES or molecular 
grade RNase free water. The peptide solution was microinjected alongside a fluorescent 
Ca²⁺ indicator as an internal control to ensure that the peptide had entered the egg 
successfully.  
Use of Chemicals and Drugs 
Most chemicals were dissolved in Dimethylsulfoxide (DMSO) where possible at a stock of 
1000 x the working concentration and stored at either -20°C or -80°C until use. D-Luciferin 
sodium salt (luciferin) was dissolved in molecular grade water at a 1000 times the working 
dilution and added to the media when required. BODIPY FL- PI(4,5)P₂ was diluted directly 
into KCL HEPES. DiIC18(3) crystals were dissolved in soybean oil until saturated before being 
centrifuged and the saturated oil removed from the remaining un-dissolved crystals.  DAG 
kinase inhibitor was added to eggs in oil free conditions. See table 2.2 for full list of 
chemicals used and working concentrations of these. All chemicals were obtained from 
Sigma Aldrich unless otherwise stated. 
Ca²⁺i Indicators 
Fluctuations in Ca²⁺i were measured using fluorescent Ca²⁺i indictors introduced into the 
eggs. Dextran linked Ca²⁺ dyes for example Oregon Green 488 BAPTA-1 Dextran (OGBD; Life 
Technologies) and Rhod-2 Dextran (RhodDex; Life Technologies) were microinjected 
directly into the cytoplasm prior to imaging at a final concentration of 1mM after dilution 
with injection buffer such as KCL HEPES dextran linked dyes such as these are retained in 
the cytoplasm for long periods of time and do not appear to compartmentalize. Rhod 
Dextran in a lot of cases is preferable for measuring Ca²⁺ fluctuations alone because it has a 
high Kd (750 nm) which reduces Ca²⁺i buffering effects and has a large dynamic range. Rhod 
dextran is excited by green light (excitation 552 nm) which has less phototoxic effects to 
the cell and the emitted red light (581 nm) is spectrally far away from the auto-
fluorescence emitted by the cell. However, when both chemiluminescence and 
fluorescence (for Ca²⁺i) were being recorded on the same system simultaneously, Rhod 
Dextran could not be used as the luminescence imaging system could only measure a single 
wavelength once recording had begun (i.e. it does not contain an automated filter wheel). 
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In these instances OGBD was used as it has a similar emissionspectrum (peak emission of 
523 nm) to the chemiluminescence produced by the variant of Firefly and click beetle 
luciferase that was used (peak emission ~550 nm). See Table 2.1 for details of peak 
emission and excitation wavelengths for the Ca²⁺i indictors used. 
Microinjection 
Solution was microinjected into eggs using high pressure pulse injection via the insertion of 
a micropipette. Prior to the microinjection itselfthe glass micropipettes (injection pipettes) 
were pulled from fine glass rods containing a filament (GC150 F, 1.5 mm outer diameter 
and 0.86 mm inner diameter, Harvard Apparatus Ltd) using a micropipette puller (model P-
30, Sutter Instrument Company) to produce micropipette with a diameter of less than 1 
μm. The injection pipette was back loaded with the desired solution (dye, cRNA, 
recombinant protein etc.) using a micro-loader pipette tip (Eppendorf) attached to a 1 ml 
plastic syringe. Eggs that were to be microinjected were then transferred to Petri dish 
(Nunc, Thermo Fisher Scientific) containing a shallow drop of M2 media under mineral oil 
which was placed on the microscope stage (inverted microscope, Eclipse TE2000-S, Nikon 
UK Ltd). The injection pipette was then fitted to a holder (ME2H25FW, World Precision 
Instruments) containing a silver wire and a side port connected to a Picopump pressure 
injector (model PV820, World Precision Instruments) via silicone tubing. This holder was 
then attached to the pre-amplifier of an electrometer (IE-25A, Warner Instrument 
Corporation) which could be manipulated manually using hydraulic manipulators (3D fine 
micromanipulator, Narashige). The eggs were held stable during injection using a holding 
pipette that had previously been pulled from G-100 TF glass (Harvard Apparatus Ltd) using 
PN-30 pipette puller (Narashige). The holding pipette was attached to syringe system (Cell 
Tram Air 5176, Eppendorf) which allowed the eggs to be sucked onto the holding pipette. 
The injection pipette was inserted through the zona pellucida surrounding the egg until it 
reached the surface of the egg plasma membrane. A small electrical oscillation using the 
electrical amplifier was then delivered to the plasma membrane which allowed the 
injection pipette to penetrate the plasma membrane and deliver solution into the 
cytoplasm by a high pressure pulse (typically 20 psi for approximately 0.5 secs). The 
amount of solution injected was estimated by measuring the diameter of cytoplasmic 
displacement created by a bolus injection and was found to be approximately 3-5 % of the 
total egg volume.  
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Immunocytochemistry 
Immunocytochemistry was used to look at both the endogenous localisation and the 
localisation of exogenously derived proteins at the subcellular level using a confocal 
microscopy system. The eggs were first washed in Phosphate buffered saline solution (PBS) 
containing 1% polyvinyl alcohol (PVA) (Sigma Aldrich) three times before being incubated in 
4% paraformaldehyde  (Sigma Aldrich) in PBS 1% poly vinyl alcohol (PVA) for 15 minutes. 
The cells were then quenched in 50mM ammonium chloride (NH₄Cl) with 0.2 % bovine 
serum albumin (BSA) in PBS for 15 minutes and permeabilised in a PBS buffer containing 
0.2% BSA and 0.1% Triton x100 in a homemade humidity chamber for a further 15 minutes. 
The cells were then washed in 10% goat’s serum (Sigma Aldrich) diluted in 1% PVA in PBS 
and incubated for 1 hour at room temperature or overnight at 4 °C. If mouse derived 
monoclonal was used as the primary antibody the cells were then incubated for 1 hour in 
“mouse-on mouse” Ig blocking agent (Invitrogen) diluted to the manufacturer’s instructions 
in  PBS 1% PVA.  The cells were then incubated with the primary antibody (diluted to an 
appropriate concentration) in 0.2% BSA in 1% PVA PBS for a further hour. The cells were 
then incubated for a final hour in a fluorescently conjugated secondary antibody 
(Invitrogen), diluted by 1:500 in 10% goat’s serum. Cells were imaged in a 5 μl drop of PBS 
under mineral oil in a glass bottom dish (FluoroDish, World precision instruments, inc). 
Between each fixing and staining step and before imaging the cells were thoroughly 
washed in PBS containing 1% PVA.  
Preparation of Eggs for Imaging 
For imagingin most cases the eggs were placed in glass bottom chambers containing a 0.9 - 
1 ml drop of HEPES Buffered KSOM media (pH 7.4, made up in cell culture grade water: 
10mM HEPES, 95 mM NaCl, 0.35 mM KH₂PO₄, 0.2 mM MgSO₄, 2.5 mM KCl, 0.01 mM EDTA, 
0.2 mM Na Pyruvate, 1 mM L-glutamine 0.2 mM glucose and 10 mg/l phenol red) under 
mineral oil. If there was to be no further addition of drugs or sperm to the chamber the 
eggs were placed directly in the dish with the zona pellucida intact. However, if the eggs 
were to be fertilised by IVF or an additional solution was going to be added chamber, the 
zona pellucida were first removed by treatment in acid Tyrode’s solution (Sigma Aldrich) 
before being washed in M2 and placed in the imaging chamber. By removing the zona 
pellucida the eggs were better able to stick to the glass cover slip and minimise movement.  
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Epifluorescence Imaging 
Imaging of fluorescent proteins was carried out using an inverted 
epifluorescencemicroscope (see fig 2.1) (Nikon Eclipse Ti-U microscope) with a heated 
stage device (Warner Instruments) so the eggs could be maintained at 35 - 37°C. During 
epifluorescence imaging light is provided by either an LED lamp (OptoliteLEDLite, Cairns 
Research Ltd) or a white halogen lamp. The light passes through an excitation filter of the 
appropriate wavelengths. Only light within the excitation spectrum of the fluorescent 
protein passes through the filter and reflects off the dichoric mirror and through the 
objective onto the sample. The fluorescent dyes or proteins inside the egg absorb this light 
and emit light of a different wavelength (at a wavelenth within the emission spectrum). The 
emitted light passes back through the objective straight through the dichroic mirror and 
the emission filter to the cooled CCD camera (CoolSNAPHQz, Photometrics) which was 
connected to the In Vivo computer Software (See fig 2.2 for schematic). The filters could be 
automatically changed using an optical filter changer (Lambda 10-3, Sutter Instrument 
Company) to allow multiple fluorescent channels to be detected during one experiment by 
switching filters at set intervals and using a double or triple bandpass filter. Different 
excitation and emission filters, diochroic mirrors and light sources were used for different 
fluorescent dyes or proteins (See Table 2.1). When measuring fluorescence the sample was 
imaged through a 20x (0.75 N.A, Fluor) objective and images were acquired every 10 secs 
with an exposure of 100- 400 millisecs. Light exposure to the eggs was kept to a minimum 
by using a camera pixel binning of 8x8 which increased camera sensitivity therefore 
reduced photo damage.Images were saved as .tif files for further analysis offline.  
In experiments where FRET based probes were used this epifluorescence imaging system 
was used to measure multiple wavelengths of fluorescence emission. The system was 
configured so that the automated filter wheel switched between allowing the yellow 
emitted signal or the green emitted signal through to be detected for 200 ms by the 
camera every 10 secs. The signal emitted by each fluorophore was recorded as a separate 
measurement for each time point. A ratio of these two signals was then calculated by 
dividing the fluorescence of the YFP signal by the CFP signal and plotting tehse values 
against time.  
Confocal Imaging 
Epifluorescence microscopy is a simple way to measure whole cell fluctuations in 
fluorescence over a long period of time however as the whole sample becomes illuminated 
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and the emitted fluorescence on all focal planes is detected therefore it is often difficult to 
resolve the localisation of the fluorescence clearly on the intracellular level. Confocal 
microscopy overcomes some of these disadvantages of standard epifluorescence imaging 
by eliminating out of focus light and using point illumination to focus on only one focal 
plane at a time. A spatial pinhole is used which means only fluorescence emitted in or very 
close to the focal plane passes to the detector (photomultiplier tube) and out of focus light 
is excluded (See fig 2.2). This means that using confocal imaging depth of field can be 
conferred and images of a greater resolution may be produced.  
Confocal imaging was used in this project to specifically look at the intracellular localisation 
of fluorescence probes. Eggs were imaged at 63x oil objective using a SP5inverted 
microscope (Leica, Wetzler, Germany) and data was acquired through the LAS-AF software 
(Leica) via a computer connected to the scanner head of the microscope. The coherent 
light source was provided by either an Argon (488 nm) or Helium-Neon laser (643 nm or 
543 nm) (at around 30% power) and the appropriate emission and excitation filters were 
used (see Table 2.1) using a pinhole aperture of 91 μm. Images were usually taken as 
equatorial or cortical cross sections of one egg at a time. Eggs were imaged at room 
temperature for short periods of time in a 5μl drop of M2 media under mineral oil. Images 
were exported as tif. files and analysed using LAS lite software (Leica).  
  
61 
 
  
Light 
Excitation 
Filter wheel 
    Objective 
(x20, 0.75 NA) 
Dichroic Mirror/ 
Multi bandpass 
Sample 
Emission Filter 
wheel 
CCD 
Camera 
Shutter 
Figure 2.1 Schematic of epifluorescence imaging system using an inverted microscope 
The light source is produced by either a halogen or LED lamp which is automatically controlled by an 
electronic gating or a motorised shutter. This light passes through an excitation filter to select the 
correct wavelength of light required for excitation. This light is then reflected off a dichroic mirror 
through a x20 objective with a numerical aperture of 0.75, onto the sample. The light emitted from 
the sample as a result of this excitation passes back through the objective, the dichroic mirror and an 
emission filter. This emission filter excludes all wavelengths of light other than that emitted from the 
sample (at a set level). This light is then projected onto a cooled or intensified CCD camera which 
reads the light signal  
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Figure 2.2 Schematic of confocal imaging system using an inverted microscope 
The excitation light source is produced by a laser that emits light of only one wavelength (blue). This light 
then passes through a pinhole aperture which directs it onto a dichroic mirror or beam splitter. This 
reflected light then passes through a series of motorised scanning mirrors which scan the laser light over 
the sample. The light passes through the x63 objective where it can illuminate the sample. As emitted 
light travels back through the scanning mirrors it is de-scanned and passes directly through the dichroic 
mirror. Only the light from the desired focal plane passes through the pinhole aperture and is detected 
by the PMT (photo-multiplier tube).  
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Measuring Chemiluminescence 
Chemiluminescence (luminescence) was measured using a different imaging system to that 
used for measuring fluorescence alone.In addition to operating as an epifluorescence 
microscope this system was also able to measure luminescence via photon counting. The 
eggs were imaged on an inverted microscope (TE200, Nikon or Axiovert S100, Zeiss) 
contained within a light proof dark box to prevent stray light entering the camera during 
imaging. The eggs were placed in a dish with a glass coverslip base contained within  0.9-1 
ml HKSOM incubated with 100μM luciferin (Sigma Aldrich) covered with mineral oil and 
maintained at 35-37 °C using a heated chamber device (Intracel Ltd) attached to the 
microscope stage. During imaging light was directed to a cooled, intensified CCD Camera 
(Photek, UK) which was connected to the microscope (see fig 2.1). Light was provided for 
bright field and fluorescence imaging by a halogen lamp which was gated by electro 
mechanical shutters (Uniblitz) and controlled through the Photek Software. Fluorescence of 
the Ca²⁺i indicator OGBD and GFP proteins were measured on this system using a 505 nm 
long-pass FITC filter block and the camera sensitivity was reduced to 10%. When measuring 
luminescence the light source was switched off, the camera sensitivity was switched to 
100% and luminescence was recorded as integrated light emission in the form of number of 
photons per second. Both fluorescence and luminescence were recorded simultaneously 
during an experiment by taking advantage of the electronic gating of the light source. At 10 
sec intervals the system switched between measuring fluorescence and luminescence by 
opening and closing the light shutter and automatically switching camera sensitivity. This 
made it possible to plot luminescence and fluorescence on the same time scale for each 
egg in a single experiment. During all experiments eggs were imaged through a x20 
objective (0.75 NA, Fluor). 
Calibrating Protein Expression 
Measuring the luminescence of a luciferase tagged construct enables the amount of 
protein expression inside the cell to be quantified.  This can be done by determining the 
conversion factor between the value of luminescence recorded during imaging and the 
amount of luminescence produced by a particular amount of luciferase protein. To do this 
luminescence values of the eggs at the end of imaging were recorded before the eggs were 
removed from the imaging system and placed in a test tube containing phosphate buffered 
saline solution with 0.5% Triton X-100 and 1mM MgATP for lysis (Sigma Aldrich).  
Luminescence of the lysed eggs was then measured in a custom made luminometer 
consisting of a cooled photomultiplier tube (S20) connected to an amplifier (Electrontubes 
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Ltd) and a dark proof tube holder. Once in the tube holder 100μM luciferin was added to 
the test tube containing the eggs and luminescence was measured using an amplifier which 
was linked to some computer software (Electrontubes Ltd). Luminescence was recorded as 
absolute photon counts plotted against time and the mean luminescence of each egg was 
calculated by dividing the total photon counts recorded by number of eggs in the group. 
This luminescence value was compared to a calibration curve of luminescence created 
using known quantities of recombinant luciferase protein in lieu of eggs in the test tubes. A 
regression analysis was carried out to determine the relationship between the end 
luminescence value of the eggs recorded by the imaging system and the luminescence 
value measured by the luminometer. This allowed the conversion of imaging luminescence 
values into luminometer luminescence values to be calculated without using the 
luminometer. These calculated luminometer luminescence values could be entered into 
the equation for the recombinant luciferase calibration curve to calculate the approximate 
amount of luciferase protein in any eggs injected with a luciferase tagged construct.  
Analysing Images 
Images that were collected using simple epifluorescence recording were analysed using the 
acquisition software Image J. The .tif files were analysed as an image stack using the multi-
measure plugin to measure fluorescence intensities. Areas were drawn around the images 
of eggs as “regions of interest” so individual fluorescence intensities of these eggs were 
calculated.Anegg-free region of interest was also taken to give a non-specific background 
fluorescence which was then subtracted from the absolute fluorescence for each egg to 
give a background corrected fluorescence value. Fluorescence was normalised by dividing 
the background corrected fluorescence (F) by the basal fluorescence value (F0) this F/F0 
was then plotted against time.  
Data analysis and Statistics 
Fluorescence and luminescence measurements recorded by the luminescence system were 
saved as numerical values (number of photons detected) therefore the data collected from 
this system was analysed in a different way to that of the epifluorescence system. Data was 
both acquired and exported using the Photek software. Once the recording had stopped 
regions of interest were drawn around each egg so the fluorescence/luminescence for 
individual eggs could be determined as well as a random egg-free region (background). 
Data in the form of “count rate” for each egg was then generated and exported in the form 
of a text file of photon counts per second, every 10 seconds, from each region of interest. 
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This text file was then imported into Sigma Plot 12 Software (Systat Software inc) for 
further analysis. The fluorescence/ luminescence of the background area was subtracted 
from the egg fluorescence/luminescence value to give a background corrected count rate 
or fluorescence for each egg.  The F/F0 was then calculated for the fluorescence data and 
luminescence was plotted as background corrected luminescence against time. 
Average luminescence values or number of Ca²⁺i ocillations were represented by calculating 
the mean. For these values either standard deviations (SD) or standard error of the means 
(SEM) were also calculated. Stastistics were conducted to test for significant differences 
between groups. In this case a Pearson’s test for normality was conducted first. If the data 
passed this test a Student’s T-test for significant difference was carried out with a 95% 
confidence interval. If the data failed the test for normality a Mann-Whitney Ranked test 
for comparision between 2 groups was conducted instead again with a 95% confidence 
interval. 
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Fluorophore or 
indicator 
Purpose/targets/ 
measures 
Colour Excitation 
wavelength 
(nm) 
Emission 
wavelength 
(nm) 
Oregon green BAPTA 
Dextran (OGBD) 
cytosolic Ca²⁺i 
indicator 
Green 494 523 
Rhod- 2 Dextran cytosolic Ca²⁺i 
indicator 
Red 552 581 
 
BODIPY FL Ceramide 
(Thermo Fisher) 
Golgi target Green 500 510 
GOLGI -ID® (Enzo Life 
Sciences) 
Golgi target Green  ~460 ~540 
 
AC-lectin  
(fluorescein)(vector 
labs) 
Golgi target Green 494  512 
DiIC18(3) 
(Thermo Fisher) 
ER target 
 
Red-
Orange 
549 
 
565  
eYFP tag 
 
Yellow 514 527 
m-Cherry  tag Red 587 610  
 
Td-Tomato 
 
tag Red 554 581 
eGFP tag Green  484 510 
 
eCFP tag  Blue  435 485 
 
Alexa Fluor 488 
(Thermo Fisher) 
conjugated 
antibody 
Green  493 519 
 
Alexa Fluor 594 
(Thermo Fisher) 
conjugated 
antibody 
Red 590 617 
Green “Upwards” 
DAG (Montana 
Molecular) 
DAG Green ~490 ~520 
PBP10 (Rhodamine 
B) (Tocris Bioscience) 
PI(4,5)P₂   Red-
orange 
540 625 
DAN20 (DAN) PI(4,5)P₂   Blue and 
Green 
405  435 - 465 (blue) 
510- 540 (green) 
BODIPY FL-PI(4,5)P₂ 
(Echelon inc) 
PI(4,5)P₂   
 
Green 494  512 
 
Table 2.1 Table showing all fluorescent tags and indicators used and the corresponding maximal 
excitation and emission wavelengths 
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Chemical/drug Molar 
concentration 
 
3-isobutyl-1-
methylxanthine (IBMX) 
 
100 μM 
 
Propranolol 
 
300 μM 
Brefeldin A (BFA) 
 
5  μM 
D-Luciferin 
 
100 μM 
Diacylglycerol Kinase 
Inhibitor I 
10 μM 
D609 
 
100 μM 
Phorbol 12,13-dibutyrate 
(PDBμ) 
 
2 μM 
phorbol-12-myristate-13-
acetate (PMA) 
 
1 μM 
Ionomycin 
 
100 μM 
A23187 
 
5 μM 
Acetyl choline chloride 
(Ach) 
100 μM 
 
Table 2.2: Table showing all chemicals/drugs added to eggs and oocytes during experiments and 
the working molar concentration of these
68 
 
3. DOES PAWP HAVE A ROLE IN INDUCING CA²⁺I OSCILLATIONS 
AND EGG ACTIVATION IN MOUSE EGGS? 
 
Introduction 
During mammalian fertilisation the initiation of early developmental events are dependent 
on the MII-arrested oocyte (egg) becoming activated following sperm-egg fusion. The 
events of egg activation are triggered by a series of transient increases in cytosolic calcium 
concentration (Ca²⁺i) known as Ca²⁺i oscillations (Stricker 1999). It is well established these 
oscillations are a result of inositol trisphosphate (IP₃) induced Ca²⁺release from the 
endoplasmic reticulum (Miyazaki 1993) which is triggered by the introduction of a sperm 
derived factor (Swann 1990b). This sperm specific factor, also known as sperm-derived 
oocytes activating factor (SOAF), is located in the perinuclear theca of mature spermatozoa 
and is deposited into the egg during egg sperm fusion (Kimura et al. 1998). The perinuclear 
theca is the first part of the sperm to dissolve into the egg cytoplasm and only sperm 
extracts which contain an intact perinuclear theca are able to elicit full egg activation 
(Sutovsky et al. 2003). 
Post-acrosomal sheath WW Domain- binding Protein (PAWP) is a sperm specific alkaline 
extractable protein located in the post-acrosomal sheath (PAS) of the perinuclear theca 
(Wu et al. 2007; Aarabi et al. 2014a). There are two main functional domains found in 
PAWP, an N-terminus which has homology with the WW domain-binding protein 2 and a 
proline rich unique C-terminus. The N-terminus of PAWP therefore has the ability to bind to 
WW domain containing proteins. WW domains are 38-40 amino acid length sequences 
named after the 2 conserved tryptophan residues (W) contained within them (Macias et al. 
1996) and is formed of 3 anti-parallel β sheets which are held tighter by hydrogen bonds 
but does not contain any disulfide bridges (Ibragimova and Wade 1999). WW domains have 
the ability to mediate protein-protein interactions through the formation of protein rich 
modules by recognising and interacting with proline rich regions (Salah et al. 2012) or in 
some cases via phosphoserine or phosphothreonine binding  (Lu et al. 1999). WWI domain 
containing proteins including  yes-associated protein (YAP), neural precursor cell expressed 
developmentally down-regulated protein 4 (Nedd4) and dystrophin mediate protein 
interactions by recognising polypeptides containing the consensus PPXY motif (PY motif) 
where P represents proline residues and Y represents tyrosine (Chen and Sudol 1995; Sudol 
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and Hunter 2000). YAP is able to bind to two specific ligands called WW domain binding 
protein 1 (WBP1) and WW domain binding protein 2 (WBP2)  both of which contain this PY 
motif and are very highly conserved between species (Chen et al. 1997). Furthermore,point 
substitution of the prolines or the tyrosine in the PY motif of either WBP1 or WBP2 can 
abolish YAP binding (Chen et al. 1997). WW domains can be considered as functionally 
similar to Src homology 3 (SH3) domains however are structurally different (Sudol 1996). In 
fact, YAP also contains a SH3 binding motif which enables it to bind to the SH3 domain of c-
Yes, a proto-oncogene of the Src family of tyrosine kinase as well as other SH3 domain-
containing proteins (Sudol 1994). 
PAWP is exclusively expressed and assembled during spermatid elongation (Wu et al. 2007; 
Aarabi et al. 2014a) with the final equivalent amount of PAWP protein found in bull sperm 
estimated to be around 80 fg (Wu et al. 2007). Microinjection of bull PAWP recombinant 
protein into porcine, bovine, Xenopus and rhesus monkey eggs has been reported to induce 
full egg activation up to pronuclear formation (Wu et al. 2007).  Resumption of meiosis was 
also recorded in Xenopus eggs following injection of PAWP indicated by the extrusion of a 
second polar body (Wu et al. 2007). Interestingly the co-injection of a competitive peptide 
containing the PPXY motif derived from PAWP alongside recombinant PAWP protein into 
Xenopus eggs prevented the resumption of meiosis previously observed (Wu et al. 2007). 
The PPXY containing peptide also inhibited the resumption of meiosis of eggs that had been 
injected with perinuclear theca alkaline extract from the sperm (Wu et al. 2007). 
Furthermore porcine eggs injectedwith anti-recombinant PAWP serum or PPXY containing 
peptide that were fertilised by ICSI displayed high rates of developmental arrest and lacked 
pronuclear formation (Wu et al. 2007) This effect was not seen in ICSI fertilised eggs 
injected with pre-immune serum or a peptide containing a point mutated version of the 
PPXY motif  (Wu et al. 2007). These data suggest that pronuclear formation and successful 
fertilisation following perinuclear theca extract injection and ICSI is mediated by PY motif – 
WWI  domain-mediated signalling within the egg (Wu et al. 2007).  
PAWP is suggested to elicit egg activation by operating upstream of Ca²⁺i signalling. Indeed 
the microinjection of bull PAWP recombinant protein into Xenopus eggs elicits Ca²⁺i 
increase (Aarabi et al. 2010). However, this Ca²⁺i increase is not observed as Ca²⁺i wave 
crossing the egg as has previously been reported in fertilised Xenopus eggs (Bugrim et al. 
2003). Nevertheless this Ca²⁺i change also appears to be dependent on PY motif /WWI 
domain interaction. The Ca²⁺i increase seen following the injection of either PAWP 
recombinant protein or Xenopus sperm could be prevented by the co-injection of the 
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peptide containing PAWP derived PPXY motif but not by a peptide with a point mutated 
version of this motif (Aarabi et al. 2010). Similar effects of PAWP have been reported in 
mammalian eggs. Microinjection of human PAWP recombinant protein into mouse eggs 
and human PAWP cRNA into human eggs has been found to elicit Ca²⁺i oscillations similar 
to those seen in eggs fertilised using ICSI (Aarabi et al. 2014b). Oscillations induced by 
either PAWP or ICSI in both species could be blocked following the co-injection of a PAWP 
derived PPXY motif containing peptide (PPXY peptide) however not by a point mutated 
version of this motif (Aarabi et al. 2014b).  
Together these data suggest that PAWP is able to activate eggs by stimulating the Ca²⁺i 
signalling pathway specifically by triggering Ca²⁺i oscillations in mammalian eggs, a process 
which is dependent on PY motif –WWI domain interaction. Far-western analysis has shown 
that the PPXY motif of bull PAWP recombinant protein has binding affinity to WWI domain 
of Yes-associated protein (YAP) however does not bind to the point mutated WW domain 
of YAPP202A (Wu et al. 2007). Furthermore the binding of recombinant PAWP protein to YAP 
could be inhibited by co-incubation with a PPXY containing peptide but was not inhibited 
by  a peptide containing the mutated PY motif PPGF (Wu et al. 2007). It has therefore been 
suggested that the PPXY motif found in the proline rich c-terminus of PAWP functionally 
binds to the WWI domain of YAP once PAWP is inside the egg cytosol (Wu et al. 2007; 
Aarabi et al. 2010; Aarabi et al. 2014b). As YAP possesses a SH3 binding motif it has been 
postulated, that on binding to PAWP, YAP may activate PLCγ through in a non-canonical 
pathway via its SH3 domain (Aarabi et al. 2014b). Once activated, PLCγ is able to hydrolyse 
PI(4,5)P₂ to generate IP₃ and elicit Ca²⁺ release (Aarabi et al. 2014b) 
These results have made way for potential clinical applications of PAWP to be proposed. It 
appears a reduced PAWP concentration within human and bull sperm can be correlated 
with failure for that sperm to successfully fertilise an egg, suggesting PAWP levels could be 
an effective indictor of sperm quality (Aarabi et al. 2014a; Kennedy et al. 2014).It has also 
been suggested that PAWP could be introduced into eggs during assisted fertility to 
increase success rates for example in ICSI failure cases (Kennedy et al. 2014). Together 
these data suggests that PAWP could be an alternative sperm factor candidate to PLCζ and 
may have a role in activating mammalian eggs at fertilisation. 
Aims 
PAWP has been proposed as a potential and promising sperm factor candidate for 
triggering the initiation of Ca²⁺i oscillations during mammalian fertilisation (Wu et al. 2007; 
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Aarabi et al. 2014b). As the Ca²⁺ releasing effects of PAWP in mammalian eggs have only be 
demonstrated by one research group and using a human derived form of PAWP (Aarabi et 
al. 2014b) this project aimed to reproduce the effects of PAWP previously seen and 
determine if mouse and human derived PAWP could cause Ca²⁺i oscillations in mouse eggs 
in a physiological manner. Furthermore this project  aimed to investigate how the Ca²⁺i 
oscillations elicited by PAWP compared to those Ca²⁺i  oscillations initiated by the 
introduction of the sperm derived PLCζ (Saunders et al. 2002) and whether these two 
proteins work together as cofactors to elicit Ca²⁺i oscillations. These experiments also 
intended to quantify the amount of PAWP protein that was required by the egg for Ca²⁺i 
oscillations to be triggered.  Finally the role of PY motif –WWI domain interaction in 
eliciting Ca²⁺i oscillations in mouse eggs at fertilisation was further investigated with the 
aim to determine if the inhibition of this interaction prevented Ca²⁺i oscillations caused by 
PAWP or any other stimuli.  
Results 
PAWP recombinant protein does not cause Ca²⁺i oscillations in mouse eggs 
As human PAWP recombinant protein has previously been shown to cause Ca²⁺i oscillations 
when injected into both human and mouse eggs (Aarabi et al. 2014b) it was important to 
investigate whether mouse derived PAWP recombinant protein had the ability to elicit Ca²⁺i 
oscillations in mouse eggs. For this, human and mouse derived protein was synthesised by 
a colleague Michail Nomikos (MN).  In the paper published by (Aarabi et al. 2014b) human 
derived PAWP recombinant protein was synthesised with only a His-tag attached however 
on trying this the recombinant protein produced was found not to be soluble therefore in 
the present study a NusA tag was also added to increase solubility. To determine if mouse 
PAWP could elicit Ca²⁺i oscillations this His and NusA tagged PAWP recombinant protein 
(NusA-mPAWP) (fig 3.1) at a pipette concentration of 0.5 μg/μl was microinjected into MII 
arrested unfertilised mouse eggs along with a fluorescent Ca²⁺i indicator (OGBD) so changes 
in Ca²⁺i could be measured. Whilst recording the fluorescence in these eggs no changes in 
cytosolic Ca²⁺i concentrations were seen in any eggs (fig 3.2) indicting that NusA-mPAWP 
was not able to elicit Ca²⁺i oscillations. As a direct comparison a group of eggs were also 
microinjected with NusA tagged mouse derived PLCζ recombinant protein (NusA-PLCζ) 
mixed with Ca²⁺i dye in the same way at the same pipette concentration as NusA-mPAWP. 
In contrast to the results seen with PAWP, at this concentration NusA-PLCζ was able to 
induce Ca²⁺i oscillations similar to those seen as fertilisation (fig 3.2).  
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To ensure there were no fundamental differences in the activity of mouse and human 
derived PAWP human derived NusA-PAWP recombinant protein (NusA-hPAWP) (fig. 3.1) 
was also injected into MII arrested unfertilised mouse eggs. Eggs were microinjected with 
NusA-hPAWP at a pipette concentration of 0.5 μg/μl mixed with the Ca²⁺i indicator Rhod 
Dextran so alteration in Ca²⁺i could be measured. Separate eggs were also microinjected 
with a lower pipette concentration of NusA-hPAWP (0.05 μg/μl) mixed with Rhod dextran 
to be sure the eggs weren’t overdosed with PAWP therefore preventing physiological 
response. In both groups of eggs no changes in cytosolic Ca²⁺i concentrations were 
recorded in any of the eggs during imaging (fig. 3.3). These data would suggest that PAWP 
recombinant protein derived from mouse or human is unable to cause Ca²⁺i oscillations in 
mouse eggs in the manner seen at fertilisation. 
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Figure 3.1 Schematic showing the different PAWP constructs that were microinjected into eggs 
A) mouse derived PAWP constructs , B) human derived PAWP constructs  
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Figure 3.2 Example Ca²⁺i traces in eggs following injection of mPAWP and PLCζ recombinant 
protein 
Examples of traces showing the changes in cytosolic Ca²⁺i in MII oocytes following 
microinjection of the Ca²⁺iindictor Oregon Green BAPTA Dextran (OGBD) mixed with; A) NusA-
mPAWP recombinant protein (pipette concentration = 0.5 μg/μl, n= 25 oocytes), and B) NusA-
mPLCζ(pipette concentration = 0.5 μg/μl, n= 12 oocytes)  
 
75 
 
  
R
h
o
d
 D
e
x
 (
F
/F
0
)
0
2
4
6
20 mins
R
h
o
d
 D
e
x
 (
F
/F
0
)
0
2
4
6
20 mins
NusA-hPAWP  A 
 
Figure 3.3 Example Ca²⁺i traces in eggs following injection of hPAWP recombinant protein 
Sample trace showing the changes in cytosolic Ca²⁺i  concentrations of MII eggs injected with 
NusA-hPAWP recombinant protein of pipette concentrations A) 0.05 μg/μl (n= 8) and B) 0.5 
μg/μl (n=10) with Rhod Dextran.  
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PAWP untagged cRNA does not cause Ca²⁺i oscillations in mouse eggs 
(Aarabi et al. 2014b) previously microinjected untagged human derived PAWP cRNA into 
mouse eggs and found it was able to induce Ca²⁺i oscillations. In light of this result, we 
wanted to explore whether mouse derived PAWP cRNA could elicit Ca²⁺i oscillations in 
mouse eggs. To ensure that the activity of PAWP was not affected by the addition of the 
NusA moiety, untagged mouse PAWP cRNA (mPAWP cRNA) synthesized by MN, at a pipette 
concentration of 1.25 μg/μl was microinjected into unfertilised MII mouse eggs with the 
Ca²⁺i indictor Rhod Dextran so Ca²⁺i changes could be recorded. The egg endogenously 
expresses this RNA to manufacture mPAWP protein intracellularly, as a result, the amount 
of PAWP protein in the egg was expected to begin at zero and increase with time. No 
changes in cytosolic Ca²⁺i concentrations were recorded in any of these eggs injected with 
mPAWP cRNA (fig 3.4). In steep contrast, microinjection of mouse PLCζ cRNA at a much 
lower pipette concentration (0.04 μg/μl) did cause Ca²⁺i oscillations which were 
comparable in frequency and pattern to those seen following fertilisation, IVF or ICSI (fig 
3.4).  
As with the PAWP recombinant protein, to be sure that there were no functional 
differences between the PAWP derived from mouse and the human derived form of PAWP 
used by (Aarabi et al. 2014b), we microinjected a different group of mouse eggs with 
hPAWP untagged cRNA (synthesised by MN). A range of pipette concentrations of hPAWP 
cRNA were injected (0.006 μg/μl, 0.06μg/μl), 0.3 μg/μl and 1 μg/μl) and in all instances no 
changes in cytosolic Ca²⁺i concentrations of the eggs were seen (fig 3.5). To verify that the 
cRNA injected was definitely being expressed a western blot was conducted using eggs that 
had been injected with 1μg/μl of hPAWP cRNA (conducted by MN). Despite no Ca²⁺i 
oscillations being recorded in eggs expressing this concentration of cRNA a huge amount of 
hPAWP protein was found in the eggs, indicating that the hPAWP cRNA was expressed very 
well (data not shown). These data suggest that mPAWP and hPAWP cRNA are not able to 
elicit Ca²⁺i oscillations at either very low nor very high concentrations and that the lack of 
Ca²⁺i oscillations elicited by NusA-mPAWP and NusA-hPAWP recombinant protein is unlikely 
to be due to the NusA tagging. 
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Figure 3.4 Example Ca²⁺i traces in eggs following injection of mPAWP and PLCζ cRNA 
Examples of traces showing the changes in cytosolic Ca²⁺i in an MII egg following 
microinjection of the Ca²⁺i indictor Rhod Dextran mixed with; A) untagged mPAWP cRNA 
(pipette concentration = 1.25 μg/μl, n= 28 eggs), and B) untagged mPLCζ cRNA (pipette 
concentration = 0.04 μg/μl, n= 24 eggs)  
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Figure 3.5 Example Ca²⁺i traces in eggs following injection of hPAWP cRNA 
Sample traces showing changes in cytosolic Ca²⁺i concentrations of eggs microinjected with 
the Ca²⁺i indicator OGBD h-PAWP untagged cRNA of different pipette concentrations A) 
0.06 μg/μl ( n=14 ), B) 0.3 μg/μl  (n=12) and C) 1μg/μl (n=11). A pipette concentration of 
0.006 μg/μl hPAWP cRNA was also microinjected (n=23) (data not shown). 
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Mouse eYFP-PAWP cRNA does not cause Ca²⁺i oscillations in mouse eggs 
In order to ensure faithful mouse PAWP cRNA expression in the eggs whilst they were 
being imaged a fluorescent e-YFP n -terminally tagged mPAWP cRNA (eYFP-mPAWP) was 
constructed (fig 3.1) by MN. eYFP-mPAWP at a pipette concentration of 1.5 μg/μl mixed 
with the Ca²⁺i  indicator Rhod Dextran was microinjected into MII arrested mouse eggs prior 
to imaging. Fluorescence from the red channel was used to measure changes in Ca²⁺i 
whereas the fluorescence from the green channel showed changes in the amount of YFP 
inside the egg. As expected, YFP fluorescence increased with time showing that the RNA 
was successfully expressed and the amount of PAWP protein inside the egg was increasing 
through the duration of the experiment (fig 3.6). As the YFP signal was visible and very 
strong a large amount of eYFP-mPAWP must have been inside the egg, however once again 
no changes in cytosolic Ca²⁺i were seen in any eggs throughout the duration of the 
experiment (fig 3.6). Furthermore no sub cellular localisation of PAWP in the egg was 
evident as the fluorescence pattern appeared relatively uniform and therefore cytoplasmic 
in its distribution.  
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Figure 3.6 Example Ca²⁺i traces in eggs following injection of YFP-PAWP cRNA 
Examples of traces showing, A) the changes in cytosolic Ca²⁺i in an MII egg following microinjection of the 
Ca²⁺i indictor Rhod Dextran mixed with eYFP tagged mPAWP cRNA (pipette concentration =1.5 μg/μl, n= 23 
eggs) and B) the YFP fluorescence for the same eggs, demonstrating expressing of the cRNA and an image 
showing the fluorescence of 13 of these eggs injected with eYFP-mPAWP cRNA. The visible fluorescence 
signal indicates faithful and high expression of cRNA.  
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PAWP is not able to induce Ca²⁺ioscillations at levels present in the sperm 
In order to accurately quantify the amounts of mPAWP protein being manufactured by the 
egg and how this related to physiological conditions, a final form of mPAWP cRNA was 
synthesised by MN and injected into MII eggs. mPAWP cRNA possessing a c-terminal firefly 
luciferase tag (mPAWP-luciferase) was constructed (fig 3.1) and mixed with the Ca²⁺i 
indicator OGBD. Using this construct it was possible to record both luminescence (which 
represents RNA expression) and fluorescence of the Ca²⁺i indicator (which represents 
changes in cytosolic Ca²⁺i ) simultaneously by switching between recording luminescence 
and fluorescence every 10 seconds (Swannet al. 2009). Using the luminescence recordings 
it was possible to calibrate the amount of mPAWP protein inside the egg at the end of 
imaging.  MII eggs were microinjected with mPAWP- luciferase at a range of pipette 
concentrations (0.04 μg/μl and 1.25 μg/μl). It has previously been reported that bovine 
sperm contains the equivalent of approximately 87 fg of bovine PAWP protein (Wu et al. 
2007). However, MII eggs containing approximately 89 fg of PAWP protein following 
injection did not undergo any Ca²⁺i changes (fig. 3.7). This indicates that mPAWP is not able 
to cause Ca²⁺i oscillations in the egg at physiological levels. Furthermore, eggs containing up 
to 1.6 pg of mPAWP protein, which is far exceeding physiological levels, also did not show 
any changes in Ca²⁺i levels (fig. 3.8).To directly compare the activity of PAWP to PLCζ at 
similar levels, PLCζ- luciferase cRNA was also microinjected into MII eggs alongside OGBD at 
varying RNA pipette concentrations (0.06μg/μl and 1μg/μl). Measurements for 
luminescence and fluorescence were recorded in the same way as for mPAWP-luciferase 
and mPLCζ protein levels were calculated. In eggs containing approximately 59 fg of PLCζ 
luciferase protein robust Ca²⁺i oscillations like those seen at fertilisation were recorded (fig 
3.7). If PLCζ-luciferase expression was increased to 360 fg Ca²⁺i oscillations again were 
recorded however this time at a higher frequency than those seen at fertilisation (fig 3.8). 
To determine if similar levels of expression were seen with the human derived PAWP used 
by (Aarabi et al. 2014b) a hPAWP-luciferase cRNA construct was produced by MN (hPAWP-
luciferase) (fig 3.1). A variety of pipette concentrations (0.04 μg/μl and 0.4 μg/μl) of 
hPAWP-luciferase cRNA mixed with OGBD were microinjected into eggs. The luminescence 
and fluorescence were measured in the same way as form PAWP-luciferase. At an average 
peak luminescence of 3.9 cps per egg which equates to approximately 59 fg of hPAWP 
protein inside the egg, which is comparable to the levels that should operate 
physiologically (Wu et al. 2007), no cytosolic Ca²⁺i changes were recorded (fig 3.9). No Ca²⁺i 
response was still seen in eggs expressing hPAWP-luciferase up to 46 cps, which far 
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exceeds physiological levels of PAWP found in the sperm (fig 3.9). These data suggest that 
human or mouse derived PAWP does not cause Ca²⁺i oscillations in mouse eggs at 
physiological levels or far exceeding them.  
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Figure 3.7 Example Ca²⁺i traces in eggs following injection of mPAWP-luciferase and mPLCζ-luciferase cRNA 
Examples of traces showing changes in cytosolic Ca²⁺i in MII eggs alongside firefly luciferase expression. Oocytes 
were microinjected with the Ca²⁺i indictor OGBD mixed with:  A) mPAWP-luciferase cRNA  (pipette 
concentration= 0.08 μg/μl, n=18 eggs) where the left trace shows changes in cytosolic Ca²⁺i in one egg and the 
right trace shows the luciferase expression in the same egg quantifying expression of mPAWP-luciferase cRNA, 
average luminescence at the end of the experiment for these eggs was 5.6 cps which equates to ~ 89 fg of 
mPAWP-luciferase protein per egg; and B) mPLCζ-luciferase cRNA (pipette concentration= 0.06μg/μl, n=13 
eggs) again the left trace shows changes in cytosolic Ca²⁺i in one egg and the right trace shows the luciferase 
expression in the same egg quantifying expression of mPLCζ -luciferase cRNA average luminescence for these 
eggs at the end of the experiment was 3.9 cps  which equates to ~59 fg of mPLCζ-luciferase protein per egg. The 
image shows the luminescence of mPAWP-luciferase and PLCζ- luciferase injected eggs being imaged at the 
same time (light integrated for 30 mins starting at 4 hours post injection) 
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Figure 3.8 Example Ca²⁺i traces in eggs following injection of high dose mPAWP-luciferase and mPLCζ-
luciferase cRNA 
Examples of traces showing changes in cytosolic Ca²⁺i in MII eggs alongside firefly luciferase expression. 
Oocytes were microinjected with the Ca²⁺i indictor OGBD mixed with:  A) mPAWP-luciferase cRNA  
(pipette concentration= 1.25 μg/μl, n=58 eggs) where the left trace shows changes in cytosolic Ca²⁺i in 
one egg and the right trace shows the luciferase expression in the same egg quantifying expression of 
mPAWP-luciferase cRNA average luminescence at the end of the experiment for these eggs was 56 cps 
which equates to ~ 1.6 pg of mPAWP-luciferase protein per egg; and B) mPLCζ-luciferase cRNA (pipette 
concentration= 1 μg/μl, n=57 eggs) again the left trace shows changes in cytosolic Ca²⁺i in one egg and 
the right trace shows the luciferase expression in the same egg quantifying expression of mPLCζ -
luciferase cRNA average luminescence at the end of the experiment for these eggs was 18 cps which 
equates to ~ 0.36 pg of mPLCζ-luciferase protein per egg. The image shows the luminescence of 
mPAWP-luciferase and PLCζ- luciferase injected eggs being imaged at the same time (light integrated 
for 30 mins starting at 4 hours post injection) 
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Figure 3.9 Example Ca²⁺i trace in an egg following injection hPAWP-luciferase cRNA 
Examples of traces showing changes in cytosolic Ca²⁺i in an egg alongside firefly luciferase expression. 
Oocytes were microinjected with the Ca²⁺i indictor OGBD mixed with PAWP-luciferase cRNA (pipette 
concentration= 0.04 μg/μl, n=27 eggs) where the left trace shows changes in cytosolic Ca²⁺i in one 
egg and the right trace shows the luciferase expression in the same egg quantifying expression of 
PAWP-luciferase cRNA average luminescence at the end of the experiment for these eggs was 3.9 cps 
which equates to approximately 59 fg of hPAWP-luciferase protein in the egg. Luminescence plotted 
as running average over 5 minutes. A pipette concentration of 0.4 μg/μl hPAWP–luciferase cRNA was 
also microinjected (n=15). These eggs had an average luminescence of 46 cps at the end of the 
experiment (data not shown). The image shows the luminescence of hPAWP-luciferase injected eggs 
being imaged at the same time (light integrated for 30 mins starting at 4 hours post injection) 
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PAWP is able to induce increased rates of 2nd polar body formation but not pronuclear 
formation 
The egg activating properties of PAWP were first recorded by (Wu et al. 2007) where 
bovine PAWP recombinant protein was found to induce pronuclear formation and meiotic 
resumption in porcine, bovine, Xenopus and rhesus monkey eggs. To investigate whether 
mouse PAWP has the ability to cause egg activation in mouse eggs following microinjection 
of untagged mPAWP, eYFP- mPAWP or mPAWP-Luciferase cRNA, eggs were scored for the 
resumption of meiosis indicated by 2nd Polar body extrusion and then pronuclear 
formation. These scores were then compared to those eggs injected with PLCζ- luciferase 
cRNA at similar levels as well as eggs injected with a control luciferase cRNA. On comparing 
activation levels eggs microinjected with mPAWP cRNA showed a small increase in the rate 
of 2nd polar body extrusion (fig 3.10). 
Of the eggs microinjected with mPAWP-luciferase (pipette concentration of 0.08 μg/μl) 
11% formed 2nd polar bodies compared to 5% seen with luciferase cRNA controls. Similar 
rates were seen in eggs injected with untagged mPAWP cRNA where 14 % formed 2nd polar 
bodies. A slightly higher 2nd polar body extrusion rateof 22%was found in eggs injected with 
eYFP mPAWP (Table 3.1). Despite this slight elevation in the amount of MII eggs resuming 
meiosis following PAWP cRNA introduction no pronuclear formation was seen in any of 
these eggs imaged. Furthermore as no Ca²⁺i oscillations were recorded in any eggs injected 
with PAWP the elevated rates of meiotic resumption can not a result of the physiological 
egg activation process which requires Ca²⁺i signalling. In contrast 100% of eggs injected with 
PLCζ-luciferase cRNA at similar concentrations formed 2nd polar bodies and underwent full 
egg activation to pronuclear formation. These results indicate that though PAWP may have 
the ability under some circumstances to resume meiosis, eggs microinjected with mPAWP 
or hPAWP do not undergo full egg activation including pronuclear formation. 
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Table 3.1 Summary showing the number of eggs forming 2nd Polar bodies following the 
microinjection of different cRNA 
 
 
  
 
cRNA injected 
 
Pipette Concentration 
of cRNA (μg/μl) 
 
 
n 
 
2nd Polar body  
formation rate (%) 
 
mPAWP- luciferase 0.08 18 11 
 
PLCζ- luciferase 0.06 13 100 
 
mPAWP untagged 1.25 28 14 
 
YFP-PAWP 1.5 23 22 
 
Luciferase Control 1.1 19 5 
 
A B 
 
Figure 3.10 Images of mouse eggs 4 hours post injection of PAWP or PLCζ 
MII eggs following microinjection of A) mPAWP-luciferase cRNA (pipette concentration= 1.25μg/μl, 
n= 18) and B) mPLCζ-luciferase (pipette concentration= 1μg/μl, n=13). 2
nd
 Polar body formation is 
visible in both groups at the end of 4 hours imaging 
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PPXY motif containing peptide does not inhibit Ca²⁺i oscillation in mouse eggs fertilised by 
IVF 
It has previously been suggested that the PY motif (PPXY) found within PAWP is crucial for 
its binding to the WWI domain of YAP, an interaction which is necessary for PAWP to 
stimulate the Ca²⁺i signalling pathway inside the egg (Wu et al. 2007). In order to 
investigate the role of this PY motif- WWI domain interaction in eliciting Ca²⁺i oscillations in 
mouse eggs a 20 amino acid synthetic peptide (PPVRYGSPPPGYEAPT) containing the PPXY 
motif (PPGY) derived from PAWP (PPXY peptide) was microinjected into MII eggsat pipette 
concentrations of either 0.5 μg/μl or 2.5 μg/μl alongside the Ca²⁺i indicator OGBD. This was 
the exact same peptide sequence used by Aarabi at al. and upon microinjection, this PPXY 
peptide should competitively bind to YAP thus inhibiting the interaction of PAWP with YAP 
(Wu et al. 2007). These eggs were then fertilised by IVF and Ca²⁺i changes were recorded. 
Eggs injected with the peptide displayed oscillations very similar to those normally seen at 
fertilisation and similar to control eggs not injected with the peptide (fig 3.11 and Table 
3.2). Similar effects were seen in those eggs that had been fertilised by ICSI (fresh sperm 
injection) as there was no clear difference between amount of eggs that oscillated 
following injection of the PPXY peptide compared to those eggs that underwent ICSI alone 
(data not shown, conducted by colleague Randa Sanusi). These results imply that the PPXY 
peptide has no inhibitory effect on Ca²⁺i signalling in fertilised eggs and therefore the PY 
motif-WWI domain interaction is not necessary to elicit Ca²⁺i oscillations at fertilisation. 
PPXY motif containing peptide does not inhibit PLCζ inducedCa²⁺i oscillations 
In order to ensure that the PPXY motif didn’t perturb the activity of PLCζ, the PPXY motif 
containing peptide (same pipette concentrations as above) was microinjected into mouse 
eggs prior to a secondary microinjection of PLCζ-luciferase cRNA at a pipette concentration 
of 0.1 μg/μl. These eggs displayed Ca²⁺i oscillations similar to those seen at fertilisation and 
those elicited by PLCζ alone (fig 3.12).  This suggests that inhibiting the PY motif-WWI 
domain interaction does not disrupt Ca²⁺i oscillations elicited by PLCζ as well as IVF and ICSI. 
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Pipette 
concentration of 
PPXY peptide (μg/μl) 
 
n 
 
mean number of  Ca²⁺i 
oscillations in 2 hrs 
 
SD of mean number of 
oscillations/2hrs 
0.5  8 27.9 6.1 
2.5  9 21.9 7.7 
No peptide  8 22.4 5.9 
 
Table 3.2 Summary showing the effect of PPXY on the Ca²⁺i oscillations at fertilisation 
Summary of the mean number of Ca²⁺i oscillations in 2 hours for IVF fertilised eggs that have been 
injected with different pipette concentrations of the PPXY peptide (peptide containing a PPGY motif) 
which may disrupt YAP-PAWP binding  and control eggs not injected with PPXY peptide  
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Figure 3.11 Example Ca²⁺i traces of fertilised mouse eggs following injection of PPXY 
Sample traces showing changes in cytosolic Ca²⁺i in eggs that were microinjected with Ca²⁺i 
indictor OGBD and A) a competitive peptide containing the PPXY motif that is thought to 
inhibit PAWP – YAP interaction (pipette concentration 2.5 μg/μl, n=13 eggs), B) the same 
peptide but at a lower pipette concentration (pipette concentration 0.5 μg/μl, n=8 eggs) C) 
OGBD alone (n= 12). All eggs were then fertilised by IVF using fresh mouse sperm during 
imaging. 
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Figure 3.12 Example Ca²⁺i traces in mouse eggs initiated by PLCζ following injection of PPXY 
Sample traces showing changes in cytosolic Ca²⁺i in eggs that were microinjected with Ca²⁺i 
indictor OGBD and mPLCζ-luciferase cRNA (pipette concentration 0.1 μg/μl). A) also injected 
with a competitive peptide containing the PPXY motif that is thought to inhibit PAWP – YAP 
interaction (pipette concentration 0.5 μg/μl, n= 16 eggs) (average luminescence for all eggs = 
0.9cps); whereas B) was injected with mPLCζ-luciferase  alone (n=8) (average luminescence 
for egg = 0.6 cps) 
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Discussion 
 Though the importance of Ca²⁺i oscillations for egg activation is undisputed there is still 
some debate surrounding the identity of the sperm factor which is responsible for 
triggering Ca²⁺i oscillations in the egg. The most widely accepted view is that the sperm 
specific PLCζ, which is deposited into the egg at fertilisation, stimulates IP₃ induced 
Ca²⁺release (Saunders et al. 2002). However, the sperm specific structural protein PAWP 
has been proposed as an alternative sperm factor candidate. PAWP has been found to 
induce egg activation up to pronuclear formation in bovine,  rhesus monkey, porcine and 
Xenopus eggs following the microinjection of bull derived PAWP recombinant protein (Wu 
et al. 2007). PAWP recombinant protein has also been reported to induce a Ca²⁺i change 
following its injection into Xenopus eggs (Aarabi et al. 2010). It is important to note 
however that this Ca²⁺i change recorded in these eggs was not comparable to the Ca²⁺i 
increase seen during fertilisation in Xenopus. Usually in a fertilised Xenopus egg a 
regenerative Ca²⁺i wave crosses the egg starting at the point of sperm entry and takes 
approximately 5 minutes to propagate across the egg (Bugrim et al. 2003). On 
microinjection of recombinant PAWP into Xenopus eggs the Ca²⁺i appeared to increase 
uniformly through the entire cytoplasm within 1 minute of imaging (Aarabi et al. 2010). 
This is not comparable to the physiological Ca²⁺i wave seen in Xenopus eggs at fertilisation. 
In addition a membrane permeable Ca²⁺i indictor was used during this study (Aarabi et al. 
2010) which is generally not used in Xenopus eggs. As the eggs of these species are very 
large, the length of incubation time necessary with membrane permeable dyes is much 
longer than usually used. As a result dyes may be compartmentalised in the egg cortex and 
therefore not diffuse across the whole cell. Therefore changes in Ca²⁺i that occur deep in 
the cytoplasm may not be detected accurately.  
Bovine recombinant protein and bovine PAWP cRNA have also been shown to elicit Ca²⁺i 
oscillations in mouse and human eggs respectively (Aarabi et al. 2014b) at final 
concentrations of 100 fg to 2.5 pg per oocytes with the equivalent of approximately 89 fg of 
PAWP protein calculated in a single bull sperm (Wu et al. 2007). Despite these data, the 
effects of PAWP are yet to be reproduced by another independent research group. The 
current study aimed to investigate the egg activating effects of PAWP and whether mouse 
PAWP was able to induce Ca²⁺i oscillations in mouse eggs as would occur physiologically 
and therefore verify the results previously recorded. In the study by (Aarabi et al. 2014b) 
untagged (his tag only) recombinant hPAWP protein was microinjected into the eggs 
however this protein was found to be insoluble so instead a NusA tagged form of  mPAWP 
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and hPAWP recombinant protein was produced to microinject into mouse eggs. However, 
in these experiments neither NusA-mPAWP nor NusA-hPAWP recombinant protein were 
able to induce Ca²⁺i oscillations, unlike the results previously reported using human PAWP 
recombinant protein (Aarabi et al. 2014b). It has been suggested that the presence of a 
molecular tag such as NusA could affect the activity of PAWP (Aarabi et al 2015) however it 
is unlikely that this would be the case as the activity of PLCζ is unperturbed by the addition 
of a NusA, fluorescent or luminescence based tag. However, to be sure this was not the 
case untagged PAWP cRNA was also microinjected into eggs which becomes expressed 
endogenously by the egg. Neither mouse nor human untagged cRNA was able to cause 
Ca²⁺i oscillations in mouse eggs at a large range of concentrations. Expression of PAWP was 
verified by carrying out a western blot on hPAWP cRNA expressing eggs using an antibody 
against hPAWP (conducted by MN, Nomikos et al 2014a). To further quantify the effect of 
PAWP, mPAWP- luciferase cRNA was microinjected into mouse eggs to range from 
approximately 100 fg – 2 pg final concentration of protein per egg. However, even though 
physiologically PAWP at these levels should elicit Ca²⁺i oscillations (Wu et al. 2007) no 
cytosolic Ca²⁺i  changes were recorded in any of eggs injected with mouse or human PAWP 
cRNA. This result is in steep contrast to the Ca²⁺i oscillations induced by human PAWP cRNA 
in human eggs by (Aarabi et al. 2014b). In experiments by Aarabi et al PAWP was found to 
be incredibly potent, causing Ca²⁺i oscillations at a pipette concentration as low as 0.006 
μg/μl.  However, this was not found to be the case in the current experiments as 
fluorescent tagged proteins must be expressed at cellular concentrations of at least 1μM to 
be seen. This means eggsinjected with YFP-mPAWP cRNA must have contained around 10 
pg of YFP-mPAWP protein at the end of the experiment which is approximately 100 x more 
mPAWP in the eggs than was previously been reported to release Ca²⁺  (Wu et al. 2007). 
Despite the eggs being microinjected with final concentrations of PAWP cRNA either 
equivalent to, or at much higher levels than those previously reported to work, no Ca²⁺i 
oscillations were recorded in any eggs. PAWP was not able to elicitCa²⁺i oscillations 
following microinjection of either human and mouse derived untagged PAWP cRNA, YFP-
PAWP cRNA, or mouse and human derived PAWP-luciferase cRNA. This would indicate that 
PAWP is not able to activate eggs by triggering Ca²⁺ioscillations under physiological 
conditions at PAWP concentrations found within the sperm or far exceeding. In contrast, 
the equivalent tagged constructs of PLCζ at the same levels and under the same conditions 
produced Ca²⁺i oscillations similar to those seen at fertilisation.  
94 
 
Tagging PAWP cRNA with a luciferase or fluorescent tag as described above acted as an 
internal verification that the cRNA was being expressed. However, in the study by (Aarabi 
et al. 2014b) no such verification or quantification of PAWP expression was performed. As a 
result we cannot be sure of the levels of PAWP that were being expressed in the eggs 
injected with PAWP cRNA during the previous study. In the paper by (Aarabi et al. 2014b) 
intracellular Ca²⁺i changes were measured using a membrane permeable Ca²⁺i indictor in 
which the eggs are incubated in prior to microinjection of PAWP cRNA or recombinant 
PAWP protein. This means that the fluorescence signal produced by the eggs was 
independent of microinjection. Consequently even if a fluorescence signal is seen it is 
unclear what quantity of PAWP cRNA, if any, was microinjected into the eggs. In the 
present study not only was PAWP cRNA tagged for quantification of expression but the 
Ca²⁺i indictor was co-injected with either PAWP cRNA or recombinant protein. This means 
that the fluorescence signal from the Ca²⁺i indicator ensures that both the Ca²⁺i dye and 
cRNA or recombinant protein have both been injected into the egg. 
One other important factor to consider is the method of microinjection. In the study by 
(Aarabi et al. 2014b) solution was injected into the eggs using an ICSI style pipette with a 
wide bore. The injection solution was then sucked into the injection pipette and carried 
over to the egg for injection. This method may have issues with diffusion of solution out of 
the end of the pipette and back-flux of media into pipette prior to insertion into egg. When 
using a low pressure injection method such as this back-flux and diffusion of injection 
solution can be avoided by “capping” the end of the injection pipette with oil prior to 
injection (Kline 2009). However, it does not appear that (Aarabi et al. 2014b) took these 
precautions. In the paper by (Wu et al. 2007) control eggs were injected with  BSA in the 
same way as PAWP using an ICSI style pipette.  BSA is easy to inject and not necessarily a 
good control as it is not comparable to injecting protein or cRNA containing solutions.  As 
the activation rates of BSA injected control eggs were relatively high (around 18%) this 
would indicate that an elevated activation rate occurred as result of the microinjection 
process alone (Wu et al. 2007). During the present study control eggs were microinjected 
with luciferase cRNA and activation rates of 5% were recorded. It is likely that the form for 
microinjection process used by (Wu et al. 2007) and (Aarabi et al. 2014b) resulted in the 
elevated egg activation rate reported. In the present study a slightly elevated rate of eggs 
undergoing meiotic resumption was recorded in eggs injected with mPAWP cRNA however 
this was considerably lower than the 80% activation rate previously recorded  (Wu et al. 
2007). Furthermore none of the eggs formed pronuclei. The slightly elevated rate of 
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meiotic resumption may be a result of a non-physiological effect of PAWP downstream of 
Ca²⁺ signalling. 
As PAWP lacks any known catalytic or PLC hydrolytic activity it was not possible to verify its 
activity before injecting it into eggs. It was found that, in vitro, PAWP is unable to hydrolyse 
PI(4,5)P₂ or act as a generic activator of PLC (Nomikos et al. 2014a). However, it has 
previously been argued that PAWP may not directly hydrolyse PI(4,5)P₂ instead works by 
activating PLCγ indirectly through PAWP binding YAP (Aarabi et al. 2014b). If this is the case 
we would not expect PAWP to hydrolyse PI(4,5)P₂  in vitro unless YAP and PLCγ were also 
present. There is evidence to suggest that stimulation of PLCγ is responsible for Ca²⁺ 
release at fertilisation in some invertebrate species for example in ascidian eggs (Runft and 
Jaffe 2000), sea urchin eggs (Carroll 1999; Abassi et al. 2000) and starfish eggs (Giusti et al. 
1999b). In these cases the Ca²⁺i increase at fertilisation could be inhibited by the injection 
of SH2 domains of Src family proteins which act as an inhibitor of Src family kinases.  Src 
kinases such as Fyn and Yes undergo autophosphorylation to become activated which then 
allows them to phosphorylate and activate PLCγ. PLCγ may then hydrolyse PI(4,5)P₂ to elicit 
IP₃ induced Ca²⁺release. Indeed in Xenopus eggs, immunoprecipitation studies have shown 
that PLCγis tyrosine phosphorylated and activated within minutes of fertilisation. 
Furthermore inhibiting the interaction of PLCγ and xyk (Src related tyrosine kinase) with a 
Src- related protein- tyrosine kinase (PTK) inhibitor blocks the Ca²⁺i increase seen at 
fertilisation (Sato et al. 2000). This evidence adds support for the role of PLCγ in stimulating 
Ca²⁺release in eggs at fertilisation however the mechanism by which PLCγ is stimulated is 
still unknown in these species. The idea that the Ca²⁺i oscillations at fertilisation may be a 
result of PLCγ induced Ca²⁺release has been around for some time and various sperm 
derived stimuli for this pathway have been proposed. For example in Xenopus eggs the 
sperm may cause phospholipase D (PLD) induced phosphatidic acid (PA) production which 
then activates egg derived Src to elicit PLCγ induced Ca²⁺ release (Bates et al. 2014). PA 
levels have been seen to increase soon after fertilisation and inhibitors for PA production 
prevent some of the events of fertilisation including gravitational rotation and delays in the 
Ca²⁺i wave normally seen at fertilisation (Bates et al. 2014).  
In mouse eggs an alternative sperm derived stimuli has previously been proposed in 
addition to PAWP in the form of the tyrosine kinase receptor tr-kit which accumulates in 
elongating spermatids (Sette et al. 1997). This is a truncated form of c-kit tyrosine kinase 
receptor which includes the carboxy terminus needed for PLCγ interaction and the 
phosphotransferase portion of cytoplasmic catalytic domain (Sette et al. 1997). Tr-kit is 
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located in the equatorial region of the sperm and appears to be an indicator for sperm 
quality as TUNEL analysis has shown a sufficient amount of tr-kit is required to maintain 
sperm DNA integrity (Muciaccia et al. 2010). Recombinant tr-kit protein and tr-kit mRNA 
have been found to induce parthenogenetic egg activation including resumption of meiosis 
and pronuclear formation following microinjection into MII mouse eggs (Sette et al. 1997).  
Furthermore co-injection of SH domains of PLCγ fused to a glutathione-s-transferase tag 
(SH-GST) alongside tr-kit has the ability to competitively inhibit egg activation (Sette et al. 
1998). Interestingly it is the SH3 region which is most effective at this inhibition as appose 
to SH2 domain and the effect is specific to SH3 domains derived from PLCγ. SH3 domains 
from Growth Receptor bound protein 2 (Grb2) do not have the same effect (Sette et al. 
1998). It has been proposed that tr-kit becomes phosphorylated by Fyn (a Src family kinase) 
whichin turn mediates the phosphorylation and auto-phosphorylation of PLCγ1 (Sette et al. 
2002).   
Even though this data suggests that tr-kit may be the sperm specific factor that causes egg 
activation it also adds support to the idea that Ca²⁺i oscillations at fertilisation in mouse 
eggs are initiated by the stimulation of PLCγ via its SH3 domain as proposed by (Aarabi et 
al. 2014b). It’s important to note however that tr-kit has never been reported to cause Ca²⁺i 
oscillations in eggs. Furthermore the role of PLCγ in stimulating IP₃ induced Ca²⁺release in 
mammalian eggs has previously been challenged. The microinjection of SH2 and SH3 
domains for PLCγ1 and PLCγ2 in eggs at an excess of approximately 100-400 times the 
endogenous levels of PLCγ did not inhibit Ca²⁺ release at fertilisationin mouse eggs. 
However this did inhibit the release of Ca²⁺ by PLCγ exogenously stimulated by platelet-
derived growth factor (PPGF) receptor (Mehlmann et al. 1998). In addition microinjection 
of SH2 domains from Src family kinases such as Fyn and Yes had no inhibitory effect on the 
Ca²⁺release at fertilisation in mouse eggs (Mehlmann and Jaffe 2005) unlike some 
invertebrates like sea urchins (Kinsey and Shen 2000). Furthermore incubating porcine 
sperm extracts with Src family kinase inhibitors had no effect on the sperm extracts ability 
to cause Ca²⁺i oscillations when injected into eggs (Kurokawa et al. 2004). This would 
suggest that SH domain mediated activation of PLCγ or Src family kinase, in contrast to 
some invertebrates and possibly amphibians, are not necessary for the Ca²⁺release at 
fertilisation in mammalian species. As a result, PAWP is unlikely to work through this 
pathway. It is possible however, that Src family kinases are involved in egg activation 
events downstream of Ca²⁺i signalling and may be required for effective oocyte maturation 
(Levi and Shalgi 2010).  
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To investigate the proposal that PAWP-YAP interaction is vital for physiological Ca²⁺i 
signalling initiation in mammalian eggs a peptide including the PPXY motif was injected into 
eggs alongside a Ca²⁺i indicator and then fertilised by IVF. The PPXY peptide has previously 
been shown to inhibit egg activation (Wu et al. 2007) and Ca²⁺i oscillations in mouse and 
human eggs fertilised by ICSI or those injected with PAWP (Aarabi et al. 2014b). The 
peptide is suggested to inhibit these oscillations by disrupting PAWP binding to YAP by 
outcompeting its binding through the PPXY motif (Aarabi et al. 2014b). The present study 
found no disruption in the Ca²⁺i oscillations of eggs fertilised by IVF following injection of 
PPXY when compared to control IVF eggs. Both frequency and pattern of oscillations were 
indistinguishable in eggs injected with Ca²⁺i indicator alone and a range of PPXY peptide 
concentrations. Furthermore no difference was seen in the amount of eggs that oscillated 
post ICSI fertilisation in those injected with the PPXY peptide and not. If PAWP does initiate 
IP₃ induced Ca²⁺release in this way there would be some delay in the Ca²⁺i increase 
recorded. Therefore it would not be possible for a uniform Ca²⁺i increase to be seen in a 
Xenopus egg within 1 minute as has previously been reported by (Aarabi et al. 2010).These 
data show further flaws in the pathway of PAWP signalling that has previously proposed 
(Aarabi et al. 2014b). Though PAWP may have the ability to bind to YAP and src-family 
tyrosine kinases expressed in the egg (Wu et al. 2007) it does not appear to initiate 
Ca²⁺release in this way physiologically during fertilisation. 
PAWP’s lack of involvement in Ca²⁺release at fertilisation has recently been further 
supported through the development of a PAWP null mutant mouse model (Satouh et al. 
2015). Male mice of this strain appeared to be perfectly fertile and the sperm from these 
mice was able to sufficiently activate eggs through Ca²⁺release in a manner comparable to 
controls. The sperm morphology of these mice was also unaltered and embryos produced 
via ICSI using this sperm developed at rates indistinguishable from controls (Satouh et al. 
2015). These data suggest that PAWP plays no involvement in egg activation in mammalian 
eggs and does not correlate convincingly to sperm quality parameters in terms of 
fertilisation or early development rates.  This result strongly supports the current studies 
that PAWP appears to play not obvious role in egg activation and is not the sperm factor 
causing Ca²⁺i oscillations at fertilisation.  
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4. FURTHER INVESTIGATIONS INTO STRUCTURAL PROPERTIES 
OF PLCZ THAT DETERMINE CA²⁺ RELEASING ACTIVITY 
Introduction 
PLCζ is the only sperm derived protein that has been shown without dispute to cause Ca²⁺i 
oscillations when introduced into mammalian eggs at physiological levels (Saunders et al. 
2002). This feature is unique amongst phospholipase C isoforms and the only other PLCs 
that are able to initiate Ca²⁺ release in eggs do so at levels far greater than physiological 
(Mehlmann et al. 2001; Swann et al. 2006; Igarashi et al. 2007). Despite PLCζ possessing the 
most elementary structure of all PLCs it has a far greater sensitivity for Ca²⁺ inside the egg 
which allows it to be active at basal levels of Ca²⁺i (Kouchi et al. 2004; Nomikos et al. 2005).  
PLCζ has been found to be most homologous with PLCδ1 for which it shares 47% similarity 
and is 33% identical, however, PLCδ1 has some major structural differences when 
compared to PLCζ which regulates its activity (Saunders et al. 2002). To begin with PLCζ 
lacks the pleckstrin homology (PH) domain that is found in PLCδ1 and many other PLCs.  
This domain allows binding to the target plasma membrane which is essential in enabling 
PLCδ1 to interact with its substrate PI(4,5)P₂ (Lemmon et al. 1995).  Interestingly PLCζ  does 
not appear to hydrolyse PI(4,5)P₂ at the plasma membrane, instead seems to target an 
alternative intracellular source of PI(4,5)P₂  found on small vesicles (Yu et al. 2012). This 
raises the question of how PLCζ is able to discriminate between different pools of PI(4,5)P₂ 
or convey membrane specificity in terms of its localisation inside the egg. It appears the 
structure of PLCζ may have a significant role in determining these unusual properties.  
It has already been shown that unique properties of the linker region between the X and Y 
catalytic domains of PLCζ influence its activity by modulating membrane interactions 
(Nomikos et al. 2007). The X-Y linker region of most PLCs has a regulatory role in catalytic 
auto-inhibition (Hicks et al. 2008). In most isoforms this region contains many negatively 
charged residues which exclude the negatively charged PI(4,5)P₂ from the active site 
through electrostatic repulsion (Hicks et al. 2008; Hajicek et al. 2013). However, unlike 
other PLCs PLCζ does not regulate auto inhibition. In contrast the X-Y linker of PLCζ is longer 
and contains more positively charged amino acid residues than, for example, PLCδ1 (Cox et 
al. 2002; Saunders et al. 2002). Testing the Ca²⁺releasing activity of PLCζ following point 
mutations which neutralise the positively charged residues in the X-Y linker has revealed 
the importance of these residues in allowing PLCζ to bind to PI(4,5)P₂ (Nomikos et al. 
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2011b). A series of constructs were created that contained PLCζ with point mutations to 
neutralise the positively charged residues within the X-Y linker. These mutations were then 
tagged to the firefly luciferase sequence to produce fusion constructs. These constructs 
were synthesised into RNA and injected into eggs so their Ca²⁺i releasing effects could be 
measured (Nomikos et al. 2011b). By measuring the luminescence of the eggs during the 
course of the experiment this allowed quantification of the expression levels of the PLCζ 
cRNA which acted as an internal control so allowing constructs to be compared (Swann et 
al. 2014).  Neutralisation of one, two or three of these positive residues causes a sequential 
decrease in the frequency of Ca²⁺i oscillations induced by PLCζ as a result of reduced 
PI(4,5)P₂  binding (Nomikos et al. 2011b). This work shows these residues create a 
positively charged region close to the catalytic domains that is able to electro-statically 
interact with the negatively charged PI(4,5)P₂ (Nomikos et al. 2011b; Nomikos et al. 2011c). 
However, even deletion of the whole X-Y linker region does not abolish all Ca²⁺ releasing 
ability of PLCζ (Nomikos et al. 2011c) which suggests that PI(4,5)P₂ binding and membrane 
interaction is also regulated by other structural domains possibly in a redundant fashion.  
One possible structural feature of PLCζ that could facilitate lipid interaction is the EF hands 
domain. Indeed this appears to be the case for PLCδ1 as a region of hydrophobic cationic 
residues found in the first EF hand motif has been found to positively interact with anionic 
phospholipids (Cai et al. 2013). These anionic phospholipids are found in target membranes 
such as the plasma membrane and the interaction is thought to enable PLCζ access to 
membrane bound PI(4,5)P₂ (Cai et al. 2013).  Interestingly this region of cationic residues is 
conserved in PLCζ, however, whether this region has a role in regulating PLCζ membrane 
and substrate interaction is yet to be established.  
Another structural domain of PLCζ that could have a role in conferring membrane 
specificity is the C2 domain. In other proteins C2 domains usually mediate membrane 
binding in a Ca²⁺ dependent manner through direct interaction with phospholipids 
(Medkova and Cho 1999). For example the C2 domain of PLCδ1 associates with plasma 
membrane bound phosphatidylserine where it becomes sequestered therefore stimulating 
activity of the protein (Lomasney et al. 1999). PLCζ is not able to initiate Ca²⁺ release 
following deletion of the C2 domain from its sequence which suggests that this region is 
vital for PLCζ’s Ca²⁺releasing activity in eggs (Nomikos et al. 2005). In vitro the C2 domain of 
PLCζ has been found to bind to the phospholipids PI(3)P and PI(5)P with low affinity (Kouchi 
et al. 2005). However, neither PI(3)P or PI(5)P appear to be distributed in the same 
vesicular pattern as PLCζ is found to be in the egg (Yu and Swann 2012 unpublished). This 
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implies that PLCζ is not topologically interacting with PI(3)P or PI(5)P making them unlikely 
binding partners in vivo. Furthermore it has been suggested that in vitro interaction with 
particularly PI(3)P actually inhibits the activity of PLCζ (Kouchi et al. 2005). This leaves the 
nature of PLCζ C2 domain membrane interaction unclear. Recently however, a human 
homozygous mutation within the C2 domain of PLCζ has been associated with infertility in 
patients (Escoffier et al. 2015a). A clinical study was conducted of 2 infertile brothers who 
both had total fertilisation failure following ICSI however had completely normal sperm 
morphology parameters. Whole exomic sequencing was carried out and only one missense 
mutation was found and that was in the C2 domain of PLCζ where isoleucine (Ile) 489 is 
converted into a phenylalanine (F) (Escoffier et al. 2015a). Injection of this protein into eggs 
was found to elicit an abnormal Ca²⁺i oscillatory pattern and poor developmental outcomes 
for embryos (Escoffier et al. 2015a). Furthermore it was suggested that these effects could 
be a result of reduced levels of PLCζ protein in the sperm, mislocalisation of the protein in 
the egg and a reduction of enzymatic activity possibly as a result of protein instability or 
misfolding (Escoffier et al. 2015a). However, there is not yet any solid evidence for these 
claims so exactly how this mutation within the C2 domain results in such a striking 
phenotype remains unknown.  
It is also possible that the structure of PLCζ could modulate its activity indirectly through 
interactions with mediator proteins. These interactions may be particularly important 
forPLCζ as it lacks many of the additional specific structural regions like a PH domain found 
in other PLCs that help modulate activity and membrane binding specificity (Lemmon et al. 
1995). For example PLCβ has a calmodulin (CaM) binding site within its N’ terminusand in 
vitro studies have shown that PLCβ positively interacts with CaM (McCullar et al. 2003). In 
this case CaM regulates PLCβ binding to membrane associated proteins such as G coupled 
proteins in a Ca²⁺ dependent manner therefore stimulating the enzymes activity (McCullar 
et al. 2007). A CaM binding motif has also been found in the catalytic domain of PLCδ1 
(Sidhu et al. 2005). However, in this case, CaM binding acts as an inhibitor for PLCδ activity, 
an affect that can be reversed by the activation of the small GTPase Ral (Sidhu et al. 2005). 
It has therefore been proposed that Ral and CaM act as a regulatory complex for PLCδ1 
activity (Sidhu et al. 2005).  Interestingly PLCζ also has a CaM binding motif however the 
role of this motif, CaM or any other potentially regulatory protein is yet to be established.  
It has been suggested that proteolytic processing of the X-Y linker could modulate PLCζ 
activity (Kurokawa et al. 2007). It was previously discovered that there are two fractions of 
the sperm that are able to initiate Ca²⁺i oscillations on injection into mouse eggs (Kurokawa 
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et al. 2005). The soluble cytosolic fraction which can be easily extracted contains a large 
amount of full length PLCζ which can be detected by immunoblotting (Kurokawa et al. 
2005). In contrast the high pH soluble fraction contains very little full length 72kDa PLCζ 
however still causes Ca²⁺i oscillations when introduced into eggs (Kurokawa et al. 2005). It 
was later found that this high pH soluble fraction contained PLCζ that had been 
proteolytically cleaved in the X-Y linker (Kurokawa et al. 2007). In fact if recombinant full 
length PLCζ is cleaved using the protease V8 derived from Staphylococcus aureusit is still 
able to cause Ca²⁺i oscillations in eggs (Kurokawa et al. 2007). Furthermore if PLCζ cRNA 
comprising of the two cleaved halves is co-expressed in eggs Ca²⁺i oscillations can be 
recorded and embryos develop well (Kurokawa et al. 2007). However, it has not yet been 
established how effective this split PLCζ is at causing Ca²⁺i oscillations compared to full 
length PLCζ or how proteolytic cleavage might regulate the activity of PLCζ in vivo. 
Aims 
Though some of the structural properties of PLCζ have been linked to its Ca²⁺i oscillation 
inducing abilities in eggs there are still many unresolved issues regarding how PLCζ 
discriminates between different pools of PI(4,5)P₂  and how the structural domains of PLCζ 
are involved in its binding to specific membranes. Positively charged residues within the X-Y 
linker appear to play a role in anchoring PLCζ to its substrate PI(4,5)P₂ however this domain 
does not account for all PLCζ PI(4,5)P₂  binding (Nomikos et al. 2011b; Nomikos et al. 
2011c). Firstly, this project aims to determine if the positively charged residues found in EF 
hand domain of PLCζ have a role in conveying PLCζ’s Ca²⁺releasing ability in vivo and if so 
whether this is due to specific phospholipid binding or mis-localisation of PLCζ in the egg. 
Secondly the role of the C2 domain in membrane binding and Ca²⁺ release will be 
investigated by exploiting the recent identification of a missense mutation in this region 
that has been correlated to male infertility. Next the role of the CaM binding motif in 
regulating the Ca²⁺releasing activity of PLCζ will be investigated. Finally this project will 
attempt to quantify the effect of proteolytic cleavage on the activity of PLCζ RNA and 
whether species differences in Ca²⁺i oscillations elicited by this RNAcan be measured.  
Results 
Neutralising the positively charged residues within the EF hand domain affects PLCζ’s 
Ca²⁺releasing ability 
It has previously been reported that positively charged residues within the first pair of EF 
hands of PLCδ1 are responsible for mediating the enzyme’s interaction with membranes 
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through anionic phospholipid binding (Cai et al. 2013). This region is conserved within PLCζ 
and may also have a role in anchoring PLCζ to intracellular membranes. In order to 
investigate the role of these positively charged residues in PLCζ  a series of cRNA constructs 
of mouse PLCζ were created with containing point mutations to neutralise positive residues 
within this region (courtesy of MN). Three single mutated constructs were created where 
the amino acids Lysine-49 (K49A), Lysine-53 (K53A) or Arginine-57 (R57A) were substituted 
for the neutral alanine using direct mutagenesis. In addition a double mutant construct was 
created with both K49A and R57A mutations (KR49,57AA), a triple mutant with all 3 
mutations (KKR49,53,57AAA) and a wild type mouse PLCζ (WT). These sequences were 
tagged with the firefly luciferase gene so fusion cRNA constructs of PLCζ-luciferase could be 
produced (See fig 4.1). Tagging the PLCζ in this way allows expression of the protein in situ 
to be measured by recording the luminescence given off by the eggs and therefore direct 
comparisons can be made between groups.  
These constructs were each tested for their Ca²⁺releasing ability by microinjection into eggs 
along with the Ca²⁺i indictor Orgeon Green BAPTA Dextran (OGBD) to measure Ca²⁺i 
fluctuations. All three single mutated versions of PLCζ, PLCζK49A, PLCζK53A and PLCζR57Acaused 
a reduction in the number of Ca²⁺i oscillations recorded in the first hour of the eggs 
oscillating when compared to PLCζWT (see fig 4.2 and Table 4.1). Despite similar cRNA 
expression levels the single mutations caused a significant reduction of around 58% in the 
number of Ca²⁺i oscillations when compared to wild type PLCζ (see fig 4.2, fig 4.6 and Table 
4.1). Each of the single mutations had very similar effects on the Ca²⁺ releasing ability of 
PLCζ. Interestingly the double mutation, PLCζKR49,57AA , also had very similar effects on the 
frequency of Ca²⁺i  oscillations as PLCζ
K49A, PLCζK53A and PLCζR57A (see fig 4.2, fig 4.6 and Table 
4.1).  PLCζKR49,57AA  caused a 62% decrease in the number of Ca²⁺i oscillations in the first hour 
of oscillating when compared to PLCζWT at comparable expression levels and was shown to 
be significantly different (see Table 4.1). However, the triple mutation PLCζKKR49,53,57AAA  
caused a more severe reduction in the number of Ca²⁺i oscillations of around 71% and again 
this was significantly reduced compared to PLCζWT at a similar expression levels (see Table 
4.1). This suggests that neutralising even one residue in the positively charged region of the 
EF hand domain of PLCζ has a detrimental impact on the ability for PLCζ to cause Ca²⁺i 
oscillations. This effect is more severe if all three of these positively charged residues are 
neutralised.  
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The effect of mutations within the EF hand domain can be rescued by over-expression 
As neutralising the positive residues within this region of the first EF hand reduces the 
frequency of Ca²⁺i oscillations it was important to see if this effect was due to reduced 
Ca²⁺releasing ability of PLCζ and whether this effect could be rescued with higher levels of 
protein expression. To test this a higher concentration of mouse PLCζKKR49,53,57AAA–luciferase 
cRNA was injected into eggs and the number of Ca²⁺ioscillations in the first hour of 
oscillating was calculated the same way as previously. At expression levels 16 times the 
level of PLCζWT, PLCζKKR49,53,57AAA was able to cause Ca²⁺i oscillations at a frequency that were 
not significantly different from PLCζWT (see fig 4.3, fig 4.6 Table 4.1). However, this data 
appeared much more scattered than that seen using PLCζWT (see Table 4.1). This is probably 
because as the pipette concentration of cRNA is increased so does the variation of 
expression level within the egg. These data suggest the positive residues within the EF hand 
domain do have some role in determining PLCζ Ca²⁺i releasing activity and mutating these 
residues makes the enzyme less efficient at releasing Ca²⁺. However, this effect can be 
rescued with over-expression of the protein. 
 
EF Hand Domain Mutations  
Figure 4.1 Schematic showing the mutations made the EF hand domain of mPLCζ 
The structural domains of mouse PLCζ and the residue substitutions carried out by point directed mutagenesis 
to create mutant RNA constructs of mPLCζ- luciferase. Positively charged residues in the 1
st
EF hand were 
neutralised for the amino acid alanine. Mutations were as follows: WT) wild type PLCζ sequence, K49A) 
substitution of the lysine at residue 49 for alanine, K53A) substitution for lysine at residue 53 for alanine, R57A) 
substitution for arginine at residue 57 for alanine, KR49,57AA) both the K49A and R57A substitutions were 
made simultaneously and KKR49,53,57AAA) the K49A,K53A and R57A substitutions were made simultaneously 
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Figure 4.2 Sample Ca²⁺i traces initiated by mPLCζ containing mutations in the EF hand domain 
Ca²⁺i and luminescence changes that occurred in individual eggs following microinjection of the Ca²⁺i 
indicator OGBD with the one of the following mPLCζ RNA constructs: A) Wild Type PLCζ- Luciferase 
RNA, B) PLCζ
KKR49,53,57AAA
- luciferase RNA (Triple EF mutant), C) PLCζ
KR49,57AA
 - luciferase RNA (Double 
EF mutant), D) PLCζ
 K49A
-luciferase RNA, E) PLCζ
K53A
-luciferase RNA and F) PLCζ
R57A
-luciferase RNA. All 
constructs were injected at a pipette concentration between 0.025 and 0.05 μg/μl. Fluorescence 
coloured in red shows relative changes in cytosolic Ca²⁺i and luminescence shown in black is 
measured in photon counts per second and is used as an indicator of PLCζ protein expression. Lumin 
= mean counts per second in the first hour of oscillating across the group, Spikes= mean total 
number of Ca²⁺i spikes in 1
st 
hour of oscillations. See Table 4.1 for details of n values.  
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Figure 4.3 Sample Ca²⁺i trace initiated by mPLCζ containing triple mutation in the EF hand domain 
Ca²⁺i and luminescence changes that occurred in individual eggs following microinjection of the Ca²⁺i 
indicator OGBD with PLCζ
KKR49,53,57AAA
- luciferase RNA (Triple EF mutant) injected at a pipette 
concentration of 0.1 μg/μl. Fluorescence coloured in red shows relative changes in cytosolic Ca²⁺i 
and luminescence shown in black is measured in photon counts per second and is used as an 
indicator of PLCζ protein expression. Lumin = mean counts per second in the first hour of oscillating 
across the group, Spikes= mean total number of Ca²⁺i spikes in 1
st 
hour of oscillations. See Table 4.1 
for details of n values. Image insert shows the luminescence signal of a group of eggs injected with 
PLCζ
KKR49,53,57AAA
- luciferase RNA (pipette concentration = 1 μg/μl) at approximately 4 hours post 
injection where the signal was integrated for 30 minutes.  
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Table 4.1 Summary showing the effects on the Ca²⁺ releasing activity of mouse PLCζ following mutations in the EF hands domain 
All PLCζ cRNA constructs were tagged with luciferase and cytosolic Ca²⁺i dynamics were measured using the fluorescent Ca²⁺i indicator Oregon Green BAPTA 
Dextran (OGBD). Test for significant differences were conducted using a Mann-Whitney Ranked test for comparison of two groups (with a 95% confidence 
interval) following a Pearson’s test for normality which all groups of data failed (data not shown). Due to the non-linear relationship between the expression of 
PLCζ protein and the frequency of Ca oscillations it was not possible to calculate “mean total counts/spike in 1
st
 hour of oscillating” for higher PLCζ cRNA 
expression levels, as a result this figure was only calculated in those instances where PLCζ expression level was below 1 cps, +/- = standard error of the mean, n = 
number of eggs injected 
Construct Pipette 
concentration 
(μg/μl) 
n Number of 
eggs 
oscillated 
Mean 
number of 
oscillations in 
first hour of 
spiking 
Mean PLCζ 
expression in 
1
st
 hour of 
oscillations 
(cps) 
Number of 
spikes 
significantly 
different from 
wild type? 
Mean total 
counts/spike in 
1
st
 hour of 
oscillating 
(counts/spike) 
Counts/spike 
significantly 
different from 
wild type? 
mPLC
WT
 0.025 - 0.05 31 31/31 9.7 ± 0.63 0.47 ± 0.038 N/A 14.61 ± 2.05 - 
mPLC
K49A
 0.025 19 19/19 3.6 ± 0.16 0.48 ± 0.024 Yes (p= <0.001) 25.92 ± 1.17 Yes 
(p=<0.001) 
mPLC
K53A
 0.025 39 39/39 4.4 ± 0.13 0.46 ± 0.014 Yes (p= <0.001) 20.78 ± 0.85 Yes 
(p=<0.001) 
mPLC
R57A
 0.025 30 30/30 4.3 ± 0.13 0.74 ± 0.032 Yes (p= <0.001) 38.21 ± 2.1 Yes 
(p=<0.001) 
mPLC
KR49,57AA
 0.05 30 30/30 3.7 ± 0.14 0.65 ± 0.030 Yes (p= <0.001) 34.96 ± 1.94 Yes 
(P=<0.001) 
mPLC
KKR49,53,57AAA
 0.025 - 0.05 43 42/43 2.8 ± 0.074 0.54 ± 0.031 Yes (p= <0.001) 37.35 ± 2.24 Yes 
(p=<0.001) 
mPLC
KKR49,53,57AAA
 1 11 11/11 8.6 ± 1.7 7.65 ± 0.92 No (p = 0.15) - - 
mPLCζ EF 
KKR49,53,57AAA 
XY Link.
k374,5,7,AAA 
 
0.1  25 0/25 0 ± 0 0.53 ± 0.046 Yes (p= <0.001) - - 
mPLCζ EF 
KKR49,53,57AAA 
XY Link.
k374,5,7,AAA 
 
2 20 0/20 0 ± 0 14.43 ± 0.80 Yes (p= <0.001) - - 
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EF hand domain and X-Y linker work in synergy to anchor PLCζ to PI(4,5)P₂ 
The X-Y linker also has a positively charged region that has been found to be involved in 
PI(4,5)P₂  binding (Nomikos et al. 2011b). Interestingly despite the fact that neutralising the 
residues in this region also has a negative effect on the Ca²⁺ releasing ability of PLCζ, even if 
the whole X-Y linker is deleted Ca²⁺i oscillations can still be induced by PLCζ albeit at a much 
higher expression (Nomikos et al. 2011c). With this in mind it possible that the positively 
charged region of the EF hand works in synergy with the X-Y linker to bind to PI(4,5)P₂ . In 
order to test this a “double triple” mutant PLCζ- luciferase construct was created that had 
both the triple EF hand mutation (PLCζKKR49,53,57AAA) and the triple X-Y linker mutation 
(PLCζK374,5,7,AAA ) to create a PLCζ EF KKR49,53,57AAA XY Link.k374,5,7,AAA -luciferase constructs (see fig 
4.4, designed and synthesised by MN). This construct was injected into eggs in the same 
way as above and Ca²⁺i oscillations and expression were recorded. PLCζ EF 
KKR49,53,57AAA XY 
Link.k374,5,7,AAA  was not able to cause Ca²⁺i oscillations in eggs even if expression levels reach 
30x the level of PLCζWT previously used (see fig 4.5, fig 4.6 and Table 4.1). This suggests that 
the positively charged residues of the EF hand and the XY linker both play a role in 
conveying Ca²⁺releasing of PLCζ, possibly through PI(4,5)P₂ binding.  
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EF hand and XY Linker mutation (Double Triple)
PLCζ EF KKR49,53,57AAA XY Link K374,375,377AA
 
Figure 4.4 Schematic showing the mutations made in the EF hand domain and X-Y linker of mPLCζ 
The structural domains of mouse PLCζ and the residue substitutions carried out by point directed 
mutagenesis to create the “double triple” PLCζ mutant (PLCζ EF 
KKR49,53,57AAA
XY Link
.K374,5,7,AAA
- 
luciferase cRNA). This mutation was made by substituting K49A,K53A and R57A in the 1
st
 EF hand 
and substituting the lysine residues at the 374, 375 and 377 position for alanines in the X-Y linker.  
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Figure 4.5 Sample Ca²⁺i trace initiated by mPLCζ containing triple mutation in the EF hand domain 
and X-Y linker 
Ca²⁺i and luminescence changes that occurred in individual eggs following microinjection of the Ca²⁺i 
indicator OGBD with PLCζ EF 
KKR49,53,57AAA
 XY Link
K374,5,7,AAA
-luciferase RNA at a pipette concentration 
of either A) 0.1 μg/μl or B) 2 μg/μl. Fluorescence trace coloured in red shows relative changes in 
cytosolic Ca²⁺i and luminescence shown in black is measured in photon counts per second and is 
used as an indicator of PLCζ protein expression. Lumin = mean counts per second in the first hour of 
oscillating across the group, Max Lumin= mean peak counts per seconds during recording averaged 
across the group of eggs, Spikes= mean total number of Ca²⁺i spikes in 1
st 
hour of oscillations. See 
Table 4.1 for details of n values.  
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Figure 4.6 Summary showing the effects of mutations in EF hand domain and X-Y linker of PLCζ on 
Ca²⁺i oscillations 
Summary bar graph showing the effect of neutralising positively charged residues in the EF hands 
domain of PLCζ on the frequency of Ca²⁺i oscillations it produced in eggs. Plot shows the mean total 
number of Ca²⁺i spikes recorded in the 1
st 
hour of oscillating in eggs injected with a range of PLCζ-
Luciferase cRNA constructs with mutations in the EF hands domain as follows: WT) Wild type PLCζ-
Luciferase, Double Triple) PLCζ EF 
KKR49,53,57AAA
 XY Link.
K374,5,7,AAA
,
Triple) PLCζ
KKR49,53,57AAA
- luciferase, 
Double) PLCζ
KR49,57AA
- luciferase, R57A) PLCζ
R57A
-luciferase, K53A) PLCζ
 K53A
-luciferase and K49A) 
PLCζ
K49A
-luciferase. Mean Expression (cps) = mean counts per second of luminescence recorded in 
the 1
st  
hour of eggs oscillating. Error bars show standard deviations. See Table 4.1 for n values and 
statistics.  
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The disruption of PI(4,5)P₂ binding following mutations in the EF hands domain of PLCζ 
cannot be detected by in vivo immunocytochemistry 
In order to investigate whether the localisation of PLCζ inside the egg appeared to be 
disrupted in response to these mutations in the EF hands domain of PLCζ 
immunocytochemistry of PLCζ in eggs was carried out. Two RNA constructs were created 
one with wild type PLCζ sequence attached to a c-Myc tag and a EF hand domain mutated 
PLCζKKR49,53,57AAA again attached to a c-Myc tag (both constructs produced by MN). These 
constructs were both injected into separate groups of eggs and allowed to express in vivo 
for approximately 2 hours before these cells were fixed and stained using the standard 
protocol (see Chapter 2). An anti c-Myc mouse monoclonal antibody was used as a primary 
antibody to mark PLCζ localisation and a fluorescent secondary anti-mouse AlexaFluor-488 
antibody. The eggs were then imaged using confocal microscopy to look at fluorescent 
distribution as a measure of PLCζ localisation. No significant differences were seen in 
localisation of PLCζ in the eggs injected with PLCζKKR49,53,57AAA compared to those injected 
with the wild type PLCζ (see fig 4.7). In both cases PLCζ was found to localise to vesicular 
structures inside the egg as has been previously recorded (see fig 4.7). This suggests that 
either the localisation of PLCζ is not affected by mutations in the EF hands domain or that 
any disruption in binding or localization cannot be detected using this technique.  
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Triple EF hand mutant: PLCζ KKR49,53,57AAA
A
B
Wild Type PLCζ
 
Figure 4.7 Images of WT and EF hand triple mutated mPLCζ localisation in mouse eggs 
Confocal images showing examples of eggs injected with (A) cMyc tagged mouse PLCζ cRNA 
(n=10) and (B) cmyc tagged mouse PLC
KKR49,53,57AAA
 cRNA (n=8), (pipette concentration of 
0.1 μg/μl). The eggs were fixed 3 hours post injection and stained using an anti-cMyc 
epitope mouse monoclonal primary antibody. An anti-mouse goat Fluor Alexa-488 
secondary antibody was used before imaging the eggs on a confocal microscope (see 
Chapter 2 for full details of protocol). 
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The I489F missense mutation in the C2 domain affects human PLCζ’s Ca²⁺ releasing ability 
A mutation in the C2 domain of human PLCζ, PLCζI489F, has recently been identified that 
reduces PLCζ’s ability to cause Ca²⁺i oscillations in male patients carrying this missense 
mutation (Escoffier et al. 2015a). Untagged PLCζI489FcRNA appears to cause abnormal Ca²⁺i 
oscillations when injected into eggs, an affect which it has been suggested to be due to 
mis-localisation of PLCζ to the target membrane or a reduction in the catalytic activity in 
PLCζ (Escoffier et al. 2015a). Exactly how this mutation affects PLCζ’s Ca²⁺ releasing activity 
and to what degree it is affected is still unknown. To test this, a human PLCζI489F cRNA 
construct tagged with the firefly luciferase sequence was synthesised alongside human 
PLCζWT– luciferase cRNA so the Ca²⁺releasing activity could be compared with comparable 
expression levels (see fig 4.8, RNA synthesised by MN). These constructs were injected into 
two groups of eggs at varying pipette concentrations. Physiological levels of hPLCζWT caused 
reliable low frequency oscillations that lasted for many hours (see fig 4.9). However, similar 
expression levels of hPLCζI489F didn’t cause any Ca²⁺i oscillations in 18/19 eggs (see fig 4.9, 
fig 4.10 and Table 4.2).  hPLCζI489F was found to be roughly 18 times worse at causing Ca²⁺i 
oscillations compared to hPLCζWT (see fig 4.10 and Table 4.2).  Interestingly if hPLCζI489F is 
expressed at much higher levels (approximately 12 times the level of expression) it is able 
to cause Ca²⁺i oscillations. If hPLCζ
WT is expressed even at half the amount of this level then 
the eggs become overstimulated, resulting in an early termination of Ca²⁺i oscillations. The 
oscillations initiated by high levels of hPLCζI489F are still at a lower frequency than that 
caused by PLCζWT at a low expression (see fig 4.9 and Table 4.2). These data clearly show 
that physiological levels of PLCζ containing theI489F missense mutation is not able to cause 
Ca²⁺i oscillations at the frequency usually seen at fertilisation and therefore cannot initiate 
egg activation.  
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Figure 4.8 Schematic showing the mutations made in the EF hand domain and X-Y linker of 
PLCζ 
The structural domains of mouse PLCζ and the residue substitutions carried out by point 
directed mutagenesis to create the “double triple” PLCζ mutant (PLCζ EF 
KKR49,53,57AAA
XY 
Link
.K374,5,7,AAA
- luciferase cRNA). This mutation was made by substituting K49A,K53A and R57A 
in the 1
st
 EF hand and substituting the lysine residues at the 374, 375 and 377 position for 
alanines in the X-Y linker 
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Figure 4.9 Sample Ca²⁺i traces initiated by human PLCζ containing a missense mutation in the C2 
domain 
Ca²⁺i and luminescence changes that occurred in individual eggs following microinjection of the ca²⁺i 
indicator OGBD with wild type hPLCζ-luciferase (A and C) and hPLCζ
 I489F
- luciferase (B and D) 
injected at pipette concentrations of either 0.015 μg/μl (A and B), 0.3 μg/μl (C ) or 0.1 μg/μl (D).  
Fluorescence traces are coloured in red shows relative changes in cytosolic Ca²⁺i and luminescence 
shown in black is measured in photon counts per second and is used as an indicator of PLCζ protein 
expression. Lumin = mean counts per second in the first hour of oscillating across the group, Spikes= 
mean total number of Ca²⁺i spikes in 1
st
hour of oscillations. See Table 4.2 for details of n values.  
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Figure 4.10 Summary showing the effects of missense mutation in C2 of hPLCζ on Ca²⁺i oscillations 
Bar graph showing the effect of the 1489F mutation in the C2 domain of human PLCζ on the 
frequency of Ca²⁺i oscillations it produced in eggs. Plot shows the mean total number of Ca²⁺i spikes 
recorded in the 1
st 
hour of oscillating in eggs injected with both wild type human PLCζ-luciferase 
cRNA (WT) and human PLCζ
1489F
-luciferase cRNA (hPLCζ
I489F
) at different cRNA expression levels. 
Mean Expression (cps) = mean counts per second of luminescence recorded in the 1
st 
hour of eggs 
oscillating. Error bars show standard deviations. See Table 4.2 for n values and SEMs. Following a 
Mann-Whitney Rank Sum test a significant difference (P=<0.001, at a 95% confidence interval) was 
seen between the number of Ca²⁺i  oscillations elicited by a low level of WT human PLCζ- luciferase 
and human PLCζ
1489F
-luciferase cRNA at an average of 0.06 cps. A significant reduction in the number 
of Ca²⁺i  oscilllations initiated by a higher level of PLCζ
1489F
-luciferase (0.074 cps) and the lower level 
of WT PLCζ- luciferase (0.06 cps) was also recorded following the same test (P=0.001, at a 95%  
confidence interval). 
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Construct Pipette 
concentration 
(μg/μl) 
n Number of 
eggs 
oscillating 
Number of 
eggs that 
stopped 
oscillating 
before end 
of 1st hr 
Mean 
number of 
spikes in 1st 
hr of 
oscillating 
Mean 
expression 
PLCζ in 1st 
hr of 
oscillating 
(cps) 
hPLCWT 0.015  20 19/20 0/20 4 +/- 0.29 0.06 +/- 
0.007 
hPLCζI489F 0.015 19 1/19 0/19 0.15 +/- 
0.16 
0.06 +/- 
0.04 
hPLCWT 0.3 18 18/18 18/18 3.4 +/- 0.29 0.32 +/- 
0.015 
hPLCζI489F 0.1  16 15/16 2/16 2.3 +/- 0.25 0.74 +/-
0.038 
Table 4.2 Summary showing the effect of missense mutation in the C2 domain of human PLCζ on 
Ca²⁺i oscillations 
The effects on the Ca²⁺ releasing activity of human PLCζ as a result of the I489F C2 domain mutation 
at different pipette concentrations. All PLCζ cRNA constructs were tagged with luciferase and 
cytosolic Ca²⁺i dynamics were measured using the fluorescent Ca²⁺i indictor OGBD. +/- = standard 
error of the mean, n= number of eggs injected  
Table 4.3 Summary showing the effect of missense mutation in the C2 domain of mouse PLCζ on 
Ca²⁺i oscillations 
The effects on the Ca²⁺ releasing activity of mouse PLCζ as a result of the I527F C2 domain mutation 
at different pipette concentrations. All PLCζ cRNA constructs were tagged with luciferase and 
cytosolic Ca²⁺i dynamics were measured using the fluorescent Ca²⁺ indictor OGBD. +/- = standard 
error of the mean, n= number of eggs injected   
Construct Pipette 
concentration 
(μg/μl) 
n Number of 
eggs 
oscillating 
Number of 
eggs that 
stopped 
oscillating 
within 1 hr 
Mean 
number 
of spikes 
1st hr of 
spiking 
Mean 
expression 
PLCζ in 1st 
hr of 
oscillating 
(cps) 
mPLCWT 0.025 - 0.05 31 31/31 0/31 9.7 ± 0.63 0.47 ± 0.04 
mPLCζI527F 0.02 - 0.03 13 13/13 0/13 3.2 +/- 
0.09 
0.4 +/- 0.04 
mPLCWT 0.06 6 6/6 6/6 2.8 +/- 
0.40 
1.5 +/- 0.13 
mPLCζI1527F 0.06 7 7/7 0/7 3.3 +/- 
0.68 
0.9 +/- 0.08 
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The homologous I527F missense mutation in the C2 domain also affects the Ca²⁺releasing 
ability of mouse PLCζ 
To see if the I489F mutation in the C2 domain has similar effects on the Ca²⁺releasing 
ability of mouse PLCζ, a mouse PLCζ luciferase tagged cRNA construct containing the 
homologous I527F mutation was created (see fig 4.8, constructs courtesy of MN). The 
activity of this mPLCζI527F-luciferase cRNA was tested for Ca²⁺ releasing activity and 
compared to that of wild type mouse PLCζ-luciferase by microinjection into mouse eggs 
following the protocol previously used. Like the human PLCζI489F, mouse PLCζI527Fshowed 
reduced Ca²⁺ releasing ability (see fig 4.11 and Table 4.3). Though all the eggs expressing a 
physiological level of this mPLCζI527F were able to elicit Ca²⁺i oscillations these oscillations 
occurred at a frequency approximately 3 times lower than that of wild type mouse PLCζ of 
similar protein expression levels (see fig 4.11 and Table 4.3). If the expression levels were 
approximately doubled no significant increase in the frequency of Ca²⁺i oscillations was 
recorded however these oscillations began sooner therefore continued for longer (see fig 
4.11 and Table 4.3). If wild type PLCζ was expressed at these higher non-physiological levels 
an overdose effect was seen where the oscillations are high frequency and terminated 
early (see fig 4.11 and Table 4.3). This would suggest that the I527F missense mutation also 
affects the Ca²⁺ releasing ability of mouse PLCζ however in a manner that is not as extreme 
as the I489F mutation in human PLCζ. It is important to note however human PLCζ has a 
much increased potency compared to mouse PLCζ and therefore is able to release Ca²⁺ at 
much lower expression levels.  
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Figure 4.11 Sample Ca²⁺i traces initiated by mouse PLCζ containing a missense mutation in the C2 
domain 
Ca²⁺i and luminescence changes that occurred in individual eggs following microinjection of the Ca²⁺i 
indicator OGBD with wild type mPLCζ-luciferase (A and C) and mPLCζ
I527F
- luciferase (B and D) 
injected at pipette concentrations of either 0.025, 0.02 μg/μl (A and B) or 0.0.06 μg/μl (Cand D). 
Fluorescence traces are coloured in red shows relative changes in cytosolic Ca²⁺i and luminescence 
shown in black is measured in photon counts per second and is used as an indicator of PLCζ protein 
expression. Lumin = mean counts per second in the first hour of oscillating across the group, Spikes= 
mean total number of Ca²⁺i spikes in 1
st 
hour of oscillations. See Table 4.3 for details of n values. 
Following a Mann-Whitney Rank Sum test a significant difference (P=<0.001, at  95%  confidence 
interval)  was seen between the number of Ca²⁺i  oscillations elicited by a low level of WT mouse 
PLCζ- luciferase and human PLCζ
1527F
-luciferase cRNA at an average of 0.47 cps and 0.4 cps 
respectively. A significant reduction in the number of Ca²⁺i  oscilllations initiated by a higher level of 
PLCζ
1527F
-luciferase (0.9 cps) and the lower level of WT PLCζ- luciferase (0.47 cps) was also recorded 
following the same test (P=0.001, at  95%  conficence interval). 
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Mutations within the CaM binding motif of PLCζ do not affect its Ca²⁺releasing ability 
Other PLCs use binding to CaM in order to regulate their activity, for example PLCδ1 is 
inhibited when CaM is bound to its CaM binding domain, a domain which is conserved in 
PLCζ (McCullar et al. 2003; Sidhu et al. 2005). To investigate whether the CaM binding motif 
of PLCζ has a role in regulating its activity a series of point mutations were created within 
this region of human PLCζ. CaM binds to a 16 residue region in the X-Y linker 
(KKTRKLKIALALSDVL), however the positively charged residues in this region also contribute 
to the interaction of PLCζ with its substrate PI(4,5)P₂ so these residues could not be altered 
(Nomikos et al. 2011b; Nomikos et al. 2011c). Therefore more subtle mutations were made 
where some of the neutrally charged residues (alanine and leucine) in this region were 
substituted glycine. A series of these mutations in human PLCζ were created by point 
mutagenesis with single (hPLCζA346G), double (hPLCζAA346G,348GG) and triple 
(hPLCζLAA343,346348GGG ) mutations made, attached to a  luciferase tag and synthesised into 
cRNA alongside wild type human PLCζWT(see fig 4.12, designed and synthesised by MN). 
The constructs were tested for Ca²⁺releasing ability by microinjection into mouse eggs and 
the changes in Ca²⁺i were recorded using a fluorescent Ca²⁺i indicator. Injection of all 
constructs of PLCζ caused Ca²⁺i oscillations at low levels of RNA expression (see fig 4.13 and 
Table 4.4). Similar levels of cRNA expression of both hPLCζWTand triple mutant 
(hPLCζLAA343,346348GGG) produced a very similar number of Ca²⁺i oscillations in the first hour of 
oscillating indicating similar Ca²⁺ releasing activity (see fig 4.13, fig 4.14 and Table 4.4). 
However, those eggs injected with the triple mutant had a greater number of eggs where 
the oscillations terminated early (before the end of the 1st hour) (see fig 4.13, fig 4.14 and 
Table 4.4). This value was relatively low at 7/26 eggs stopping before the end of the 1st 
hour of oscillating however this could be an indicator of increased PLCζ activity in these 
eggs, like that seen if PLCζ protein levels are overexpressed past physiological levels. Very 
similar Ca²⁺i responses were recorded in eggs injected with the single mutant hPLCζ
A346G 
when compared to those injected with hPLCζWT however eggs injected with the double 
mutant (hPLCζAA346G,348GG) had Ca²⁺i oscillations at a slightly lower frequency than 
hPLCζWT(see fig 4.13, fig 4.14 and Table 4.4). These variations could be accounted for by the 
small variations in expression levels of the cRNA between the groups. These data therefore 
show that no significant differences can be recorded in the Ca²⁺releasing ability of PLCζ 
following these mutations in the CaM binding motif of PLCζ. 
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Figure 4.12 Schematic showing mutations made in the CaM binding domain of hPLCζ 
The structural domains of human PLCζ and the residue substitutions carried out by point directed 
mutagenesis to create RNA constructs of PLCζ- luciferase with mutations in the CaM binding motif in 
the X-Y linker. Mutations were as follows: WT) wild type PLCζ sequence, A346G) substitution of the 
alanine at residue 346 for glycine (single), AA346,348GG) substitution of the alanines at residue 346 
and 348 for glycines (double) and LAA343,346,348GGG) substitution of the alanines at residue 343, 
346 and 348 for glycines (triple).  
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Table 4.4 Summary showing the effects of mutations in the CaM binding domain of human PLCζ on 
Ca²⁺i  oscillations 
The effects on the Ca²⁺ releasing activity of human PLCζ as a result of different mutations in the CaM 
binding motif of this protein. All PLCζ RNA constructs were tagged with luciferase and cytosolic Ca²⁺i 
dynamics were measured using the fluorescent Ca²⁺i indictor OGBD. +/- = standard error of the 
mean, n= number of eggs injected 
Construct Pipette 
concentration 
(μg/μl) 
n Number of 
eggs 
oscillating 
Number 
of eggs 
that 
stopped 
oscillating 
within 1 hr 
Mean 
number of 
spikes 1
st
 
hr of 
oscillating 
Mean 
expression 
in 1
st
 hr of 
oscillating 
(cps) 
hPLC
WT
 0.02 24 24/24 0/24 6.0 +/- 
0.36 
0.06  +/- 
0.004 
hPLCζ
A346G
  
(Single) 
0.02 12 12/12 1/12 7.2 +/- 
0.62 
0.08 +/- 
0.004 
hPLCζ
AA346G,348GG
 
(Double) 
0.02 11 11/11 0/11 3.4 +/- 
0.40 
0.04+/-
0.005 
hPLCζ
LAA343,346348
GGG
 (Triple) 
0.02 26 26/26 7/26 6.1 +/- 
0.38 
0.06 +/ 
0.004 
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Figure 4.13 Sample Ca²⁺i traces initiated by hPLCζ containing mutations in the CaM binding domain 
Ca²⁺i changes that occurred in individual eggs following microinjection of the Ca²⁺i indicator OGBD 
with the one of the following PLCζ RNA constructs: A) Wild Type human PLCζ- Luciferase cRNA, B) 
PLCζ 
A346G
- luciferase RNA (single mutant), C) PLCζ 
AA346,348GG
-luciferase cRNA (double mutant) and D) 
PLCζ 
LAA343,346,348GGG
-luciferase cRNA (triple mutant). All constructs were injected at a pipette 
concentration of 0.02 μg/μl. Relative fluorescence plotted as F/F0, Lumin = mean counts per second 
in the first hour of oscillating across the group, Spikes= mean total number of Ca²⁺i spikes in 1
st
 hour 
of oscillations. See Table 4.4 for details of n values.  
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Figure 4.14 Summary showing the effects of mutations in CaM binding domain of hPLCζ on Ca²⁺i 
oscillations 
Bar graph showing the effect of point mutations in the CaM binding motif of human PLCζ on the 
frequency of Ca²⁺i oscillations it produced in eggs. Plot shows the mean total number of Ca²⁺i spikes 
recorded in the 1
st
 hour of oscillating in eggs injected with 0.02 μg/μl of wild type human PLCζ-
luciferase cRNA (WT), PLCζ 
A346G-
 luciferase cRNA (single), PLCζ 
AA346,348GG
-luciferase cRNA (double) 
and PLCζ 
LAA343,346,348GGG
-luciferase cRNA (triple). Mean Expression (cps) = mean counts per second of 
luminescence recorded in the 1
st 
hour of eggs oscillating. Error bars show standard deviations. See 
Table 4.4 for n values and SEMs 
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Split PLCζ is able to cause Ca²⁺i oscillations when injected into mouse eggs however with 
reduced efficiency 
It has previously been shown that a fraction of PLCζ in the sperm of pigs is proteolytically 
cleaved at the X-Y linker however is still able to hydrolyse PI(4,5)P₂ and Ca²⁺ioscillations 
(Kurokawa et al. 2007). In order to investigate how effective this “split” PLCζ is, at releasing 
Ca²⁺ constructs were created with two halves of mouse PLCζ (residues 1-361 and residues 
362-647) and each half was tagged with a different half of luciferase sequence (see fig 4.15, 
constructs created by MN). This way if the two halves of PLCζ come together the two halves 
of luciferase will also join, become enzymatically active and produce luminescent light. The 
corresponding human PLCζ constructs were also created (residues 1-328 and residues 329-
608). The two halves of the split PLCζ were co-microinjected into eggs alongside the Ca²⁺i 
indictor OGBD and both the Ca²⁺i and luminescence were measured simultaneously. Both 
split mouse PLCζ and split human PLCζ were able to cause Ca²⁺i oscillations in mouse eggs 
however with less efficiency (See fig 4.16, fig 4.17 and Table 4.5). Split mPLCζ was required 
approximately 5-10 times the pipette concentration that would usually be required of full 
length mPLCζ in order to cause reliable Ca²⁺i oscillations and these oscillations were much 
lower frequency with a delay in the timing of the first spike (See fig 4.16 and Table 4.5). 
Despite a considerably higher pipette concentration of cRNAthe luminescence values were 
a lot lower than is seen with full length mPLCζ (see Table 4.5). In fact at expression levels at 
one fifth of that seen for full length mPLCζ, split mPLCζ caused 7/16 eggs to oscillate 
however 6 of these stopped oscillating within one hour which could indicate an overdose 
effect (See Table 4.5). Interestingly split hPLCζ was able to cause Ca²⁺i  oscillations at a 
much lower pipette concentration at levels that were very similar to full length hPLCζ 
causing 10/11 eggs to oscillate (see fig 4.17 and Table 4.5). However, at this level no 
luminescence was seen, the frequency of oscillations were reduced compared to full length 
hPLCζ and there was a delay in the timing of the first spike (see Table 4.5). If the pipette 
concentration was increased luminescence could still not be recorded even though all eggs 
oscillated and 8/11 appeared to stop early in response to an overdose effect (see fig 4.17 
and Table 4.5). These data suggest that proteolytically cleaved PLCζ is able to cause Ca²⁺i 
oscillations in eggs and this may occur at fertilisation however it is not as efficient as full 
length PLCζ. Furthermore as with human PLCζ there are dramatic differences between 
species regarding the potency of PLCζ. Interestingly the luminescence values were much 
lower than for wild type full length PLCζ. 
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Cleaved PLCζ Chimeras 
 
Figure 4.15 Schematic showing the structural domains of proteolytcially cleaved (split) mouse and 
human PLCζ-luciferase constructs 
cRNA of mouse PLCζ was synthesized in two halves, residues 1- 361 (M1) and 362- 647 (M2) each of 
these was then tagged with opposite halves of the luciferase sequence. cRNA of human PLCζ was 
synthesized in two halves, residues 1- 328 (H1) and 329-608 (H2) with each of these also attached to 
opposite halves of the luciferase sequence.  
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Figure 4.16 Sample Ca²⁺i traces initiated by split mouse PLCζ 
Ca²⁺i changes that occurred in individual eggs following microinjection of the Ca²⁺i indicator OGBD 
with proteolytically cleaved mouse PLCζ. M1 (mPLCζ 1-361) and M2 (mPLCζ 362-647) cRNA were co-
injected into eggs at a pipette concentration of either 0.25 μg/μl (A) or 0.5 μg/μl (B). Relative 
fluorescence plotted as F/F0. See Table 4.5 for full details and n values. 
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Figure 4.17Sample Ca²⁺i traces initiated by split human PLCζ 
Ca²⁺i changes that occurred in individual eggs following microinjection of the Ca²⁺i indicator OGBD 
with proteolytically cleaved human PLCζ. H1 (hPLCζ 1-328) and H2 (hPLCζ 329-608) cRNA were co-
injected into eggs at a pipette concentration of either 0.02 μg/μl (A) or 0.1 μg/μl (B). Fluorescence 
plotted as F/F0. See Table 4.5 for full details and n values.  
129 
 
Table 4.5 Summary of Ca²⁺ releasing ability of mouse and human split PLCζ constructs 
Differences in Ca²⁺ releasing ability of proteolytically cleaved mouse and human PLCζ compared to full length cRNA and combinations of these 2 species. All PLCζ 
RNA constructs were tagged with luciferase and in the case of cleaved PLCζ constructs the only half of the luciferase tag was attached to each half of the PLCζ 
construct. Ca²⁺i dynamics were measured using the fluorescent Ca²⁺i indictor OGBD. +/- = standard error of the mean, n= number of eggs injected 
Construct Pipette 
concentration 
(μg/μl) 
N Number of 
eggs 
oscillated 
Number of eggs that 
stopped oscillating 
within 1 hr 
Mean number 
of spikes 1st hr 
of oscillating 
Mean expression 
in 1st hr of 
oscillating (cps) 
Mean time of 
1st spike (s) 
Full length mPLCζ 0.025 - 0.05 31 31/31 0 9.7 ± 0.63 0.47 ± 0.038 1921 +/- 41.6 
Split mPLCζ (M1 & M2) 0.25 14 11/14 1/11 3.07 +/- 0.47 0.045 +/- 0.006 5437 +/- 266.6 
Split mPLCζ (M1 & M2) 0.5 16 7/16 6/7 1.5 +/-  0.45 0.165 +/-0.012 3896 +/-118.6 
Full length hPLCζ 0.015 - 0.02 43 42/43 0 5.07 +/- 0.29 0.058 +/- 0.003 2160 +/- 182.5 
Split hPLCζ (H1 & H2) 0.02 11 10/11 0 2.46 +/- 0.28 - 6141 +/-558.2 
Split hPLCζ (H1 & H2) 0.1 11 11/11 8/11 3.64 +/- 0.53 - 845+/- 113.1 
Chimeras 
1: M1 & H2 0.025 19 15/19 0 2.0 +/- 0.29 - 11209 +/- 869.2 
1: M1 & H2 0.1 20 20/20 5/20 3.7 +/- 0.15 - 2968.5 +/- 
161.6 
2: H1 & M2 0.025 11 11/11 8/11 3.4 +/- 0.47 - 2461 +/- 422.4 
2: H1 & M2 0.1 16 16/16 0 2.3 +/- 0.11 - 6766 +/- 462.1 
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Chimeras of split human and mouse PLCζ are able to cause Ca²⁺i oscillations in mouse eggs 
with variations in potency 
As it was established that both mouse and human cleaved PLCζ  were able cause Ca²⁺i 
oscillations in mouse eggs the next question raised was whether chimeras of human and 
mouse split PLCζ could cause Ca²⁺i oscillations and whether there were any potency 
differences depending on the combination of these halves. To test this instead of co-
injecting the two cleaved halves of mouse PLCζ  the N’ terminal half of mouse PLCζ was co-
injected alongside the C’ terminal half of human PLCζ and vice versa. A higher and a lower 
pipette concentration of the two chimeras were injected in the same way as described 
above.  The first chimera which consisted of co-injection of the N’ terminal half of mouse 
PLCζ (M1) and the C’ terminal half of human PLCζ (H2) caused low frequency at a similar 
concentration (0.025 g/l) to that of split human PLCζ (H1 and H2) and at a similar frequency 
(see fig 4.18 and Table 4.5). There was however a significant delay in the time of the first 
spike compared to split human PLCζ (see Table 4.5). If the pipette concentration was 
increased to (0.1 g/l) the time of the first spike was sooner however not as soon as that 
split human PLCζ of the same concentration (See Table 4.5). The frequency of the 
oscillations was slightly higher than that of the lower concentration with 5/20 of these eggs 
stopping within the first hour (See Table 4.5).This rate was lower than human split PLCζ of 
the same concentration. This implies that the M1- H2 chimera is slightly reduced in potency 
compared split human H1 and H2 however is not as reduced as mouse split PLCζ and has an 
activity that is much more like human split PLCζ. Interestingly if the inverse chimera was 
used (H1-M2) the opposite appeared to be true (See fig 4.19 and Table 4.5). The lower 
pipette concentration of 0.025 g/l caused Ca²⁺i oscillations that were similar in frequency to 
the response elicited by the same pipette concentration of M1-H2 and human split PLCζ, 
however these oscillations began much earlier (See fig 4.19 and Table 4.5). This suggests 
that H1-M2 is more potent than mouse split PLCζ and M1-H2 chimera. In contrast a higher 
pipette concentration (0.1 g/l) of H1-M2 produced oscillations that were lower in 
frequency and delayed in initiation compared to the lower concentration H1-M2 (see fig 
4.19 and Table 4.5). The pattern of these Ca²⁺i oscillations most closely resembled those 
produced by a low concentration (0.02 g/l) human split PLCζ and would therefore suggest 
that H1 and M2 is reduced in potency compared to human split PLCζ and M1-H2 however 
still more potent than split mouse PLCζ (see Table 4.5). These data indicate that various 
structural regions of PLCζ must convey potency differences between species however 
particular regions, possibly related to the ‘N-terminal or ‘C terminal halves of the protein, 
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have a more of an influence on the enzyme’s potency than others. In summary it appears 
that human split (H1-H2) PLCζ is the most potent at releasing Ca²⁺, followed by the chimera 
M1 and H2, then the chimera H1 and M2 and finally split mouse PLCζ  M1- M2 is least 
potent at releasing Ca²⁺. 
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Figure 4.18 Sample Ca²⁺i traces initiated by split PLCζ chimera 1 
Ca²⁺i changes that occurred in individual eggs following microinjection of the Ca²⁺i indicator OGBD 
with proteolytically cleaved combined mouse and human PLCζ M1 (mPLCζ 1-361) and H2 (hPLCζ 329-
608) cRNA were co-injected into eggs at a pipette concentration of either 0.02 μg/μl (A) or 0.1 μg/μl 
(B). Fluorescence plotted as F/F0. See Table 4.5 for full details and n values.  
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Figure 4.19 Sample Ca²⁺i traces initiated by split PLCζ chimera 2 
Ca²⁺i changes that occurred in individual eggs following microinjection of the Ca²⁺i indicator OGBD 
with proteolytically cleaved combined mouse and human PLCζ. H1 (hPLCζ 1- 328) and M2 (mPLCζ 
361-647) cRNA were co-injected into eggs at a pipette concentration of either 0.02 μg/μl (A) or 0.1 
μg/μl (B). Fluorescence plotted as F/F0. See Table 4.5 for full details and n values.  
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Discussion 
It is well established that the structural domains of PLCs convey their activity and allow 
them to work in different ways. PLCζ is no exception to this and it is already known that 
omission of particular functional domains either impairs or completely abolishes the ability 
for PLCζ to elicit Ca²⁺release (Nomikos et al. 2005; Nomikos et al. 2011c; Theodoridou et al. 
2013). As the substrate for PLCζ, PI(4,5)P₂, is membrane bound it is particularly important 
that PLCζ is able to localise and bind to these membranes. However, unlike other PLCs PLCζ 
lacks a pleckstrin homology domain (PH domain) that targets other PLCs to the target 
plasma membrane. PH domains are found on most PLCs however target the enzyme to the 
membrane in different ways which all ultimately allow it to access its phospholipid 
substrate (Lemmon et al. 1995)..For example PLCδ1 binds directly to PI(4,5)P₂ in the target 
membrane  via its PH domain (Pawelczyk and Lowenstein 1993). Despite PLCζ sharing a 
great amount of similarity with PLCδ1 this is one of the big differences between the two 
isoforms. This would suggest that PLCζ uses a novel mechanism to target membranes that 
may account for both the difference in PI(4,5)P₂ targeting and the ability of PLCζ to release 
Ca²⁺ at egg basal Ca²⁺i levels however the mechanism for this remain to be fully explained.  
There are a variety of ways binding to a membrane may be ensured,for example either by 
biochemical interactions conveyed by particular structural properties of PLCζ or by 
interactions with additional proteins and lipids. Previous data has shown that positively 
charged residues within the linker region of PLCζ between the X and Y catalytic domains 
bind to negatively charged PI(4,5)P₂ (Nomikos et al. 2011b). Neutralising these residues 
impairs the ability for PLCζ to elicit Ca²⁺release when injected into eggs (Nomikos et al. 
2011b). Interestingly however, even removal of the whole X-Y linker does not completely 
ablate the Ca²⁺i oscillation inducing response of PLCζ or its binding to PI(4,5)P₂ (Nomikos et 
al. 2011c) . This suggests even though the X-Y linker does play a role in binding to PI(4,5)P₂ 
and conveying PLCζ’s activity other structural features of PLCζ must also be involved. The 
two most likely domains to be involved in this interaction are the C2 domain and The EF 
hands domain.  
In PLCδ1 the first N terminal EF hand has been found to bind with moderate affinity to 
vesicles containing anionic phospholipids (Cai et al. 2013). This domain contains positively 
charged residues which are thought to help anchor PLCδ1 to its substrate through 
electrostatic interactions. Direct mutagenesis of these positive residues compromises PLC 
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activity (Cai et al. 2013). This region within the 1st EF hand domain is conserved in PLCζ 
however the role of this in membrane targeting has not yet been established.  
The current study shows that in PLCζ these positively charged residues within the first EF 
hand do appear to play a role in determining PLCζ’s Ca²⁺releasing ability. Neutralisation of 
even one positively charged residue by direct mutagenesis was shown to have an effect on 
the ability of PLCζ to cause Ca²⁺ release. A greater effect was seen if this was increased to 
neutralisation of 3 positively charged residues suggesting that the role for these residues is 
a cumulative one.Interestingly this effect can be rescued if the mutated PLCζ 
(PLCζKKR49,53,57AAA) is expressed in the egg at approximately 16 times the physiological level. 
This indicates that the positively charged residues in EF hand are not essential for PLCζ 
activity, however, they do play a role in determining the enzyme’s potency and are 
required for maximal activity. As is the case for PLCδ1, it appears that this decrease in Ca²⁺ 
releasing ability is due to a reduction in binding to phospholipids. Other data by fellow 
colleagues has found that neutralising these positive residues reduces binding of PLCζ to 
PI(4,5)P₂  containing liposomes with an increase in Km of around 5 fold, however, in vitro  
PI(4,5)P₂ hydrolysis by PLCζ is not affected (Nomikos et al. 2015). This supports the notion 
that, as with PLCδ1, positively charged residues within the EF hand domain of PLCζ 
contribute to its Ca²⁺ releasing ability by assisting its anchoring to phospholipids on target 
membranes. This occurs by electrostatic interactions in a manner that is independent of 
enzymatic activity (Cai et al. 2013).  This theory is supported by mathematical modelling 
data which shows that simulated Ca²⁺i oscillations created based on this theoretical 
relationship between PLCζ and PI(4,5)P₂ match extremely well with that seen 
physiologically in eggs as a result of cRNA injection of the different EF hand mutants 
(Nomikos et al. 2015). As a result,the difference in Ca²⁺i oscillation frequency seen as a 
result of these mutations can be accounted for by a deficiency in PI(4,5)P₂  binding 
(Nomikos et al. 2015). This provides a novel role for the EF hand domain of PLCζ that is 
distinct from its role in conveying Ca²⁺ sensitivity (Nomikos et al. 2005). It was previously 
shown that deletion of one or all the EF hands of PLCζ abolished its Ca²⁺ releasing ability 
(Nomikos et al. 2005). This effect could now be considered as a result both a loss of Ca²⁺ 
sensitivity and a reduction in PI(4,5)P₂ binding.  
Mutations solely within the EF hands domain of PLCζ do not appear to be significant 
enough to disrupt PLCζ localisation as immunostaining shows no obvious difference 
between intracellular localisation of PLCζKKR49,53,57AAA compared to wild type PLCζ. There 
could be several reasons for this, the first could be that PLCζ localisation simply isn’t 
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disrupted enough to be seen by these methods and a significant amount of PLCζ is still 
binding to the target membrane. This idea is supported by the findings that overexpression 
of PLCζ protein is able to rescue the effects of this mutation. Furthermore in order to get an 
adequate fluorescent signal using this method it is often necessary to introduce a slightly 
higher concentration of RNA into the eggs than would be physiological. This provides an 
excess of RNA that is also stained and can provide a localisation pattern that isn’t 
physiological. Another possibility is that the cMyc antibody underwent some nonspecific 
binding which would, following secondary antibody treatment, show fluorescence signal in 
other areas of the cell in addition to where PLCζ was localised. Finally it is possible that PLCζ 
is still localised to the correct membranes due to reduced PI(4,5)P₂  binding the enzyme 
isn’t able to hydrolyse its substrate effectively. As a result much of the correctly localised 
PLCζ protein is not able to elicit Ca²⁺release.  
The electrostatic interactions between the positive residues of the EF hand and negatively 
charged PI(4,5)P₂  appear to serve a very similar purpose to those between the positively 
charged residues in the X-Y linker and PI(4,5)P₂ (Nomikos et al. 2011b) . For this reason it 
was necessary to establish whether the X-Y linker and the EF hand domain had redundant 
roles in terms of PI(4,5)P₂  binding or whether these two domains work together to 
sufficiently anchor PLCζ to membrane bound PI(4,5)P₂. The current study tested this using a 
double mutated form of RNA with triple neutralisations of positive residues in both the X-Y 
linker (previously used by (Nomikos et al. 2011b) and the EF hand domain. It was found 
that if the positively charged residues in the X-Y linker and the EF hand domain were 
neutralised simultaneously PLCζ is not able to elicit Ca²⁺i oscillations. This remained the 
case even if the expression of this RNA is increased to 30 times the level the physiological 
level. The fact that a good luciferase signal was seen in the eggs following injection of this 
mutation confirms that the RNA was being expressed in the eggs and this  was confirmed 
by other colleagues (credit Michail Nomikos) using an immunoblot which showed clear 
faithful expression of the un-fragmented double mutant PLCζ in eggs (Nomikos et al. 2015). 
Further work by (Nomikos et al. 2015) showed that despite the PLCζ EF KKR49,53,57AAA XY 
Link.k374,5,7,AAA losing all ability to release Ca²⁺ in eggs in vivo, biochemical assays show this 
mutant still retains 80% of its enzymatic activity and has unchanged Ca²⁺ sensitivity 
(Nomikos et al. 2015). However, this mutant does display significantly reduced binding to 
PI(4,5)P₂ containing vesicles (Nomikos et al. 2015). This suggests that the X-Y linker and the 
EF hand may work in synergy so PLCζ can bind electro-statically to PI(4,5)P₂. It is possible 
that PLCζ EF KKR49,53,57AAA XY Link.k374,5,7,AAA   doesn’t cause Ca²⁺release in eggs because this 
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mutant is not able to bind sufficiently to PI(4,5)P₂  at the target membrane and therefore 
may  become mislocalised. In order to investigate this fully it would be advantageous to 
repeat the immunocytochemistry experiments using the PLCζ EF KKR49,53,57AAAXY 
Link.k374,5,7,AAA   construct to look at the localisation of this protein in the egg. It is more likely 
that an effect on PLCζ localisation would be seen with this construct as it causes a more 
severe effect on PI(4,5)P₂  binding that cannot be rescued by overexpression of the protein. 
It appears that the positively charged regions of both the X-Y linker and the EF hands 
domain are required for physiological levels of PLCζ to sufficiently bind to PI(4,5)P₂ in order 
to elicit Ca²⁺ release and positive residues in either are necessary to enable PLCζ to release 
Ca²⁺ in eggs. 
As the positively charged residues in the EF hand domain appear to be required for 
maximal Ca²⁺releasing ability of both PLCζ and PLCδ1 this interactions does not provide 
much insight into either the differences in potency between PLCζ and PLCδ1 or how PLCζ 
discriminates between different sources of PI(4,5)P₂ . In other words if PLCζ is targeted to 
its membrane of interest purely through electrostatic binding to PI(4,5)P₂  by its EF hand 
domain and X-Y linker there is no reason why it shouldn’t bind and hydrolyse all sources of 
PI(4,5)P₂   available in the cell. However, this is not the case as PLCζ is able to discriminate 
between different sources of PI(4,5)P₂  and subsequently only hydrolyses vesicular PI(4,5)P₂  
not plasma membrane PI(4,5)P₂ (Yu et al. 2012) . This difference could be accounted for by 
PLCζ’s lack of a PH domain, however it has previously been shown that the addition of a PH 
domain onto the N’ terminus of PLCζ does not give it the ability to hydrolyse plasma 
membrane PI(4,5)P₂  (Theodoridou et al. 2013). In addition this does not alter 
theCa²⁺releasing abilities of PLCζ at all (Theodoridou et al. 2013).  This would suggest that 
other structural properties of PLCζ other than the EF hand domain and the lack of a PH 
domain enable vesicular PI(4,5)P₂  hydrolysis or prevent plasma membrane PI(4,5)P₂ 
hydrolysis.  
One structural domain that could be involved in this is the C2 domain. Despite the C2 
domain of PLCζ being necessary for it to cause Ca²⁺ release it is not yet clear what the role 
of this domain is (Nomikos et al. 2005). C2 domains are characteristically considered as 
membrane targeting domains with a wide range of selectivity for membrane lipids 
(Medkova and Cho 1999). In PLCδ1 for example the C2 domain binds to phosphatidylserine 
in a Ca²⁺ dependent manner to allow substrate access to the active site (Lomasney et al. 
1999). In PLCζ however there is currently no evidence for this. Furthermore liposome 
binding assays and protein lipid overlay experiments have shown the C2 domain of PLCζ 
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does not to bind to PI(4,5)P₂ (Nomikos et al. 2011b).  In fact in vitro studies have shown the 
C2 domain of PLCζ will only bind to mono phospholipids specifically PI(3)P and PI(5)P 
however significantly has not been shown to bind not PI(4)P (Kouchi et al. 2005). However, 
the significance of this binding remains unknown. However, a mutation in the C2 domain of 
human PLCζ that has been shown to result in human infertility has recently been 
characterised (Escoffier et al. 2015a). This point mutation is the result of isoleucine (I) 489 
being switched for a phenylalanine (F) and results in the production of PLCζ that has a 
reduced ability to cause Ca²⁺ release when injected into eggs (Escoffier et al. 2015a). 
Though it has been suggested that this effect could be due to mislocalisation of PLCζ in the 
egg, misfolding or reduced stability of the PLCζ protein the biochemical interactions of this 
mutated PLCζ with potential target lipids has yet to be established nor has the difference in 
Ca²⁺releasing ability been sufficiently quantified (Escoffier et al. 2015a).  
The current study aimed to accurately quantify the reduction in Ca²⁺releasing ability of this 
mutation and try and establish why theCa²⁺releasing ability of PLCζ is impaired. To do this, 
luciferase tagged human PLCζ RNA containing this point mutation was tested for 
Ca²⁺releasing ability against wild type human PLCζ- luciferase RNA. It was found that at 
physiological levels of expression the mutated PLCζ was not able to cause Ca²⁺i oscillations 
however this effect could be partially rescued by overexpression of this PLCζ protein by up 
to 10 fold.  This effect was supported by other data from colleagues showing that MBP 
tagged human PLCζ recombinant protein containing this mutation was not able to cause 
Ca²⁺i oscillations in eggs at physiological levels however if the concentration of this protein 
was doubled it was able to cause Ca²⁺i oscillations (Nomikos et al. 2017a). A similar effect 
on Ca²⁺i oscillations was seen following injection of mouse PLCζ cRNA containing this 
mutation however the impairment on Ca²⁺ release was not as extreme as that seen for 
human PLCζ suggesting there may be some species differences in the role or structure of 
the C2 domain of mouse compared to human. 
It appears that the effect of this I469F mutation on Ca²⁺ release is not due to a reduction in 
PLCζ’s ability to hydrolyse PI(4,5)P₂, a reductioninCa²⁺sensitivity nor PI(4,5)P₂  binding 
(Nomikos et al. 2017a).  However, liposome binding assays and pull downs have shown that 
PLCζ binding to mono- phospholipids, specifically PI(3)P and PI(5)P is reduced by up to 50% 
(Nomikos et al. 2017a). It could therefore be suggested that the C2 domain conveys 
Ca²⁺releasing activity on PLCζ by localising it to specific membranes by binding to these 
phospholipids. By discrete localisation of PLCζ to these membranes via its C2 domain, the 
enzyme is then able to bind to PI(4,5)P₂  localised there by electrostatic interactions of the 
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X-Y linker and the EF hands domain. This theory would suggest that PLCζ C2 domain binding 
to the mono phospholipids PI(3)P and PI(5)P is necessary for optimal Ca²⁺releasing ability of 
PLCζ and could even explain why PLCζ does not localise to the plasma membrane. This idea 
is interesting because even though PLCζ has been found to bind to both PI(3)P and PI(5)P in 
vitro, PI(3)P particularly has actually been found to reduce the hydrolytic activity of PLCζ 
suggesting that this lipid is likely to have a regulatory role on the enzyme’s activity(Kouchi 
et al. 2005). It could therefore be considered unlikely that binding to an inhibitory lipid such 
as PI(3)P would be required for optimal activity of PLCζ. Furthermore, it is unlikely that 
PI(3)P and PI(5)P are involved in localising PLCζ to specific membranes mainly because 
topologically inside the egg these molecules are not found in the same compartments. 
PI(3)P is found almost solely in the membranes of early endosomes which is supported by 
both immunostaining overlap with early endosome markers and the fluorescently tagged 
FYVE domain localisation which binds very specifically to PI(3)P (Gillooly et al. 2003). The 
vesicular source of PI(4,5)P₂  found within the egg which overlaps strongly with PLCζ 
localisation does not overlap with early endosome markers such as the small GTPase Rab 5 
or with YFP-FYVE domain RNA expressed in the egg (Yu, Moon and Swann 2012 
unpublished). Instead the most likely origin for the intracellular vesicles that PLCζ localises 
to is the Golgi apparatus. This idea is supported by co-localisation of immunocytochemistry 
of Golgi markers such as Giantin and Rab 6 with PLCζ and PI(4,5)P₂ (Yu et al. 2012). 
However, there is no evidence to suggest that PI(3)P is located on Golgi membranes, 
instead the mono-phospholipid located here is PI(4)P which has not been found to bind to 
the C2 domain of PLCζ in vitro (Lorente-Rodríguez and Barlowe 2011). Furthermore the 
inhibition of PI(3)P production by the drug Wortamannin, which inhibits the enzyme PI3K, 
does not seem to affect the Ca²⁺releasing ability of PLCζ in the egg in fact appears to 
increase the frequency of these Ca²⁺i oscillations (Moon and Swann 2012 unpublished). This 
would suggest that it is unlikely that PI(3)P binding by the C2 domain is required for PLCζ’s 
ability to release Ca²⁺. Infact it is possible that the localisation of PI(3)P on other 
membranes could regulate PLCζ activity and prevent it hydrolysing PI(4,5)P₂ there. Little is 
known about the cellular localisation of PI(5)P however most data suggests that it is mainly 
localised to the nucleus however its’ localisation and role in other cellular membranes 
remains to be established (Bulley et al. 2015).  
One other way that localisation and activity of PLCζ could be controlled is indirectly by its 
interaction with accessory proteins through biochemical interactions with the structural 
domains of PLCζ. One example of this is Calmodulin (CaM). Like other PLCs PLCζ has a CaM 
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binding site within its structure and in PLCζ this sequence is found within the X-Y linker. In 
other PLCs interaction with CaM can have both negative and positive effects. For example 
PLCβ has a positive association with CaM (McCullar et al. 2003; McCullar et al. 2007). There 
is evidence that CaM may help localisation of PLCβ to the plasma membrane in a Ca²⁺i 
dependent manner and therefore stimulate it’s activity (McCullar et al. 2007). In contrast 
CaM appears to have an inhibitory effect on PLCδ1 in a manner that is reversible by the 
small GTPase Ral (Sidhu et al. 2005). Even though PLCζ possesses a binding motif for CaM 
the significance of this motif and the role of CaM interaction on PLCζ activity is still 
unknown. Recent results have shown that CaM reduces PLCζ hydrolytic activity at high Ca²⁺i 
concentrations by binding to it (Nomikos et al. 2017b). 
To investigate the role of the CaM binding motif of PLCζ in the current study 3 mutated 
versions of human PLCζ RNA were created containing point mutations within selected 
residues in the CaM binding motif. Each were tested for their Ca²⁺ releasing ability in 
mouse eggs. It was found that none of these mutations had a significant effect on the 
ability for PLCζ to release Ca²⁺. A slight increase was recorded in the number of eggs that 
had Ca²⁺i oscillations terminate early in those eggs injected with the triple mutant 
(PLCζLAA343,346,348GGG) which can be an indicator of high Ca²⁺releasing activity for example like 
that seen when wild type PLCζ is expressed at high levels. However, this effect is not 
significant enough to allow any strong conclusions to be drawn. This is particularly relevant 
as human PLCζ was used in these experiments. Due to the high potency of human PLCζ 
(higher than that of mouse PLCζ) expression levels of the protein required to give a 
physiological response are often very low. As a result the luminescence signal recorded per 
egg is much lower and therefore contains more noise in that signal, which ultimately gives 
a less accurate measure of expression. As human PLCζ is so potent very small differences in 
expression levels, particularly between different eggs, can have a significant effect the Ca²⁺i 
response recorded. This makes measuring subtle changes in the Ca²⁺releasing activity of 
PLCζ is response to subtle mutations difficult to measure. 
In this experiment it was difficult to make significant alterations to the residues in the X-Y 
linker without altering PI(4,5)P₂  binding therefore the mutations made within the binding 
domain may have been too subtle to have an effect on CaM interaction. It is unclear 
precisely how CaM would interact with PLCζ and whether it would have a positive or 
negative effect on its activity. Unlike PLCδ1 there is no evidence that PLCζ is stimulated by 
Ral activity so it is unlikely that PLCζ is regulated by a CaM –Ral complex in the same way as 
PLCδ1. Furthermore unlike PLCβ, PLCζ does not require high cytosolic Ca²⁺i levels in order 
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to hydrolyse PI(4,5)P₂ (Nomikos et al. 2005).  Instead, PLCζ is a lot more sensitiveto Ca²⁺ 
and is able to operate at basal cytosolic concentrations of Ca²⁺i making it unlikely that PLCζ 
is stimulated by CaM in a Ca²⁺ dependent manner the way PLCβ is (McCullar et al. 2007). It 
is possible however that CaM is able to regulate PLCζ activity through the involvement of 
other accessory proteins. There may be proteins other than Ral, particularly other small 
GTPases that could help regulate PLCζ activity. Most other PLC isoforms interact with small 
GTPases in some way (Gresset et al. 2012) so it is quite possible that PLCζ also does 
however the identity of this protein and the nature ofthis potential interaction remains 
unknown.  Interestingly, small GTPases are often localised to specific intracellular 
membranes and can act as markers for these organelles (Simons and Zerial 1993). It is not 
yet understood whether a small GTPase is involved in regulating PLCζ activity by playing a 
role in membrane targeting or by forming a regulatory complex with CaM in the way Ral 
does for PLCδ.  
Though the structure of PLCζ’s functional domains undoubtedly play a significant role in 
regulating and determining its Ca²⁺i releasing activity it is possible that post translational 
modifications of PLCζ may also play a role. One such modification that has previously been 
identified is proteolytic cleavage of the PLCζ protein.  It has previously been shown that the 
sperm extract from some species, porcine and mouse in particular, contains not only a 
large percentage of freely extractable full length PLCζ but also a significant amount of 
cleaved non-soluble PLCζ that may only be extracted under alkaline conditions (Kurokawa 
et al. 2005). Interestingly, following extraction, this sperm extract fraction containing 
cleaved PLCζ is able to cause Ca²⁺i oscillations when injected into eggs (Kurokawa et al. 
2007). Furthermore if cleaved PLCζ RNA is synthesised and then injected into eggs it is also 
able to cause Ca²⁺i oscillations (Kurokawa et al. 2007). These active PLCζ fragments always 
appear to be cleaved at a similar point in the X-Y linker region suggesting that proteolytic 
cleavage may occur as a post translational modification therefore could play a role in 
regulating PLCζ activity (Kurokawa et al. 2007). Neither of these halves of PLCζ are able to 
cause Ca²⁺ release alone because all structural domains of PLCζ have been found to be 
necessary in enabling PLCζ to release Ca²⁺ (Kurokawa et al. 2007). When these two halves 
of PLCζ are co-injected they form a functional complex in the egg that co-localises enabling 
hydrolysis of PI(4,5)P₂ (Kurokawa et al. 2007). It still remains unclear exactly how cleaved 
PLCζ is able to do this or how functional this split PLCζ is compared to full length PLCζ.  
The current study aimed to investigate the differences between the functional activities of 
cleaved human and mouse PLCζ compared to their full length counterparts. In order to 
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quantify these differences a colleague synthesised the two halves of cleaved PLCζ RNA and 
attached two separate halves of a luciferase tag so expression of the protein could be 
measured. These two halves were co-injected into eggs for both the human and the mouse 
PLCζ so that the Ca²⁺ releasing activity could be compared to full length PLCζ –luciferase 
RNA. It appears that for both species there is a reduction in the functional activity of 
cleaved PLCζ compared to full length PLCζ however at even relatively low RNA pipette 
concentrations cleaved PLCζ was still able to cause Ca²⁺i oscillations. It is most likely that 
the reduction in functional activity of split PLCζ is due to a reduced efficiency in these two 
halves of PLCζ coming together and co-localising in the egg. The main evidence for this is 
for a given concentration of RNA the luminescence signal was much lower for split PLCζ 
RNA compared to full length PLCζ. This would suggest that despite a reasonable expression 
of protein the efficiency of these two halves of PLCζ protein coming together in the right 
location in the egg is somewhat reduced. As a result the pipette concentration of RNA and 
protein expression would need to be higher in order to get the same amount of 
functionally active PLCζ protein compared to full length PLCζ RNA. This data is supported by 
the time delay in the beginning of Ca²⁺i oscillations seen in eggs injected with split PLCζ RNA 
compared to wild type PLCζ. However, as it is necessary for the two ends of luciferase to 
come together in order for the luciferase enzyme to work, it is also possible that a 
reduction in luminescence signal is due to a reduced efficiency in the two halves of 
luciferase joining. If this is the case it may be possible that despite an equivalent level of 
functional, available PLCζ protein the luciferase signal is still reduced. It is also possible that 
the differences in luciferase signal could be a result of differences in protein expression of 
the split PLCζ RNA compared to full length wild type PLCζ or differences in protein stability. 
Nevertheless the differences in luminescence signal between the eggs injected with split 
PLCζ RNA and full length PLCζ make it harder to accurately compare the functional activity 
of these two groups. 
The proteolytic cleavage of PLCζ occurs within the X-Y linker region which may be 
significant because despite having an important role in PI(4,5)P₂ binding this region can be 
considered the most structurally variable between species (Nomikos et al. 2011c). The X-Y 
linker of other PLC isoforms has been found susceptible to in vitro proteolysis including 
PLCγ (Fernald et al. 1994) , PLCβ (Schnabel and Camps 1998) and PLCδ1 (Ellis et al. 1993). It 
is thought these fragments come together to form a functional complex which in some 
cases has been found to stimulate activity (Jones and Wu 2000). This is because cleavage in 
the X-Y linker can lead to a conformational change which allows PI(4,5)P₂ to gain better 
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access to the X and Y catalytic domain (Jones and Wu 2000). The X-Y linker of PLCζ is 
different from other isoform in that it is so variable and though PLCζ is universal at 
releasing Ca²⁺in mammalian eggs there are strong differences in the potency of the protein 
in terms of Ca²⁺ releasing ability between species (Nomikos et al. 2014b). It is also possible 
that some species possess more proteolytically cleaved PLCζ compared to others. With 
both full length and split PLCζ marked differences in potency between mouse and human 
PLCζ have been recorded during all the current experiments. One explanation for this could 
be due to differences in the length and structure of the X-Y linker. To investigate this 
further the mouse and human split PLCζ RNA previously used was combined so N’ terminal  
half of one species was co-injected with C’ terminal half of the other species. Interestingly 
the potency of PLCζ appears to be dependent on which half of the split PLCζ originates from 
which species. For example, it appears that the N’ terminal half of PLCζ before the 
proteolytic split has more influence on the potency of PLCζ than the C’ terminal half. This 
may be because the majority of the X-Y linker is found in this half of PLCζ and in fact varies 
more in length between mouse and human derived PLCζ when compared to the C’terminal 
half. Human PLCζ is shorter in length than mouse PLCζ with a shorter X-Y linker so it is 
possible that this structural difference may contribute to the increased potency of human 
PLCζ compared to mouse (Cox et al. 2002; Saunders et al. 2002). However, when the N’ 
terminal half of human PLCζ is co-injected with the C’ terminal half of mouse PLCζ the Ca²⁺i 
response recorded in the eggs is not as strong as that seen when both halves of PLCζ are 
human derived. This suggests that it is not just the N-terminal half of PLCζ that confers 
potency differences between species. Furthermore it remains to be established whether it 
is structural differences the X-Y linker of PLCζ that are responsible for species differences in 
potency or whether it is because of other differences in other structural domains of PLCζ 
such as the EF hand domains or the catalytic domains. Right now it remains uncertain 
exactly which structural features of PLCζ determine the potency of the enzyme between 
species. More experiments need to be conducted to establish how the functional domains 
of PLCζ vary between different species and what role post translational modifications, such 
as proteolytic cleavage, play in regulating its activity. 
It is clear that the structural properties of PLCζ play a significant role in regulating its 
activity and all functional domains appear to be necessary in order for PLCζ to be maximally 
functionally active. These functional domains play independent distinct roles in conferring 
PLCζ’s Ca²⁺releasing ability and some domains have multiple roles in this regard. For 
example these experiments demonstrated a novel role for the EF hands domain separate to 
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conferring Ca²⁺ sensitivity. This region has been found to work in conjunction with the X-Y 
linker in binding to the substrate PI(4,5)P₂  therefore enabling the anchoring of PLCζ to this 
membrane bound substrate.  However, it has not been established how PLCζ becomes 
targeted to specific pools of intracellular PI(4,5)P₂  and which structural properties of the 
enzyme are involved in this process. The current studies suggest the possibility that the C2 
domain of PLCζ binding to specific membrane markers for example other phospholipids. 
However, it remains unclear what the significance of this domain is in terms of membrane 
localisation. It is likely that other protein interactions are involved in regulating the activity 
of PLCζ but it has still not been established what these interactions are. Likewise though 
proteolytic cleavage may play a role in regulating PLCζ activity the significance of this and 
other post translational modifications of PLCζ still need to be explored in more detail.  As a 
result the question to why PLCζ is uniquely able to cause Ca²⁺i oscillations in eggs remains 
to be fully answered, though it is highly likely this process involves both egg cellular factors 
aswell as particularly structural properties of the PLCζ enzyme.  
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5. CHARACTERISTICS OF EGGS WHICH ENABLE CA²⁺ RELEASE 
BY PLCZ 
Introduction 
At fertilisation the ability for eggs to release Ca²⁺in response to PLCζ is essential to ensure 
egg activation occurs effectively (Saunders et al. 2002). Though PLCs release Ca²⁺ via IP3 in a 
large array of somatic cells, eggs appear to be the only cell type in which physiological 
levels of PLCζ are able to cause Ca²⁺ release. If PLCζ is expressed in CHO cells no Ca²⁺ 
release is seen, however, if these transfected cells are then injected into eggs Ca²⁺i 
oscillations are triggered in these eggs (Phillips et al. 2011). This implies there is something 
unique about the cell biology of eggs that enables PLCζ to release Ca²⁺.  Indeed, this is a 
feature that seems to develop during oocyte maturation. Immature oocytes, specifically GV 
oocytes, do not release Ca²⁺aseffectively as mature MII arrested eggs. Original evidence for 
this comes from experiments by fertilising immature hamsteroocytes. It was found that GV 
oocytes did not release Ca²⁺as well as MII eggs in response to sperm. Specifically there was 
a reduction in frequency, duration and amplitude of these oscillations (Fujiwara et al. 
1993). This effect has also been recorded in immature mouse oocytes (Jones et al. 1995b). 
Similar results were seen in mouse oocytes where Ca²⁺i oscillations were induced using 
hamster derived sperm extracts. There was a 2 fold increase in size and duration of Ca²⁺ 
release in MII eggs compared to immature oocytes (Carroll et al. 1994). Furthermore the 
Ca²⁺ release in immature oocytes did not cross the oocyte as a wave in the same way as 
that seen in MII eggs (Swann et al. 1994).  This idea was further supported by experiments 
using PLCζ RNA that found Ca²⁺i oscillations initiated by PLCζ in GV oocytes were lower in 
frequency and amplitude compared to those initiated in mature eggs with the most marked 
difference occurring after GVBD (Wakai et al. 2012). These differences in Ca²⁺i releasing 
ability have been attributed to an increase in IP₃ receptor sensitivity during oocyte 
maturation (Mehlmann and Kline 1994). Many factors may influence the sensitivity of the 
IP₃ receptor including its phosphorylation status, the amount of Ca²⁺ in the ER and the 
localisation of those receptors. Experiments using thapsigargin and ionomycin have shown 
that immature mouse oocytes contain significantly less Ca²⁺ in their stores compared to 
mature eggs (Jones et al. 1995b). In fact there is an 11 fold increase in the area under the 
curve for Ca²⁺ release in response to thapsigargin in mature eggs compared to immature 
oocytes (Tombes et al. 1992; Jones et al. 1995b).  This change in luminal ER Ca²⁺ 
concentration directly affects the IP₃R sensitivity (Missiaen et al. 1992). In addition to an 
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increase in ER Ca²⁺ levels, oocyte maturation is also correlated with an increase in the 
number of IP₃R of approximately 2 fold (Mehlmann et al. 1996). In addition to this the IP₃R 
appear to become phosphorylated during oocyte maturation (Wakai et al. 2012). 
Collectively these changes are believed to increase the sensitivity of the IP₃R and therefore 
increase Ca²⁺ release. However, it is not yet known what role components upstream of IP3R 
play in enabling Ca²⁺ release during oocyte maturation, for example the availability of 
PI(4,5)P₂.  
One significant difference between mature eggs, immature oocytes and somatic cells is 
their point in the cell cycle. Somatic cells spend the majority of the time in interphase and 
only enter mitosis when they divide. Oocytes begin the process of oogenesis as oogonia 
which are very much like somatic cells however as they differentiate into oocytes these 
cells enter meiosis. GV oocytes become arrested in interphase of the first round of meiosis 
however during oocyte maturation they resume meiosis I and eventually become arrested 
in metaphase of meiosis II as mature eggs. This means that GV oocytes, maturing oocytes 
and eggs are at different phases of the meiotic cell cycle and Ca²⁺i releasing ability seems to 
be dependent on what point of the cell cycle thes oocutes are in. When fertilised eggs form 
pronuclei and enter interphase sperm induced Ca²⁺i oscillations cease however if these eggs 
are prevented from exiting metaphase Ca²⁺i oscillations persist for many hours (Jones et al. 
1995a). Furthermore if MI oocytes are induced to enter interphase they fail to oscillate. 
However, if these oocytes then undergo nuclear envelope breakdown and renter 
metaphase Ca²⁺i oscillations return (Jones et al. 1995a; Kono et al. 1996). Interestingly 
when zygotes enter their first mitotic division and the nuclear envelope breaks down Ca²⁺i 
transients return but this effect is not seen in embryos activated by strontium chloride 
(Kono et al. 1996). If karyoplast are taken from these fertilised eggs or 2 cell embryos and 
microinjected into unfertilised eggs Ca²⁺i oscillations can be recorded in these eggs (Kono et 
al. 1995). This effect can be seen using karyoplasts from embryos produced by fertilisation 
and those parthenogenetically activated with sperm extract suggesting that a Ca²⁺releasing 
factor becomes associated with the nucleus at interphase (Kono et al. 1995). It has been 
shown that fluorescent tagged PLCζ becomes localised to the pronucleus when Ca²⁺i 
oscillations cease (Larman et al. 2004; Yoda et al. 2004). This suggests that PLCζ is not able 
to cause Ca²⁺release during interphase due to nuclear localisation, however when this 
nuclear envelope breaks down PLCζ is free to cause Ca²⁺release (Larman et al. 2004).  
One reason why PLCζ is unable to cause Ca²⁺i oscillations whilst sequestered in the nucleus 
could be the inaccessibility to its substrate PI(4,5)P₂ . All other PLCs translocate to the 
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plasma membrane on activation (Suh et al. 2008). This is because in somatic cells the 
majority of PI(4,5)P₂  in the cell is found at the plasma membrane (Watt et al. 2002). 
However, PLCζ does not appear to hydrolyse this source of PI(4,5)P₂ under physiological 
conditions (Yu et al. 2012). Fluorescently tagged versions of PLCζ do not localize in the 
plasma membrane (Yoda et al. 2004; Ito et al. 2008; Phillips et al. 2011). In addition PLCζ 
does not cause DAG production at the plasma membrane during Ca²⁺i oscillations however 
PLCδ1 does (Yu et al. 2008). Furthermore no change in plasma membrane PI(4,5)P₂  are 
recorded during PLCζ activity and depleting plasma membrane PI(4,5)P₂ has no effect on 
Ca²⁺i recorded at fertilisation (Yu et al. 2012). However, the opposite is true for PLCδ1 
induced Ca²⁺i oscillations (Yu et al. 2012). This suggests that PLCζ is hydrolysing an 
intracellular source of PI(4,5)P₂ different to other PLCs. There is evidence using 
immunostaining that this PI(4,5)P₂ is found on small vesicles in the cytoplasm in mature 
mouse (Yu et al. 2012). This is significant as the availability of a vesicular source of PI(4,5)P₂ 
and sufficient targeting of PLCζ to it may be necessary for effective Ca²⁺ release in mature 
eggs. Previous evidence using immunocytochemistry has shown that significantly less 
vesicular PI(4,5)P₂ is present in GV oocytes and instead most PI(4,5)P₂ is found to be 
associated with the plasma membrane and the nucleus (Yu et al. 2012).  
All previous measures of intracellular PI(4,5)P₂ in mouse eggs have been carried out on 
fixed cells using immunostaining. One reason for this is the lack of specific probes to 
measure PI(4,5)P₂ in live cells. Though PI(4,5)P₂ and its parent derivative PI(4)P are the 
most prevalent phosphoinositides in cells, phosphoinositides collectively only make up 
approximately 5% of all phospholipids in the cell (Di Paolo and De Camilli 2006). There is 
therefore a challenge in distinguishing between small quantities of specific 
phosphoinositides in the cell. PH domain based probes have routinely been used to 
measure PI(4,5)P₂ at the plasma membrane (Balla 2007; Yoon et al. 2011). The PH domain 
of PLCδ1 binds to both PI(4,5)P₂ and IP₃ so if this domain is tagged with a fluorescent 
protein such as GFP, a fluorescent PI(4,5)P₂ probe can be developed (Lemmon et al. 1995; 
Holz et al. 2000). In somatic cells these probes have shown that in somatic cells the 
majority of PI(4,5)P₂ is present in the plasma membrane (Watt et al. 2002). PH domain 
probes have also successfully been used to detect changes in PI(4,5)P₂ levels at the plasma 
membrane in response to agonist stimulation (Szentpetery et al. 2009).  Interestingly GFP-
PH domain was also found to localise to the plasma membrane in eggs (Halet et al. 2002; 
Chun et al. 2010). Despite this no change in signal was seen in response to PLCζ or 
fertilisation (Yu et al. 2012). However, PH probes are not cell permeable so even if they are 
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transfected or injected into cells it may be difficult for the probes to access the PI(4,5)P₂  
located on the inner leaflet of intracellular organelles (Mondal et al. 2016).  
Recently some alternative probes have been developed that allow PI(4,5)P₂ to be measured 
in live cells dynamically using a radiometric method. These probes are based on the actin 
regulating protein gelsolin (Yin and Stossel 1979). Gelsolin has two PI(4,5)P₂  binding 
domains located on short polypeptides (Janmey et al. 1987; Janmey and Stossel 1987). The 
binding properties of gelsolin peptides have been examined in vitro and a 20 amino acid 
sequence of gelsolin (residues 150-169) has been shown to bind both PI(4)P and PI(4,5)P₂ 
however with an increased selectivity for PI(4,5)P₂  (Janmey et al. 1992). Residues 160-169 
contain multiple cationic side chains which bind to the negatively charged headgroup of 
PI(4,5)P₂  by electrostatic interactions (Liepina et al. 2003). This 20 amino acid sequence 
was tagged with the polarity sensitive fluorophore 2-dimethylamino-6-acyl-naphthalene 
(DAN) (Mondal et al. 2016). DAN undergoes a significant 60-70 nm shift from a green 
emission to a blue emission signal following binding to membrane bound 
phosphoinositides (Cicchetti et al. 2004). This can then be conjugated to proteins by 
attaching it to a cysteine (Prendergast et al. 1983). To create a DAN tagged gelsolin based 
peptide the Val 159 residue of this 20 amino acid gelsolin peptide was replaced with a 
cysteine to allow attachment of DAN (Mondal et al. 2016). This produced a PI(4,5)P₂ probe 
called DAN20 that responds in a ratiometic way to dynamic changes in PI(4,5)P₂ (Mondal et 
al. 2016). DAN20 has been shown to bind SUVs containing PC, PI(4,5)P₂  and PI(4)P with a 
shift in blue signal following an increase in the amount of PI(4,5)P₂ (Mondal et al. 2016). 
This probe is sensitive enough to detect low level PI(4,5)P₂ in vesicles down to 2% of 
membrane constituents. DAN20 has also been able used to measure PI(4,5)P₂ in live 
HEK293T cells. As to be expected the greatest intensity in blue signal was detected at the 
plasma membrane indicating the greatest amount of PI(4,5)P₂ present here (Mondal et al. 
2016). A significant blue signal was also detected in the perinuclear region suggesting that 
there is also an alternative pool of intracellular PI(4,5)P₂ (Mondal et al. 2016). Other shorter 
peptides of gelsolin have also been used as probes for measuring PI(4,5)P₂ for example the 
10 residue peptide PBP10 is labelled with the fluorophore rhodamine-B which produces a 
bright and stable red signal (Bucki et al. 2001; Cunningham et al. 2001). As this peptide is 
shorter it more readily permeates cell membranes.PBP10 has been shown to successfully 
bind PI(4,5)P₂ in vitro and somatic cells (Bucki et al. 2001; Cunningham et al. 2001). None of 
these gelsolin based probes have been used to measure the distribution or amount of 
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PI(4,5)P₂ in the eggs or oocytes. Furthermore the availability and role of vesicular PI(4,5)P₂ 
in Ca²⁺ release at fertilisation is yet to resolved in detail.  
It also remains unclear what the origin of these PI(4,5)P₂ containing vesicles are. Usually 
particular phosphoinositides are associated with particular membrane compartments and 
help convey the specificity of that membrane (De Matteis and Godi 2004). For example 
PI(3)P is usually associated with endocytic membranes such as endosomes (Mills et al. 
2001; Dale 2012). Fluorescent FYVE domain that bind to PI(3)P  has been in expressed in 
eggs and shows binding to large vesicular structures that are most concentrated in the 
cortex (Stenmark et al. 2002; Dale 2012)(Moon and Swann 2013 unpublished). However, 
marking for these vesicles using immunostaining against Rab 5 and immunostaining for 
PLCζ do not overlap (Yu and Swann 2013 unpublished) 
Though PI(4,5)P₂  is usually associated with the plasma membrane it also found in small 
quantities in the Golgi apparatus (Godi et al. 1999; Tan et al. 2015). The Golgi also contains 
PI(4)P which is the precursor for PI(4,5)P₂ (Godi et al. 1999; De Matteis and D'Angelo 2007). 
Previous data has shown that there is a strong evidence that PLCζ could hydrolyse PI(4,5)P₂  
localised to the Golgi apparatus. Immunocytochemistry shows that the vesicles that PLCζ is 
bound to overlap with staining for Golgi marker giantin and PI(4,5)P₂ (Yu and Swann 2012 
unpublished).  
In somatic cells the Golgi takes the form of stack like structures. However, there is evidence 
that the Golgi apparatus is restructured during oocyte maturation and takes a different 
form in eggs. In GV oocytes the Golgi appears as small stacks termed “mini-Golgi” (Payne 
and Schatten 2003). During germinal vesicle breakdown these structures get fragmented 
into vesicles which spread outwards from the centre of the egg during meiosis I (Moreno et 
al. 2002; Payne and Schatten 2003). This feature appears to be cell cycle dependent 
because a similar process is seen during mitosis of somatic cells. The Golgi fragments into 
very small vesicles called the “Golgi haze” which is a very transient condition (Altan-Bonnet 
et al. 2003; Axelsson and Warren 2004). Unlike somatic cells, eggs are maintained in the M 
phase of the meiotic cell cycle and therefore these Golgi fragments persist much longer 
than would be seen during mitosis. It remains unclear what role Golgi fragmentation plays 
on enabling mature eggs to release Ca²⁺ in response to sperm.  
Another possible origin of PI(4,5)P₂ containing vesicles is the ER. In fact fluorescent Venus 
tagged human derived PLCζ cRNA is found to overlap with the ER marker DsRed-ER cRNA in 
mouse eggs (Escoffier et al. 2015a). The ER also contains the parent phospholipid PI which 
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is required for the synthesis of if all phosphoinositides including PI(4,5)P₂ (van Golde et al. 
1974). Like the Golgi apparatus the ER alters significantly in distribution during oocyte 
maturation. In a GV oocytes the ER is continuous with the nuclear envelope however after 
GVBD the ER forms a ring around the spindle apparatus (FitzHarris et al. 2007). In MII eggs 
the ER appears as cortical clusters which are packed close to mitochondria (FitzHarris et al. 
2007). As the ER acts as the Ca²⁺ store in eggs it has been suggested that this re-distribution 
may be involved in enabling effective Ca²⁺ release in eggs. 
It is likely that the cytoplasmic features of eggs play a role enabling PLCζ to release Ca²⁺at 
fertilisation. Furthermore these features are likely to be acquired during oocyte maturation 
in a cell cycle dependent manner. It still remains very unclear however precisely what these 
features are and specifically what impact they have on PLCζ induced Ca²⁺i oscillations.  
Aims 
The aim of the current study is to investigate the particular cytoplasmic features of eggs 
that may enable PLCζ induced Ca²⁺i oscillations. Specifically this involves determining the 
localisation of PLCζ, and the potential sources of intracellular PI(4,5)P₂. The identity of 
these vesicles will then be explored with particular focus on the distribution of the Golgi 
apparatus and ER in eggs. The functional effect of disrupting PI(4,5)P₂  metabolism or 
availability will also be examined. Finally the differences in the PLCζ induced Ca²⁺i releasing 
ability at different stages of oocyte maturation will be quantified with the distribution of 
Golgi apparatus and intracellular PI(4,5)P₂ being compared to that of mature eggs.  
Results 
PLCζ localises to intracellular vesicles in eggs 
Immuno-staining confirms PLCζ localises to intracellular vesicles in the egg 
There is evidence that PLCζ hydrolyses an intracellular vesicular source of PI(4,5)P₂ instead 
of plasma membrane derived PI(4,5)P₂ (Yu et al. 2008; Yu et al. 2012). 
Immunocytochemistry of cMyc tagged PLCζ has previously shown that PLCζ localises to 
small vesicles in mature eggs (Yu et al. 2012). However, this data is yet to be reproduced so 
in order to verify this result the experiment was repeated. As few specific antibodies 
against PLCζ exist, mouse PLCζ DNA was tagged with a cMyc sequence and synthesised into 
cRNA that could be microinjected into eggs and endogenously expressed. This allows 
antibodies against cmyc to be used to look at the localisation of PLCζ. This cMyc-mPLCζ 
cRNA was microinjected into eggs at a concentration of 0.01 μg/μl and left to express for 3 
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hours. Injected eggs were then fixed using 4% paraformaldehyde and permeabilised using 
0.1 % triton prior to incubation in the mouse Ig blocking reagent then 10% BSA as a 
blocking agent. The eggs were then incubated in mouse derived anti- cMyc (epitope) 
antibody for 1 hour followed by a secondary anti-mouse fluorescent Alexa (488) antibody 
for 45 minutes. The eggs were washed through clean media and imaged on a confocal 
microscope. Fluorescent staining appeared concentrated on small vesicles distributed 
throughout the cytoplasm, particularly concentrated in the cortical region however with no 
significant fluorescence signal at the plasma membrane (see fig 5.1). This would suggest 
that PLCζ localises on intracellular vesicles and does not bind to the plasma membrane.  
It has previously been shown that mPLCζ contains a nuclear targeting sequence which 
localises PLCζ to the nucleus following pronuclei formation possibly leading to the cessation 
of the Ca²⁺I oscillations (Yoda et al. 2004). To establish whether this effect could be verified 
using immunostaining the protocol above was repeated however the eggs were left to 
express the cMyc-mPLCζ cRNA for 5 hours prior to fixation. This ensured the eggs had 
become fully parthenogenetically activated including the formation of pronuclei. When 
these activated eggs were imaged on the confocal microscope some fluorescence was 
concentrated on small vesicles throughout the cytoplasm however the strongest 
fluorescent signal came from the pronucleus which appeared to contain a lot of cMyc-
mPLCζ (see fig 5.1). This suggests as previously described cMyc-mPLCζ becomes localised to 
the nucleus following pronuclear formation at egg activation. However, the fact that some 
PLCζ is still present in the cytoplasm suggests that not all the PLCζ is sequestered in the 
nucleus.  
Fluorescently tagged PLCζ does not localise specifically in eggs  
In order to carry out immunostaining it is necessary to first fix the cells. Therefore, to look 
at the localisation of PLCζ in live cells it is necessary to develop a genetically encoded probe 
that may be expressed in eggs. However, as PLCζ hydrolyses PI(4,5)P₂  and releases Ca²⁺the 
localisation of PLCζ may alter. To avoid this a probe was developed based on a mutated 
catalytically inactive version of the mouse PLCζ gene (mPLCζD210). This sequence was then 
tagged with fluorescent mCherry to produce a mPLCζD210- mCherry (by MN). This fusion 
protein was then synthesised into cRNA so it could expressed in live eggs and fluorescently 
imaged to determine the localisation of this PLCζ. This RNA was injected into live eggs at a 
pipette concentration of 0.5 μg/μl and left to be expressed into protein for approximately 3 
hours. The eggs were then imaged on a confocal microscope to look at localisation of the 
fluorescent probe. The eggs emitted a red fluorescence indicating that the PLCζD210- 
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mCherry RNA was expressed by the eggs. However the localisation of the mPLCζD210- 
mCherry was uniform throughout the cytoplasm and did not appear to localise to any 
particular membrane. The fluorescent signal emitted by PLCζD210- mCherry was very weak 
despite the high concentrations of cRNA injected (see fig 5.2). To try and increase the 
fluorescent signal emitted the mPLCζD210gene was tagged with an alternative fluorescent 
tag called tdTomato which is known to produce a very bright signal (Morris et al. 2010). 
mPLCζD210– tdTomato cRNA was synthesised and microinjected into eggs at a pipette 
concentration of 1.7 μg/μl and left to translate into protein for approximately 3 hours. The 
eggs were then imaged on a confocal imaging system to determine the distribution of 
mPLCζD210– tdTomato. The fluorescent signal emitted by the eggs was extremely low and 
not visible using the confocal microscope and therefore it was not possible to determine 
the localisation of the protein. This suggests thatmPLCζD210– tdTomato construct was not 
successfully translated into protein by the eggs.  
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MII egg
PN  
c-Myc PLCζ immuno-staining
 
Figure 5.1 Confocal image showing the immunostaining of cMyc-PLCζ in an MII egg 
3 hours post injection of c-Myc-PLCζ cRNA (pipette concentration of 0.01 μg/μl, n=12) and a 
fully activated egg (PN) 5 hours post-injection of c-Myc-PLCζ cRNA (pipette concentration of 
0.01 μg/μl, n=6) 
 
 
  
Pronuclei 
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PLCζ D210- mCherry
 
Figure 5.2 Confocal image showing distribution of PLCζ 
D210
- mCherry in an egg 
MII egg 3 hours post injection of PLCζ
D210
- mCherry cRNA (pipette concentration of 0.5 μg/μl, n=8) 
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Intracellular vesicles in eggs contain PI(4,5)P₂ 
Immuno-staining shows that PI(4,5)P₂  is found on intracellular vesicles  
Given the evidence that PLCζ does not hydrolyse plasma membrane PI(4,5)P₂ and that PLCζ 
localises to intracellular membranes it is likely that these vesicles contain PI(4,5)P₂ (Yu et al. 
2012). A vesicular, intracellular source of PI(4,5)P₂ has previously been identified in eggs by 
immunostaining using antibodies raised against PI(4,5)P₂ (Yu et al. 2012). Furthermore, 
these PI(4,5)P₂ positive vesicles appeared to co-localise with cMyc tagged PLCζ (Yu and 
Swann 2012, unpublished). To verify the endogenous PI(4,5)P₂ localisation in eggs immuno-
staining was performed using antibodies raised against PI(4,5)P₂ . The same immuno-
staining protocol was used as that for cMyc-PLCζ but mouse monoclonal anti-PI(4,5)P₂ was 
used as a primary antibody instead of the anti-cMyc antibody. These eggs were then 
imaged using the confocal microscope to determine the localisation of these antibodies. 
Some fluorescent vesicles were visible however there was also a very large amount of 
diffuse fluorescence throughout the cytoplasm (fig 5.3). A greater amount of vesicles were 
found in the cortical region of the egg however it was difficult to ascertain whether specific 
plasma membrane staining was apparent. This suggests there is some endogenous 
vesicular PI(4,5)P₂ in eggs however there was a large amount of background fluorescent 
staining which made it difficult to resolve these vesicles accurately. Furthermore, there was 
a large degree of variability in staining between eggs and across repeats.  
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PI(4,5)P₂  immunostaining
 
Figure 5.3 Confocal image showing immunostaining of PI(4,5)P₂ in an MII egg 
Immunostaining against endogenous PI(4,5)P₂ in an MII egg (n=10) 
 
  
157 
 
Fluorescent PI(4,5)P₂ localises to intracellular vesicles in eggs 
As the immunostaining was not able to quantitatively measure PI(4,5)P₂ in live cells and 
because of the difficulties in obtaining consistent results free of background signal, an 
alternative way to verify whether a vesicular source of PI(4,5)P₂ is present in eggs was 
required. For this a fluorescent BODIPY-FL tagged version of PI(4,5)P₂  (FL-PI(4,5)P₂ ) was 
microinjected into eggs at a pipette concentration of 1 mM in KCL HEPES and the 
localisation was observed on a confocal microscope (see fig 5.4). This fluorescent tagged 
PI(4,5)P₂ has previously been used to measure PI(4,5)P₂ distribution in somatic cells 
(Golebiewska et al. 2008). In FL-PI(4,5)P₂ the BODIPY fluorophore is located on one of the 
acyl chains within the synthetic PI(4,5)P₂. Within the first 30 minutes post injection FL-
PI(4,5)P₂ this staining appeared to localize within multiple internal membranes but mainly 
within reticular structures. With time the fluorescence reduces significantly in these 
compartments and small fluorescent vesicles began to become visible. Between 45 minutes 
and 1.5 hours post injection virtually all reticular staining disappears and the FL-PI(4,5)P₂  
appears only to be bound to small vesicles. These vesicles were diffuse throughout the 
cytoplasm but very little fluorescent staining of the plasma membrane was evident. This 
supports the notion that a vesicular intracellular source of PI(4,5)P₂ is present in eggs. 
Furthermore as the FL-PI(4,5)P₂  partitions with time this suggests that PI(4,5)P₂  becomes 
anchored to small intracellular vesicles and is excluded from other membranes and plasma 
membrane (see fig 5.5).  
To determine if the distribution of FL-PI(4,5)P₂ was disrupted by PLCζ activity a group eggs 
were injected with mPLCζ cRNA(pipette concentration of 0.02 μg/μl) and  left for half an 
hour to allow for expression of PLCζ protein. These eggs were then injected with FL-
PI(4,5)P₂  in the same manner as described previously alongside control eggs that were not 
pre-injected with mPLCζ cRNA. After 45 minutes these eggs were imaged on the confocal 
microscope so the distribution of FL-PI(4,5)P₂ could be visualised. Those eggs injected with 
mPLCζ cRNA showed a more diffuse and less vesicular distribution of fluorescence 
compared to PLCζ-free control eggs. All the eggs were then left for a further 45 minutes 
before being imaged again on the confocal microscope. In the eggs injected with PLCζ there 
was an even further reduction in fluorescence signal and by this stage no vesicular staining 
was seen in these eggs. However, after this time the control eggs that had not been 
injected with PLCζ still showed strong vesicular fluorescence staining (fig 5.6). This shows 
that FL- PI(4,5)P₂ distribution is disrupted and reduced by PLCζ activity suggesting that PLCζ 
is affecting the metabolism of the  vesicular FL-PI(4,5)P₂ .  
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15 mins 30 mins
45 mins 1.5 hrs 
Time course of BODIPY-FL PI(4,5)P₂ in MII eggs 
BODIPY-FL
BODIPY-FL PI(4,5)P₂ Structure
 
Figure 5.4 Schematic showing the chemical structure of BODIPY-FL PI(4,5)P₂ 
(taken from echelon-inc.com) 
 
 
Figure 5.5: Confocal images showing the distribution of BODIPY-FL PI(4,5)P₂ in MII eggs 
BODIPY-FL PI(4,5)P₂ (pipette concentration=1mM) in MII eggs at different time points post injection  
(n=7) 
 
Reticular 
structures 
Vesicular 
structures 
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PLCζ cRNA
45 mins
(1.25 hrs post 
PLCζ injection)
1.5 hrs
(2 hrs post 
PLCζ injection)
Control
BODIPY-FL PI(4,5)P₂ in MII eggs in the presence of PLCζ
 
Figure 5.6 Confocal images showing how the distribution of BODIPY-FL PI(4,5)P₂ is affected by PLCζ 
The distribution of BODIPY-FL PI(4,5)P₂ in MII eggs either injected with PLCζ cRNA (pipette 
concentration 0.04 µg/µl, n=7) or not injected with PLCζ cRNA (n=6) Images show eggs 45 minutes 
and 1.5 hours post BODIPY-FL PI(4,5)P₂ injection 
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The DAN20 PI(4,5)P₂ probe shows that PI(4,5)P₂  is localised to intracellular vesicles in eggs 
Though fluorescent PI(4,5)P₂  provided a reliable and simple method to determining where 
exogenous PI(4,5)P₂ becomes localised in live eggs it does not allow endogenous PI(4,5)P₂ 
to be measured. As a result a live cell probe that bound to endogenous PI(4,5)P₂ was 
required to verify this vesicular localisation of PI(4,5)P₂ . The ratiometric fluorescent DAN20 
probe has previously been used to measure PI(4,5)P₂  in live somatic cells (Mondal et al. 
2016) (see fig 5.7). This probe is based on a gelsolin peptide that binds to PI(4,5)P₂  and 
therefore is able to measure PI(4,5)P₂ in live cells dynamically. To determine whether 
DAN20 could be used to effectively measure PI(4,5)P₂  distribution in eggs, DAN20 was 
injected into eggs at a concentration of 270 μM diluted in KCL HEPES (experiments 
conducted with the help of Sophie Davies). Approximately 1 hour after injection these eggs 
were imaged on the confocal microscope. Light emitted from the blue and green channels 
were measured simultaneously. In both channels however DAN20 appeared to bind small 
vesicles diffuse throughout the cytoplasm. These vesicles looked similar in size and 
distribution to that FL-PI(4,5)P₂  bound. Some larger vesicular structures were also 
apparent which looked different to that seen with the other PI(4,5)P₂ markers (see fig 5.8). 
No obvious plasma membrane staining in eggs was detected using DAN 20. This suggests 
that DAN20 is an effective probe to measure intracellular pools of PI(4,5)P₂ in live eggs. 
Unfortunately, the DAN20 signal was found to bleach quickly and after approximately 1 and 
a half hours post injection only a weak signal was recorded.  
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DAN20 (PI(4,5)P₂  probe) in MII egg 
Gelsolin
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DAN20 Structure 
 
Figure 5.7 Schematic showing the structure of the PI(4,5)P₂ probe DAN20 
 
DAN20 (PI(4,5)P₂  probe) in MII egg 
Gelsolin
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Dansyl Fluorophore
DAN20 Structure 
 
 
Figure 5.8 Confocal image showing the distribution of DAN20 in an MII egg 
DAN20 1 hour post injection in an MII egg. Signal emitted from the green and blue channel shown 
(n=17) 
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The PI(4,5)P₂ probe PBP10 shows that PI(4,5)P₂  is localised to intracellular vesicles in eggs 
PBP10 is another live cell PI(4,5)P₂ peptide that is based on the polyphosphoinositide 
binding site of gelsolin however in this case is conjugated to  fluorescent rhodamine B 
(Bucki et al. 2001; Cunningham et al. 2001). This means that this probe emits red 
fluorescent light and could be considered slightly more stable and less environmentally 
sensitive than DAN20. As a result the localisation of PBP10 was used as an alternative 
marker for intracellular PI(4,5)P₂. PBP10 at a concentration of 1 mM mixed with KCL HEPES 
was injected into eggs and approximately 1 hour post injection the distribution of PBP10 
was examined using a confocal microscope (experiments conducted with the help of 
Sophie Davies). PBP10 was once again found to localise primarily to small vesicles 
throughout the cytoplasm similar to that seen by DAN20 and FL-PI(4,5)P₂ . Unlike DAN20, 
PBP10 did not localise to larger vesicles or any other membrane structures (see fig 5.9). 
Furthermore PBP10 did not appear to bind to the plasma membrane. This provides further 
support to the idea that an intracellular vesicular source of PI(4,5)P₂ is present in eggs and 
has the potential to provide the alternative pool of PI(4,5)P₂ hydrolysed by PLCζ. 
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PBP10 (PI(4,5)P₂  probe) in MII egg 
  
Figure 5.9 Confocal image showing the distribution of PBP10 in an MII egg 
PBP10 1 hour post injection in an MII egg (n=9) 
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The distribution of the Golgi apparatus and endoplasmic reticulum in eggs 
The dye DiIC18(3) labels the endoplasmic reticulum in live eggs and does not localise to 
intracellular vesicles 
Through there is evidence indicating that PLCζ localises to intracellular vesicles in the egg 
the origin or identity of these vesicles remains to be established. These vesicles are very 
likely to contain the vesicular source of PI(4,5)P₂ that is hydrolysed by PLCζ to initiate Ca²⁺ 
release. Given studies on somatic cells, it is most likely that these PI(4,5)P₂ containing 
vesicles originate either from the ER or the Golgi. It has previously been suggested that 
PLCζ could bind to or associate with the endoplasmic reticulum in eggs. Venus tagged PLCζ 
was found to co-localise with the ER marker DsRed-ER (Escoffier et al. 2015a).  Furthermore 
in HEK293T cell lines PLCζ appears to bind to cytoplasmic structures associated with the 
reticular network (Kashir et al. 2011) . It was therefore important to determine the 
localisation and structural appearance of the ER so this could be compared to the 
distribution of PLCζ and PI(4,5)P₂. The ER dye DiIC18(3) is a well-established marker for the 
ER (see fig 5.10) and has previously been microinjected into eggs (FitzHarris et al. 2007). In 
order to micro-inject DiIC18(3) it must first be dissolved in soybean oil. This DiIC18(3) in 
soybean oil is then microinjected direct into eggs using a very high pressure of around 40 
psi. After approximately 30 minutes post injection the DiIC18(3) became partitioned into the 
ER and was imaged on a confocal microscope. DiIC18(3)marked reticular structures 
throughout the egg cytoplasm as seen previously and therefore is likely to specifically mark 
the ER (Fitzharris et al 2007) (see fig 5.11). This data confirms that staining of the 
endoplasmic reticulum is very different the vesicular distribution of PLCζ and PI(4,5)P₂. 
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DiIC18(3) 
DiIC18(3) (ER marker)  in MII eggs 
 
Figure 5.10 Schematic showing the chemical structure of DiIC18(3) 
(taken from thermofisher.com) 
 
DiIC18(3) 
DiIC18(3) (ER marker)  in MII eggs 
 
Figure 5.11 Confocal image of DiIC18(3) in MII eggs 
DiIC
18
(3) in MII eggs approximately 30 minutes post injection (n=8). The excluded area 
shows the soybean oil drop that was injected into the egg 
 
Soybean oil drop 
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Immuno-staining of the Golgi marker giantin shows the Golgi apparatus forms vesicles in eggs 
There is some evidence that the Golgi apparatus takes a fragmented form in eggs that 
appear as vesicles (Moreno et al. 2002; Payne and Schatten 2003). Immunostaining against 
the Golgi marker giantin has previously shown that the Golgi appears as small vesicles 
throughout the cytoplasm which are particularly concentrated in the cortex (Yu and Swann 
2012, unpublished). Furthermore these giantin containing vesicles co-localise significantly 
with immunostaining of PI(4,5)P₂ (Yu and Swann 2012, unpublished).  
To verify the structure and nature of the Golgi in mature eggs immunostaining was 
repeated against the endogenous Golgi specific marker, giantin. Eggs were fixed and 
permeabilised as stated previously before being bathed in 5% goat’s serum as a blocking 
agent. The eggs were then incubated in rabbit derived polyclonal anti-giantin antibody 
followed by anti-rabbit Alexa (488) conjugated secondary antibody. These immuostained 
eggs were then imaged on a confocal microscope to determine the localisation of giantin. 
Giantin was found to be located in small vesicles throughout the cytoplasm however these 
vesicles are more concentrated in the cortical region of the egg fig 5.12). This data confirms 
and reproduces previous results and indicates that the Golgi is fragmented into small 
vesicles in mature eggs (Payne and Schatten 2003 .  
The Golgi apparatus marker fluorescent AC-lectin localises to intracellular vesicles  
Immunostaining can provide inconsistent results as it is multi-step process with many 
parameters that are often difficult to optimise. To avoid this issue and validate the Golgi 
distribution indicated by giantin staining the localisation of another Golgi specific marker 
was investigated. Amarathus caudatus lectin (AC-lectin) binds oligosaccharide containing 
galactosyl-beta 1,3-N-acetylglucosamine (Galβ3GalNAC) and is very specific to the Golgi 
apparatus (Rinderle et al. 1990). If this is conjugated to a fluorescent fluorescein tag then 
fluorescent AC-lectin can be used as a marker of the Golgi. As this AC-lectin is fluorescently 
tagged it is not necessary to use fluorescent antibodies so the cells only need to be fixed 
and permeabilised as previously described prior to incubation in AC-lectin (diluted 1:100) 
for 1 hour. After being washed through in clean media these eggs were then placed on a 
confocal imaging system so the localisation could be determined. As with giantin 
immunostaining, AC-lectin appeared to label small vesicles diffuse throughout the 
cytoplasm however particularly concentrated in the cortical region (see fig 5.13). This data 
strongly suggests that the Golgi apparatus is structured as small vesicles in eggs.  
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Equatorial Section 
Giantin immunostaining in MII eggs 
Cortical Section 
  
Figure 5.12 Confocal images showing immunostaining of giantin in MII eggs 
Images show an equatorial and a cortical section of the whole egg (n=8) 
 
AC-Lectin (Golgi marker)  in MII eggs 
 
Figure 5.13 Confocal image showing AC-Lectin staining in an MII egg 
(n=9)   
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The Golgi apparatus marker BODIPY-FL ceramide does not localise specifically to intracellular 
vesicles 
Though these markers for the Golgi apparatus appear to be specific neither of them is able 
to measure Golgi distribution in live cells or dynamically. To do this the distribution of the 
Golgi marker BODIPY-FL ceramide was used (see fig 5.14). This is a fluorescently tagged 
version of the lipid ceramide which is taken into the Golgi. Though BODIPY FL-ceramide is 
cell permeable it relies on CERT expression to get into the Golgi compartment (Hanada 
2010). Little is known about the extent of membrane trafficking or lipid transport in eggs so 
the BODIPY ceramide was directly injected into eggs instead. BODIPY-FL ceramide was 
diluted in KCL HEPES prior to microinjection at a pipette concentration of 500 μM. These 
eggs were then imaged on a confocal microscope after approximately 1 hour to examine 
the localisation of the marker. Unlike the other Golgi markers used, BODIPY-FL ceramide 
did not appear to localise to small intracellular vesicles but instead appeared to mark 
membranes that were more reticular in structure which appeared dense in distribution 
(see fig 5.15). This could suggest that BODIPY-FL ceramide does not specifically mark the 
Golgi apparatus but may also be binding to other membranes such as the endoplasmic 
reticulum. 
The Golgi apparatus marker GOLGI-ID® localises to intracellular vesicles 
As BODIPY FL ceramide does not act as a specific marker for Golgi apparatus, the 
distribution of another live cell marker for the Golgi was tested. GOLGI-ID® is a 
commercially available assay kit that contains a green fluorescent dye for staining the Golgi 
apparatus. This dye is promoted as being very specific at targeting the Golgi apparatus. Egg 
were incubated in the GOLGI-ID® dye for one hour in the fridge before undergoing an 
extensive wash out in media containing 10% serum for an hour and a half. These eggs were 
then imaged on the confocal microscope to determine the distribution of the GOLGI-ID® 
probe. GOLGI-ID® did appear to localise to some vesicles in the cytoplasm (see fig 5.16). 
There was also some fluorescence seen emitted from other intracellular membranes that 
appeared more reticular, however this staining was much weaker than the vesicular 
staining. This suggests that GOLGI-ID® binds to Golgi derived intracellular vesicles 
throughout the cytoplasm. However it also binds in a less specific fashion to other 
membranes albeit with a reduced affinity.  
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BODIPY-FL ceramide (Golgi marker)  in MII eggs 
BODIPY-FL ceramide
 
Figure 5.14 Schematic showing the chemical structure of the BODIPY-FL ceramide 
(taken from thermofisher.com) 
 
 
BODIPY-FL ceramide (Golgi marker)  in MII eggs 
BODIPY-FL ceramide
 
Figure 5.15 Confocal image showing BODIPY-FL ceramide staining in an MII egg 
Approximately 30 minutes post injection of BODIPY-FL cermamide (pipette 
concentration 500 μM, n=10) 
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GOLGI- ID (Golgi marker)  in MII eggs 
 
Figure 5.16 Confocal image showing GOLGI-ID staining in an MII egg 
(n=15) 
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The Golgi apparatus dye BODIPY FL- ceramide overlaps strongly with the ER marker DiIC18(3) 
As BODIPY-FL ceramide appears to mark reticular structures in the egg cytoplasm that 
looked very similar to the distribution of the ER, it is possible that BODIPY FL- ceramide is 
acting as a marker for the ER rather than the Golgi. To determine if this was the case eggs 
were injected with both DiIC18(3) and BODIPY FL- ceramide (at a pipette concentration of 
500 μM) during 2 separate injections. Eggs were first injected with BODIPY FL- ceramide 
and then DiIC18(3) half an hour later. Approximately 30 minutes following the DiIC18(3) 
injection the eggs were imaged on a confocal microscope to determine whether these two 
probes co-localised. Images were captured of the fluorescent signals emitted by both 
BODIPY FL-ceramide and DiIC18(3), these images were then overlaid to determine where 
the signals overlapped. The co-localisation of these two markers was extremely strong 
suggesting that rather than acting as a marker for the Golgi apparatus BODIPY FL- ceramide 
is actually acting as a marker for the endoplasmic reticulum in eggs (see fig 5.17). 
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Figure 5.17 Confocal images showing the co-localisation between BODIPY-FL ceramide and 
DiIC18(3) 
A)  in MII eggs (n=6) B), GV oocytes (n=8).  Oocytes/eggs were injected first with BODIPY FL-
ceramide, then 30 minutes later injected with DiIC18(3) . Eggs were then imaged 30 minutes post 
injection of  DiIC18(3). Both dyes were excluded from the germinal vesicle  
 
  
Germinal 
vesicle 
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The Golgi associated protein Rab 6 may localise to intracellular vesicles in eggs  
Rab proteins are a large family of membrane bound GTPases that play a key role vesicle 
trafficking. Different members of the Rab family are specifically associated with different 
membranes and therefore can be used as markers for specific membrane compartments 
(Simons and Zerial 1993). Rab 6 is known to be associated with the Golgi and the trans-
Golgi network (Goud et al. 1990). Therefore Rab 6 distribution can be used as a marker for 
the Golgi apparatus. Immunostaining of Rab 6 in eggs has previously shown that it is 
localised to small vesicles diffused throughout the cytoplasm (Yu and Swann 2012, 
unpublished). Furthermore this immunostaining of Rab 6 has been found to co-localise with 
cMyc-PLCζ suggesting that Rab 6 positive vesicles may be the target for PLCζ in the egg (Yu 
and Swann 2012, unpublished). To investigate the distribution of Rab 6 in live eggs, 
fluorescently labelled Rab 6 cRNA was microinjected into eggs and left to be translated for 
approximately 3 hours prior to confocal imaging. A series of 3 different Rab 6 cRNA 
constructs were created, first of these was the Rab 6 sequence tagged with fluorescent GFP 
sequence. Rab 6- GFP cRNA was synthesised by MN and microinjected into mouse eggs at a 
concentration of 1 μg/μl. When imaged on the confocal microscope Rab 6-GFP appeared to 
localise to intracellular vesicles however there was also fluorescence signal emitted from 
other intracellular membranes that appear more aggregated in structure (see fig 5.18).  
This additional membrane staining could be Rab 6 –GFP localising to the ER because Rab 6 
has been shown to be involved in anterograde and retrograde membrane trafficking, 
shuttling proteins between the Golgi and the ER (Martinez et al. 1994). Overexpression of 
the GTP bound form of Rab 6 inhibits anterograde trafficking through the Golgi and 
promotes retrograde transport. As a result Golgi resident proteins can end up in the ER 
(Martinez et al. 1994; Martinez et al. 1997). In contrast if a mutated GDP bound form of 
Rab 6 is over-expressed, Rab6T27N,  this retrograde transport is inhibited (White et al. 1999) 
To try and minimise ER localisation this Rab6T27Nsequence was used to produce a 
fluorescent construct that was incapable of moving between the ER and Golgi 
compartments. The Rab6T27N sequence was tagged with either YFP or mCherry fluorescent 
tags and synthesised into cRNA by MN. These constructs were then injected into eggs in 
the same manner as Rab 6 –GFP and left to express for approximately 3 hours. Confocal 
imaging showed the fluorescence emitted by Rab6T27N-YFP was very low which made it too 
difficult to resolve specific localisation. A similar result was seen in those eggs 
microinjected with Rab6T27N-mcherry. 
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Immuno-staining shows Rab 6 is localised to intracellular vesicles in the egg 
 
Due to variable results obtained using exogenous fluorescent Rab 6 it was important to 
verify that endogenous Rab 6 is localised to vesicles in eggs. To do this immunostaining was 
performed using the same protocol as for giantin however using rabbit polyclonal 
antibodies against Rab 6 instead. When these eggs were imaged on the confocal 
microscope Rab 6 was seen to localise to small vesicles throughout the cytoplasm (see fig 
5.19). Some fluorescence was emitted from other intracellular membranes that did not 
appear vesicular in structure however this fluorescence was much weaker than that 
emitted from intracellular vesicles.  
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Figure 5.18 Confocal image of Rab 6-GFP distribution in an MII egg 
3 hours post injection of Rab 6-GFP cRNA (pipette concentration of 1 µg/µl) (n=5) 
 
 
 
 
 
 
Figure 5.19 Confocal image showing the immunostaining of Rab 6A in an MII egg 
(n= 15) 
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Functional effects of treatments designed to disrupt PI(4,5)P₂ availability and PI cycling on 
the Ca²⁺i releasing ability of eggs in response to PLCζ 
Expressing the phosphatase OCRL1 in eggs does not affect PLCζ induced Ca²⁺i oscillations  
As it is the substrate of PLCζ the availability of PI(4,5)P₂ is likely to play a role in the Ca²⁺i 
releasing ability of PLCζ in eggs. Therefore to investigate whether the availability of 
PI(4,5)P₂  is a limiting factor for PLCζ activity several experiments were designed to 
specifically reduce PI(4,5)P₂  levels in live eggs and then  analyse Ca²⁺ oscillations initiated 
by PLCζ.  
OCRL1 is a gene that is endogenously expressed in cells that encodes for inositol 
polyphosphate 5-phosphatase (OCRL1) (Zhang et al. 1995). OCRL1 protein is localised 
primarily to the Golgi apparatus (Olivos-Glander et al. 1995). As it is a phosphatase OCRL1 
catalyses the conversion of PI(4,5)P₂ to PI(4)P and therefore regulates specific pools of 
PI(4,5)P₂  levels (Zhang et al. 1995). To determine whether the Ca²⁺ releasing activity of 
PLCζ was affected by the cellular levels of PI(4,5)P₂, OCRL1 cRNA (concentration of (1 μg/μl) 
was microinjected into eggs in order to try and deplete the levels of endogenous PI(4,5)P₂ . 
These eggs were then left to express this cRNA for approximately 3 hours before being 
injected with mPLCζ-luciferase cRNA (0.02 μg/μl) and the Ca²⁺i indicator OGBD. The Ca²⁺i 
oscillations in these eggs were then compared to eggs that had only been injected with 
mPLCζ-luciferase and not OCRL1. OCRL1 did cause a small reduction in the frequency of 
Ca²⁺i oscillations compared to controls not injected with OCRL1 however this reduction is 
not significant (see fig 5.20).  
It is possible that much of the PI(4,5)P₂  is synthesised during oocyte maturation so to try 
and reduce the levels of PI(4,5)P₂  during this time OCRL1 cRNA was microinjected into GV 
oocytes that were left to mature to MII in vitro. These in vitro matured eggs were then 
injected with mPLCζ-luciferase cRNA (0.02 μg/μl) mixed with OGBD so the dynamics of Ca²⁺i 
oscillations could be measured. Again there was a slight reduction in the frequency of Ca²⁺i 
oscillations compared to those eggs not injected with OCRL1 however this difference was 
not significant. This suggests that OCRL1 over expression does not affect PLCζ’s 
Ca²⁺releasing ability significantly (see fig 5.20). 
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Figure 5.20 Ca²⁺i traces showing the effect of OCRL1 on oscillations induced by PLCζ 
Ca²⁺i oscillations induced by PLCζ –luciferase cRNA (pipette concentration of  0.5 µg/µl) A) eggs were 
injected with untagged OCRL1 cRNA (pipette concentration of 1.5 µg/µl and left to express for 
approximately 3 hours before injection of PLCζ –luciferase cRNA  (n= 9,  mean number of Ca²⁺i 
oscillations  in the first hour of spiking = 5.3, mean luminescence in the first hour of spiking =0.5 cps) 
B) GV oocytes were injected with untagged OCRL1 cRNA (pipette concentration of 1.5 µg/µl and left 
to express for approximately 18 hours whilst maturing before injection of PLCζ –luciferase cRNA  (n= 
6,  mean number of Ca²⁺i oscillations  in the first hour of spiking = 7.8, mean luminescence in the first 
hour of spiking =0.8 cps C) eggs were injected with only PLCζ –luciferase cRNA  (n= 13,  mean 
number of Ca²i oscillations  in the first hour of spiking = 7.2, mean luminescence in the first hour of 
spiking =0.4 cps) 
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Attempts to deplete Golgi located PI(4,5)P₂ using phosphatase tagged Golgi markers does not 
affect PLCζ induced Ca²⁺i oscillations 
As it is was  possible to determine which pools of PI(4,5)P₂  are being metabolised by OCRL1 
a series of other constructs were developed by MN in attempt to deplete specific pools of 
PI(4,5)P₂  notably that found at the Golgi apparatus. Firstly the C1b domain of PKC was 
selected to target the Golgi as it binds to both DAG and PI(4)P, both of which should be 
localised to the Golgi apparatus (De Matteis and Godi 2004). This domain was tagged to a 
5’ phosphatase and a mCherry fluorescent tag to createC1b- mCherry-phosphatase fusion 
construct that was then synthesised into cRNA (by MN). This cRNA was then microinjected 
into eggs at a concentration of 1μg/μl. Approximately 3 hours after microinjection these 
eggs were then microinjected with mPLCζ-luciferase cRNA (0.02 μg/μl) mixed with the Ca²⁺i 
indictor OGBD so the Ca²⁺i dynamics could be recorded and analysed. These results were 
then compared to the Ca²⁺i oscillations of control eggs that had been injected with mCherry 
cRNA (1μg/μl) instead of C1b- mCherry-phosphatase. No difference in the frequency or 
pattern of Ca²⁺i oscillations were seen between the two groups which suggests that the 
expression of C1b- mCherry-phosphatase cRNA does not affect PLCζ induced Ca²⁺i 
oscillations (fig 5.21). 
The second targeted construct that was developed contained the PH domain of oxy-sterol 
binding protein (OSBP) which should also target the Golgi apparatus through binding to 
PI(4)P (Levine and Munro 1998). This OSBP(PH) was tagged again to a 5’phosphatase and 
synthesised into cRNA (by MN). The OSBP(PH)-phosphatase cRNA was microinjected into 
eggs at a pipette concentration of 1μg/μl. Approximately 3 hours after injection these eggs 
were then microinjected a second time with mPLCζ-luciferase cRNA and OGBD as 
previously described. The Ca²⁺i oscillations in these eggs were analysed and compared to 
those eggs that had been injected with mPLCζ-luciferase cRNA and OGBD alone. The 
addition of OSBP (PH)-phosphatase did not appear to affect the Ca²⁺i oscillations initiated 
by PLCζ when compared to those that had not been microinjected with OSBP(PH)-
phosphatase cRNA (see fig 5.21). This would suggest that either targeting 5’phophatase to 
the Golgi apparatus does not affect Ca²⁺i oscillations induced by PLCζ or these constructs 
are not targeting the Golgi. 
 It was important to establish if the C1b domain and OSBP(PH) domain were correctly 
targeting the construct to the Golgi apparatus. To identify where C1b domain and 
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OSBP(PH) were localising in the egg, fluorescent mCherry tagged constructs were created 
of each domain. Firstly the C1b domain was tagged with mCherry and synthesised into 
cRNA (by MN). This cRNA was microinjected into eggs at a concentration of 1 μg/μl and left 
to express for approximately 3 hours before being imaged on the confocal microscope to 
determine localisation of the C1b-mCherry construct. Unlike other markers for the Golgi 
apparatus C1b-mcherry did not appear to localise to small intracellular vesicles but instead 
was more reticular in appearance and more similar to the distribution of markers of the ER 
(see fig 5.22). The same experiment was conducted using the OSBP(PH) domain tagged 
with mCherry that was synthesised into OSBP(PH)-mCherry cRNA (by MN). Eggs were 
microinjected with OSBP(PH)-mCherry cRNA (1.5 μg/μl) and left to express this RNA for 
approximately 3 hours. These eggs were then imaged on the confocal microscope to 
analyse the distribution of the construct. Like C1b-mcherry, OSBP(PH)-mCherry didn’t 
appear to be vesicular in distribution but instead appeared as a reticular pattern like 
markers of the ER however this signal was extremely low (see fig 5.22). This would suggest 
that neither C1b nor OSBP (PH) domain localise to a vesicular form of the Golgi or at least 
the same compartment of the Golgi that intracellular vesicular PI(4,5)P₂ resides. This could 
explain why these constructs did not have any effect on Ca²⁺i oscillations. 
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Figure 5.21 Ca²⁺i traces showing the effect of phosphatase tagged OSBP(PH) and C1b domain on 
oscillations induced by PLCζ 
Ca²⁺i oscillations induced by PLCζ –luciferase cRNA (pipette concentration of  0.5 µg/µl) A) eggs were 
injected with c1b-cherry-phosphatase cRNA (pipette concentration of 1 µg/µl and left to express for 
approximately 3 hours before injection of PLCζ –luciferase cRNA  (n= 8,  mean number of Ca²⁺i 
oscillations  in the first hour of spiking = 10.3, mean luminescence in the first hour of spiking =1.3 
cps) B) eggs were injected with OSBP-phosphatase cRNA (pipette concentration of 1 µg/µl and left to 
express for approximately 3 hours before injection of PLCζ –luciferase cRNA  (n= 10,  mean number 
of Ca²⁺i oscillations  in the first hour of spiking = 6.4, mean luminescence in the first hour of spiking 
=0.5 cps) 
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Figure 5.22 Confocal images showing the distribution of OSBP(PH)-mCherry and C1b-mCherry in 
MII eggs 
A) mCherry tagged PH domain of OSBP cRNA pipette concentration 1.5 µg/µl) ( (n=5) 
and B) mCherry tagged C1b domain cRNA (pipette concentration 1 µg/µl) (n=5)  
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Disrupting PI cycling through inhibition of DAG kinase prevents PLCζ induced Ca²⁺i oscillations 
As opposed to depleting already synthesised PI(4,5)P₂ using 5’ phosphatases another 
method for reducing the levels of PI(4,5)P₂  is to prevent its synthesis from other 
phosphoinositides. The enzyme DAG kinase (DGK) is responsible for catalysing the 
production of phosphatidic acid (PA) from DAG (Call and Rubert 1973). This PA feeds into 
the PI cycle by interacting with CTP to produce CTP-DAG which is the precursor for 
phosphoinositol (PI)(Carter and Kennedy 1966). As a result, preventing the synthesis of PA 
by inhibiting DGK could prevent all further PI cycling and synthesis (see fig 5.23). To 
investigate the impact of disrupting PA production on PLCζ induced Ca²⁺i oscillations, the 
effect of DAG kinase inhibitor on the pattern of PLCζ induced Ca²⁺i oscillations was 
analysed. Eggs were first microinjected with mPLCζ cRNA mixed with the Ca²⁺i indicator 
Rhod Dextran and the Ca²⁺i oscillations initiated were recorded using an epifluorescence 
imaging system. After approximately 30 minutes of Ca²⁺i oscillations 10 μM DGK inhibitor 
was added to the media surrounding the eggs and imaging was continued. Due to the 
chemical structure of DGK inhibitor this drug was likely to be hydrophobic and therefore 
may partition into the mineral oil covering the media containing the eggs therefore the 
drug was added to media alone that was not covered with oil instead evaporation was 
prevented using a fitteddish lid. The addition of DGK inhibitor inhibited the PLCζ induced 
Ca²⁺i oscillations (see fig 5.24). Furthermore the basal level of Ca²⁺i remained fairly constant 
after the addition of DGK inhibitor. This would suggest that inhibiting PA synthesis by DGK 
inhibitor disrupts Ca²⁺i oscillations induced by PLCζ.  
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Figure 5.23 Schematic showing the different pathways of DAG and PA production 
The inhibitors of these pathways are shown in red. Two species of DAG and PA are shown those with 
poly unsaturated acyl chains (poly) and those with saturated acyl chains (poly).  
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Figure 5.24 Ca²⁺i trace showing the effect of DGK inhibitor on oscillations in MII eggs 
The effect of DAGK inhibitor (10µM) on Ca²⁺i oscillations induced by PLCζ cRNA (pipette 
concentration of 0.2 µg/µl) mixed with the Ca²⁺i indicator Rhod dex (n=13) 
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The effect of preventing PA synthesis by other pathways on PLCζ induced Ca²⁺i oscillations 
PA is synthesised by multiple pathways and not all pathways are connected to the PI cycle. 
An example of one such pathway is Phospholipase D (PLD) stimulated PA synthesis. PLD 
hydrolyses phosphatidylcholine (PC) to produce choline and PA (Liscovitch et al. 1993). The 
production of PA via this pathway can be prevented by the addition of primary alcohol 
which prevents PLD hydrolysing PC instead it undergoes a transphosphatidylation reaction 
to produce phosphatidyl alcohols instead of PA (Kotter and Klein 1999) (see fig 5.23).In 
Xenopus frog eggs there is a suggestion that a sperm factor stimulates PLD mediated PA 
synthesis, which the triggers src family PLCγ activation in order to release Ca²⁺(Bates et al. 
2014). To investigate whether PA synthesised by this pathway is also essential to maintain 
PLCζ induced Ca²⁺i oscillations the primary alcohol 1-butanolol was used to inhibit PA 
synthesis. Egg were first microinjected with PLCζ cRNA alongside the Ca²⁺i indicator OGBD, 
these eggs were then imaged for approximately 1 hour and all eggs were reported to have 
relatively low frequency Ca²⁺i oscillations. 1-butanol was then added to the media 
containing the eggs. 1-butanolol was found to raise the baseline Ca²⁺i of the eggs and 
dramatically increase the frequency of the Ca²⁺i oscillations (see fig 5.25). To determine 
whether this was a specific effect of primary alcohols a control experiment was conducted 
where the secondary alcohol 2-butanol was added instead of the 1-butanol. However, 2-
butanol had a very similar effect as 1-butanolol which suggests that this effect was not a 
specific response to primary alcohol (fig 5.25).  
DAG and PA are also produced as a result of phosphatidylcholine (PC) specific PLCs. This 
pathways operates distinctively from DAG and PA produced by phosphoinositol specific 
PLCs such as PLCζ. The anti-viral tricyclodecan-9-yl-xanthogenate (D609) is an inhibitor of 
PC-PLCs and therefore inhibits the synthesis of DAG and PA by this pathway (Adibhatla et 
al. 2012) (see fig 5.23). It is important to note it also inhibits the production of metabolic 
DAG produced from PC by SMS (see fig 5.23). To determine whether D609 has an impact on 
Ca²⁺i oscillations induced by PLCζ, eggs were injected with PLCζ cRNA mixed with the Ca²⁺i 
indicator OGBD and the Ca²⁺i changes were measured using an epifluorescence system. 
After approximately 1 hour of imaging D609 was added to the media surrounding the eggs. 
Once D609 had been added the eggs continued to oscillate for several minutes before the 
oscillations stopped (see fig 5.26). When the oscillations stopped the baseline Ca²⁺i 
increased slightly and reached a plateau.  
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Figure 5.25 Ca²⁺i traces showing the effect of primary and secondary alcohols on oscillations in MII 
eggs 
Traces showing the effect of A) the primary alcohol 1-butanolol on Ca²⁺I oscillations induced by PLCζ 
cRNA (pipette concentration of  0.2 µg/µl) n=13 B) the secondary alcohol 2-butanolol on Ca²⁺i 
oscillations induced by PLCζ cRNA (pipette concentration of  0.2 µg/µl) n=9 
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Figure 5.26 Ca²⁺i trace showing the effect of D609 on oscillations in MII eggs 
Showing the effect of the drug D609 (100 µM) Ca²⁺i oscillations induced by PLCζ cRNA (pipette 
concentration of 0.2 µg/µl) n=11 
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Propranolol, a drug that disrupts the localisation of Golgi structural proteins, inhibits Ca²⁺i 
oscillations 
The structure of the intracellular membrane bound organelles like the Golgi is maintained 
by charged lipids such as DAG. Propranolol is an inhibitor of the enzyme phosphatidate 
phosphohydrolase (PAP) which produces DAG by the phosphatidylcholine (PC) pathway 
(Asp et al. 2009) (see fig 5.23). As this metabolic DAG is required for maintaining the 
structure the Golgi, propranolol disrupts the structure of the Golgi and results in the mis-
localisation of Golgi associated proteins (Baron and Malhotra 2002). It is possible that Golgi 
structure and proteins may be involved in determining PLCζ localisation and activity 
therefore it was interesting to determine what effect propranolol has on the Ca²⁺i 
oscillations induced by PLCζ. Ca²⁺i oscillations were induced in eggs following microinjection 
of untagged mouse PLCζ cRNA (0.02 μg/μl) mixed with Rhod dextran and allowed to 
oscillate for approximately 2 hours. Propranolol was then added to the media containing 
the eggs at a concentration of 300 μM. Within minutes of adding propranolol the Ca²⁺i 
oscillations in the eggs ceased. Furthermore the basal level Ca²⁺i remained low after 
addition of propranolol for the remaining of the recording (see fig 5.27). 
 To determine whether this effect was reversible the same experiment was repeated 
however approximately 1 hour after addition of propranolol clean media was perfused into 
the dish surrounding the eggs to wash out the propranolol. Once the propranolol had been 
removed the Ca²⁺i oscillations restarted. These Ca²⁺i oscillations were higher in amplitude 
and increased in frequency in the 1 hour after propranolol removal compared to the Ca²⁺i 
oscillations initiated before propranolol addition (see fig 5.27. The basal Ca²⁺i levels were 
also found to increase following propranolol removal and in some cases resulted in a very 
large increase in Ca²⁺i after approximately 1 hour post propranolol removal.  
PLCδ1 causes Ca²⁺i oscillations in eggs at very high expression levels. Unlike PLCζ, PLCδ1 
appears to produce IP₃ and release Ca²⁺ by hydrolysing PI(4,5)P₂  at the plasma membrane 
(Yu et al. 2012). In order to establish what affect propranolol has on Ca²⁺i oscillations 
induced by PLCδ1, eggs were microinjected with untagged mouse PLCδ1 cRNA mixed with 
Rhod dextran and left to oscillate for approximately 2 hours before adding 300 μM of 
propranolol in the same was as described previously. As for PLCζ, Ca²⁺i oscillations initiated 
by PLCδ1 were inhibited very soon after the addition of propranolol. Once again the basal 
Ca²⁺i levels remained low following the addition of propranolol (see fig 5.28).  These data 
suggest that propranolol can inhibit Ca²⁺i oscillations associated with PI turnover in mouse 
eggs but the effect is not specific to PLCζ.  
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Figure 5.27 Ca²⁺i traces showing the effect of propranolol on PLCζ induced oscillations in MII eggs 
A) The effect of propranolol (300 µM) on Ca²⁺i oscillations induced by PLCζ cRNA (pipette 
concentration of 0.025 µg/µl) n=36, B) the effect of  propranolol (300 µM) on Ca²⁺i oscillations 
induced by PLCζ cRNA (pipette concentration of  0.025 µg/µl) and effect of the removal of this 
propranolol (n=8) 
190 
 
F
/F
0
1
2
3
4
5
Propranolol 
added
1 hr
PLCδ + Propranolol 
 
Figure 5.28 Ca²⁺i trace showing the effect of propranolol on PLCδ1 induced oscillations in MII eggs 
The effect of propranolol (300 µM) on Ca²⁺i oscillations induced by PLCδ1 (pipette concentration of 
1µg/µl)  n=36 
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Brefeldin A, a drug that disrupts retrograde membrane trafficking, inhibits Ca²⁺i oscillations 
As well as disrupting the localisation of Golgi resident proteins, propranolol also inhibits the 
formation of vesicular buds at the Golgi which play a role in retrograde membrane 
transport from the Golgi to the ER (Asp et al. 2009). Brefeldin A (BFA) is an antiviral 
antibiotic that inhibits protein transport from the ER to the Golgi (Fujiwara et al. 1988). 
Furthermore BFA induces retrograde transport leading to the accumulation of Golgi 
derived proteins in the ER (Doms et al. 1989). To examine the effects of BFA on the Ca²⁺i 
oscillations induced by PLCζ, eggs were injected with mouse PLCζ-luciferase cRNA at a 
pipette concentration of (0.05μg/μl) mixed with OGBD. These eggs were left to express the 
cRNA for approximately 30 minutes before being incubated and imaged in media 
containing luciferin and 5μM BFA. Ca²⁺i oscillations were recorded for approximately 1 hour 
before these oscillations ceased with a slight elevation in basal level Ca²⁺i. After 
approximately 1 hour many of these eggs experienced a large increase in Ca²⁺i and died 
(see fig 5.29). This suggests that BFA does inhibit Ca²⁺i oscillations however this does not 
occur quickly and eventually has a toxic effect on these eggs.  
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Figure 5.29 Ca²⁺i trace showing the effect of BFA on PLCζ induced oscillations in MII eggs 
The effect of Brefeldin A (BFA) 5µM Ca²⁺i oscillations induced by PLCζ cRNA (pipette concentration of 
0.2 µg/µl) (n=10) 
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Eggs acquire the ability to release Ca²⁺ in response to PLCζ during oocyte maturation 
Immature oocytes have a reduced sensitivity to PLCζ 
It has previously been established that eggs acquire the ability to release Ca²⁺in response to 
sperm during oocyte maturation (Carroll et al. 1994; Jones et al. 1995b). This effect has also 
been mirrored in Ca²⁺i oscillations induced by PLCζ cRNA however these effects have not 
been quantified effectively (Wakai et al. 2012). To directly compare the PLCζ sensitivity of 
oocytes at different stages of oocyte maturation oocytes were microinjected with mPLCζ-
luciferase cRNA so that expression levels could be accurately quantified. GV oocytes, MI 
oocytes (characterised as approximately 5 hours post collection from the ovary) and MII 
eggs were all injected with the same concentration of mPLCζ-luciferase cRNA (0.02 µg/µl) 
mixed with OGBD (conducted with the help of Ethan Bates). The Ca²⁺i oscillations initiated 
in these eggs were recorded and analysed. The luminescence signal emitted was also 
recorded so the amount of protein expression could be correlated with the Ca²⁺i pattern. Of 
21 GV oocytes microinjected with mPLCζ-luciferase cRNA only 3 oocytes were recorded to 
have oscillations in Ca²⁺i at a luminescence value of 0.26 counts per second (in the first 
hour of Ca²⁺i oscillations) (see fig 5.30, fig 5.31). In contrast 20 out of 26 MI oocytes 
emitting very similar luminescence value experienced Ca²⁺i oscillations (see fig 5.30, 5.31). 
Ca²⁺i oscillations were recorded in all MII eggs (31 out of 31) microinjected with mPLCζ-
luciferase cRNA (se fig 5.30, 5.31). This data suggests that GV oocytes do not release Ca²⁺as 
well as MI or MII oocytes in response to PLCζ. Consequently it appears oocytes undergo a 
dramatic increase in PLCζ sensitivity after GVBD.  
The amplitude of Ca²⁺i oscillations increases during oocyte maturation  
It has previously been suggested that both the amplitude and frequency of Ca²⁺i oscillations 
increase in response to PLCζ during oocyte maturation (Carroll et al. 1994; Jones et al. 
1995b; Wakai et al. 2012). To quantify the differences in the amplitude of Ca²⁺i oscillations 
between GV oocytes, MI oocytes and MII eggs the mean Ca²⁺i oscillation amplitude of each 
egg and oocyte used in the experiment described above was calculated. In the case of GV 
oocytes this was only calculated for the 3 oocytes that experienced Ca²⁺i oscillations. Mean 
Ca²⁺i oscillation amplitudes were then taken across the group of GV oocytes, MI oocytes 
and MII eggs and compared. MII eggs have significantly larger amplitude of Ca²⁺i oscillations 
compared to GV and MI oocytes expressing mPLCζ-luciferase cRNA at similar levels (see fig 
5.31). There was also a reduction in the amplitude of the Ca²⁺i oscillations recorded in GV 
oocytes compared to MI oocytes however this was much smaller than the difference in 
194 
 
amplitude recorded between MI oocytes and MII eggs (see fig 5.31). This data indicates 
that the amplitude of PLCζ induced Ca²⁺i oscillations increases in the later stages of oocyte 
maturation between metaphase I and metaphase II.   
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Figure 5.30 Ca²⁺i traces showing oscillations induced by PLCζ in oocytes at different stages of 
maturation 
Ca²⁺i oscillations induced by PLCζ-luciferase cRNA (pipette concentration of 0.02 µg/µl) A) in GV 
oocytes (n=21) 3/21 oocytes oscillated at a mean luminescence value of 0.26 cps, B) in MI oocytes 
(n=26) 20/26 oocytes oscillated at a mean luminescence value of 0.24 cps, C) in MII eggs (n=31) 
31/31 oocytes oscillated at a mean luminescence value of 0.18 cps 
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Figure 5.31 Summary of the Ca²⁺i releasing ability of oocytes in response to PLCζ at different stages 
of maturation 
A) Bar graph showing the percentage of oocytes experiencing Ca²⁺i oscillations induced by PLCζ-
luciferase cRNA (pipette concentration of 0.02 µg/µl) in GV oocytes (n=21), in MI oocytes n=26 
oocytes and MII eggs n=31, B) box plot showing the amplitude of the Ca²⁺i oscillations recorded in 
these oocytes 
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Deficiency of Ca²⁺i oscillations in GV oocytes cannot be rescued by increased levels of PLCζ 
To investigate whether the decrease in sensitivity to PLCζ in GV and MI oocytes could be 
overcome by increasing the amount of PLCζ protein expressed by the cells the previous 
experiments were repeated using GV and MI oocyte however using higher concentrations 
of mPLCζ-luciferase cRNA (conducted with the help of Ethan Bates). Once again the number 
of oocytes that had oscillations in Ca²⁺i were recorded as well as the frequency of those 
oscillations. When the protein expression levels of mPLCζ-luciferase cRNA were increased 
to a mean of 1.7 cps, approximately 7 times the protein expression used previously, Ca²⁺i 
oscillations were recorded in all 11 MI oocytes with a slightly increased frequency (see fig 
5.32, fig 5.33). However, in GV oocytes if PLCζ-luciferase cRNA expression was increased to 
5.5 cps (up to 30 times the PLCζ expression used previously) only 6 out of the 25 oocytes 
oscillated (see fig 5.32, fig 5.33). This indicates that increasing the amount of PLCζ protein 
expressed in GV oocytes does not overcome the effects of the reduction in sensitivity to 
PLCζ. In contrast MI oocytes do have a slightly decreased sensitivity to PLCζ compared to 
MII eggs that can be partially overcome by an increase in PLCζ protein expression levels.  
IP₃ response increases during oocyte maturation  
It has previously been suggested that the differences in the Ca²⁺ releasing ability of oocytes 
at different stages of maturation could be attributed to differences in the sensitivity of the 
IP₃ receptor (Wakai et al. 2012). It is believed that IP₃ receptor sensitivity increases during 
oocyte maturation possibly due to an increase in ER Ca²⁺ concentrations and 
phosphorylation of the IP₃R. However, this is considered as a gradual process during oocyte 
maturation. To determine the difference in sensitivity to IP₃ between oocytes at different 
stages of maturation, the Ca²⁺ release in response to ‘caged-IP₃’ was investigated. Caged-
IP₃ remains in-active in cells until it is exposed to UV light which photolyses the bonds that 
attach the protective groups to the phosphate groups of IP₃ which releases active IP₃. As a 
result the longer the exposure to UV light the more IP₃ is active to release Ca²⁺. Caged IP₃ 
(pipette concentration of 1mM) mixed with the Ca²⁺i indicator OGBD was microinjected into 
GV oocytes, MI oocytes and MII eggs and then transferred onto the epifluorescence 
imaging system. The fluorescence signals from the eggs and oocytes were recorded as a 
measure of Ca²⁺i whilst they were exposed short pulses of UV light of 50, 100, 500, 1000 
and 3000 ms in duration. The amplitude of the Ca²⁺i increase during each of these pulses 
was recorded and the mean Ca²⁺i amplitudes were calculated for GV oocytes, MI oocytes 
and MII oocytes (see fig 5.34). All eggs and oocytes experienced an increase in Ca²⁺i 
following every UV pulse including the 50 ms pulse. The amplitude of Ca²⁺release increased 
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most significantly between 50 ms and 500 ms UV pulses in all eggs and oocytes before 
reaching a plateau (see fig 5.34).All Ca²⁺i increases recorded in GV oocytes regardless of 
duration of the UV pulse were reduced in amplitude compared to MI oocytes and MII eggs 
(see fig 5.34). Furthermore the Ca²⁺i increases seen in MI oocytes were also reduced in 
amplitude compared to MII eggs (see fig 5.34). The greatest difference in amplitude was 
recorded between MII eggs and MI oocytes suggesting that these differences in response 
to IP₃ are most significant later in oocyte maturation (see fig 5.34). The reduction in 
amplitude of Ca²⁺release in GV and MI oocytes in response to IP₃ is suggestive of a 
reduction in the levels of Ca²⁺i available in the ER and not of a reduced sensitivity to IP₃.  
  
199 
 
F
/F
0
1
2
3
1 hr
F
/F
0
1
2
3
1 hr
A
B
GV oocyte
MI oocyte
 
Figure 5.32 Ca²⁺i traces showing oscillations induced by high levels of PLCζ in GV and MI oocytes 
Ca²⁺i oscillations induced by PLCζ-luciferase cRNA (pipette concentration of 0.25 µg/µl) A) in GV 
oocytes (n=25) 6/25 oocytes oscillated at a mean luminescence value of 5.5 cps, B) in MI oocytes 
(n=11) 11/11 oocytes oscillated at a mean luminescence value of 1.7 cps 
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Figure 5.33 The percentage of MI and GV oocytes oscillating in response to high levels of PLCζ 
Bar graph showing the percentage of oocytes experiencing Ca²⁺i oscillations induced by PLCζ-
luciferase cRNA (pipette concentration of 0.25 µg/µl) in GV oocytes (n=25) and in MI oocytes (n=11) 
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Figure 5.34 Ca²⁺i responses triggered by caged IP3 in oocytes at different stages of maturation 
A) Example of Ca²⁺i increases in an MII egg in response to the photo-release of caged IP3 by different 
duration of UV pulses (in ms) (n=5), B) line graph showing the mean amplitude of Ca²⁺i increase in 
response to the photo-release of caged IP3 by different duration of UV pulses (in ms), in MII eggs (n= 
5), MI oocyte (n=5) and GV oocytes (n=5) 
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The lack of Ca²⁺i response in GV oocytes cannot be accounted for by nuclear localisation of PLCζ 
Mouse derived PLCζ contains a nuclear localisation sequence (NLS) in its structure that 
targets PLCζ to the nucleus when the pronuclei form during fertilisation (Larman et al. 
2004). This process occurs many hours after sperm egg fusion and coincides with the 
termination of Ca²⁺i oscillations (Larman et al. 2004; Ito et al. 2008). During the first mitotic 
cycle the nuclear envelope breaks down and PLCζ is released into the cytosol once again 
(Larman et al. 2004). This results in Ca²⁺i oscillations that appear to play no significant role 
in embryo development. This suggests that PLCζ becomes sequestered in the nucleus 
where it is not able to hydrolyse PI(4,5)P₂ and release Ca²⁺. It is therefore possible that the 
lack of Ca²⁺release initiated by PLCζ in GV oocytes could be a result of nuclear localisation 
of PLCζ. To determine if this is the case the localisation of mPLCζ-luciferase protein was 
examined as this is a fusion protein concentration of luminescence value equates to 
concentration of PLCζ protein. Images of the luminescence signals were captured of GV 
oocytes expressing high levels of mPLCζ-luciferase cRNA where the luminescence signal 
was integrated for 30 minutes 1.5 hours post microinjection. The luminescence signal 
appeared distributed throughout the cytoplasm in these oocytes suggesting that mPLCζ-
luciferase protein is not concentrated to the nucleus (see fig 5.35). However, as these 
images were of a low resolution it was important to establish if luciferase protein contained 
within the nucleus of a GV oocyte would be evident using this type of imaging. To test this 
luciferase protein was microinjected directly into the germinal vesicle of GV oocytes. The 
size of this luciferase protein meant that is was too big to be exported out of the nucleus 
through the nuclear pores as a result the protein was retained in the nucleus. When these 
GV oocytes were imaged in the same way as those expressing mPLCζ-luciferase cRNA, it 
was clear there was a strong luminescence signal emitting from the nucleus compared to 
the cytoplasm (see fig 5.35). This suggests that if mPLCζ-luciferase was located in the 
nucleus in GV oocytes this would be visible by an increase in luminescence signal emitted 
from the nucleus. As this was not the case it appears the lack of Ca²⁺i oscillations in 
response to PLCζ is not due to the nuclear localisation of the mPLCζ-luciferase.  
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Figure 5.35 Luminescence images of GV oocytes injected with luciferase protein and PLCζ-
luciferase 
A) Luminescence image of a GV oocyte injected with luciferase (70 kda) protein at a pipette 
concentration of 1 µg/l directly into the GV, light integrated over 30 minutes (n= 4), B) Luminescence 
image of a GV oocyte injected with PLCζ-luciferase cRNA (pipette concentration of 0.25 µg/µl) Image 
taken 1.5 hours post injection and light integrated over 30 minutes (n= 7) 
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Changes in PI(4,5)P₂ availability and organelle distribution during oocyte maturation may 
enable PLCζ induced Ca²⁺i oscillations to occur in eggs 
Immuno-staining shows PI(4,5)P₂ localisation alters during oocyte maturation  
As previously mentioned PLCζ is believed to hydrolyse a specific vesicular source of 
PI(4,5)P₂ in eggs in order to produce IP₃ and release Ca²⁺ (Yu et al. 2012). It has previously 
been suggested that this vesicular source of PI(4,5)P₂ becomes available during oocyte 
maturation (Yu et al. 2012). Immunostaining of endogenous PI(4,5)P₂ shows that in GV 
oocytes PI(4,5)P₂  is localised primarily to the plasma membrane and the germinal vesicle 
(Yu et al. 2012). In MI oocytes and MII eggs PI(4,5)P₂  can be seen in small vesicles 
throughout the cytoplasm however the number and density of the vesicles is much 
reduced in MI oocytes (Yu et al. 2012). This result was verified in the current study using 
immunostaining with antibodies raised against PI(4,5)P₂. Immunostaining against PI(4,5)P₂  
was carried out as described previously on both MII eggs and GV oocytes. Once again GV 
oocytes were found to have very little vesicular PI(4,5)P₂  instead PI(4,5)P₂ was 
concentrated to nucleus however very little PI(4,5)P₂ was localised to the plasma 
membrane unlike that seen previously (see fig 5.36).  
PI(4,5)P₂ localisation during oocyte maturation in live cells 
To investigate the distribution of PI(4,5)P₂ in oocytes at different stages of maturation in 
live cells the localisation of exogenous BODIPY FL-PI(4,5)P₂  was investigated in GV oocytes 
and MII eggs. FL-PI(4,5)P₂  was microinjected into GV oocytes and MII eggs in the same 
manner as described previously. These oocytes were then imaged on the confocal 
microscope to determine the distribution of FL-PI(4,5)P₂ . As recorded previously FL-
PI(4,5)P₂ bound to small vesicles throughout the cytoplasm in MII eggs. These small 
PI(4,5)P₂  positive vesicles were also recorded in GV oocytes however the number of 
vesicles appeared reduced in amount and density compared to those seen in MII eggs (see 
fig 5.37).  
In order to investigate the distribution of endogenous PI(4,5)P₂  in immature oocytes 
compared to MII eggs DAN20 was once again used as a live cell probe for measuring 
PI(4,5)P₂  distribution. DAN20 was injected into GV oocytes in exactly the same manner as 
it had been in MII eggs. These oocytes were then imaged using the same imaging settings 
on the confocal microscope as that for the MII eggs. As with MII eggs DAN20 appeared to 
localise small vesicles throughout the cytoplasm in GV oocytes. This suggests that a 
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vesicular source of PI(4,5)P₂ that is accessible by DAN20 is present in GV oocytes as well as 
MII eggs (see fig 5.38). 
Finally the distribution of PBP10 was examined in GV oocytes and compared to that 
distribution in MII eggs. PBP10 was microinjected into GV oocytes in the same way it was 
injected into MII eggs and imaged using the exact same parameters. PBP10 was found to 
localise to small vesicles that were similar in distribution and pattern to that seen in MII 
eggs (see fig 5.39). Once again these results suggest that GV oocytes do contain some 
intracellular source of PI(4,5)P₂ .  
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Figure 5.36 Confocal images of PI(4,5)P₂ immunostaining in GV oocyte and MII egg 
A) GV oocyte (n=5), B) MII egg (n= 10) 
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Figure 5.37 Confocal images showing the distribution of BODIPY-FL PI(4,5)P in GV oocyte and MII 
egg 
1.5 hours post BODIPY-FL PI(4,5)P₂  injection in A) GV oocyte (n=5), and B) MII egg (n=7) 
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Figure 5.38 Confocal images showing the distribution of DAN20 in GV oocyte and MII egg 
1 hr post DAN20 injection A) GV oocyte (n=6), and B) MII egg (n=17) 
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Figure 5.39 Confocal images showing the distribution of PBP10 in GV oocyte and MII egg 
        1.5 hr post PBP10 injection A) GV oocyte (n=12), and B) MII egg (n=15) 
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Golgi apparatus distribution during oocyte maturation using the Golgi marker AC-lectin in fixed 
cells 
Experiments conducted during this study have shown that the Golgi marker AC-lectin 
localises to small vesicles throughout the cytoplasm of MII eggs suggesting that the Golgi is 
fragmented into small vesicles in mature eggs. This idea is supported by previous 
immunocytochemistry experiments showing that Golgi markers localise to small vesicles in 
mature eggs (Moreno et al. 2002; Payne and Schatten 2003) (Yu et al 2012 unpublished). 
Interestingly this Golgi fragmentation seems to occur during oocyte maturation (Moreno et 
al. 2002). GV oocytes are found to have Golgi stacks which break down and fragment 
during GVBD (Moreno et al. 2002). As it is possible that the vesicular source of PI(4,5)P₂  
required for PLCζ activity is associated with the Golgi apparatus a change in Golgi structure 
during oocyte maturation may enable vesicular PI(4,5)P₂ to become available. The structure 
and cellular localisation of the Golgi apparatus during oocyte maturation was investigated 
further using the Golgi marker AC-lectin. GV oocytes were collected and maintained in 
IBMX whilst another group of GV oocytes were allowed to spontaneously mature for 
approximately 5 hours until GVBD had clearly occurred, these oocytes were referred to as 
MI oocytes. The GV oocytes, MI oocytes and MII eggs were all fixed and permeabilised 
before being incubated in fluorescent AC-lectin as described previously. In all oocytes and 
eggs the AC-lectin appeared to localise to small vesicles throughout the cytoplasm. This 
staining did not appear significantly different between GV, MI, and MII oocytes (see fig 
5.40). This suggests that the Golgi apparatus is already fragmented in GV oocytes and this 
does not alter significantly during oocyte maturation.  
Golgi apparatus distribution during oocyte maturation in live cells 
The live cell Golgi marker GOLGI-ID® was used to determine the localisation of the Golgi in 
unfixed MII eggs and showed binding to small intracellular vesicles. It was therefore 
necessary to use this probe to establish distribution of the Golgi in live GV oocytes. GV 
oocytes were treated with GOLGI-ID® assay kit in the same way as described previously 
however with the addition of IBMX to ensure the oocytes didn’t spontaneously mature. A 
selection of MII eggs were also treated in this way to ensure that the presence of IBMX did 
not alter the staining pattern of the GOLGI-ID®. The eggs and oocytes were also imaged on 
the confocal microscope using the same settings. As was described previously GOLGI-ID® 
bound mainly to small vesicles in MII eggs with some weaker nonspecific staining also (see 
fig 5.41). However the GOLGI-ID® did not appear to bind small vesicles in GV oocytes but 
instead larger more aggregated structures (see fig 5.41). This suggests that in the GV 
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oocytes the Golgi is not fully fragmented and during oocyte maturation it gets broken down 
into small intracellular vesicles.  
BODIPY FL ceramide and DiIC18(3) co-localisation does not significantly alter during oocyte 
maturation  
BODIPY FL ceramide and DiIC18(3) both appear to act as fluorescent markers for the 
endoplasmic reticulum in MII eggs. However, BODIPY FL ceramide is an established marker 
for the Golgi apparatus in somatic cells. The distribution of endoplasmic reticulum is 
reported to alter during oocyte maturation as does the Golgi apparatus. It is possible 
therefore that BODIPY-FL ceramide could act as a marker for the Golgi apparatus in 
immature oocytes. To determine whether BODIPY- FL ceramide distribution overlaps with 
that of DiIC18(3) in GV oocytes these were both microinjected into GV oocytes as described 
previously. The distribution of both these probes was examined in GV oocytes by imaging 
on a confocal microscope. As in MII eggs, BODIPY-FL ceramide and DiIC18(3)   very strongly 
co-localised in the GV oocytes. This would suggest that as in MII oocytes BODIPY-FL 
ceramide is acting as a marker for the ER in GV oocytes. The distribution of both of these 
probes was different in GV oocytes compared to MII eggs. For example in GV oocytes the 
pattern of staining appeared less reticular and more fragmented when compared to the 
staining in MII eggs indicating that the structure and distribution of the ER alters during 
oocyte maturation (see fig 5.17).  
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Figure 5.40 Confocal images showing AC-Lectin staining in oocytes at different stages of 
maturation 
A) GV oocyte (n=5), B) MI oocyte (n=5) and C) MII egg (n=9)  
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Figure 5.41 Confocal images showing the distribution of GOLGI-ID in GV oocytes and MII egg 
A) GV oocyte (n=5), B) MII egg (n=15) 
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Discussion 
PLCζ has a unique ability to cause Ca²⁺i oscillations in mature eggs at basal cellular Ca²⁺i 
levels (Saunders et al. 2002). This ability is not only a result of particular features of PLCζ 
structure but also a collection of specific cellular characteristics of the egg. This is most 
clearly demonstrated by the lack of Ca²⁺i releasing activity elicited by PLCζ in other cell 
types. There are many features that make mature eggs different to other cell types 
however exactly how these features directly impact PLCζ activity remains fully understood. 
Though PLCζ hydrolyses PI(4,5)P₂  like all other PLC isoforms, it has strongly been suggested 
that this PI(4,5)P₂ is not  located on the plasma membrane. Instead PLCζ is thought to 
target and hydrolyse and alternative source of PI(4,5)P₂ (Yu et al. 2012). This idea is 
supported by immunostaining results that have shown PLCζ localises to vesicular structures 
in eggs and does not appear to target the plasma membrane (Yu et al. 2008; Yu et al. 2012). 
The current experiments aimed to determine where PLCζ is localises, what potential 
organelles it targets, whether there is an alternative source of PI(4,5)P₂ in the egg and how 
these features may alter during oocyte maturation.  
First of all it was important to verify where PLCζ localised in mature eggs. 
Immunocytochemisty analysing the distribution of cMyc tagged PLCζ reproduced results 
seen previously that PLCζ targets small vesicles throughout the cytoplasm which are 
concentrated in the cortical region of the egg (Yu et al. 2012). Furthermore, this staining 
does not show PLCζ targeting to the plasma membrane which provides further support that 
PLCζ does not localise to the plasma membrane in eggs (Yu et al. 2012). However, this 
staining alters following pronuclei formation. Four hours post PLCζ injection the same 
protocol shows that PLCζ is still localised to small vesicles throughout the cytoplasm but 
also became concentrated in the newly formed pronuclei. This supports previous data 
showing that fluorescently tagged PLCζ becomes localised to the pronucleus following egg 
activation (Larman et al. 2004; Yoda et al. 2004). 
Tagging PLCζ with cMyc enabled antibodies raised against cMyc to be used to determine 
cMyc-PLCζ localisation in the egg. This allows the immunostaining for PLCζ to be more 
specific than would be achieved using the current antibodies raised against PLCζ. However, 
as the cMyc antibodies used were mouse derived monoclonal antibodies and the eggs used 
also derived from mouse extra blocking steps were required in order to ensure specific 
staining. Optimising the correct blocking conditions and antibody parameters in order to 
get optimal staining is a challenge. This also makes it difficult to get consistent results 
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between groups of eggs.For example as previously recorded a greater amount of this 
vesicular bound PLCζ was concentrated in the cortical region of the egg (Yu et al. 2012). 
However, it is possible that this increase in fluorescent signal was a result of increased 
permeability of those membranes closer to the egg plasma membrane. This is because 
once the cells have been they must be permeablised to allow the antibodies to enter the 
cell. The eggs are incubated in the permeabilsation media so the membranes become 
permeablised from the outside of the cell inwards. Eggs are larger in size than most other 
cells as a result if the membranes towards the centre of the egg do not become sufficiently 
permeablised then the antibodies may not penetrate the egg sufficiently. In addition 
immunostaining may only be performed on fixed cells, therefore, this technique cannot be 
used to investigate PLCζ localisation in live eggs.  
To try and address this issue two fluorescently tagged genetically encoded PLCζ constructs 
were developed that could be injected into live cells. Both of constructs were based on a 
mutated catalytically dead form of PLCζ, PLCζD210. The two fluorescent tags chosen are both 
known to be stable fluorophores that produce a bright signal. However, the fluorescent 
signal produced by PLCζD210-cherry expressed in eggs was low and appeared uniform 
throughout the cytoplasm with no specific intracellular localisation. This suggests that PLCζ 
does not target specific membranes in the egg. However, it is important to note that in 
order to see a fluorescent signal a protein must be expressed at relatively high levels of 
well over 100 nM whereas PLCζ’s operational range is between 1 and 10 nM in mouse eggs 
(Niswender et al. 1995; Saunders et al. 2002). It can therefore be assumed that the 
detectable amount of PLCζD210-cherry far exceeds the physiological levels of PLCζ usually in 
the egg. This could mean the binding sites for PLCζD210-cherry may already be saturated at 
levels much lower than is detectable which could result in a large amount of mis-localised 
unbound PLCζD210-cherry in the egg cytoplasm. Once again however there was no binding of 
PLCζ specifically to the plasma membrane. Fluorescent Venus-tagged PLCζ has also shown 
previously that PLCζ remains in the cytoplasm and does not target the plasma membrane 
(Yoda et al. 2004; Ito et al. 2008; Phillips et al. 2011). 
This lack of plasma membrane bound PLCζ and its binding to intracellular vesicles supports 
the notion PLCζ targets an alternative pool of PI(4,5)P₂ . This is because PLCζ must bind to a 
PI(4,5)P₂  source directly in order to hydrolyse it. It was therefore important to determine 
whether an alternative source of PI(4,5)P₂ was available in eggs. The immunostaining data 
by (Yu et al. 2012)showing that PI(4,5)P₂ localises in intracellular vesicles was reproduced. 
This suggests that an alternative vesicular source of PI(4,5)P₂  is present in eggs however 
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these results were variable and the staining appeared inconsistent. This may be because 
PI(4,5)P₂  is located on the inner leaflet of membranes. Small variations in the 
permeablisation of intracellular membranes could result in dramatic changes in the 
accessibility antibodies to the PI(4,5)P₂ . Alternatively, over permeablisation of these 
membranes could cause the PI(4,5)P₂  to be dislodged from its resident membrane and 
therefore immunostaining may not give a clear representation of PI(4,5)P₂  in  live cells. 
It was therefore helpful to find an alternative way to measure PI(4,5)P₂ localisation in live 
eggs. One simple way to investigate the localisation of PI(4,5)P₂  is to inject exogenous 
fluorescently tagged PI(4,5)P₂ into eggs and see where it localises. It is very likely that this 
PI(4,5)P₂ will be anchored to membranes that contain endogenous PI(4,5)P₂ (Golebiewska 
et al. 2008). In somatic cells fluorescently tagged PI(4,5)P₂ is shown to localise primarily to 
the plasma membrane (Golebiewska et al. 2008) When injected into eggs, FL-PI(4,5)P₂ 
appeared to bind to small vesicles throughout the cytoplasm and did not bind significantly 
to the plasma membrane. However, it took approximately 1 and a half hours for this 
PI(4,5)P₂ to become partitioned into these vesicles. This suggests that when first injected 
the PI(4,5)P₂ will bind to any intracellular membrane however with time PI(4,5)P₂ is 
excluded from these membranes and instead becomes concentrated on vesicles. It is 
therefore possible that rather than being synthesised on vesicles, endogenous PI(4,5)P₂ 
could be made on other cellular membranes and transported to these small vesicles where 
it becomes sequestered. PI transfer proteins (PITP) for example may be involved in this 
process(Cockcroft et al. 1985). In somatic cells for example plasma membrane localised 
PI(4,5)P₂ levels are dependent on the availability of its precursor, PI(4)P at both the plasma 
membrane and Golgi apparatus (Dickson et al. 2014).  
It was next necessary to establish whether PLCζ was able to hydrolyse this vesicular source 
of PI(4,5)P₂ . Indeed the FL-PI(4,5)P₂  localisation and signal was seen to disperse following 
PLCζcRNA addition. After approximately 1 hour and a half the fluorescent signal became 
much more diffuse in those eggs expressing PLCζ and virtually all vesicular signal had gone. 
This may be because as the FL-PI(4,5)P₂  is hydrolysed fluorescent DAG is produced which 
may be transported to other membranes involved in DAG metabolism and therefore this 
could lead to a loss of  fluorescent signal from the vesicles. This is yet to be explored 
however. In contrast the control eggs that had not been injected with PLCζ still showed a 
strong fluorescent signal emitting from vesicles in the egg. This suggests the PLCζ is capable 
of hydrolysing vesicular localised fluorescent PI(4,5)P₂ .  
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However, the localisation of exogenous PI(4,5)P₂ does not necessarily give a true 
representation of endogenous PI(4,5)P₂ distribution in eggs. In order to investigate this a 
PI(4,5)P₂ binding probe was required that was capable of binding all sources of PI(4,5)P₂ in 
the egg. Recently one such probe has been developed. DAN20 is a gelsolin peptide based 
probe that is cell permeable and produces a ratiometric fluorescent signal (Mondal et al. 
2016). It has been shown to bind both PI(4)P and PI(4,5)P₂ in vitro with an increased 
specificity for PI(4,5)P₂  (Mondal et al. 2016). DAN 20 has also been used to successfully 
measure PI(4,5)P₂ levels and distribution in live somatic cells (Mondal et al. 2016). As 
expected DAN20 was found to localise primarily to the plasma membrane of HEK cells 
however staining was also seen in the perinuclear region of the cell indicating an 
intracellular pool of PI(4,5)P₂  (Mondal et al. 2016). When injected into eggs DAN20 was 
found to localise to intracellular vesicles throughout the cytoplasm. These vesicles 
appeared similar in nature to the ones FL-PI(4,5)P₂  bound to. This suggests that DAN20 is 
able to measure an intracellular source of PI(4,5)P₂ in eggs. 
In addition to binding the small vesicular structures previously seen, DAN20 was also found 
to bind larger vesicular structures closer to the cortex. These structures appeared similar in 
size and structure to those associated with the endocytic pathway such as early endosomes 
(Moon and Swann 2013, unpublished). Early endosomes are rich in the phosphoinostide 
PI(3)P so it is possible that as well as binding PI(4,5)P₂ , DAN20  is also binding other 
phosphoinostides such as PI(3)P. Some binding to the precursor of PI(4,5)P₂ , PI(4)P was 
identified in vitro and though this was much lower than PI(4,5)P₂  DAN20 cannot be 
considered solely specific for PI(4,5)P₂ (Mondal et al. 2016) . However, unlike the PH 
domain DAN20 was not found to bind IP3so a reduced amount of non-specific cytosolic 
staining would be expected (Mondal et al. 2016).PH domain binding to PI(4,5)P₂ is also 
suggested to be dependent on the levels of cholesterol present in the membrane(Rissanen 
et al. 2017). Due to ratiometric nature of the DAN tag DAN20 allows quantitative and 
dynamic measurements of PI(4,5)P₂  to be made. However, this tag is environmentally 
sensitive and was found to be susceptible to bleaching. This means that a stable signal did 
not last long in eggs injected with DAN20 and made designing dynamic experiments or 
repeat imaging difficult. As a result another gelsolin peptide based PI(4,5)P₂  probe was 
tested. PBP10 is based on a 10 amino acid sequence that is conjugated to fluorescent 
rhodamine B (Bucki et al. 2001; Cunningham et al. 2001). Rhodamine B produces a stable 
red signal and is much less susceptible to bleaching than DAN20 so made it easier to image. 
The shorter nature of PBP10 also makes it more cell permeable than DAN20 
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(Cunninghamet al. 2001; Mondal et al. 2016). This could make access through intracellular 
membranes easier. However, shorter gelsolin peptides are thought to be less specific to 
PI(4,5)P₂  and more likely to bind other phosphoinositides. For example a 13 amino acid 
version of DAN20 (DAN13) is binds to PI(4)P with a greater affinity than DAN20 (Mondal et 
al. 2016). When injected into eggs however PBP10 appeared to bind strongly to small 
vesicles throughout the cytoplasm in eggs. These vesicles looked very similar in nature to 
that seen with DAN20 and FL-PI(4,5)P₂ .  
No clear plasma membrane staining with DAN20 or PBP10 was apparent in eggs. Though 
this suggests that there is not any plasma membrane PI(4,5)P₂  present in eggs it is possible 
that the PI(4,5)P₂  levels in the plasma membrane are simply lower than that seen on 
vesicles. As a result the fluorescent signal from these compartments would be much 
greater than that of the plasma membrane. This would make the plasma membrane signal 
difficult to detect. It is also possible that DAN20 and PBP10 do not actually bind to PI(4,5)P₂ 
on the plasma membrane in eggs. Though DAN20 and PH domains both show strong 
plasma membrane staining in somatic cells these two probes do not appear to bind to the 
same pools of PI(4,5)P₂ (Mondal et al. 2016). This is significant as GFP PH domains have 
previous shown to bind to plasma membrane resident PI(4,5)P₂ in eggs (Halet et al. 2002). 
However, this source of PI(4,5)P₂ does not seem to be hydrolysed by PLCζ (Yu et al 2012). It 
may be possible therefore that PLCζ discriminates between different pools of PI(4,5)P₂. 
PLCζ lacks the PI(4,5)P₂  binding PH domain located on other PLCs which ensures sufficient 
localisation and targeting to plasma membrane PI(4,5)P₂ (Lemmon et al. 1995). It is now 
known that other functional domains of PLCζ fulfil this role, with both the XY linker region 
and the EF hand domain being shown to play a role in PI(4,5)P₂  binding thus enabling 
effective Ca²⁺release (Nomikos et al. 2011b), (see Chapter 4). It is possible that PLCζ targets 
a specific pool of PI(4,5)P₂  either by discrimination of PI(4,5)P₂  binding or binding to a 
target protein on a specific membrane. Unfortunately it was difficult to conduct 
colocalisation experiments with either PBP10 or DAN20 and other markers because neither 
of these probes were fixable and were environmentally sensitive.  
This data shows consistently that there is a vesicular source of PI(4,5)P₂  present in mature 
eggs. It is therefore very possible that PLCζ directly binds to these PI(4,5)P₂  containing 
vesicles as has previously been suggested (Yu et al. 2012)(Yu and Swann 2013, 
unpublished). It is this accessibility to a vesicular source of PI(4,5)P₂  that may enable PLCζ 
to release Ca²⁺in eggs. For example CHO cells do not contain a vesicular source of PI(4,5)P₂  
instead they localise all their PI(4,5)P₂  to the plasma membrane and these cells are not 
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able to release Ca²⁺response to PLCζ (Phillips et al. 2011). Therefore it is possible that PLCζ 
is not able to hydrolyse any PI(4,5)P₂  generated in cells but instead requires PI(4,5)P₂  
present in intracellular vesicles. 
It still remains unclear where these PI(4,5)P₂  positive vesicles come from and how they are 
formed. Understanding the identity of these vesicles could provide clues to how PLCζ is 
localised there. There are two main candidates for the origin of these vesicles based on 
previous evidence. First of these is he endoplasmic reticulum. The ER marker DsRed-ER has 
been found to co-localise with Venus tagged PLCζ in eggs (Escoffier et al. 2015a). mCherry 
tagged PLCζ was also found to bind cytoplasmic organelles associated with the reticular 
network in somatic cell lines (Kashir et al. 2011) . However, the ER is not known to take a 
fragmented form in eggs, instead remains reticular in structure and becomes clustered in 
the cortex (FitzHarris et al. 2007).  This result was verified in the current study using the ER 
dye DiIC18(3)which showed consistently that the ER formed a reticular pattern in the 
mature eggs. This staining pattern was very different to the small vesicles detected by both 
PLCζ and PI(4,5)P₂  markers. It is therefore unlikely that these vesicles are derived from the 
ER. However, during membrane trafficking portions of the ER are syphoned off to produce 
vesicles. During this process some proteins retain the ER proper whilst other proteins or 
lipids bind to the vesicles. It is therefore possible that these PLCζ binding vesicles could be 
vesicular fragments of the ER.  However, the ER is not known to contain PI(4,5)P₂  or its 
precursor PI(4)P. Furthermore it is likely that the co-localisation seen by (Escoffier et al. 
2015a) was an artefact due to the overexpression of fluorescent proteins therefore true 
localisation of these markers at physiological levels would have been difficult to ascertain.  
The other potential origin for the PI(4,5)P₂  containing vesicles is the Golgi apparatus. There 
are numerous reasons why these vesicles are likely to originate from the Golgi. Firstly in 
eggs the Golgi is thought to be fragmented into vesicles. This is a cell cycle dependent 
process that sees the Golgi become fragmented into what is known as a “Golgi haze” 
during metaphase of mitosis (Altan-Bonnet et al. 2003; Axelsson and Warren 2004). A 
similar process is thought to occur during meiosis in eggs (Moreno et al. 2002; Payne and 
Schatten 2003). Indeed immunostaining against the Golgi marker giantin has previously 
shown that this protein is located in small vesicles throughout the cytoplasm and 
particularly concentrated in the cortex (Yu and Swann 2013 unpublished). This result is a 
result that was reproduced in the current study. The Golgi is also thought to contain 
PI(4,5)P₂  and its precursor PI(4)P (Godi et al. 1999; De Matteis and D'Angelo 2007). This 
would enable efficient and quick resynthesis of PI(4,5)P₂  following hydrolysis by PLCζ. 
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Finally immunostaining has shown that markers for the Golgi such as giantin co-localise 
significantly with PLCζ and PI(4,5)P₂  in eggs (Yu and Swann 2012 unpublished). 
Given that the Golgi was a likely candidate for the origin of these PI(4,5)P₂  containing 
vesicles it was necessary to determine the localisation of other Golgi markers in eggs. The 
Amarathus caudate lectin acts as a specific marker for the Golgi by binding soley galactosyl-
beta 1,3-N- acetylglucosamine (Galβ3GalNAC) containing oligosaccharides (Rinderle et al. 
1990) . AC-lectin can be conjugated to a flurophore, for example fluorescein, to produce a 
fluorescent marker for the Golgi (AC-lectin). As this probe is already fluorescent it avoids 
the need to use secondary antibodies, as a result non-specific binding of the secondary 
antibody is eliminated. In eggs AC-lectin consistently bound to small vesicles throughout 
the cytoplasm. These fluorescent vesicles were similar in distribution and pattern to those 
seen following giantin immunostaining (Yu and Swann 2012 unpublished). These vesicles 
also appeared very similar to the PI(4,5)P₂ and PLCζ containing vesicles identified previously 
(Yu et al. 2012). The fluorescein tag produced a bright and stable signal however AC-lectin 
cannot be used in live cells as it requires the cells to be fixed and permeablised in order to 
get into the cell. Therefore it was necessary to explore the distribution of live cell probes 
for the Golgi as well.  
One commonly used live cell marker for the Golgi is BODIPY- FL ceramide, a fluorescently 
labelled version of the lipid ceramide which is taken into to the Golgi. The advantage of 
BODIPY FL-ceramide is it allows dynamic changes in Golgi structure to be measured. Due to 
its lipid nature BODIPY-ceramide is usually considered cell permeable but depends on the 
expression of the lipid transfer protein CERT for it to be transported into the Golgi (Hanada 
2010). It is not known whether CERT is expressed or active in eggs, so instead BODIPY FL-
ceramide was microinjected into eggs to determine its localisation in eggs. However, 
BODIPY FL-ceramide showed a very different distribution to previous Golgi markers used. 
Rather than binding to small intracellular vesicles BODIPY-FL ceramide bound reticular 
structures that looked similar in distribution to the ER. In fact the ER marker DiIC18(3) 
overlapped very strongly with the signal emitted from the BODIPY ceramide. It is therefore 
very likely that BODIPY-FL ceramide is not acting as a marker for the Golgi at all but in fact 
for the ER. Due to the fragmented nature of the Golgi it is possible that many proteins and 
lipids that usually reside the Golgi are found in the ER instead. During the formation of the 
“Golgi haze” in somatic cells many Golgi resident markers are temporarily absorbed into 
the ER (Axelsson and Warren 2004). During these experiments it was discovered that a 
fluorescent version of the DAG binding domain C1b localised to similar reticular structures 
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to that seen by BODIPY ceramide and DiIC18(3). This suggests that a lot of DAG is present in 
the ER so it is possible that other lipids such as ceramide are also located here. However, 
ceramide is usally made in ER and rapidly transported to the Golgi(Tidhar and Futerman 
2013). Alternatively the BODIPY-FL ceramide injected could contain a lot unconjugated 
BODIPY-FL that has become dissociated from the ceramide. This free BODIPY-FL could be 
binding to any membrane available in the cell non-specifically rather than marking the 
Golgi. The distribution of BODIPY-FL ceramide seen in these experiments could also be 
because it was injected directly into the cytoplasm rather than incubated from the 
outsideit has been in other cell types.  
As there is some uncertainty surrounding the specificity of BODIPY-FL ceramide targeting 
an alternative live cell Golgi marker was tested in eggs. GOGLI-ID® is a commercially 
available Golgi localisation kit. The company claim that this dye is much more specific to 
Golgi membranes than other markers available and as it is cell permeable does not require 
microinjection.  In eggs GOLGI-ID® appeared to bind to small intracellular vesicles similar in 
nature to that seen by AC-lectin. Some staining of other internal membranes was also seen 
using GOLGI- ID® however the fluorescent signal emitted from these membranes was far 
weaker than that emitted from the vesicles. This would suggest that GOLGI-ID® either binds 
to other intracellular membranes as well as the Golgi albeit with a reduced affinity or the 
binding target of GOLGI-ID® is also present in small quantities in other organelles in the 
egg. As GOLGI–ID® is commercially developed it is not possible to find out how and what it 
binds to and therefore makes it difficult to explain why non-specific staining may occur. The 
fluorescent signal emitted by GOLGI-ID® is also generally weak in comparison to that of AC-
lectin. However, GOLGI-ID® shows that a live cell marker for the Golgi may successfully be 
used in eggs.  
These Golgi derived vesicles appear very similar in nature and distribution to that bound by 
PLCζ. However, if PLCζ is infact binding to these Golgi derived vesicles it is unclear exactly 
how it becomes localised here.  Though it is very likely that these vesicles contain PI(4,5)P₂ , 
which PLCζ is able to bind directly to, this is unlikely to be the targeting factor for PLCζ. This 
is because PI(4,5)P₂  is also believed to reside in the plasma membrane which PLCζ doesn’t 
bind, therefore it is much more likely that PLCζ binds an alternative partner that resides 
only in these intracellular vesicles. Alternatively proteins or lipids in this target membrane 
could regulate PLCζ activity ensuring it is only active in specific membranes. Many other 
PLC isoforms are regulated by small GTPases. For example PLCδ1 activity is regulated by 
interacting with the small GTPase Ral in the plasma membrane (Sidhu et al. 2005). Different 
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small GTPases are found in different membranes and play a role in conveying specificity of 
these membranes. Rab 6 is a Golgi resident small GTPase which has been identified as 
playing a role in membrane trafficking between the Golgi and the ER (Goud et al. 1990). 
Rab 6 is also often used as a marker for the Golgi as it appears to localise only to the Golgi 
and the trans-Golgi network (Goud et al. 1990).  Given this it was interesting to determine 
where Rab 6 was localised in eggs and whether it was found on small intracellular vesicles. 
Indeed exogenous Rab 6-GFP expressed in eggs was found to localise to some small vesicles 
throughout the cytoplasm however this staining was not specific to vesicular structures and 
some Rab 6-GFP was found to bind other membrane structures made it difficult to resolve 
its specific localisation. As Rab 6 is involved in shuttling proteins between the ER and Golgi 
it is possible that some Rab 6 is also residing in the ER (Goud et al. 1990). Rab 6-GFP was 
found to bind some reticular structures that looked similar in appearance to those marked 
by the ER dye DiIC18(3). It is also unclear exactly what form the trans-Golgi network takes in 
eggs. Though the exogenous fluorescently tagged Rab 6 allows Rab 6 distribution to be 
examined in live eggs, this does not act as a direct measure of endogenous Rab 6 in the cell. 
It was therefore necessary to verify previous immunostaining data which shows Rab 6 is 
localised to small vesicles in eggs (Yu and Swann 2012 unpublished). This result was 
reproduced and once again many small Rab 6 positive vesicles were found distributed 
throughout the cytoplasm. The vesicles identified appeared similar to those seen using 
other markers for the Golgi, suggesting that Rab 6 distribution could be another way of 
determining the structure of the Golgi. These Rab 6 containing vesicles have previously 
been shown to co-localise with PLCζ in eggs following immunostaining (Yu and Swan 2012 
unpublished). This provides further evidence that PLCζ is binding to vesicles which derive 
from the Golgi. However, it remains to be determined whether Rab 6 interacts with PLCζ or 
regulates its activity in any way. 
Multiple markers for the Golgi in both live and fixed cells suggest that it takes a fragmented 
vesicular form in eggs which is supported by previous data (Moreno et al. 2002), (Yu and 
Swann 2012, unpublished). It is also likely that these vesicles contain PI(4,5)P₂  and undergo 
PLCζ binding at fertilisation. Some co-localisation between the Golgi markers giantin and 
Rab 6 with both PI(4,5)P₂  and PLCζ have previously been recorded with immunostaining in 
eggs (Yu et al 2012 unpublished). However, these cells were fixed and immunostaining can 
produce inconsistent results. It is therefore necessary to do co-localisation studies between 
PLCζ or PI(4,5)P₂  with the Golgi in live cells. This can be a challenge however as live cell 
markers can be susceptible to bleaching or may have optimum maturation times. This can 
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make optimising the protocol for more than one live cell probe very difficult. However, it 
remains very unlikely that PLCζ would be targeting PI(4,5)P₂  on either the ER or endocytic 
vesicles as the staining pattern of markers for makers for these organelles looks much 
different to that of PLCζ or PI(4,5)P₂ . 
It is unclear how PLCζ can discriminate between different pools of PI(4,5)P₂ or bind to 
Golgi-derived vesicles. It is possible that a target protein or lipid is present in this 
membrane which acts to anchor PLCζ so it may access its substrate PI(4,5)P₂ . The C2 
domain of PLCζ has been found to play a role in enabling Ca²⁺release in eggs (Chapter 4). 
However, it is unclear exactly what role this domain plays in this process as it does not 
convey any catalytic activity, Ca²⁺i sensitivity properties or binding to PI(4,5)P₂ (Chapter 4) . 
It is therefore possible that the C2 domain of PLCζ may be responsible for binding and 
anchoring it to its target membrane. However, the only known binding partners for the C2 
domain of PLCζ are the phospholipids PI(3)P which resides in early endosomes and PI(5)P 
which is mainly contained in the nuclear envelope (Mills et al. 2001; Kouchi et al. 2005; 
Reynoird and Gozani 2014; Nomikos et al. 2017a).  
The process of Golgi fragmentation and therefore the accumulation of PI(4,5)P₂  on 
vesicular structures may be an essential feature in ensuring eggs can respond to PLCζ. For 
example CHO cells transfected with PLCζ do not release Ca²⁺ (Phillips et al. 2011). These 
cells do not have a vesicular source of PI(4,5)P₂  or a fragmented Golgi apparatus (Phillips et 
al. 2011).  It is therefore intriguing to ask how eggs would respond to PLCζ if this vesicular 
source of PI(4,5)P₂  was depleted. It has already been shown that unlike PLCδ1 PLCζ does 
not hydrolyse plasma membrane PI(4,5)P₂  (Yu et al. 2012). GFP-PH domain, which targets 
plasma membrane PI(4,5)P₂,  has shown no decrease in plasma membrane PI(4,5)P₂  in 
response to PLCζ or sperm induced Ca²⁺i oscillation (Yu et al. 2012). However, a large 
decrease in this PI(4,5)P₂  source is seen during PLCδ1 induced Ca²⁺i oscillations  (Yu et al. 
2012). Furthermore direct depletion of plasma membrane PI(4,5)P₂  using a plasma 
membrane targeted, lyn tagged inositol polyphosphate 5’phosphatse (Lyn-Ins5P) did not 
affect Ca²⁺i oscillations initiated by PLCζ or sperm however completely inhibited oscillations 
initiated by PLCδ1 (Yu et al. 2012). This technique was adapted in attempt to deplete 
intracellular PI(4,5)P₂ . Insp54P was tagged with a catalytically dead form of PLCζ (PLCζD210) 
and a GFP to produce a PLCζD210-Insp5P- GFP construct. Confocal imaging showed that this 
construct remained in the cytoplasm and did not bind to the plasma membrane (Yu et al. 
2012). Depleting PI(4,5)P₂  in this way did not affect those Ca²⁺i oscillations initiated by 
PLCδ1, however did inhibit or greatly reduced the Ca²⁺i response to PLCζ or sperm (Yu et 
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al.2012). Given this interesting result functional effects of trying to deplete vesicular 
PI(4,5)P₂  were examined further.  
OCRL1 is an endogenously expressed inositol 5’phosphastase which converts PI(4,5)P₂  to 
PI(4)P by de-phosphorylation (Zhang et al. 1995). It resides in the trans-Golgi network of 
cells ensuring that the balance of phosphoinostides is maintained. As a result OCRL1 should 
target the Golgi without the need for any additional tags. OCRL1 was overexpressed in eggs 
in attempt to deplete Golgi localised PI(4,5)P₂. However, this did not appear to have any 
significant effect on Ca²⁺i oscillations initiated by PLCζ. This was the case even if OCRL1 was 
expressed for over 18 hours whilst oocytes were maturing. This result is in contrast to the 
disruption of Ca²⁺i oscillations seen following PLCζ
D210-Insp54P- GFP expression (Yu et al. 
2012). Unlike PLCζD210-Insp5P- GFP, OCRL1 does not contain a targeting sequence for the 
Golgi. Previous evidence suggests that OCRL1 resides in the trans Golgi network of cells, 
however there is also data indicating that it might target PI(4,5)P₂  in lysosomes also to 
mediate membrane trafficking here (Ungewickell and Majerus 1999). As the cellular 
localisation of the OCRL1 expressed in mouse eggs could not be determined it’s unclear 
whether the correct pool of PI(4,5)P₂  was being depleted to affect PLCζ activity.  
With this in mind, to try and deplete PI(4,5)P₂ in Golgi alone, the Insp54P was tagged with 
markers which usually reliably target the Golgi. Two different targeting proteins were used, 
the C1b domain which is known to bind DAG in the Golgi and the PH domain of Oxy sterol 
binding protein (OSBP) which binds to PI(4)P in the Golgi (Burns and Bell 1991; Levine and 
Munro 1998). The effects of overexpressing both C1b-Ins5P and OSBP(PH)-Ins5P on PLCζ 
induced Ca²⁺i oscillations were tested in eggs. However, no impact on Ca²⁺i oscillations were 
recorded following expression of either of these constructs.  
As these probes contained a targeting protein for the Golgi it was important to determine 
whether these constructs actually targeted the vesicular structures identified by other 
Golgi markers. However, when fluorescently tagged versions of these domains were 
expressed in eggs they were not found to localise to small vesicles. In contrast they 
appeared to bind reticular structures that looked similar to markers for the ER and BODIPY-
FL ceramide staining. It is possible therefore that in eggs these domains do not target the 
Golgi or target a part of the Golgi that is not fragmented.  It is important to note that PI(4)P 
is also found in other intracellular membranes thereofore OSBP(PH) may not have targeted 
just the Golgi (D'Angelo et al. 2008)hese probes could have been expressed at such high 
levels that the usual binding sites for these proteins became saturated. As a result excess 
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OSBP(PH) and C1b could have bound other membranes that they would not usually bind 
under physiological conditions. Nevertheless, as neither OSBP(PH) nor C1b appeared to 
bind these small vesicles previously identified it is unlikely that the Ins5P was being 
localised to the correct membrane. As a result it is unlikely that these probes targeted the 
correct source of PI(4,5)P₂. Expressing untagged Ins5P which remains in the cytoplasm has 
previously shown to have no impact on PLCζ or sperm induced Ca²⁺i oscillations in eggs (Yu 
et al. 2012).  
It is possible that even if the OCRL1 and Ins5P are dephosphorylating some PI(4,5)P₂  there 
is so much vesicular PI(4,5)P₂  available in the egg that it is difficult to deplete significant 
levels (Snow et al. 1996). Furthermore as PLCζ is incredibly potent at releasing Ca²⁺i it may 
only require a relatively small amount of vesicular PI(4,5)P₂  in order to elicit Ca²⁺i 
oscillations (Saunders et al. 2002). It has also been shown that during fertilisation in sea 
urchin eggs there is a very fast turnover of phosphoinositides (Ciapa et al. 1992). Though PI 
turnover has not been successfully measured in mammalian eggs this could also be the 
case in mouse eggs. If so the re-synthesis of PI(4,5)P₂  could be so fast that overexpressing 
phosphatases has no effect on the availability of PI(4,5)P₂  to PLCζ. Phosphatases act as part 
of a tightly regulated pathway regulating the levels of all phosphoinositides keeping 
everything in fine balance. As a result it may be difficult to see any functional effects of 
overexpressing enzymes in this pathway. The possibility cannot be ruled out that OCRL1, 
OSBP(PH)-Ins5P and C1b-Ins5P are depleting Golgi derived PI(4,5)P₂  however this pool of 
PI(4,5)P₂  is not that targeted by PLCζ and therefore does not play a role Ca²⁺i oscillations at 
fertilisation. However, as it was not possible to quantify the specific levels of PI(4,5)P₂   
before and after expression of these probes it was impossible to determine whether the 
phosphatases were actually effective at dephosphorylating PI(4,5)P₂.  
One alternative method of depleting PI(4,5)P₂ is by disrupting the production if its 
precursors such as the parent phosphoinostide molecule, PI. PI is synthesised in the ER by 
the enzyme PI synthase from CDP-DAG (Tanaka et al. 1996). CDP-DAG is generated from 
signalling PA and CTP (Carter and Kennedy 1966). Therefore the formation of all other 
phosphoinostides can be prevented by inhibiting the generation of PI and its precursors. 
The PA required to make CDP-DAG comes from the conversion of DAG to PA by the enzyme 
DAG kinase (Call and Rubert 1973). Therefore by inhibiting DAG kinase it may be possible to 
prevent the synthesis of PI. Indeed an inhibitor for DAG kinase has been found to ablate 
Ca²⁺i oscillations stimulated by PLCζ in eggs. Furthermore the basal level of Ca²⁺i remains 
low following addition of this drug suggesting that it is unlikely to be having a toxic effect 
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on these eggs. Inhibiting DAG kinases in pancreatic islet and β cell lines has been shown to 
reduce Ca²⁺release in these cells (Kaneko and Ishikawa 2016) Whereas in platelets DAG 
kinase inhibitors reduce thrombin induced Ca²⁺influx but not Ca²⁺ release induced by 
thapsigargin (Marumo et al. 2012). However, in this cell type DAG kinase inhibitor does not 
appear to effect PI turnover (de Chaffoy de Courcelles et al. 1985). 
To determine whether preventing PA synthesis by other means effected PLCζ induced Ca²⁺i 
oscillations two other inhibitors of PA synthesis were used both of which disrupt different 
PA synthesis by different pathways. One of the main pathways for PA production is via the 
PLD pathway which involves the hydrolysis of PS to produce choline and PA (Liscovitch et 
al. 1993).This process can be inhibited by the addition of primary alcohols (Kotter and Klein 
1999). Therefore the primary alcohol 1-butanol (1:1000) was added to eggs oscillating in 
response to PLCζ to determine how this affected Ca²⁺release. Interestingly after the 
addition of 1-butanol the Ca²⁺i oscillations increase in frequency quite dramatically which 
was paired with an increase in basal level Ca²⁺i.  To be sure this affect was specific the same 
experiment was conducted with the secondary alcohol 2-butanol which should not affect 
PA synthesis by the pathway. However, a very similar effect was seen after the addition of 
2-butanol (1:1000). This suggests that this could be a non-specific effect seen as a result of 
alcohol addition. The increase in basal level Ca²⁺i indicates there could be an increase in 
Ca²⁺ infux or Ca²⁺ ER leakage both of which would be expected to increase the frequency of 
Ca²⁺i oscillations initiated by PLCζ (see Chapter 7).  This rise in basal Ca²⁺i could be indicative 
of non-specific effects on egg metabolism.  Alcohols are also thought to stimulate the IP3R 
which could therefore increase Ca²⁺release by PLCζ (Mizuno et al. 2013). 
Another pathway by which PA is generated is by the activity of PC- specific PLCs which 
operate in a distinct pathway to PI specific PLCs like PLCζ. The toxin D609 acts as inhibitor 
of PC- specific PLCs (Adibhatla et al. 2012). As a result the effect of D609 on Ca²⁺i 
oscillations stimulated by PLCζ was investigated. D609 was found to inhibit these Ca²⁺i 
oscillations shortly after addition however a small increase in basal level Ca²⁺i oscillations 
was seen. This suggests that though it would appear inhibiting PA production via this 
pathway impacted negatively on PLCζ ability to release Ca²⁺ this effect is likely to be due to 
non-specific toxic effects on the egg. If D609 is disrupting the metabolism of the egg for 
example this could prevent effective Ca²⁺ release. 
It is therefore unclear whether the production of PA as a whole play in the cell plays a 
significant role in Ca²⁺releasing ability of eggs or whether PA specifically generated as a 
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result of DAG kinase activity is vital for the production of PI(4,5)P₂ and therefore PLCζ 
activity. Preventing PI(4,5)P₂ or PI synthesis by inhibiting PA production is not very specific. 
The DAG/ PA pathway plays a significant homeostatic role in cells and maintaining correct 
levels of these molecules is vital to ensure any signalling in the cell occurs effectively across 
multiple pathways. The effects of these drugs could therefore, rather than being specific on 
PI(4,5)P₂  levels, be a result of a more general disruption of signalling in the egg.  
The effect of a final drug was tested on Ca²⁺ releasing ability of eggs. Rather than disrupting 
the production of PI or PI(4,5)P₂  propranolol is thought to disrupt the structure of the Golgi 
apparatus, membrane trafficking and leads to mis-localisation of proteins in this region 
(Asp et al. 2009). It is possible that PLCζ binds to PI(4,5)P₂  positive vesicles originating from 
the Golgi. As a result disrupting the structure and localisation of potential target proteins 
here could affect PLCζ induced Ca²⁺i oscillations in eggs. Indeed addition of propranolol did 
inhibit Ca²⁺i oscillations stimulated by PLCζ and no elevation in basal level Ca²⁺i was 
recorded. Furthermore the effects of this drug could be reversed by removal. Interestingly 
these Ca²⁺i returned with a  higher frequency which appeared unsustainable leading to an 
increase in basal Ca²⁺i levels and  in most cases lead to the eggs eventually dying after 
approximately 1 and a half hours. Besides disrupting the Golgi, propranolol also prevents 
COPI coated vesicle membrane trafficking (Asp et al. 2009). It has previously been shown 
that this effect is reversible and if propranolol is removed there is a sudden burst of 
trafficking vesicles formed at the ER (Asp et al. 2009). Propranolol may be preventing the 
trafficking of phosphoinostides from the ER to the Golgi for example PI(4,5)P₂  or PI(4)P 
which could be essential for PLCζ activity. When this drug is removed it could lead to a 
surge in trafficking vesicles, containing these molecules, to arrive at the Golgi and stimulate 
PLCζ activity. Alternatively propranolol may disrupt Golgi derived binding partners for PLCζ 
which then become relocalised following propranolol removal. Propranolol has been shown 
to redistribute trans-golgi network resident proteins to the cytosol in a reversible fashion 
(Baron and Malhotra 2002).  Propranolol prevents Golgi derived DAG production (Asp et al. 
2009). Disrupting PA production has been shown to effect the Ca²⁺i releasing ability of eggs 
in response to PLCζ. PA and DAG production are closely related interconnected pathways. It 
is possible that disrupting DAG/PA metabolism in any way could have a severe effect on the 
cell signalling events in the egg. For example propranolol also inhibited Ca²⁺i oscillations 
stimulated by PLCδ1 which does not hydrolyse a vesicular source of PI(4,5)P₂  (Yu et al. 
2012). 
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The Ca²⁺releasing ability of eggs is cell cycle dependent. Mature MII arrested eggs are the 
only cells which are able to respond to PLCζ to produce Ca²⁺i oscillations like that seen at 
fertilisation (Carroll et al. 1994; Jones et al. 1995a; Wakai et al. 2012). It has previously 
been reported that eggs acquire this ability to respond to sperm during oocyte maturation 
(Carroll et al. 1994; Jones et al. 1995b; Wakai et al. 2012). The response of oocytes at 
different stages of maturation to PLCζ cRNA has previously been recorded (Wakai et al. 
2012). However, oocytes sensitivity to PLCζ during oocyte maturation has not previously 
been quantified accurately. This is because immature oocytes express exogenous cRNA 
differently to mature eggs and it is not possible to quantify the expression of untagged 
cRNA easily. Therefore in order to quantify this response accurately the Ca²⁺i releasing 
response of oocytes at different stages of maturation was tested using luciferase tagged 
PLCζ cRNA. Adding a luciferase tag onto a sequence to create a fusion construct allows the 
amount of protein expressed to be measured by recording the bioluminescence produced 
by the luciferase enzyme. The greater the amount of luciferase the greater amount of 
bioluminescence emitted and as the luciferase is bound to PLCζ this quantification of 
bioluminescence emitted is also directly related to the amount of PLCζ protein in the egg 
(Swann et al. 2014) This allows comparisons to be made between oocytes expressing the 
same amount of PLCζ protein. Using this method it was found that all MII eggs oscillated 
with a frequency of approximately 4 spikes per hour. However, only 20 out of 26 MI 
oocytes oscillated in response to PLCζ expressed at very similar levels. These 
Ca²⁺ioscillations were slightly reduced in frequency compared to that seen in MII eggs and 
normally stopped within approximately 1 hour. However, remarkably only 3 out of 21 GV 
oocytes responded to PLCζ at these levels suggesting that there is a marked increase in 
Ca²⁺i releasing ability in oocytes after germinal vesicle breakdown. Furthermore this effect 
could not be rescued by over expressingPLCζ up to 30 times the physiological level as only 6 
out of 25 oocytes oscillated. This is surprising as it has previously been suggested that egg 
acquire their ability to respond to PLCζ fairly gradually throughout maturation and that the 
responses to PLCζ in GV oocytes are reduced in frequency compared to MI oocytes and MII 
eggs (Wakai et al. 2012). This effect had previously been attributed to a reduction in the 
sensitivity of the IP3R in immature oocytes (Carroll et al. 1994; Wakai et al. 2012). In other 
words PLCζ produces IP3in the same way however the IP3R is less responsive to this and 
therefore releases less Ca²⁺. The complete absence of Ca²⁺i oscillations recorded in most GV 
oocytes suggests that this is not the explanation for this difference in response. This is 
because if the IP3R sensitivity was reduced in GV oocytes then you would expect that over 
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expressing PLCζ in order to produce a lot more IP3would rescue the effect. However, this is 
not the case. Furthermore experiments using caged IP3have shown that GV oocytes are 
able to respond even to low levels of IP3. This further supports the notion that sensitivity 
changes in the IP3R during oocyte maturation are not large enough to account for the 
dramatic increase in Ca²⁺releasing ability of oocyte after germinal vesicle breakdown.  
One reason for the proposed increase in sensitivity of the IP3R during oocyte maturation is 
an increase in ER Ca²⁺ concentrations (Carroll et al. 1994; Jones et al. 1995b; Wakai et al. 
2012) The level of ER luminal Ca²⁺ concentrations is believed to directly impact the 
sensitivity of the  IP3R  (Missiaen et al. 1992). It has already been shown that ER Ca²⁺ 
concentration increase during oocyte maturation for example as oocytes mature they 
become more responsive to Ca²⁺ionophore and thapsigargin (Jones et al. 1995b). The 
current experiments showed that there is a reduced amplitude of Ca²⁺i oscillations in 
response to PLCζ in both MI and GV oocytes. Furthermore the Ca²⁺i response stimulated by 
the un-caging of caged IP3 was also reduced in amplitude in GV oocytes and MI oocytes 
compared to MII eggs. This supports the idea that ER Ca²⁺ concentrations increase during 
oocyte maturation however this is something which appears to happen more dramatically 
in the later stages of oocyte maturation. The biggest difference in the amplitude of 
Ca²⁺release was recorded between MI oocytes and MII eggs, with GV oocytes only having 
slight reduced amplitude in comparison to MI oocytes. This suggests that the increase in ER 
Ca²⁺ concentrations occurs relatively late in maturation. Therefore an increase in ER Ca²⁺ 
cannot account for the dramatic increase in Ca²⁺i releasing ability occurring during 
transition to MI.  One big difference between GV and MI oocytes is the change in cell cycle 
state. GV oocytes are arrested in interphase whereas MI and MII oocytes are in metaphase. 
This may be significant as it appears that an eggs ability to respond to PLCζ and sperm is cell 
cycle dependent (Jones et al. 1995a). For example zygotes in interphase do not respond to 
PLCζ however following nuclear envelope breakdown during the first mitotic cell cycle 
these Ca²⁺i oscillations return (Kono et al. 1996) This is because when the pronucleus forms 
PLCζ becomes sequestered here due to the presence of a nuclear targeting sequence in its 
structure (Larman et al. 2004). Fluorescently labelled PLCζ has been seen to sequester in 
the nucleus when the pronuclei form at egg activation (Yoda et al. 2004). It is also been 
suggested the same thing could happen in a GV oocytes were PLCζ accumulation in the GV 
and this could prevent Ca²⁺i oscillations (Yu et al. 2012).  However, this does not appear to 
be the case with PLCζ- luciferase. The bioluminescence signal emitted by this construct can 
be seen uniformly throughout the cytoplasm of eggs and oocytes. However, if luciferase is 
229 
 
injected directly into the germinal vesicle of GV oocytes a bright signal can be clearly 
emitted from this region. Therefore, if PLCζ- luciferase is being sequestered in the nucleus it 
would be visible using these imaging methods. Furthermore at very high levels of PLCζ- 
luciferase expression the nucleus would become saturated and some PLCζ- luciferase 
would end up in the cytoplasm. Therefore it is very unlikely that nuclear localisation of 
PLCζ- luciferase is the reason it does not cause Ca²⁺i oscillations in GV oocytes. It is possible 
due to the length of the PLCζ- luciferase construct it is not able to enter the nucleus of GV 
oocytes easily whereas shorter length fluorescently tagged PLCζ constructs may be ableto 
get into the nuclear envelope. As a result fluorescently tagged PLCζ could accumulate in the 
GV (Yu et al. 2012). Other mammalian species such as humans do not contain a functional 
nuclear targeting sequence in PLCζ and therefore oscillations must be halted in these 
species by another mechanism (Cox et al. 2002). As intracellular  
PI(4,5)P₂  is very likely to play a role in enabling PLCζ to release Ca²⁺. It is possible that PLCζ 
is not able to release Ca²⁺in GV oocytes because they lack of this pool of PI(4,5)P₂ (Yu et al. 
2012). Immunostaining of PI(4,5)P₂  during oocyte maturation has shown that GV oocytes 
do not have a visible source of vesicular PI(4,5)P₂,  instead all their PI(4,5)P₂  is located on 
the plasma membrane or contained within the germinal vesicle (Yu et al. 2012). As oocytes 
progress through MI some vesicular PI(4,5)P₂  becomes apparent however an abundance in 
PI(4,5)P₂ positive vesicles do not appear until the eggs are fully matured and arrested in MII 
(Yu et al. 2012). This result was reproduced with PI(4,5)P₂ immunostaining showing that 
once again PI(4,5)P₂  in GV oocytes localises to the germinal vesicle however little plasma 
membrane PI(4,5)P₂  staining was seen. This suggests that the vesicular source of PI(4,5)P₂  
required for PLCζ activity is not existent in GV oocytes and therefore Ca²⁺ cannot be 
released effectively. However, these cells must be fixed and permeabilised in order to 
conduct immunostaining and this process can disrupt the distribution of membrane bound 
proteins (Sharma et al. 2008). As a result it proved difficult to obtain consistent results with 
all immunostaining experiment. 
Because of this, the localisation of live cell markers for PI(4,5)P₂  were also investigated 
during oocyte maturation. FL-PI(4,5)P₂ , DAN 20 and PBP10 were all injected into GV 
oocytes so the staining pattern of these probes could be compared to that of MII eggs. 
However, all these probes showed a vesicular source of PI(4,5)P₂  was present in GV 
oocytes that appeared similar to that seen in MII eggs. Furthermore no plasma membrane 
PI(4,5)P₂  was apparent in GV oocytes using these markers. Even if vesicular PI(4,5)P₂ is 
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present in GV oocytes it does not necessarily mean that this PI(4,5)P₂  is available to PLCζ. 
For example it is unclear where these PI(4,5)P₂ containing vesicles originate from in GV 
oocytes. Though there is strong support for the idea that the PI(4,5)P₂  containing vesicles 
in eggs originate from the Golgi this may not be the case in GV oocytes. There is evidence 
from immunostaining data that in GV oocytes the Golgi takes the form of cisternal stacks 
like that seen in somatic cells (Moreno et al. 2002; Payne and Schatten 2003). Staining with 
the lectin AC-lectin unlike immunostaining showed that the Golgi appears fragmented in 
GV and MI oocytes. Furthermore these vesicles appeared very similar to that seen in MII 
eggs. This indicates that the Golgi does not alter significantly in structure during oocyte 
maturation. However, the live cell Golgi marker GOLGI-ID® did show a difference in Golgi 
localisation between GV oocytes and MII eggs. In GV oocytes the staining pattern by this 
probe does not appear vesicular but instead appears to bind larger clustered structures 
throughout the cytoplasm. This suggests that the Golgi fragments during oocyte maturation 
and does not appear as vesicles prior to oocyte maturation. However, variability in results 
with different probes makes it difficult to draw conclusions on how the Golgi matures 
during oocyte maturation. As previously described however the structure of the ER does 
appear to alter during oocyte maturation with the ER becoming more reticular and 
clustered in MII eggs (FitzHarris et al. 2007). It is unclear exactly how the structural changes 
of organelles during oocyte maturation play a role in enabling PLCζ to release Ca²⁺ It is 
possible that structural changes are required to either make PI(4,5)P₂ accessible to PLCζ or 
ensure the correct localisation of targeting proteins for PLCζ. Alternatively germinal vesicle 
breakdown could result in the release of a targeting protein for PLCζ that may be required 
for PLCζ activity.  This is something which needs to be explored in more detail.  
It is apparent that rather than hydrolysing PI(4,5)P₂  at the plasma membrane like all other 
known PLC isoforms, PLCζ hydrolyses an alternative source of PI(4,5)P₂  (Yu et al. 2012). 
Many different probes for PI(4,5)P₂  have indicated that this PI(4,5)P₂  is located on small 
vesicles throughout the cytoplasm in mature eggs. It is unclear exactly what the origin of 
vesicles is, however, there is strong evidence that these could originate from the Golgi. The 
availability of this vesicular PI(4,5)P₂ may be a cell cycle dependent process which is a 
feature of MII arrested oocytes. Furthermore the inability of PLCζ to cause Ca²⁺i oscillations 
in somatic cells or immature oocytes could be due to the inaccessibility of this vesicular 
PI(4,5)P₂.The functional effects of vesicular PI(4,5)P₂ availability are yet to be investigated 
in detail and exactly how PLCζ targets this specific source of PI(4,5)P₂ is yet to be fully 
understood.  
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6. ASSESSING POTENTIAL PROBES TO MONITOR IP3 AND DAG 
DYNAMICS DURING PLCZ INDUCED CA²⁺I OSCILLATIONS 
Introduction 
Secondary messengers are signalling molecules that play a key role in regulating the activity 
of other proteins and signalling pathways. During fertilisation, though Ca²⁺i itself is a key 
signalling molecule, other messenger molecules are also produced that may play a role in 
egg activation.  Two key secondary messengers are produced during PLCζ activity both of 
which are the cleavage products of PI(4,5)P₂ . Firstly is the production of IP₃ from the 
inositol head component PI(4,5)P₂  which diffuses into the cytoplasm. IP₃ goes on to 
stimulate the IP₃ receptor and release Ca²⁺ from the endoplasmic reticulum giving the 
characteristic Ca²⁺i oscillations seen at fertilisation (Miyazaki 1988). The second is the 
glyceride diacylglycerol (DAG) consisting of the glycerol backbone and fatty acid tails of 
PI(4,5)P₂  which remains in the plasma membrane (Ciapa and Whitaker 1986). 
Though it is fully recognised that IP₃ is the means by which Ca²⁺is released from stores 
during fertilisation the exact dynamics of IP₃ production during fertilisation remain 
unknown. This is significant as the pattern of IP₃ production could play a key role in 
determining the pattern of the Ca²⁺i oscillations. Different models of Ca²⁺ioscillations have 
been proposed each of which makes different assumptions on the pattern of IP₃ 
production. One theory suggests that the rate of IP₃ synthesis is constant and therefore 
does not dynamically change during Ca²⁺i oscillations (Iino 1990). In this model it is the 
intrinsic properties of the IP₃R that allow dramatic changes in Ca²⁺ release as the receptor is 
seen to have biphasic dependence on Ca²⁺ (Iino 1990). The opposing theory suggests that 
IP₃ is produced in an oscillatory manner which increases prior to each Ca²⁺i transient (Meyer 
and Stryer 1988). In this model cytosolic Ca²⁺i levels positively feedback onto PLC activity 
producing spikes in IP₃ which act as the pacemaker for Ca²⁺i oscillations (Meyer and Stryer 
1988).  
In the past the only way to measure IP₃ production was biochemical assays using either 
isotope labelling or IP₃ radio-receptor assays (Balla et al. 1986; Bredt et al. 1989). Neither of 
these allows dynamic changes in the IP₃ of individual live cells to be measured, and they 
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generally require too much material to be used on mammalian eggs. As a result many 
genetic based probes have been developed to measure IP₃ dynamics in live cells. Most of 
these are based on the IP₃ binding domain of the IP₃R and adopt the fluorescence 
resonance energy transfer (FRET) technique. The benefit of FRET based genetically encoded 
probes is that FRET allows small changes over short distances to be measured relatively 
sensitively (Stryer 1978).  
One of the first such probes was LIBRA which was successfully used to measure real-time  
IP₃ changes in acetylcholine stimulated SH-SY5Y cells (Tanimura et al. 2004).  Similarly the 
IP₃R based IP₃ sensor 1  (IRIS), has been used to measure IP₃ changes in HeLa cells following 
stimulation of endogenously expressed histamine receptors or metabotropic glutamate 
receptor 5 (Matsu-ura et al. 2006).Other IP₃ probes have been developed in order to 
measure IP₃ dynamics in other cell types including the fluorescent IP₃ responsive element 
(FIRE) which has been used to measure IP₃ in COS cells, neonatal cardiac myocytes and 
cardiac ventricular myocytes (Remus et al. 2006). The FRETINO probe has been used to 
measure nuclear IP₃ dynamics alongside cytosolic IP₃ changes in neuronal dendrites (Sato et 
al. 2005).  
IP₃ probes provide different evidence on how IP₃ levels change prior to Ca²⁺ release and 
these probes possibly behave in a cell specific manner. A GFP tagged probe based on the 
PH domain of PLCδ1 which translocates from the plasma membrane to the cytoplasm as IP₃ 
increases has shown that IP₃ oscillates with Ca²⁺i in Madin-Darby canine kidney epithelial 
cells (Hirose et al. 1999). However, this probe does not directly measure cytosolic IP₃ in the 
way that genetically encoded IP₃ binding domain based probes do.  Direct measurements 
of IP₃ using the IRIS probeshowed no acceleration in the rate of IP₃ production with 
Ca²⁺ioscillations in HeLa cells (Matsu-ura et al. 2006). This result was verified in COS-7 cells 
using LIBRA (Tanimura et al. 2009). However, in HSY-EA1  cells the same probe found that 
there was repetitive spikes in IP₃ with Ca²⁺ioscillations (Tanimura et al. 2009). Therefore it 
remains unclear which model of IP3 production is most common place during Ca²⁺i 
oscillations. 
Some attempts have been made to measure IP₃ dynamics in mammalian eggs at 
fertilisation using these existing probes. The FRETINO probe has been used to look at IP3 
dynamics in mouse eggs during fertilisation and in response to PLCζ (Shirakawa et al. 2006). 
Only very small oscillations in IP₃ levels were detected alongside Ca²⁺i oscillations however 
these did get bigger with time (Shirakawa et al. 2006). It was also found that addition of 
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extracellular Ca²⁺ to eggs previously injected with PLCζ caused a large increase in Ca²⁺i and 
IP₃ which suggested a positive feedback loop between Ca²⁺i, IP₃ and PLCζ activity 
(Shirakawa et al. 2006). However, this probe was not able to measure any significant 
change in IP3in response to individual Ca²⁺i oscillations during fertilization (Shirakawa et al. 
2006). 
The signalling role of DAG in egg activation is not yet clearly understood. Unlike IP₃, which 
has a direct known affect via Ca²⁺ release, DAG has multiple targets with many overlapping 
signalling pathways. Different species of DAG are produced in different cellular 
compartments via different mechanisms and therefore these species may play distinct 
signalling roles (Carrasco and Merida 2007). In somatic cells DAG production as a result of 
PLC activity via the hydrolysis of PI(4,5)P₂  generally occurs at the plasma membrane. As a 
result changes in DAG levels of PLC stimulated cells can be detected at the plasma 
membrane. This type of DAG is often referred to as “signalling” DAG and can be considered 
as distinct from the “metabolic” DAG   produced on internal membranes via other 
metabolic pathways (Hodgkin et al. 1998). The role of signalling DAG is primarily considered 
to act as secondary messenger to activate PKC by recruiting it to the plasma membrane 
(Kraft et al. 1982).   
Fairly simple indictors have been developed that allow signalling DAG to be measured 
dynamically in live cells. Most of these are based on the idea that DAG binds cysteine rich 
domains (CRD) for example the C1 domain of PKCs (Oancea et al. 1998). The tandem C1 
domain of conventional PKCγ tagged with GFP has been used to detect the translocation of 
DAG in response to hormonal stimulation in Rat basophilic leukemia 2H3 cells (Oancea and 
Meyer 1998). However, as these probes only emit one wavelength of fluorescent light in 
order to measure dynamic changes in DAG the translocation of the probe has to be 
measured using high resolution microscopy. To try and get around this issue the DAG 
reporter (DAGR), a FRET based probe containing the C1 domain of PKCβ, has also been 
used to measure DAG levels in MDCK cells (Violin et al. 2003). DAGR translocates from the 
cytosol to the plasma membrane as DAG increases here (Violin et al. 2003). Interestingly 
there are differences in the affinity for DAG of C1 domains from different PKCs. The C1 
domains of novel PKCs such as PKCδ actually have a higher affinity for DAG than 
conventional PKCs (Dries et al. 2007). 
Probes based solely on the C1 domain are not able to discriminate between DAG produced 
in different cellular compartments as a result a series of membrane specific DAG probes 
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have been developed.  DAGLAS probes are FRET based probes containing a CRD from PKCβ 
fixed between CFP and YFP molecules with α helix linkers (Sato et al. 2006). This core probe 
is then fused specific membrane targeting sequences to direct the probe to specific 
membranes. Once the probe is anchored to this membrane if it binds to DAG the probe 
undergoes a FLIP FLOP conformational change giving a change in FRET ratio (Sato et al. 
2006). These probes have been successfully used to measure DAG dynamics in the different 
cellular compartments of MDCK cells (Sato et al. 2006). 
More recently a series of new probes have been developed that are not based on FRET. 
Instead these biosensors are based on circularly permuted fluorescent proteins. When 
fluorescent proteins are circularly permuted the amino and carboxyl halves of the β barrel 
are switched over and linked with spacer (Baird et al. 1999). This allows the barrel to open 
and close more freely and leads to conformational changes. The fluorophore is still able to 
work effectively however due to an altered orientation the signal emitted can be enhanced 
several fold (Baird et al. 1999). By fusing with a protein sequence of interest these proteins 
can be used to develop probes to measure cellular dynamics (Baird et al. 1999). This 
technique has successfully been used to develop a Ca²⁺i sensor named Peri-cam, which 
contains a circularly permuted GFP fused to CaM and CaM binding peptide M13 (Nagai et 
al. 2001). This probe has been adapted and improved upon to create many more 
sophisticated Ca²⁺i sensors including GCaMP3, G-GECO and R-GECO (Akerboom et al. 2009; 
Zhao et al. 2011). One of these probes, G-GECO, has been adapted to produce a DAG 
sensor based on the same principle. In this probe the circularly permuted GFP from G-GECO 
was fused between C1 domain of PKCδ1 and its pseudo-substrate domain (Tewson et al. 
2012). Both upwards and downwards versions of this probe were developed and both 
showed dynamic changes in fluorescence of at least 40% following carbachol treatment 
(Tewson et al. 2012). This change is greater than that previously recorded by FRET based 
probes.  
It is not clear how DAG dynamics change during Ca²⁺i oscillations. Oscillations in DAG 
production along with Ca²⁺i oscillations have been detected following glutamate stimulation 
of astrocytes (Codazzi et al. 2001). GFP tagged C1 domain of both PKCγ and PKCδ showed 
oscillatory translocation between the cytosol and plasma membrane (Codazzi et al. 2001). 
Attempts have been made to measure changes in DAG levels in eggs during fertilisation. 
Oscillations in conventional PKC plasma membrane translocation, using GFP-tagged PKCγ 
and PKCα have been recorded in eggs during fertilisation (Halet 2004). This could be 
considered as an indirect measure of DAG production however, this PKC translocation 
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appears to be solely Ca²⁺ dependent mediated by the C2 domain and didn’t indicate any 
changes in plasma membrane DAG (Halet 2004). Interestingly, PKC induced 
phosphorylation, as measured by the c-kinase activity reporter (CKAR), probe has been 
found to oscillate with Ca²⁺i oscillations in fertilising eggs. CKAR signal was seen to 
repetitively increase in both the plasma membrane and the cytoplasm. This is significant as 
it suggests DAG may be produced not just at the plasma membrane but also on internal 
membranes (Gonzalez-Garcia et al. 2013). Direct measurements of DAG using a GFP tagged 
tandem C1 domain of PKCδ (C12δ1-GFP) found no detectable change in DAG levels at the 
plasma membrane during fertilisation (Yu et al. 2008). However, if PLCζ is over-expressed 
beyond physiological levels, or Ca²⁺is released via PLCδ1, changes in plasma membrane 
DAG are detected (Yu et al. 2008; Yu et al. 2012). This suggests that DAG is not being 
produced at the plasma membrane via PI(4,5)P₂  hydrolysis. Instead it is more likely that 
PLCζ is hydrolysing PI(4,5)P₂  on internal cellular membranes which are not being measured 
by this technique (Yu et al. 2008; Yu et al. 2012). DAG production in internal membranes of 
eggs during fertilisation is yet to be explored. 
Though it is undisputed that IP3 and DAG are produced via PI(4,5)P₂  hydrolysis, the 
dynamics of these signalling molecules have not yet been successfully measured in live eggs 
during fertilisation or PLCζ induced Ca²⁺i oscillations.    
Aims 
These series of experiments aimed to measure the live cell dynamics of DAG and IP3 during 
PLCζ activity with the use of novel probes and some existing probes. These probes were 
used to look at the changes in these secondary messengers both during Ca²⁺i oscillations 
and in response to various other stimuli.  
Results 
Measuring DAG using C1 domain based inter-molecular FRET probe 
C1b inter-FRET signal alters in response to phorbol esters 
Some of the most basic DAG probes are based on a fluorescent tagged cysteine rich domain 
(CRD) such as a GFP tagged C1 domain of PKC (Oancea and Meyer 1998). For example the 
C12δ1-GFP probe was used to measure DAG changes in plasma membrane in eggs during 
fertilisation, however no change in DAG levels was detected using this probe (Yu et al. 
2008).  A new potential probe was developed (courtesy of MN) to try and measure whole 
cell changes in DAG levels in eggs at fertilisation. This construct was based on a 
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fluorescently tagged C1 domain.This principle has previously been used to measure 
PI(4,5)P₂  at the plasma membrane in somatic cells using an inter-molecular PH domain 
based FRET probe (van der Wal et al. 2001). Two constructs were produced with one C1 
domain being tagged to either YFP (C1b-YFP) or CFP (C1b-GFP) collectively referred to as 
C1b inter-FRET (see fig 6.1B). When both of these constructs are expressed simultaneously 
and the YFP tag from one construct comes in close proximity with the CFP a change in inter-
molecular FRET signal can be detected. A change in FRET indicates that the constructs are 
co-localising on a membrane due to DAG binding. To test the dynamic range of this probe, 
eggs were co-microinjected with 2μg/μl of C1b- YFP and C1b-CFP cRNA diluted in KCL 
hepes. Eggs were then left approximately 3 hours to allow protein levels of the constructs 
to accumulate. The injected eggs were then transferred onto a fluorescence imaging 
system and the FRET ratio was recorded. After around 15 minutes of recording 1 μM of 
phorbol myristate acetate (PMA) was added to the media surrounding the eggs. PMA acts 
as a DAG analogue therefore mimics the effects of DAG increase. There was a signal 
increase of around 6.6% in FRET ratio after the addition of PMA (see fig 6.2, Table 6.1). 
Though this shows that C1b inter-FRET can detect changes in DAG, this change was very 
low given that PMA at this concentration is such a strong stimulus which suggests that the 
dynamic range of the probe is relatively low.  
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Figure 6.1 Schematic diagrams showing the structure of the genetically encoded constructs used to 
measure DAG 
A) DAGR consisting of the C1 domain from PKCβ tagged with  CFP and YFP fluorescent tags; B) C1 
Inter-FRET probe consisting of two separate constructs that were co-injected  both based on the C1b 
domain tagged with either YFP and CFP; C) Green ‘Upwards’ DAG containing the DAG binding C1 
domain of PKCδ attached to a circularly permutated GFP.  
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Figure 6.2 FRET changes of C1 Inter-FRET probe in response to PMA 
An example fluorescence trace of an egg showing the change in FRET ratio of the C1 Inter-FRET 
probe in response to the addition of phorbol ester PMA  (1μM) (n= 5), see Table 6.1 for analysis.  
 
 
Probe Stimuli N % Change  SD of % change 
C1 inter-FRET PMA 5 6.6 3.1 
mPLCζ 6 0 0.2 
DAGR PMA 9 28.5 8.7 
mPLCζ 5 1.39 0.9 
Green ‘Upwards’ DAG PDBμ 8 96.8 6.1 
mPLCζ 19 0.53 1.7 
 
Table 6.1 Summary of the dynamic range of different DAG probes in response to different stimuli 
Summary table showing the dynamic range of different DAG probes and the mean percentage 
change in signal in response to the phorbol esters either PMA (phorbol myristate acetate) (1µM), 
PDBµ (phorbol 12,13-dibutyrate )(2µM) or during mPLCζ cRNA (0.025µg/µl) induced Ca²⁺i 
oscillations. SD= standard deviation of that percentage change.  
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C1b inter-FRET signal does not alter in response to PLCζ activity 
Next it was important to determine whether C1 inter-FRET could detect any changes in 
DAG levels in eggs at fertilisation. As Ca²⁺i oscillations at fertilisation are triggered by PLCζ, 
stimulation by PLCζ alone is a good way to parthenogenetically activate eggs and look at 
cellular dynamics during fertilisation.  Therefore following microinjection of C1b inter-FRET 
as described previously and 4 hours of expression the eggs were injected with 0.025 μg/μl 
of mouse derived PLCζ (mPLCζ) mixed with the Ca²⁺i indictor Rhod dextran. These eggs 
were then placed immediately on the imaging system as well as recording the fluorescence  
of the FRET ratio the fluorescence from the fluorescence from the Ca²⁺i indictor was also 
recorded. This simultaneous recording allowed the FRET change during the Ca²⁺i oscillations 
to be recorded. To determine if changes in DAG could be detected with each Ca²⁺i transient 
the FRET ratio before the Ca²⁺i spike and after were noted for 3 Ca²⁺i oscillations from each 
egg. The difference between these 2 values was calculated and used to determine the 
percentage change. The percentage change for each Ca²⁺i oscillation was averaged across 
the egg and the group. C1 inter-FRET found 0% change in FRET signal with each Ca²⁺i 
oscillation (see fig 6.3, Table 6. 1) which suggests that C1 inter-FRET is not able to detect 
changes in DAG with Ca²⁺i oscillations. Alternatively, DAG levels may not change during 
Ca²⁺i oscillations.  
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Figure 6.3 FRET and Ca²⁺i changes of C1 Inter-FRET probe in response to PLCζ 
A sample trace showing the change in FRET ratio of C1 Inter-FRET probe alongside mPLCζ induced 
Ca²⁺i oscillations. Ca²⁺i oscillations were initiated by the microinjection of 0.025 μg/μl RNA 
concentration and measured using the fluorescent Ca²⁺iindicator Rhod Dextran. R.F.U= relative 
fluorescence units, (n=6). See Table 6.1 for analysis.  
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Measuring DAG using DAGR probe 
DAGR FRET ratio alters in response to phorbol esters 
The DAG reporter probe (DAGR) is a FRET based probe that has been shown to measure 
whole cell changes of DAG in cell lines such as MDCK cells (Violin et al. 2003). However, this 
probe has never been used to try and measure changes in DAG levels in eggs during 
fertilisation. An experiment was conducted to determine whether DAGR could be 
successfully used to measure whole cell changes of DAG in eggs. In order to do this the 
genetic probe DAGR was microinjected into eggs in the form of cRNA (pipette 
concentration 2.5 μg/μl) and left to express for approximately 3 hours (see fig 6.1A). This 
gave time for levels of the DAGR protein to accumulate. The eggs were then placed on the 
fluorescence imaging system to determine the strength of the baseline fluorescence in the 
eggs prior to stimulation. In order to test the response of DAGR in egg, after half an hour 1 
μM of PMA was added into the egg containing media. PMA acts as a DAG analogue 
therefore mimics the effects of DAG increase. DAGR responded to the stimulus by an 
average increase in FRET ratio (YFP/CFP) of 28.5% (see fig 6.4).  This suggests that DAGR can 
be used to detect an increase in DAG in eggs.  
DAGR FRET ratio does not alter in response to PLCζ activity 
As DAGR was able to detect changes in DAG levels in eggs the next step was to see if DAGR 
was able to measure any alterations in DAG levels during Ca²⁺i oscillations seen at 
fertilisation. Once again the eggs were microinjected with 2.5 μg/μl DAGR cRNA and left to 
express for 4 hours. In order to look at how DAGR responded in line with Ca²⁺i oscillations 
at fertilisation eggs were then microinjected with 0.025 μg/μl mPLCζ RNA alongside the 
Ca²⁺i indicator Rhod Dextran. These eggs were then imaged so the Ca²⁺i dynamics and the 
FRET ratio could be recorded for several hours. During the first 2 hours of recording the 
DAGR ratio appeared to steadily increase over time before reaching a plateau. It is unclear 
how this increase in DAGR FRET ratio relates to the Ca²⁺i oscillations as in most of the eggs 
the FRET signal did not plateau until after the eggs had stopped oscillating (see fig 6.5A). In 
order to measure how the FRET signal changed with the Ca²⁺i oscillations, for each egg 
three Ca²⁺i oscillations were selected and the DAGR FRET signal before and after was noted. 
The FRET ratio percentage change for these 3 spikes was calculated and averaged across all 
the eggs. Only a very small percentage change of DAGR signal was seen with individual Ca²⁺i 
oscillations of 1.4 % (see fig 6.5B, Table 6.1). The same experiment was then repeated with 
human derived PLCζ (hPLCζ) as this has more potent activity in terms of releasing terms of 
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releasing Ca²⁺ (Cox et al 2002). hPLCζ was injected into eggs at a concentration of 0.02 
μg/μl which caused strong Ca²⁺i oscillations. As with mPLCζ during the first 2 hours of 
recording there is a steady increase in the DAGR FRET ratio before reaching a plateau and 
then decreasing slightly (see fig 6.6A). There was no detectable change in DAGR FRET signal 
with each oscillation initiated with hPLCζ (see fig 6.6B). These experiments taken together 
suggest that PLCζ does not cause a detectable change in DAGR signal alongside Ca²⁺i 
oscillations. 
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Figure 6.4 FRET changes of DAGR probe in response to PMA 
A sample trace from an egg showing the FRET ratio change of the DAGR probe in response to 1 μM 
PMA (n=9) , see Table 6.1 for analysis  
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Figure 6.5 FRET and Ca²⁺i changes of DAGR probe in response to mouse PLCζ 
Example traces showing how the FRET ratio of the DAGR probe changes alongside Ca²⁺ i oscillations in 
an egg. Ca²⁺i oscillations were initiated by 0.025 μg/μl mPLCζ RNA and measured using the Ca²⁺i 
indictor Rhod Dextran. A) shows the change during the whole recording  and B) shows a sample 
section of the same trace magnified  R.F.U= relative fluorescence units (n=5), see Table 6.1 for 
analysis 
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Figure 6.6 FRET and Ca²⁺i changes of DAGR probe in response to human PLCζ 
Example traces showing how the FRET ratio of the DAGR probe changes alongside Ca²⁺ i oscillations in 
an egg. Ca²⁺ioscillations were initiated by 0.02 μg/μl hPLCζ RNA and measured using the Ca²⁺i 
indicator Rhod Dextran. A)shows the change during the whole recording  and B) shows a sample 
section of the same trace magnified, R.F.U= relative fluorescence units (n=7), see Table 6.1 for 
analysis  
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Measuring DAG using Green ‘Upwards’ DAG probe 
The signal of Green ‘Upwards’ DAG alters in response to phorbol esters 
In recent years a series of new probes have been developed to measure DAG, which rather 
than relying on FRET, contain only a single fluorescent protein which has been altered to 
produce a circularly permuted fluorescent protein. This adaptation produces a protein that 
is not only more fluorescent but that is also able to respond to conformational changes of 
the probe that occur on binding (Baird et al. 1999). This conformational binding results in a 
signal change which can be detected through fluorescence microscopy. Green ‘Upwards’ 
DAG is one such probe that has been successfully used to measure live cell changes in DAG 
levels in cell lines (Tewson et al. 2012). However, this probe has not been used to measure 
DAG changes in any eggs. To test this Green ‘Upwards’ DAG (Montana Molecular) was 
microinjected into eggs in the form of RNA (1 g/l) (see fig 6.1C). The probe was then left to 
express in the eggs for 3 hours before the eggs were transferred to the imaging system. 
Following imaging for approximately 30 minutes the phorbol ester, phorbol 12,13-
dibutyrate (PDBμ) at a concentration of 2 uM was added to the media containing the eggs 
to mimic an increase in DAG. This caused an immediate large increase in the Green 
‘Upwards’ DAG fluorescence signal of around 96.8 % (see fig 6.7, Table 6.1). This suggests 
that Green Upwards DAG is able to detect changes in DAG levels in eggs effectively.  
Green ‘Upwards’ DAG does not detect changes in DAG during PLCζ induced Ca²⁺ioscillations 
 Green ‘Upwards’ DAG has a relatively large dynamic range therefore it could be a good 
probe for detecting DAG changes during fertilisation. To investigate this eggs were injected 
with Green ‘Upwards’ DAG cRNA in the same way as previously (pipette concentration 
2μg/μl) and left the express for approximately 3 hours. The eggs were then microinjected 
again with mPLCζ RNA (0.02 g/l) mixed with Rhod Dextran. The eggs were then transferred 
to the imaging system and the GFP signal from the Green ‘Upwards’ DAG was then 
measured simultaneously with the Rhod dextran signal. This enabled the change in Green 
‘Upwards’ DAG signal to be measured with each Ca²⁺i oscillation. The Green ‘Upwards’ DAG 
signal was then noted before and after 3 Ca²⁺i oscillations for each eggs. These values were 
used to calculate the percentage change in signal for these Ca²⁺i oscillations which was 
averaged over the egg and then the group of eggs. Very small changes in green fluorescent 
signal were detected of around 0.53 % with each Ca²⁺i oscillation. However, this change is 
not considered a significant change in signal (see fig 6.8A). These small changes could be 
spill over from the red fluorescence channel; measuring Ca²⁺i Furthermore there was a 
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constant drift up of Green ‘Upwards’ DAG signal during the course of recording which may 
indicate increased  expression of the probe with time  (see fig 6.8B).  
To try and address the expression drift issue of the Green ‘Upwards’ DAG probe this 
experiment was repeated but the Green ‘Upwards’ DAG RNA was microinjected into 
immature GV oocytes. These oocytes were then allowed to in vitro mature (IVM) overnight 
until they reached MII phase. The eggs were then microinjected with 0.02 μg/μl mPLCζ RNA 
mixed with Rhod dextran to trigger Ca²⁺i oscillations in the eggs. The signals were then 
recorded and analysed as previously. Allowing the protein levels of Green ‘Upwards’ DAG 
to increase for the extended time period during IVM did reduce the problem associated 
with the drift in signal caused by increased  expression with time (see fig 6.9B). However, in 
these eggs no detectable change in signal of Green ‘Upwards’ DAG was recorded with each 
Ca²⁺i oscillation as there was a very small decrease 0.17% (see fig 6.9A). Though there were 
some very small changes in the Green ‘Upwards’ fluorescence signal that corresponded 
with the Ca²⁺i oscillations it is difficult to determine whether these changes are significant. 
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Figure 6.7 FRET changes of Green ‘Upwards’ DAG probe in response to PDBµ 
A sample trace from an egg showing the change in fluorescence of Green “Upwards” DAG probe 
response to 2 μM PDBμ (n=8) 
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Figure 6.8 FRET and Ca²⁺i changes of Green ‘Upwards’ DAG probe in response to mouse PLCζ 
Example traces from an egg expressing Green ‘Upwards’ DAG which show the changes in 
fluorescence signal of this probe alongside Ca²⁺i oscillations triggered by 0.02 μg/μl mPLCζ cRNA 
mixed with Rhod Dextran. A) shows  the change in Green ‘Upwards’ DAG signal with Ca²⁺i oscillations 
and B) shows the change in Green ‘Upwards’ DAG  signal alone over the course of the experiment , 
R.F.U= relative fluorescence units, F/F0= absolute fluorescence divided by mean baseline 
fluorescence (n=19) 
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Figure 6.9 FRET and Ca²⁺i changes of in vitro matured Green ‘Upwards’ DAG probe in response to 
mouse PLCζ 
Example traces from an egg expressing Green ‘Upwards’ DAG  by in vitro maturation which show the 
changes in fluorescence signal of this probe alongside Ca²⁺i oscillations triggered by 0.02 μg/μl mPLCζ 
cRNA mixed with Rhod Dextran. A) shows the change in Green ‘Upwards’ DAG signal with Ca²⁺i 
oscillations and B) shows the change in Green ‘Upwards’ DAG  signal alone over the course of the 
experiment . R.F.U= relative fluorescence units, F/F0= absolute fluorescence divided by mean 
baseline fluorescence (n=6) 
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Green ‘Upwards’ DAG doesn’t detect changes in DAG during secondary oscillations induced by 
PLCζ overdose 
If PLCζ is over-expressed past physiological levels in an egg its Ca²⁺i oscillations occur at a 
very high frequency and usually stop within approximately 2 hour. If the eggs continue to 
be imaged however, ‘secondary’ oscillations can occur (Yu et al 2008). It has previously 
been suggested that these secondary oscillations are different in nature to normal Ca²⁺i 
oscillations that occur during fertilisation. Secondary oscillations appear to be stimulated 
by conventional PKCs recruitment to the plasma membrane which become activated 
following an increase in Ca²⁺ influx (Yu et al. 2008). Due to the alternative mechanism of 
these secondary Ca²⁺i oscillations it was important to measure how DAG levels altered 
during these oscillations compared to regular Ca²⁺i oscillations induced by PLCζ. To do this 
the eggs were microinjected with Green Upwards DAG and PLCζ RNA as described 
previously however a much higher concentration of PLCζ RNA was used  (0.8 μg/μl) to 
stimulate Ca²⁺i oscillations. As seen previously the Green ‘Upwards’ DAG signal was found 
to increase over the course of recording before reaching a plateau many hours later(see fig 
6.10A). Interestingly, with the first Ca²⁺i oscillation alone a decrease in Green ‘Upwards’ 
DAG was seen  of around 12 % however this was not seen with subsequent oscillations. 
This is possibly an arefact of green autofluorescence emitted from flavin adenine 
dinucleotide (FAD++). Once secondary oscillations began no change in Green ‘Upwards’ DAG 
signal was recorded (see fig 6.10B). There was a slight decrease in overall Green ‘Upwards’ 
DAG signal during the onset of the secondary Ca²⁺i oscillations however this decrease was 
observed in all eggs during this time including those that did not have secondary Ca²⁺i 
oscillations (see fig 6.10B). This signal change is likely to be a result of a reduction in FAD++ 
autofluorescence.   
Green ‘Upwards’ DAG detects little change in DAG when Ca²⁺i oscillations are inhibited by 
Propranolol and DAG kinase inhibitor  
Ca²⁺i oscillations induced by PLCζ can be inhibited by two inhibitors as shown in Chapter 
5).The first is propranolol which inhibits the enzyme LPP3 thereby inhibiting DAG 
production from phosphatidic acid (PA). The other is DAG kinase (DGK) inhibitor which 
inhibits the activity of the enzyme DGK which converts DAG to PA. In order to get a clearer 
idea of how these drugs inhibit PLCζ activity the Green ‘Upwards’ DAG probe was used to 
measure DAG dynamics in eggs during the action of these inhibitors. Eggs were 
microinjected with Green ‘Upwards’ DAG RNA and left to express as previously described. 
Eggs were then microinjected with mPLCζ RNA (0.025 μg/μl) and Rhod dextran to initiate 
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Ca²⁺i oscillations. Once the eggs had been oscillating for approximately 30 mins either DGK 
inhibitor (10 μM) or propranolol (300 μM) were added to the dish.  In the case of DGK 
inhibitor the eggs were kept in media that was not covered in mineral oil instead a cap was 
placed on the dish to prevent evaporation. In all cases the drugs successfully inhibited the 
Ca²⁺i oscillations whilst keeping the baseline Ca²⁺i low (see fig 6.11). Interestingly though 
DGK inhibitor would be expected to have caused  an increase in DAG actually this lead to a 
very small decrease in Green ‘Upwards’ DAG signal of 0.94% (fig 6.11A). In contrast 
propranolol, that should have caused a decrease in DAG production following addition, 
actually caused an immediate increase in Upwards’ DAG signal of 8.5 % which quickly 
returned to basal levels (fig 6.11B). It is unclear what the explanation for this result is.  
Green ‘Upwards’ DAG detects changes in DAG during PLCδ1 induced Ca²⁺i oscillations  
PLCζ is unique amongst the PLC isoforms in being able to cause Ca²⁺i oscillations in eggs at 
the physiological levels found in the sperm in the absence of any further stimulation. PLCζ 
is most closely related to PLCδ1 and if PLCδ1 is expressed at very high levels in eggs it is 
able to cause some Ca²⁺ release in eggs. However, these oscillations do not look like Ca²⁺i 
oscillations elicited by PLCζ and appear to be biochemically quite different (Kouchi et al. 
2004). For example, Ca²⁺i oscillations elicited by PLCδ1  generate DAG at the plasma 
membrane however no such DAG increase is found in PLCζ stimulated eggs (Yu et al. 2008). 
To investigate whether Green ‘Upwards’ DAG is able to measure changes in DAG levels in 
eggs stimulated by PLCδ1, eggs were micro-injected with Green “Upwards” DAG cRNA (2 
μg/μl) and left to express as previously stated. After approximately 3 hours the eggs were 
injected with mPLCδ1 cRNA (2 μg/μl) mixed with Rhod dextran and then transferred onto 
the imaging system. Ca²⁺i oscillations were recorded however each oscillation was 
immediately followed by two to three smaller oscillations. Once the oscillations started a 
decrease in Green ‘Upwards’ DAG signal was recorded of approximately 14 % (see fig 
6.12A). This signal then appeared to increase again slightly before decreasing again slightly 
when the next large Ca²⁺i oscillations occurred before increasing further (see fig 6.12A). 
Therefore once the initial decrease in signal occurred during the first Ca²⁺i transient the 
Green ‘Upwards’ DAG signal appeared to increase eventually up until the level recorded 
prior to the initiation of the Ca²⁺i oscillations (see fig 6.12A). Once again this decrease in 
green signal is likely to be result of a reduction in FAD++ autofluorescence.  
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Green ‘Upwards’ DAG does not detect changes in DAG during acetylcholine induced Ca²⁺i 
oscillations 
Acetylcholine chloride (Ach) is able to trigger Ca²⁺ioscillations in eggs by stimulating the Gq 
coupled muscarinic acetylcholine receptors found on the plasma membrane (Felder et al. 
1989). This causes the production of IP₃ which acts on the IP₃R to release Ca²⁺ (Gillo et al. 
1987). As Ach leads to the production of IP₃ it is assumed that DAG must also be produced 
during this process. To test whether Green ‘Upwards’ DAG was able to detect any changes 
in DAG during Ca²⁺i oscillations initiated by acetylcholine eggs were microinjected with 
Green ‘Upwards’ DAG cRNA as previously described. Following expression for 
approximately 3 hours a second injection of Rhod Dextran was carried out before the eggs 
were immediately transferred to the imaging system. Once the eggs had been imaged for 
approximately 15 mins Ach (100 μM) was added to media surrounding the eggs. A very 
small decrease of 2.28% in Green ‘Upwards’ DAG signal was recorded during the first Ca²⁺i 
oscillation however no change was recorded with subsequent Ca²⁺i oscillations (see fig  
6.13B). As a result Green ‘Upwards’ DAG does not appear to be able to detect any changes 
in DAG during Ach induced Ca²⁺i oscillations.  
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Figure 6.10 FRET and Ca²⁺i changes of in vitro matured Green ‘Upwards’ DAG probe in response to 
high dose mouse PLCζ 
Traces showing how the Green ‘Upwards’ DAG signal changes in line with Ca²⁺i oscillations initiated 
by a high dose (0.8 μg/μl) of mPLCζ cRNA mixed with the Ca²⁺i indicator Rhod Dextran A) shows a 
magnified section of the beginning of this trace (primary Ca²⁺i oscillations) and B) shows a magnified 
section of the end of this trace (secondary Ca²⁺i oscillations) , R.F.U= relative fluorescence units, 
F/F0= absolute fluorescence divided by mean baseline fluorescence , (n=8) 
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Figure 6.11 FRET and Ca²⁺i changes of Green ‘Upwards’ DAG probe in response to mouse PLCζ plus 
propranolol and DGK inhibitor 
Traces showing how the Green ‘Upwards’ DAG signal changes in response to the induction of Ca²⁺i 
oscillations by mPLCζ cRNA (0.02 μg/μl) and following inhibition of Ca²⁺i oscillations  by A) DAG 
Kinase inhibitor (100 μM) n= 5 or B) Propranolol (300μM) n= 9, R.F.U= relative fluorescence units 
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Figure 6.12 FRET and Ca²⁺i changes of Green ‘Upwards’ DAG probe in response PLCδ1 and Ach 
Traces showing how the Green ‘Upwards’ DAG signal responds to other Ca²⁺i oscillations inducing 
agents  A) PLCδ cRNA (2 μg/μl) (n= 5), B) Acetylcholine chloride (100μM) (n= 11). In both cases Ca²⁺i 
changes were measured using the indicator Rhod Dextran. R.F.U= relative fluorescence units, F/F0= 
absolute fluorescence divided by mean baseline fluorescence  
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Measuring IP₃ using a firefly split-luciferase IP₃ probe (F-SLIP) 
In the last few years a new biosensor has been developed that is able measure IP3 dynamics 
in live cell lines that is based on luminescence complementation (see fig 6.13) (Ataei et al. 
2013). The probe is able to bind to IP₃ by the IP₃ binding core (IBC) which is tagged with the 
two halves of firefly luciferase at either terminus. Once IP₃ binds the IBC the probe 
undergoes a conformation change which brings the two halves of luciferase together (Ataei 
et al. 2013). When this happens the luciferase enzyme is active and able to produce light. 
The more IP₃ that is produced the higher the luminescence signal emitted. This probe has 
successfully been used to detect changes in IP₃ HEK293T showing a 11 fold increase when 
saturated (Ataei et al. 2013). This probe has never been used before to measure changes in 
IP₃ during Ca²⁺ioscillations at fertilisation. To investigate whether this probe could be used 
for this purpose, the firefly split-luciferase IP₃ probe (F-SLIP) cRNA was micro-injected into 
eggs (1 μg/μl) and left to express for approximately 3 hours. These eggs were then 
microinjected for a second time with the Ca²⁺i indicator Oregon Green BAPTA Dextran 
(OGBD) mixed with mPLCζ cRNA (0.02 μg/μl). The eggs were then transferred to the 
imaging system and placed in media containing 1μM luciferin where fluorescence (for the 
OGBD) and luminescence (F-SLIP) were both measured by switching back and forth 
between fluorescence and luminescence imaging modes on a 10 second cycle. An overall 
increase in luminescence signal was recorded during the course of imaging that was still 
occurring 6 hours post-injection. Despite this increase the luminescence emitted by F-SLIP 
was very low even at the end of the experiment (maximum around 4 cps) (see fig 6.15). A 
small increase of 6.9 % was recorded in luminescence signal with each Ca²⁺i oscillation (see 
fig 6.15) however there was a large degree of variability in this making it difficult to draw 
conclusions. 
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Figure 6.13 Structure of F-SLIP IP3 probe 
Schematic diagram showing the structure of the genetically encoded probe F-SLIP used to measure 
IP
3
 dynamics. The probe consists of an IP
3
 binding core (IBC) tagged with the N and C terminal halves 
of firefly luciferase joined with a 10 amino acid long linker.  
 
L
u
m
in
e
s
c
e
n
c
e
 (
c
p
s
)
0
1
2
3
4
1 hr
L
u
m
in
e
s
c
e
n
c
e
 (
c
p
s
)
0.0
0.4
0.8
1.2
10 mins
R
.F
.U
R
.F
.U
A
B
 
Figure 6.14 Luminescence and Ca²⁺i changes of F-SLIP probe in response mouse PLCζ 
Sample traces showing changes in the luminescence signal from the F-SLIP probe alongside Ca²⁺i 
oscillations. Ca²⁺i oscillations were initiated by 0.02 μg/μl mPLCζ RNA and measured using the Ca²⁺i 
indicator Rhod Dextran. A) shows the change during the whole recording  and B) shows a sample 
section of the same trace magnified, R.F.U= relative fluorescence units, cps= photon counts per 
second, (n=10) 
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Measuring IP₃ using a novel click beetle split-luciferase IP₃ probes (CB-SLIPs) 
To try and increase the signal of F-SLIP the construct was redesigned to create a novel 
potential probe based in the same principles of F-SLIP. This probe contained the same IBC 
as F-SLIP however this core was tagged with 2 N termini of click beetle luciferase which is 
considered to produce a brighter signal than firefly luciferase (Miloud et al 2007).  A series 
of click beetle split-luciferase IP₃ probes (CB-SLIPs) were produced each with a varying 
length of linker region to determine if any of these probes produced a higher signal than F-
SLIP or measure a change in IP₃ in eggs during PLCζ induced Ca²⁺ioscillations. The constructs 
were designed and synthesised by MN (see fig 6.14). 
CB-SLIP (2aa), CB-SLIP (4aa) and CB-SLIP (10aa) contained a 2, 4 and 10 amino acid long 
linker attaching the two click beetle luciferase fragments to the IBC respectively (see fig 
6.14). The RNA of for each of these constructs was microinjected into eggs (1 μg/μl) and 
left to express for approximately 3 hours. After this time PLCζ cRNA (0.02 μg/μl) mixed with 
OGBD was microinjected into the eggs to cause Ca²⁺i oscillations. The eggs were then 
placed in luciferin containing media on the imaging system whilst the luminescence and 
fluorescence of the eggs was measured for approximately 2 hours. During the course of 
imaging, for all constructs the luminescence increased steadily and eventually reached a 
very low maximum of about 10cps for CB-SLIP(2aa) (see fig 6.16), between 1-4 cps for CB-
SLIP (4aa)  (see fig 6.17) and a stronger signal of around 100 cps for CB-SLIP (10aa).  In the 
case of CB-SLIP(2aa) was no clear change in luminescence during each Ca²⁺i oscillation was 
recorded (see fig 6.16). CB-SLIP(4aa) showed an increase in 14.1 % however this effect was 
extremely variable and was not consistent (see fig 6.17). Again CB-SLIP (10aa only recorded 
a very small change (1.14 %) in luminescence signal with each Ca²⁺i oscillation (see fig 6.18). 
This suggests that CB-SLIPs cannot accurately measure a change in IP₃ with Ca²⁺i 
oscillations.  
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Figure 6.15 Schematic showing the structure of CB-SLIP IP3constructs 
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Figure 6.16 Luminescence and Ca²⁺i changes of CB-SLIP(2aa) probe in response mouse PLCζ 
Sample traces showing changes in the luminescence signal from the CB-SLIP(2aa) probe alongside 
Ca²⁺i oscillations. Ca²⁺i oscillations were initiated by 0.02 μg/μl mPLCζ RNA and measured using the 
Ca²⁺i indicator Rhod Dextran. A) shows the change during the whole recording and B) shows a 
sample section of the same trace magnified , R.F.U= relative fluorescence units, , cps= photon counts 
per second (n=11) 
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Figure 6.17 Luminescence and Ca²⁺i changes of CB-SLIP(4aa) probe in response mouse PLCζ 
Sample traces showing changes in the luminescence signal from the CB-SLIP(4aa)probe alongside 
Ca²⁺i oscillations. Ca²⁺i oscillations were initiated by 0.02 μg/μl mPLCζ RNA and measured using the 
Ca²⁺i indicator Rhod Dextran. A) shows the change during the whole recording and B) shows a 
sample section of the same trace magnified  R.F.U= relative fluorescence units, , cps= photon counts 
per second (n=10) 
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Figure 6.18 Luminescence and Ca²⁺i changes of CB-SLIP(10aa) probe in response mouse 
PLCζ 
Sample trace showing changes in the luminescence signal from the CB-SLIP(10aa) probe 
alongside Ca²⁺i oscillations. Ca²⁺i oscillations were initiated by 0.02 μg/μl mPLCζ RNA and 
measured using the Ca²⁺i indicator Rhod Dextran. A) shows the change during the whole 
recording  and B) shows a sample section of the same trace magnified, R.F.U= relative 
fluorescence units (n=10) 
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Discussion 
As Ca²⁺i oscillations at fertilisation are a result of the hydrolysis of PI(4,5)P₂ by PLCζ activity 
it is undisputed that IP3 and DAG are produced during this process however it is unclear 
exactly what the dynamics of these messengers are in live eggs. The lack of understanding 
the dynamics of these messengers leaves disputes around exactly what role they play 
dynamically as messengers and what impact this has on Ca²⁺i oscillation pattern or egg 
activation. Due to the often low cell number available of mammalian eggs it is unpractical 
to do some of the conventional  biochemistry based experiments to measure the 
production of these messengers following fertilisation such as isotope labelling. 
Furthermore these methods do not allow accurate measures of messenger production to 
be made in live cells in response to different stimuli for example alongside a series of Ca²⁺i 
oscillations.  
In order to measure messengers like IP3 and DAG in real time genetically encoded probes 
need to used that can be expressed in cells. Many such probes have been developed to 
measure either IP3 or DAG. These probes are usually tested by transfection into cell lines 
and measuring the signal of this probe in response un-physiological exogenous stimuli. 
Despite the vast array of probes available these are rarely used to measure physiological 
cell dynamics in physiological cell types and seem to produce cell specific effects in many 
cases. With this in mind these experiments aimed to find genetic based probes that had the 
ability to measure IP3 and DAG dynamics in eggs in response to a physiological stimulus.  
In many cell types DAG has been successfully measured using simple probes consisting of a 
DAG binding domain tagged to a fluorescent protein (Oancea and Meyer 1998; Oancea et 
al. 1998). These probes require the accurate measurement of probe translocation from the 
cytosol to a membrane (Oancea et al. 1998). In most cell types this is not an issue as the 
majority of signalling DAG is produced at the plasma membrane and translocation onto the 
plasma membrane is fairly easy to detect. However, in eggs at fertilisation there is a strong 
evidence to suggest signalling DAG is produced on intracellular membranes and not the 
plasma membrane (Yu et al. 2008; Yu et al. 2012). It is much harder to measure 
translocation dynamics of probes on and off intracellular membranes which requires 
specialist optical techniques and very high resolution imaging. Therefore in order to 
measure whole cell DAG levels in eggs it was necessary to use a probe that would produce 
changes in signal that could be detected on whole cell level. One technique that may be 
adopted is FRET (fluorescence resonance energy transfer). This requires two fluorophores 
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to come in close proximity such as coalescing on a membrane which produces a change in 
the ratio of one fluorophore signal to the other (Stryer 1978). This means FRET ratio 
changes can be detected in whole cells using simple epifluorescence imaging.  Many 
different FRET based probes have been developed to measure all kinds of cell signalling 
dynamics. Indeed many FRET based DAG probes have been developed and used to 
measure whole cell DAG changes in cell lines (Violin et al. 2003; Sato et al. 2005).  
For these experiments a very simple intermolecular FRET reporting system containing the 
C1b domain of PKC was used. Two constructs were created one tagged with YFP and the 
other with CFP and collectively termed C1b Inter-FRET. This probe only produced a small 
change in signal in response to the strong stimulus PMA. PMA is a phorbol ester which 
means it acts as a DAG analogue so should produce a near saturated response in signal of 
the probe, much greater than that seen by a physiological stimuli. This probe detected no 
change in probe signal during Ca²⁺i oscillations initiated by PLCζ which would suggest that 
there is no detectable change in DAG levels in line with Ca²⁺i oscillations. Similar results 
were recorded with the intra-molecular FRET based DAGR probe which has previously been 
used to measure DAG in MDCK cells in response to phorbol ester (Violin et al. 2003). When 
expressed in mouse eggs however, this probe only detected a small change in signal in 
response to PMA. Again, no dynamic change in DAGR signal was recorded during the PLCζ 
induced Ca²⁺i oscillations stimulated either by human or mouse derived PLCζ cRNA. The fact 
both probes show no change in DAG levels during Ca²⁺ioscillations may mean that DAG 
levels do not significantly alter during PLCζ induced Ca²⁺ioscillations. However, due to the 
small change recorded in response to a strong stimulus it is just as likely that probes were 
not sensitive enough to detect any changes in DAG. 
 When recording FRET because 2 fluorophores are excited the sample is exposed to a large 
range of visible light which increases the chances of probe photo-bleaching.  Furthermore 
the two fluorophores used may react differently to the high amount of light exposure. For 
example these may photobleach at different rates. If one flurophore photobleaches to a 
greater extent than the other this can disrupt the ratio of the 2 signals in the absence of 
stimuli. This effect could account for the upwards drift in the signal that was recorded 
during these experiments.  However, it is very likely that this drift is due to differential 
expression of these two fluorescent probes. Nevertheless the drift makes it difficult to 
accurately calculate changes in signal in response to a stimulus. One of the issues with FRET 
based probes is the mechanism by with the signal change is created. FRET relies on the 
emission light from one fluorescent protein exciting a second fluorescent protein once 
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these two proteins come in close range.  This can either occur between fluorescent 
proteins on two different molecules (inter-molecular FRET) or between two fluorescent 
proteins within the same molecule (intra-molecular FRET). Intra-molecular FRET, like that 
used by the DAGR probe, changes when the probe binds to a protein of interest and 
undergoes a conformational change which brings the two fluorescent proteins within range 
for FRET to occur. However, in addition to this intra-molecular FRET, undesired inter-
molecular FRET between two fluorophores from different probe molecules can also occur if 
these co-localise. This produces a background signal that can disrupt the true intra-
molecular FRET signal change. Furthermore FRET probes generally only produce a  
maximum signal change of around 20% which can be as low as 5% using physiological 
stimuli (Gonzalez Garcia 2013). In contrast to conventional fluorescent tagged probes and 
FRET based probes, circularly permuted fluorescent probes give off a much larger signal 
and allow for a greater dynamic change in signal (Baird et al. 1999). As a result these 
circularly permuted fluorescent proteins are being used more and more within biosensors. 
One example of such probe is the Green ‘Upwards’ DAG probe which has previously been 
shown to cause a 109% increase in signal in response to carbachol and PDBμ in M1 
acetylcholine receptor expressing  HEK 293 cells (Tewson et al. 2012). The current 
experiments found that a similar change of around 97% increase in signal in eggs 
expressing the probe in response to PDBμ alone. This would suggest that Green’ Upwards’ 
DAG is very responsive to changes in DAG levels in eggs however no significant changes in 
signal was recorded in response to PLCζ induced Ca²⁺ioscillations. However, in all traces 
even 5 hours post injection an upwards drift in Green ‘Upwards’ DAG signal was recorded. 
As this increase was seen in eggs irrespective of stimuli and a single wavelength indictor 
was used this is most likely due to protein expression drift. To try and avoid this situation 
GV oocytes were injected with Green ‘Upwards’ DAG and matured in vitro to express the 
probe and spontaneously mature to MII prior to PLCζ cRNA injection. This did help stabilise 
the Green ‘Upwards’ DAG signal when the eggs were imaged however no change in Green 
‘Upwards’ DAG signal was recorded in response to PLCζ induced Ca²⁺i oscillations in these 
eggs . This technique was not routinely used however as mouse eggs that mature via in 
vitro maturation are rarely the same quality of in vivo matured. For example many of the 
oocytes failed to mature fully following maturation. This could be due either to the high 
expression of exogenous RNA or the maturation conditions. For this reason in vitro 
maturation was not routinely used during these experiments.  
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The emission spectrum of Green ‘Upwards’ DAG overlaps with the  FAD++ auto-fluorescence 
emitted by eggs during Ca²⁺ioscillations therefore there was a concern that the decrease in 
GFP signal from the FAD++ auto-fluorescence could confound  the signal from the Green 
‘Upwards’ DAG probe (Dumollard et al. 2004). Indeed this appeared to be the case in many 
of the green fluorescence signals emitted from the eggs and this effect was appeared to be 
variable between eggs.  Therefore it would be advantageous to use an alternative circularly 
permuted fluorescent protein that had an emission signal that did not overlap with auto-
fluorescence. 
Physiological levels of PLCζ, equivalent to that found in the sperm, cause low frequency 
regular Ca²⁺i oscillations that last for many hours in an egg (Saunders et al 2002). However, 
if much higher levels of PLCζ protein are expressed or introduced into eggs then a different 
pattern of Ca²⁺i oscillations can occur. These oscillations are much higher frequency and 
usually stop within 2 hours (Yu et al 2008). After an hour or more these eggs can then start 
oscillating again producing very high frequency oscillations which looks very different in 
pattern to usual fertilisation induced Ca²⁺ioscillations (Yu et al 2008). It is believed that 
these Ca²⁺i oscillations occur via an alternative mechanism to those that occur at 
fertilisation. There is evidence that secondary oscillations are initiated by DAG and PKC 
activation which increases Ca²⁺ influx (Yu et al 2008). Secondary oscillations can be 
mimicked by the addition of PMA to eggs that have ceased Ca²⁺i oscillations as well as an 
increase in extracellular Ca²⁺ (Yu et al. 2008). Previously a GFP tagged tandem PKCδ C1 
domain probe (C12δ–GFP) has shown that DAG is produced at the plasma membrane 
during PLCζ induced secondary Ca²⁺i oscillations (Yu et al. 2008). Furthermore secondary 
Ca²⁺i oscillations can be prevented using the PKC inhibitor, cherlerythrine chloride (CHE) (Yu 
et al. 2008). 
However, Green ‘Upwards’ DAG detected no change significant change in signal during 
primary or secondary Ca²⁺i oscillations in eggs expressing high levels of PLCζ. Small 
decreases in signal were detected during primary oscillations however these looked like an 
arefact of FAD++ autofluorescence (Dumollard et al. 2004). A decrease in signal was 
recorded during the first Ca²⁺i spike in most eggs. It is unclear why this would be the case 
for eggs expressing high levels of PLCζ and not the lower levels used in the other 
experiments.  Furthermore, you would expect an increase in signal corresponding to an 
increase in DAG rather than a decrease. Unlike C12δ–GFP which measures DAG by plasma 
membrane translocation it is not possible for Green ‘Upwards’ DAG to show where DAG is 
being produced. This means that Green ‘Upwards’ DAG is not able to discriminate between 
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measuring metabolic or signalling DAG. PLCζ induced DAG production  should only take the 
form of signalling DAG but Green ‘Upwards’ DAG could also be measuring changes in 
metabolic DAG that disrupts the Green ‘Upwards’ DAG signal changes.  
Propranolol and DAG kinase inhibitor are two drugs that are able to inhibit PLCζ induced 
Ca²⁺i oscillations and both have roles in disruption DAG metabolism however it is unclear 
what effect the drugs have on the DAG levels of Ca²⁺i oscillating eggs. The Green Upwards 
DAG probe only reported a small change in signal in response to DAG kinase inhibitor and 
propranolol but different types of effects were seen. Propranolol gave a small increase in 
Green ‘Upwards’ DAG signal, however, DGK inhibitor produced a small decrease in signal. 
This is contradictory to the known modes of action of these drugs. Propranolol inhibits the 
enzyme which converts phosphatidic acid (PA) into DAG whereas DGK inhibitor inhibits the 
enzyme that converts DAG to phosphatidic acid (Asp et al. 2009; Kaneko and Ishikawa 
2016). As a result you would expect propranolol to decrease levels of DAG however this is 
likely to be an alternative source of DAG to that produced by PLCζ.  Furthermore it remains 
unclear exactly how propranolol inhibit PLCζ induced Ca²⁺i oscillations. Rather than Ca²⁺i 
oscillations being inhibited as a result of DAG metabolic disruption propranolol may work 
by disrupting Golgi structure and membrane trafficking (Asp et al. 2009).  
It is unclear if other stimuli that also release Ca²⁺ via IP₃ will result in a significant alteration 
in DAG levels. Interestingly Ca²⁺i oscillations initiated by PLCδ1 cRNA did cause an alteration 
in Green ‘Upwards’ DAG signal in the form of a significant decrease. It is unclear why PLCδ1 
would lead to a decrease in DAG levels as it has previously been shown using the C12δ–GFP 
probe that DAG levels at the plasma membrane increase during PLCδ1 induced Ca²⁺i 
oscillations (Yu et al. 2008). PLCδ1 is thought to hydrolyse plasma membrane PI(4,5)P₂  
which would lead to DAG production in the plasma membrane. However, it is unclear 
whether PI(4,5)P₂ is hydrolysed in any other compartments of the cell in response to PLCδ1 
and therefore whether DAG is made here also. It is worth noting that in order to trigger 
Ca²⁺ioscillations using PLCδ1 over 100 times more cRNA needed to the expressed. These 
are levels far past physiological and the decrease in signal may be a result of over-
expression of the protein, which could also account for the decrease in signal recorded 
during the first Ca²⁺i spikes caused by the over-expression of PLCζ. Furthermore, the 
decrease in green fluorescent signal is likely to be an artefact of FAD++ autofluorescence 
(Dumollard et al. 2004) 
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Acetylcholine chloride (Ach) is another agent that is able to initiate Ca²⁺i oscillations in eggs 
via the production of IP₃ (Felder et al. 1989). These oscillations follow a different form to 
Ca²⁺i oscillations initiated by fertilisation or PLCζ. Green ‘Upwards’ DAG did not record any 
alterations in signal in these eggs stimulated by Ach either. This suggests that as with PLCζ 
induced Ca²⁺i oscillations, no alterations in DAG are seen with Ach induced Ca²⁺i oscillations 
either. However, it is unclear exactly how Ach causes Ca²⁺i oscillations in eggs and what 
determines the pattern of Ca²⁺i oscillations. It most likely that Ach stimulates IP₃ production 
by G proteins (Swann 1992). 
Data from all the current experiments suggests that there is no significant change in DAG 
during PLCζ induced Ca²⁺i oscillations. This supports previous evidence using the 
translocation of a C12δ-GFP which recorded no change in plasma membrane DAG levels 
during PLCζ induced Ca²⁺i oscillations (Yu et al. 2008). However, it has previously been 
suggested that PLCζ hydrolyses a vesicular source of PI(4,5)P₂  and therefore would 
produce DAG on intracellular membranes and not that plasma membrane (Yu et al. 2012). 
Furthermore indirect DAG measurement of PKC phosphorylation using the CKAR probe 
showed that DAG levels did change during PLCζ induced Ca²⁺i oscillations in eggs and this 
change was predominantly in the cytoplasm (Gonzalez-Garcia et al. 2013). All the probes 
used during these experiments measure whole cell changes in DAG levels and were not 
specific to certain cellular membranes. DAGLAS is a FRET based probe that is able to 
measure DAG production at specific membranes by addition of a membrane targeting 
sequence (Sato et al. 2006). In order to specifically measure intracellular DAG production 
that may occur as a result of vesicular PI(4,5)P₂  hydrolysis, a similar probe could be 
developed that contains a targeting sequence for these vesicles. However, it is not yet fully 
established what the identity of these vesicles are and therefore would make it difficult to 
identify a suitable targeting sequence. Furthermore different species of DAG are present in 
the cell. Only ‘signalling’ DAG is thought to be produced as a result of PLCζ activity however 
many different species of metabolic DAG are also produced on intracellular organelles. For 
example YFP tagged DAG binding domain has shown that DAG is also produced in the Golgi 
(Gallegos et al. 2006). Nevertheless it is unclear what species of DAG this is, as a result 
producing a DAG probe which targets the Golgi for example would detect changes in all 
species of DAG present here not just signalling DAG. To escape this issue it would be 
necessary to discover a DAG binding domain which was able to bind specifically to one 
molecular species of DAG with a particular fatty acid composition. As of yet no such domain 
has been developed. Because no distinction was made during these experiments between 
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different species of DAG, all DAG production and metabolism was measured which may not 
have given an accurate measure of changes in signalling DAG dynamics. Alternatively the 
level of “metabolic” DAG may be so high that it is not possibly the distinguish changes in 
“signalling” DAG as the “metabolic” DAG signal would drown this out. 
It is also possible that no change in DAG levels were seen because signalling DAG is being 
synthesised but quickly metabolised, that is the rate of DAG turnover may have increased. 
As a result no detectable changes in DAG levels could be seen with the probes. It is likely 
that a delicate balance between metabolism and synthesis is required to enable the eggs to 
oscillate effectively. For example  high turnover for DAG may be necessary for a Ca²⁺i 
oscillating eggs to ensure that DAG levels do not get too high and lead to overstimulation of 
PKC (Yu et al. 2008). PKC activation can lead to Ca²⁺ influx which produced non-
physiologically high frequency oscillations (Yu et al. 2008). Oscillations of this nature are 
harmful to a fertilising egg as too high frequency Ca²⁺i  oscillations can lead to poor 
development in early embryos (Ozil et al. 2006). As a result it may be necessary to keep the 
DAG levels low to prevent Ca²⁺ influx and ensure low frequency Ca²⁺i oscillations.  All 
probes used to try and measure DAG in these experiments were fluorescence based which 
often makes it difficult to measure small changes in signal as the background noise is 
relatively high. Furthermore single fluorophore probes such as Green ‘Upwards’ DAG are 
not ratiometic in their signal so are dependent on lamp intensity to determine signal 
strength. This makes it difficult to make comparisons between different experiments. This 
also makes it impossible to determine the true strength of the signal produced by probe. 
FRET on the other hand is dependent on the ratio between two fluorophores which may 
have different stabilities.  
To try and avoid some of the issues that arise using FRET and fluorescence based probes 
more and more biosensors centred on bioluminescence (luminescence) are being 
developed. Luminescence tagged probes are effective at measuring small changes in signals 
as a very low level of background is produced. These probes also do not vary with lamp 
intensity and doesn’t photo- bleach in the way fluorescent probes can. Luminescence 
based probes can even be used to look at protein –protein interactions for example the 
technique of bioluminescence resonance energy transfer  (BRET) contains a donor 
luminescence sequence which emits light that excites the fluorescent acceptor protein(Xu 
et al. 2002). However, BRET is rarely used on individual cells due to the very low level of 
light emitted. Alternatively split bioluminescence (luminescence) complementation is 
another way to look at cellular interactions that is able to produce a greater overall signal 
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that BRET therefore is being used more and more to develop biosensors (Paulmurugan and 
Gambhir 2003). These probes have a very low background value so are more sensitive at 
measuring small changes in signal. One such probe is the IP3biosensor which is tagged with 
the N and C terminal halves of firefly luciferase and has previously been used to measure 
IP3 in cell lines (Ataei et al. 2013). This firefly split luciferase IP₃ probe (F-SLIP) has never 
been used in measure IP₃ changes in eggs before so was utilised to try and measure IP₃ 
dynamics in PLCζ induced Ca²⁺i  oscillating eggs. When this probe was injected into eggs the 
luminescence signal was very low and no change was seen in the luminescence signal in 
line with Ca²⁺i oscillations. The very low baseline signal recorded could have made it 
difficult to detect any changes in the signal. This is because the square root of the mean 
number of photons counts is proportionate to the signal to noise ratio. Therefore if the 
mean signal is 10 counts per second then approximately 3 of these counts can be 
considered as stochastic noise. As a result for a probe producing a signal of around 10 
counts per second a change in signal of more than 30 % would need to be produced in 
order to be detected a in one second window. In contrast a signal of around 1000 counts 
per second would only contain around 32 counts of stochastic noise and therefore a signal 
change of around 3% would be detectable. It is important to note however that  in order to 
be sure an effect is genuinely significant this change would need to be much higher, at least 
1 standard deviation more than the change that can be accounted for by stochastic noise.  
 In attempt to try and increase the luminescence signal a new set of probes were 
constructed that replaced the firefly luciferase for click beetle luciferase. Click beetle 
luciferase is thought to produce a brighter signal than firefly luciferase however this 
construct design had not previously been used to measure IP3 changes in any cell types 
(Miloud et al. 2007). A series of constructs were developed based on this principle with 
varying amino acid linker lengths joining the luciferase to the IBC. Altering the linker length 
in luciferase complementation based probes can dramatically alter the sensitivity of the 
probe as this can optimise the efficiency of the two halves of luciferase joining during the 
conformational change. 
Both CB-SLIP (2aa) and CB-SLIP (4aa) produced a very low luminescence signal in eggs 
following microinjection. No change was seen in CB SLIP (2aa) probe signal as a result of 
Ca²⁺ioscillations. A small change of 14.1 % was detected by CB-SLIP (4aa) however this 
result was extremely variable and due to the low signal count was not significant. With 
photons counts this low it would be necessary to have a signal change significantly higher 
than 50% before in one second before any meaningful change could be claimed.  CB-SLIP 
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(10aa) however showed a relatively stronger signal in comparison to the other probes 
tested however this probe only reached a maximum signal of around 120 cps. This means 
that only a signal change of greater than 10% would be detectable with this probe. Only a 
very small change in signal was recorded with each Ca²⁺i oscillations of around 1% so this 
was not significant.   
As no IP₃ probe expressed high enough to detect a change in IP₃ dynamics during Ca²⁺i 
oscillations it is unclear how IP₃ dynamics change during Ca²⁺i oscillations. There is an issue 
however with expressing probes such as this at very high levels. The probe senses IP₃ by 
binding to it via the IBC. If levels of IBC are very high there is a chance that IP₃ will be 
buffered and therefore not release Ca²⁺ effectively. This makes it difficult to measure IP₃ 
using such probes which have a high affinity for IP₃. Improved version of this domain has 
been developed that contains mutations which lower the binding affinity to IP₃ (Gulyas et 
al. 2015). Two versions of this probe were developed one based on FRET with Cerulean and 
Venus tags the other based on BRET where the Cerulean tag is replaced with Renilla 
luciferase (Gulyas et al. 2015). These probes were used on individual and cell sheets of 
HEK293T cells respectively to successfully measure IP₃ changes (Gulyas et al. 2015). It could 
therefore be possible in the future to develop a lower affinity IP3 probe based on this 
IP3binding domain that uses luminescence complementation. This could allow for greater 
expression of the probe without the concerns of buffering or at the expense of sensitivity. 
Indirect measures of IP₃ via measurement of PI(4,5)P₂  hydrolysis have suggested that IP₃ 
oscillates with Ca²⁺i oscillations. Measuring IP₃ production using fluorescently tagged PH 
domain which binds to plasma membrane PI(4,5)P₂  and translocates to the cytosol on 
PI(4,5)P₂ cleavage suggests that IP₃ production and Ca²⁺i oscillations are phase locked in 
MDCK cells stimulated by ATP (Hirose et al. 1999). Similar effects have been recorded using 
FRET based probes in other cell types (Violin et al. 2003). However, this method is only able 
to measure IP₃ produced at the plasma membrane as a result of plasma membrane 
PI(4,5)P₂  hydrolysis. This does not appear to be the case during PLCζ induced Ca²⁺i 
oscillations as plasma membrane PI(4,5)P₂ is not hydrolysed in eggs at fertilisation (Yu et al. 
2012). Interestingly when additional caged IP₃ is released in eggs already oscillating in 
response to PLCζ, a Ca²⁺i oscillation is triggered and the pattern of Ca²⁺i oscillations are reset 
in the process of phase resetting. During this process the oscillations do not change 
frequency. This suggests that oscillations in IP₃ set the pace for Ca²⁺i oscillations with a spike 
in IP₃ corresponding to a spike in Ca²⁺i (Swann and Yu 2008). This supports the idea that IP₃, 
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Ca²⁺i and PLCζ are part of a positive feedback loop that set the pace for Ca²⁺i oscillations 
(Hirose et al. 1999).  
To conclude the data from these experiments did not find that DAG or IP₃ changed 
dynamically during PLCζ induced Ca²⁺i oscillations. However, this is most likely because the 
probes used were not sensitive enough to measure any changes that may occur during this 
process or a result of poor expression of the probes.  
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7. CONCLUSIONS 
Summary of Findings 
Though there is an overwhelming amount of evidence that PLCζ is the physiological sperm 
factor that releases Ca²⁺ in mammalian eggs at fertilisation the mechanisms by which it 
does so are still not fully understood. The subject of this thesis was to determine the 
structural characteristics of PLCζ and the cellular characteristics of the egg that enable Ca²⁺i 
oscillations at fertilisation. Positively charged residues in the EF hand domain and X-Y linker 
of PLCζ were found to play a crucial role in enabling PLCζ to release Ca²⁺by ensuring 
sufficient binding of the enzyme to its substrate PI(4,5)P₂. An intracellular source of 
PI(4,5)P₂ was detected on small  vesicles in the egg cytoplasm and these vesicles are likely 
to be the binding site of PLCζ.  The ability for PLCζ to release Ca²⁺ is likely to be a cell cycle 
dependent feature that is acquired during oocyte maturation. The role of the potential 
alternative sperm factor PAWP was investigated however the data collected in this thesis 
indicated that PAWP is not able to release Ca²⁺in eggs under physiological conditions. 
Finally attempts were made to measure DAG and IP₃ dynamics in eggs during PLCζ induced 
Ca²⁺i oscillations but none of the probes tested measured a significant change in either DAG 
or IP₃ during Ca²⁺i oscillations.  
 
PLCζ as the Sperm Factor 
It is now well established that egg activation in mammalian eggs is caused by a sperm 
derived factor that diffuses into at sperm egg fusion (Swann 1990a). In mouse eggs this 
sperm factor diffuses into the egg and causes Ca²⁺i oscillations within 1 to 2 minutes (Swann 
1990a; Lawrence et al. 1997; Lee et al. 2001). The sperm factor appears to be universal in 
initiating egg activation in mammals. Injection of sperm extracts from a variety of 
mammalian species causes Ca²⁺i oscillations and egg activation in a range of (Swann 1990a; 
Homa and Swann 1994; Swann 1994). Mammalian sperm extracts can also cause egg 
activation in species from other animal groups such as marine worms and sea urchin eggs 
(Parrington et al. 1999; Witton et al. 1999; Stricker et al. 2000). In some mammalian 
species, such as hamster, the sperm factor is soluble however in other species for example 
mouse, this sperm factor is only extractable under reducing conditions (Swann 1994; 
Kimura et al. 1998). It would appear in both instances PLCζ is the sperm factor that causes 
Ca²⁺i oscillations (Saunders et al. 2002; Fujimoto et al. 2004). Indeed the ability for PLCζ to 
cause Ca²⁺i oscillations in mammalian eggs has been established in many species. The 
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results contained in this thesis consistently show that mouse or human derived PLCζ 
protein or cRNA are able cause Ca²⁺i oscillations reliably in mouse eggs even at very low 
levels of these proteins.  
However, in order for PLCζ to be considered the physiological sperm factor that activates 
mammalian eggs at fertilisation it has to satisfy a number of characteristics. Firstly it must 
stimulate the production of IP₃ in order to release Ca²⁺ as it is well established that Ca²⁺i 
oscillations at fertilisation occur as a result of IP₃ induced Ca²⁺ release (IICR) (Miyazaki 
1988). The Ca²⁺i oscillations initiated by sperm extract are also caused by IICR (Jones et al. 
1998). Like all other PLC isoforms PLCζ is able to directly hydrolyse PI(4,5)P₂ to produce IP₃ 
(Lee et al. 2001; Saunders et al. 2002). Secondly PLCζ must be present in the correct part of 
the sperm. The perinuclear theca is the first part of the sperm to fuse with the egg and 
appears to contain active Ca²⁺i releasing ability (Kimura et al. 1998; Fujimoto et al. 2004; 
Kurokawa et al. 2005). Immunocytochemistry has shown that PLCζ is also present in this 
region of the sperm (Heytens et al. 2009; Kashir et al. 2012; Yoon et al. 2012; Escoffier et al. 
2015b; Kashir et al. 2017). Finally the absence of PLCζ from the sperm must ablate its Ca²⁺i 
releasing ability. It has been difficult to develop a PLCζ null mouse model as these mutants 
do not complete spermatogenesis and therefore are infertile (Ito 2010). However, when 
the level of PLCζ in the sperm is reduced significantly using RNA interference the Ca²⁺i 
oscillations initiated by this sperm stop earlier than that initiated by control sperm (Knott et 
al. 2005). Furthermore depletion of PLCζ in sperm extracts with immuno-depletion using 
antibodies against PLCζ affects the Ca²⁺i releasing ability of these sperm extracts (Saunders 
et al. 2002). Sperm from mice lacking PLCζ is unable to cause Ca²⁺i oscillations initiated by 
ICSI (Parrington 2017, unpublished). Therefore, PLCζ is the only sperm derived protein 
which is able to cause Ca²⁺ioscillations in a physiological manner.  
Despite this vast array of evidence supporting the role of PLCζ as the sperm factor another 
candidate has been proposed. Post-acrosomal sheath WW domain-binding protein (PAWP) 
appeared to fulfil many of the characteristics of a sperm factor candidate. For example 
PAWP is localised in the perinuclear theca of the sperm head specifically the post-
acrosomal sheath of this region (Wu et al. 2007; Aarabi et al. 2014b). PAWP has also found 
to promote egg activation in a range of species following injection of recombinant protein 
(Wu et al. 2007). In mouse and Xenopus eggs this egg activation has been attributed to the 
stimulation of Ca²⁺ release (Wu et al. 2007; Aarabi et al. 2010). Most specifically human 
derived PAWP recombinant protein and cRNA was reported to cause Ca²⁺i oscillations in 
mouse eggs (Aarabi et al. 2014b). Furthermore, the Ca²⁺releasing characteristics of sperm 
276 
 
could be abolished by interfering with PAWP activity by injecting a PPXY peptide into eggs 
that is supposed to interfere with PAWP binding in egg (Aarabi et al. 2014b).  
However, the results shown in Chapter 3 indicate that the Ca²⁺i releasing abilities of PAWP 
could not be reproduced using a range of human and mouse derived PAWP constructs. 
Under no circumstances were Ca²⁺i oscillations initiated by PAWP even at very high levels of 
PAWP protein. Furthermore the Ca²⁺i oscillations initiated by both IVF and PLCζ were not 
affected by the PPXY peptide. There is also no clear pathway defined as to how PAWP is 
able to cause IP₃ production as PAWP does not possess any catalytic activity of its own 
(Nomikos et al. 2014a). It has been suggested that the PPXY motif in the proline rich region 
of PAWP binds to the WW1 domain of Yes-associated protein (YAP) in the egg (Wu et al. 
2007). YAP possesses a SH3 domain that could then activate PLCγ via some unknown 
pathway which could then hydrolyse PI(4,5)P₂ to produce IP₃ (Aarabi et al. 2014b).  
The role of PLCγ in activating mouse eggs has previously been speculated. Another 
proposed sperm factor candidate the tyrosine kinase tr-kit has also been found to activate 
mouse eggs and is believed to do so by activating PLCγ (Sette et al. 1997). Interestingly the 
injection of excess SH3 domains of PLCγ inhibits tr-Kit induced egg activation (Sette et al. 
1998). However, no Ca²⁺i oscillations have been recorded in response to tr-kit.This suggests 
that in mouse eggs PLCγ activation through interactions with its SH2 or SH3 domains is 
unlikely. PLCζ on the other hand possesses inherent catalytic activity and is able to 
hydrolyse PI(4,5)P₂  in the egg directly without any further stimulus (Saunders et al. 2002). 
Furthermore the potency and reliability of PLCζ at eliciting Ca²⁺i oscillations makes it a good 
egg activator. Ca²⁺release is so essential for correct egg activation in eggs it would make 
sense that the stimulus from this process would produce IP₃ in simple and reliable way. The 
data in this thesis PLCζ has found to consistently cause Ca²⁺i oscillations and activate eggs at 
physiological concentrations however this is not the case for PAWP. Finally gene knockout 
experiments have shown that PAWP null mice are perfectly fertile suggesting that PAWP 
plays no physiological role in activating eggs (Satouh et al. 2015). Unlike PLCζ PAWP 
appears to possess no Ca²⁺i releasing ability and does not possess all the characteristics 
necessary to be considered the mammalian sperm factor. Furthermore unlike PLCζ, PAWP 
is not present in the fraction of sperm that has Ca²⁺I releasing ability when injected into 
eggs (Fujimoto et al. 2004).  
Homologues of the PLCζ gene have been also been found in non-mammalian species across 
the animal kingdom. For example PLCζ is expressed in fish such as teleosts, eels and 
pufferfish (Coward et al. 2003; Coward et al. 2011; Morini et al. 2015) amphibians such as 
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newts (Harada et al. 2007) and birds such as chickens and quails (Coward et al. 2005; 
Mizushima et al. 2008). However, it is not clear whether PLCζ plays a role in activating eggs 
physiologically in these species. For example, though the newt Cynopspyrrhogastercan 
release Ca²⁺in response to mouse derived PLCζ RNA, fractionation of sperm extracts has 
shown that physiologically it is citrate synthase which triggers Ca²⁺releases in these eggs 
(Harada et al. 2007). Though Xenopus PLCζ is able to cause Ca²⁺ release in mouse eggs it has 
been suggested that endogenous PLCγ is activated by Src in response to PA production 
(Bates et al. 2014). Despite the fact a PLCζ homologue is present in pufferfish it is expressed 
in the oocyte and not the sperm so it unclear what role this plays in egg activation (Coward 
et al. 2011). However, in at least some birds, for example quails, PLCζ is considered the 
sperm factor which activates the egg physiologically (Mizushima et al. 2008). It is important 
to note that birds are evolutionarily more closely related to mammals than amphibians and 
fish, as a result it is more likely that birds and mammals may share characteristics of egg 
activation. The evolutionary relationship between how eggs activate is not clear mainly 
because different eggs release Ca²⁺ via different mechanisms depending on the method of 
fertilisation and environmental niche that species occupies.  
 
Mechanisms and models of Ca²⁺i signalling in eggs 
The importance of Ca²⁺i signalling in the egg activation of animal species is undisputed 
(Stricker 1999). However, the mechanisms by which this Ca²⁺i increases varies dramatically 
between species. For example in some species such as Drosophilia fruit flies and Sicyonia 
shrimps Ca²⁺i induced egg activation occurs during ovulation not fertilisation (Lindsay et al. 
1992; Heifetz et al. 2001). Of the eggs that activate following sperm-egg fusion some 
species rely on Ca²⁺ influx in order to increase Ca²⁺i, others rely on Ca²⁺release from stores 
or a combination of both. For example limpets activate solely by Ca²⁺i influx which produces 
a uniform increase in Ca²⁺i (Deguchi 2007). In contrast other marine invertebrates like sea 
urchins release Ca²⁺ from stores (Whitaker and Steinhardt 1982). This is also true for 
Xenopuseggs (Busa and Nuccitelli 1985). Medaka fish and bivalves such as mussels use a 
combination of these mechanisms (Yamamoto 1954; Gilkey et al. 1978; Deguchi et al. 
1996). Mammalian eggs increase Ca²⁺i solely through Ca²⁺release in the form of Ca²⁺i 
oscillations (Igusa et al. 1983; Igusa and Miyazaki 1986). These oscillations cross the egg in 
the form of a wave that takes less than 1 minute (Deguchi et al. 2000). These Ca²⁺i waves 
are a product of IP₃ induced Ca²⁺ release and have a generative component that requires 
positive feedback onto PLCζ (Miyazaki 1988; Miyazaki et al. 1992; Swann and Yu 2008).  
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There are two different ideas for how these regenerative waves can be produced.  
 The first idea is reliant on the intrinsic biphasic nature of the IP₃ receptor (Iino 1990). Ca²⁺i 
acts directly on the IP₃R so when cytosolic Ca²⁺i levels are low increase in Ca²⁺i are able to 
act positively, in the presence of IP3 open and the IP₃R (Bezprozvanny et al. 1991; De Young 
and Keizer 1992).  However, when the Ca²⁺i is high the IP₃ receptor closes (Bezprozvanny et 
al. 1991). 
This model often relies on changes in ER Ca²⁺concentrations to act as the pacemaker of the 
Ca²⁺i oscillations and it is considered raising the ER Ca²⁺concentrations increases the 
sensitivity of the IP₃R which results in the release in Ca²⁺from these stores (Iino 1990). 
According to this model when ER Ca²⁺ levels are low eggs would not be-able to oscillate.  
However, this is not the case. If eggs experiencing PLCζ induced Ca²⁺i oscillations are 
exposed to thapsigargin, which depletes ER Ca²⁺ levels, these eggs continue to oscillate but 
with a reduced amplitude (Wakai et al. 2013). As this model is dependent solely on the 
properties of the IP₃ receptor it does not rely on fluctuations in cytosolic IP₃ instead 
assumes a constant production of IP₃. However, injecting the IP3 analogue adenophostin, 
which mimics a constant level of IP3 production does not cause Ca²⁺i oscillations that look 
like that at fertilisation (Swann and Yu 2008). Furthermore the biphasic properties of the 
IP3R are only relevant at low levels of Ca²⁺i (Mak et al. 1998). Therefore it is unlikely that this 
model of IP3 induced Ca²⁺release is how the regenerative Ca²⁺i waves are produced in 
mammalian eggs at fertilisation. 
The other model by which the regenerative Ca²⁺i wave could be produced is by Ca²⁺i 
induced IP3 formation (see fig 7.1). This model does not rely on the level of ER 
Ca²⁺concentrations but instead is dependent on cytosolic Ca²⁺i concentrations (Meyer and 
Stryer 1988; Swann and Yu 2008).  In this model IP₃ is produced in an oscillatory manner. 
During peaks in IP₃ levels the IP₃R are opened to release Ca²⁺ (Meyer and Stryer 1988). This 
produces an increase in Ca²⁺i which positively feeds back onto IP₃ production (Iino and Endo 
1992). As a result if this model of regenerative Ca²⁺i increase is taking place in mammalian 
eggs at fertilisation you would expect there to be oscillations in IP3 formation. Using a FRET 
based probe for IP3 in mouse eggs has shown that there are small changes in IP3 levels 
during Ca²⁺i oscillations. The results of Chapter 6 attempted to measure these dynamic 
using novel bioluminescent IP3 probes. However, none of these probes appeared sensitive 
enough to measure changes in IP3 during PLCζ induced Ca²⁺i oscillations. 
It is significant that the rapid Ca²⁺I waves in mouse eggs that generate the upstroke of each 
Ca²⁺i oscillation occur with a 1 sec rise time (Dupont and Dumollard 2004). If Ca²⁺I  induced 
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IP3 formation is responsible for each wave then IP3 must diffuse from its generation point to 
the IP3R on the ER  within less than 1 second (Dupont and Goldbeter 1994) . However, it 
has recently been shown that, intact cells, IP3 can only diffuse approximately 3-5 µm in a 1 
second time period (Dickinson et al. 2016). Therefore in order for Ca²⁺i oscillations to be 
initiated by Ca²⁺i induced IP3 formation the production site of IP3 needs to be less than 5 µm 
away from the ER containing the IP3R. It is unlikely that IP3 generated at the plasma 
membrane in mouse eggs (with a radius of 35um) could account for such a rapid Ca²⁺i rise 
time.  It is therefore probably essential for an intracellular source of PI(4,5)P₂  to be in close 
proximity to the ER. Chapter 5 shows that a vesicular source of PI(4,5)P₂ distributed 
throughout the cytoplasm is present in mouse eggs and would be in close enough proximity 
to the ER in order to release Ca²⁺ by the mechanism described. Furthermore it appears PLCζ 
is able to hydrolyse this pool of PI(4,5)P₂. In fact there is evidence that this PI(4,5)P₂ is vital 
for PLCζ activity (Yu et al. 2012) 
 It has previously been suggested that Ca²⁺i dependent IP₃ formation is responsible for 
helping the propagation of the Ca²⁺i wave in sea urchin eggs (Whitaker and Irvine 1984). 
Seas urchin eggs also contain a source of PI(4,5)P₂ in their yolk platelets which could help 
facilitate the spread of the Ca²⁺i wave across the whole egg efficiently (Rice et al. 
2000).Interestingly PLCζ from mammalian sperm extracts is able to hydrolyse this 
intracellular source of PI(4,5)P₂ in sea urchin homogenates (Rice et al. 2000). There is also 
evidence that a  cytoplasmic organelle bound PI(4,5)P₂  in is present in Xenopus eggs (Snow 
et al. 1996). It is very likely that an intracellular PI(4,5)P₂  source is necessary for the 
regenerative Ca²⁺i increase in mammalian eggs (see fig 7.1). However, an intracellular 
source of PI(4,5)P₂  may also be necessary for the propagation of Ca²⁺i waves in all eggs that 
release Ca²⁺ by a wave.  
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Figure 7.1 Diagram showing how PLCζ may release Ca²⁺ in mammalian eggs 
Proposed model of PLCζ initiated Ca²⁺ release by Ca²⁺i induced IP₃ formation in mammalian eggs. In 
this model PLCζ diffuses into the egg and hydrolyses a vesicular source of PI(4,5)P₂ at low Ca²⁺i 
concentrations. This produces a surge in IP₃ this diffuses a distances of less than 5μm before binding 
to IP₃R on the ER (yellow) which releases Ca²⁺. This Ca²⁺i increase positively feeds back onto PLCζ 
activity to produce more IP₃. When IP₃ levels get too high the IP₃R becomes desensitised and closes.  
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Cell cycle dependent organelle redistribution and Ca²⁺release 
Unlike other PLC isoforms PLCζ appears to be highly selective in which cell types it releases 
Ca²⁺. For example it is only able to release Ca²⁺i at physiological levels in eggs and will not 
release Ca²⁺in CHO cells even at very high expression levels (Phillips et al. 2011). One of the 
main differences between mammalian eggs and somatic cells is their cell cycle state.  
Mammalian eggs are arrested in metaphase of the second round of meiosis. This is a highly 
unnatural state for cells as they usually remain in interphase for the majority of the time 
and progress through the other stages of the cell cycle, including metaphase, relatively 
quickly. During cell division cells undergo major cytoplasmic alterations and organelle 
redistribution. For example the network structure of the ER alters during mitosis and as the 
nuclear envelope breakdown proteins disperse from the NE into the ER (Ellenberg et al. 
1997; Puhka et al. 2007).  In contrast the Golgi apparatus fragments into very small vesicles 
known as the “Golgi haze” (Axelsson and Warren 2004). During this process many of the 
proteins that usually reside in the Golgi get absorbed into the ER (Axelsson and Warren 
2004). 
Unlike mitotic cell division which occurs very quickly meiotic cell division of oocytes occurs 
over a much more prolonged period of time. The cells also become arrested at various 
points in this cell cycle. For example GV oocytes are arrested in interphase of the first 
round of meiosis for many years. The oocytes then enter oocyte maturation which occurs 
over many hours before being arrested in the metaphase of meiosis II. There are significant 
disadvantages to being arrested in this phase of cell cycle for example there is an increased 
risk of chromosomal errors.  
However, like mitotic cell divisions many cytoplasmic alterations occur during oocyte 
maturation which includes the redistribution of organelles. First of all the ER alters from 
forming a continuous network with the nuclear envelope that is seen in GV oocytes to 
forming clusters in the cortex of MII eggs (FitzHarris et al. 2007). These clusters are located 
close to the mitochondria (FitzHarris et al. 2007). The ER staining in Chapter 5 confirms this 
clustering of the ER during metaphase arrest in mouse eggs. 
Like in mitotic cells the Golgi fragments during entry into meiosis. In GV oocytes the Golgi 
appears as small stacks called mini-Golgi but once the GV breaks down these stacks 
become fragmented into small vesicles (Moreno et al. 2002; Payne and Schatten 2003). The 
results in Chapter 5 support this notion as using both immunocytochemistry techniques on 
fixed cells and live Golgi markers show that the Golgi is vesicular in mature eggs. 
Interestingly these Golgi vesicles are more concentrated in the cortex like the ER and 
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mitochondria.  
Oocyte maturation appears to be associated with an increase in Ca²⁺ releasing ability of 
oocytes specifically after germinal vesicle breakdown. It has previously been shown that 
the Ca²⁺i oscillations in immature mouse and hamster eggs are reduced in frequency, 
duration and amplitude compared to that in mature eggs in response to sperm, sperm 
extracts and PLCζ (Fujiwara et al. 1993; Jones et al. 1995b; Carroll et al. 1996; Wakai et al. 
2012).The results in Chapter 5 verify this effect and show that mouse GV oocytes have 
more than a 30 fold reduction in sensitivity to PLCζ compared to MII eggs which is a far 
bigger reduction than ever reported previously.  
This effect is not unique to mammalian eggs. Starfish eggs also acquire the ability to release 
Ca²⁺during maturation(Chiba et al. 1990). This also appears to be true for Xenopus frog 
eggs. In immature Xenopusoocytes Ca²⁺ is released in response to IP3in a series of 
oscillations. However, in mature eggs these Ca²⁺i puffs become concentrated to form a 
large single Ca²⁺i wave that takes several minutes to cross the egg (Machaca 2004). Ca²⁺i 
oscillations initiated by sperm in immature oocytes from the nemertean marine worm 
Cerebratulus lacteus are also reduced in amplitude and duration compared to that in 
mature eggs (Stricker 1996). Interestingly these oscillations initiated in immature oocytes 
do not have the same wave form as that seen in mature eggs (Stricker 1996). This is also 
something that has also been noted for immature mouse oocytes (Swann 1994). 
Significantly in all the species noted above including mammals, mature eggs become 
arrested in during metaphase of either the first or second round of meiosis. This is in 
contrast to the GV oocytes which are usually arrested in prophase or interphase. This 
suggests that the ability for eggs to release Ca²⁺ could be a cell cycle dependent feature, 
particularly a feature of cells in metaphase. This is certainly true for ascidian eggs. Mature 
ascidian eggs are arrested in metaphase I and release Ca²⁺ in the form of oscillations when 
fertilised. However, as these eggs progress into the meiosis II these oscillations stop for 
approximately 5 minutes before resuming as the eggs enter metaphase II (McDougall and 
Levasseur 1998).  This feature appears to be dependent on MPF levels as the Ca²⁺i 
oscillations persist whilst the levels of MPF and cease when the MPF levels fall (McDougall 
and Levasseur 1998). 
Unlike most other species, mature sea urchin eggs complete the second round of meiosis 
before being fertilised and therefore are in interphase of the cell cycle when they are 
activated (Mazia 1974). It is unclear whether Ca²⁺ release alters during oocyte maturation 
in this species. The Ca²⁺ releasing channel/ryanodine receptor is concentrated to the cortex 
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in mature eggs however in immature oocytes this channel is absent in most cases or not 
localised (McPherson et al. 1992). The effect that this has physiologically on Ca²⁺ release is 
not fully understood as there appears to be both IP3 sensitive and non-IP3sensitive 
pathways for Ca²⁺ release in sea urchin eggs (Kuroda et al. 2001). 
In mammalian eggs the increase in Ca²⁺ releasing ability during oocyte maturation has been 
attributed to an increase in IP3 receptor sensitivity (Wakai et al. 2012). This appears to be 
the case in starfish, as immature oocytes require 100 times more IP3than mature eggs to 
elicit the same Ca²⁺iresponse (Chiba et al. 1990). The increase in Ca²⁺release in Xenopus 
eggs is also attributed to an increase in IP3 sensitivity during oocyte maturation (Kume et al. 
1997; Terasaki et al. 2001).  
In mammalian eggs this increase in IP3 receptor sensitivity is thought to be due to an 
increase in ER Ca²⁺ concentrations and phosphorylation status of the receptor (Wakai et al. 
2012). Indeed the results in Chapter 5 show that the amount of Ca²⁺i in the stores does 
increase during oocyte maturation. However, this occurs in the later stages of maturation, 
between the first metaphase and the second metaphase not after GVBD when the greatest 
increase in Ca²⁺i releasing ability of oocytes is seen. Furthermore this relatively small 
increase in ER Ca²⁺ levels during maturation is not enough to attribute to the dramatic 
increase in PLCζ sensitivity during this time. Furthermore the sensitivity of IP3R to luminal 
ER Ca²⁺concentrations is a feature of the biphasic nature of the IP3R and it is unlikely that 
this sets the pace for the Ca²⁺i   oscillations (see previous section).  
It is more likely that the cell cycle dependent nature of Ca²⁺i oscillations in eggs is due to the 
large structural changes in the cell that occur during this time. In many species for example, 
the structural reorganisation of the ER plays a significant role in enabling effective 
Ca²⁺release. Reorganisation of the ER during oocyte maturation has been recorded in 
Xenopusfrogs, starfish, hamster, nematode worms and mouse eggs (Jaffe and Terasaki 
1994; Shiraishi et al. 1995; Stricker 1996; Terasaki et al. 2001; FitzHarris et al. 2003, 2007). 
In mouse eggs this ER re-organisation has been linked very closely with the increase in 
Ca²⁺release (FitzHarris et al. 2003). However, this is unlikely to account for the stark 
difference in PLCζ sensitivity between phases of the cell cycle. 
The fragmentation of the Golgi could however play a role in this. The results in Chapter 5 
suggest that the vesicles containing intracellular PI(4,5)P₂  could originate from the Golgi 
apparatus. As the Golgi fragments during oocyte maturation it is possible that this plays a 
role in enabling effective Ca²⁺ release. For instance if PI(4,5)P₂ is contained in the Golgi 
vesicles, Golgi fragmentation may enable this PI(4,5)P₂is available for PLCζ binding. 
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Alternatively these Golgi vesicles may contain a targeting protein for PLCζ that only 
becomes accessible when the Golgi fragments. Chapter 5 shows that this vesicular Golgi is 
only present after GVBD however PI(4,5)P₂ markers suggest that PI(4,5)P₂  is localised in 
vesicular structures before that time. This may be because PI(4,5)P₂  synthesised in other 
compartments and is trafficked to the Golgi derived vesicles once it has fragmented.  
It is also significant that the Golgi and PI(4,5)P₂  containing vesicles are distributed 
throughout the cytoplasm but concentrated in the cortex as this has two key implications. 
Firstly it allows concentration of PI(4,5)P₂  in close proximity to the ER which contains the 
IP3R. This means that the IP3 produced at these vesicles could have time to diffuse to the 
site of Ca²⁺ release in order to produce the fast Ca²⁺i rise time recorded. This means the 
Golgi, ER and mitochondria could all be within close proximity to each other and coupled to 
produce regular, paced Ca²⁺i oscillations. Secondly as this PI(4,5)P₂  is distributed 
throughout the whole egg cytoplasm a fast wave of Ca²⁺i release can occur from one side of 
the egg to the other.  
One other key feature of cells in metaphase is the lack of an intact nuclear envelope. This 
membrane is usually continuous with the ER but when this envelope breaks down proteins 
within it get absorbed into the ER (Puhka et al. 2007). This means that cells that are in 
interphase and prophase have an intact nucleus. GV oocytes are arrested in prophase I and 
have a large intact nuclear envelope called the germinal vesicle however this envelope 
breaks down as these oocytes progress into metaphase in a process called germinal vesicle 
breakdown (GVBD). The results in Chapter 5 show that mouse eggs develop a dramatic 
increase in Ca²⁺i releasing ability after GVBD and one reason for this could be the 
localisation of PLCζ in GV oocytes compared to mature eggs. Mouse PLCζ contains a nuclear 
localisation sequence which targets PLCζ to the nucleus after pronuclear formation (Larman 
et al. 2004; Yoda et al. 2004). This sequestering of PLCζ in the nucleus ablates PLCζ induced 
Ca²⁺i oscillations. 
There is also a suggestion that PLCζ could be localised to the nucleus in mouse GV oocytes 
and this may account for the dramatic reduction in PLCζ sensitivity seen in mouse GV 
oocytes (Yu et al. 2012). However, Chapter 5 shows that luciferase tagged PLCζ does not 
appear to localise to nucleus in GV oocytes possibly due to the size of the fusion protein. 
Though untagged PLCζ may localise to the nucleus in GV oocytes luciferase tagged PLCζ 
appears to be retained in the cytoplasm however it is still not able to produce Ca²⁺i 
oscillations. This suggests that other cytoplasmic differences are likely to account for the 
lack of Ca²⁺ release in these instances. In addition PLCζ doesn’t localise to the nucleus in 
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oocytes and eggs of other mammalian species. 
These cellular features are all a result of cells being arrested in a metaphase. It is possible 
that the reason most eggs, even those distantly related evolutionarily, are arrested in 
metaphase is because these cellular features are required for effective and sustainable IP₃ 
induced Ca²⁺ release through the whole egg at egg activation. For example the re-
distribution of organelles during this time ensures that the production of IP₃, the IP₃R 
receptors and ATP generation site can all be in close proximity (see Fig 7.2). Furthermore 
this process may enable an intracellular source of PI(4,5)P₂  to become available and 
accessible. The need for arrest in metaphase may be particularly important in eggs that 
release Ca²⁺ in the form of oscillations. Particularly in order to set the pace and pattern of 
these Ca²⁺i oscillations, which could explain why the wave form of Ca²⁺ release is disrupted 
in immature mouse oocytes (Swann 1994). As a result it is possible that the structural 
reorganisation that occurs as eggs enter metaphase is vital for the model Ca²⁺i induced IP3 
formation that is likely to take place in those eggs that release Ca²⁺ as a wave. 
 
Phosphoinositide turnover in eggs 
IP₃ induced Ca²⁺ release requires the production of IP₃ from the phosphoinositide PI(4,5)P₂ . 
This means that in order to release Ca²⁺ by IP₃ there must be an available source of 
PI(4,5)P₂  for hydrolysis. As a result it makes sense that there would be a high amount of 
phosphoinositide turnover in eggs. This turnover has been successfully measured in sea 
urchin eggs.  The parent molecule for all phosphoinositides, PI, is essential for maintaining 
Ca²⁺i homeostasis in sea urchin eggs during fertilisation (Sillers and Forer 1985). 
Measurements have shown that there 600 fold increase in phosphoinositide turn over 
within the 1st minute of fertilisation (Ciapa et al. 1992). Furthermore there is a 5 fold 
increase in PI(4,5)P₂  production from PI in the first 10 minutes after fertilisation (Kamel et 
al. 1985). Another echinoderm, the starfish, experiences a biphasic increase in PI(4,5)P₂  
levels in eggs at fertilisation. There is initial increase in PI(4,5)P₂ following sperm-egg fusion 
which then falls before at longer prolonged increase in PI(4,5)P₂  levels is produced (Chun 
et al. 2010). 
 An increase in PI turnover was also recorded in Xenopus frog eggs. Levels of both IP₃ and 
PI(4,5)P₂  were found to increase following fertilisation with a continuous rise in IP₃ during 
Ca²⁺ release and a two fold increase in PI(4,5)P₂  in the two minutes after the Ca²⁺i wave 
(Snow et al. 1996). Before fertilisation the levels of PI(4,5)P₂ in mature Xenopus eggs are 
higher than PI(4)P (Le Peuch et al. 1985). Interestingly PI turnover also seems to be 
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significant in protosome eggs such as surf clams. Unlike most eggs surf clam eggs are 
fertilised as GV oocytes with a GV intact. As a consequence GVBD occurs as an event of 
fertilisation. Nevertheless radio-labelling lipids in these cells has shown that PI and PI(4)P 
levels do not alter during fertilisation, however PI(4,5)P₂  levels appear to decrease (Bloom 
et al. 1988). 
Attempts have been made to measure PI(4,5)P₂  levels at the plasma membrane in mouse 
eggs during fertilisation using fluorescent PH domain and no detectable loss of PI(4,5)P₂ 
was recorded  (Halet et al. 2002). This technique is based on the premise that PI(4,5)P₂  is 
usually associated with plasma membrane which makes it easily accessible to PLCs (Watt et 
al. 2002). These probes have been used previously in somatic cells has been to show that 
PI(4,5)P₂  is hydrolysed at the plasma membrane to produce IP₃ that diffuses into the 
cytoplasm (Watt et al. 2002). However, this does not appear to be the case in mouse eggs 
(Yu et al. 2008; Yu et al. 2012). Furthermore depleting PI(4,5)P₂  in the plasma membrane 
has no effect on sperm or PLCζ induced Ca²⁺i oscillations (Yu et al. 2012). As a result probes 
that measure plasma membrane PI turnover would not be appropriate to measure 
PI(4,5)P₂  hydrolysis and IP₃ production in mammalian eggs. In Chapter 6 attempts were 
made to measure whole cell PI turnover in mouse eggs in response to PLCζ by measuring 
DAG and IP3 using probes. However, none of these probes appeared sensitive 
enoughtomeasure any significant changes in DAG or IP3 during PLCζ induced 
Ca²⁺ioscillations. Oscillations in IP₃ production is a feature required for Ca²⁺i induced IP₃ 
formation. However, it is possible that the turnover of phosphoinositides is so high that it is 
difficult to detect significant dynamic changes in PI(4,5)P₂, IP₃ and DAG. 
As discussed previously spatial regulation of PI turnover such as intracellular IP₃ production 
may be important for wave front Ca²⁺release and in setting the pace of Ca²⁺i oscillations. 
This may also be a feature that is unique to mature eggs. As a result it is possible that 
phosphoinositide synthesis may be stimulated during oocyte maturation and there is 
evidence for this in some species. For example, limpet oocyte maturation is initiated by a 
change in intracellular pH which stimulates a 30 -50% increase in PI and PIP synthesis and a 
50 fold turnover in phosphoinositides (Borg et al. 1992). However, these eggs do not 
increase Ca²⁺i by a wave of Ca²⁺ release but by Ca²⁺ influx. There is also a significant 
increase in phosphoinositide turnover in Xenopuseggs during oocyte maturation indicated 
by an increased incorporation of myo(3H) inositol (Carrasco et al. 1990). There is also a 
suggestion that PI turnover in bovine eggs may play multiple roles in oocyte maturation 
(Homa et al. 1991). However, somatic cells and maturing oocytes still contain high levels of 
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plasma membrane PI(4,5)P₂ . It may be the case therefore that this PI(4,5)P₂  is not 
localised sufficiently and a significant source of intracellular PI(4,5)P₂  must be present in 
eggs. Interestingly the results in Chapter 5 show that a vesicular source of PI(4,5)P₂ is 
present in immature oocytes however it is possible that this PI(4,5)P₂  is not localised 
correctly or in close enough proximity to PLCζ binding partners or the ER. The synthesis and 
sequestering of PI(4,5)P₂  in the correct membranes may be feature of oocyte maturation 
and could require membrane trafficking. 
Chapter 5 also shows that disruptors of membrane trafficking and Golgi structure appear to 
inhibit Ca²⁺i oscillations in eggs however it is still unclear what the mechanism of action of 
these drugs actually are. Furthermore it is unclear how much membrane trafficking is 
actually taking place in eggs. It may be possible for example that some anterograde and 
retrograde trafficking is occurring between the ER and the Golgi compartments shuttling 
proteins from one to other (see fig 7.2).  
Interestingly unlike somatic cells, a probe based on the PH domain of OSBP shows that 
PI(4)P in eggs does not appear to be localised to the Golgi or at least the vesicular 
compartment of the Golgi that contains PI(4,5)P₂  (see Chapter 5).  This is significant as 
PI(4)P is the precursor for PI(4,5)P₂  therefore it is possible that PI(4,5)P₂  is synthesised for 
example in the ER or another cellular compartment and is trafficked to the Golgi fragments 
where it can be hydrolysed by PLCζ (see fig 7.2) . This could offer an explanation for why 
disrupting membrane trafficking inhibits Ca²⁺i oscillations induced by PLCζ (See fig 7.2).  
It is possible that an upregulation of PI(4,5)P₂  synthesis during oocyte maturation acts to 
produce eggs that have the capacity to respond effectively to PLCζ. However, it is also likely 
that the maintenance of these oscillations is dependent on rapid re-synthesis of PI(4,5)P₂  
and PI turnover during these Ca²⁺ioscillations (see fig 7.2). This could explain why it is 
difficult to record phosphoinositide turnover dynamically at fertilisation and why it is so 
difficult to deplete levels of PI(4,5)P₂  in eggs. This may also explain why no dominant 
negative effect has been recorded using PLCζ. Very high levels of catalytically dead PLCζ do 
not appear to effect wild type PLCζ activity. However, this may be because if there is a large 
amount of vesicular PI(4,5)P₂  in eggs and high rate of PI(4,5)P₂  synthesis it may prove very 
difficult to saturate or deplete this PI(4,5)P₂. It is also possible that as well as possessing a 
high level of the substrate PI(4,5)P₂ there is also an abundance of PLCζ binding partner 
present in target membranes.  
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Figure 7.2 Proposed model of PI and DAG signalling between Golgi vesicles and the ER during Ca²⁺ i 
oscillations in mammalian eggs 
PI(4,5)P₂ synthesised from PI(4)P either at the ER or the Golgi.  PI(4,5)P₂  generated at the ER may be 
transported to the Golgi by PI transfer proteins. Once in the Golgi PI(4,5)P₂ is available for hydrolysis 
by PLCζ that diffused into the egg at sperm-egg fusion. Hydrolysis of PI(4,5)P₂ produces IP3 that 
diffuses into the cytoplasm and DAG which stays in the membrane. Interestingly DAG doesn’t appear 
to stay the membranes of these vesicles. DAG the ER is converted into PA by the enzyme DGK. PA 
eventually gets recycled to PI which is the precursor for PI(4)P. The drug propranolol blocks 
formation of DAG by the activity of PAP. Propranolol also inhibits retrograde transport from the 
Golgi-ER. BFA inhibits anterograde transport from the ER-Golgi. The enzyme DGK might also be 
involved in anterograde transport by stimulating localised PA levels.  
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PLC mediated Ca²⁺release in eggs 
Many species that release Ca²⁺ from internal stores at fertilisation do so by IP₃ pathway 
therefore must require the activity of a PI- specific PLC. Most PLC isoforms are expressed in 
the target cell and respond to internal or external stimulation. 
It appears that in most species, during egg activation, Ca²⁺release is triggered by the 
activation of egg derived endogenously expressed PLCs. For example it has been suggested 
that PLCγ is involved in Ca²⁺ release in sea urchin eggs during egg activation (Carroll 1999). 
One mechanism by which PLCγ could be activated is through the stimulation of src family 
kinases (Abassi et al. 2000). However, PLCγ activity alone does not appear sufficient to 
account for all the Ca²⁺release at fertilisation in sea urchins as inhibiting PLCγ activity 
reduces but does not ablate all Ca²⁺ release (Carroll 1999). Sea urchins eggs do express 
other PLC isoforms, for example PLCβ and PLCδ homologues have both been identified 
(Coward et al. 2004; Kulisz et al. 2005). However, it is not clear what role if any these PLC 
isoforms play in sea urchin egg activation. For example injection of PLCδ does not cause 
Ca²⁺release in sea urchin eggs (Coward et al. 2007). Furthermore recombinant protein of 
PLCβ, PLCδ and PLCγ are not able to cause Ca²⁺ release in sea urchin egg homogenates 
(Jones et al. 2000). 
Starfish egg activation also appears to be dependent on endogenous PLC activation. 
Inhibiting PLCγ activity using SH2 domains prevents egg activation at fertilisation (Carroll et 
al. 1997). As in sea urchin eggs PLCγ in starfish eggs appears to be activated by src family 
kinases (Giusti et al. 1999a; Giusti et al. 2000; Runft et al. 2004). This also appears to be the 
case in ascidian eggs (Runft and Jaffe 2000). PLCγ activation also appears to play a 
significant role in the egg activation of some amphibian species for example polyspermic 
newts (Ueno et al. 2014). There is some suggestion that Src family kinase activated PLCγ is 
also responsible for egg activation in Xenopus (Sato et al. 2000). The theory is that sperm 
activates phospholipase D which results in an increase in phosphatidic acid (Bates et al. 
2014). PA then stimulates PLC γ by src family kinases (Bates et al. 2014). Membrane 
associated PLCs can be activated by an increase in PA (Jackowski and Rock 1989). 
Furthermore an increase in PA has previously been associated with an increase in PI(4,5)P₂ 
and PI hydrolysis(Jacob et al. 1993).  However, SH2 domains do not appear to inhibit Ca²⁺i 
oscillations stimulated at fertilisation (Runft et al. 1999). PLCγ activation also appears to 
play a role in polychaete annelid worm egg activation (Yin and Eckberg 2009). 
This evidence would suggest that endogenously expressed PLCs, specifically PLCγ, appear to 
be involved in eliciting Ca²⁺ release during egg activation in many species. Despite the 
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expressing PLCγ PLCβ and PLCδ, this does not appear to be the case in mammalian eggs 
(Dupont et al. 1996). For example expression of excessive SH2 and SH3 domains, which act 
as an inhibitor for PLCγ, has no effect on Ca²⁺i oscillations initiated by sperm (Mehlmann et 
al. 1998). Furthermore inhibiting tyrosine kinase mediated PLCγ hinders sperm induced 
Ca²⁺release however does not ablate Ca²⁺i oscillations (Dupont et al. 1996). Despite there 
being some suggestions that G protein activated PLCβ is involved in Ca²⁺release in mouse 
eggs inhibiting PLCβ using Gq family G proteins does not inhibit Ca²⁺i oscillations (Moore et 
al. 1994; Williams et al. 1998). However, depleting PLCβ levels using iRNAs effect the 
amplitude of sperm induced Ca²⁺i oscillations however over-expression of PLCβ reduces the 
frequency and duration of these oscillations (Igarashi et al. 2007). Therefore it is possible 
that PLCβ does play some role in determining the pattern Ca²⁺release in mammalian eggs 
however it is unclear what the significance of this effect is.  
Unlike other animal groups Ca²⁺ release in mammals is initiated by an exogenous PLC. This 
may be significant for imposing the properties of Ca²⁺release in eggs. For example there are 
some unique properties of PLCζ compared to other PLC isoforms and there are some 
unique features of Ca²⁺ release in mammalian eggs compared to that of other animal 
groups. For example PLCζ is unique amongst PLCs at causing Ca²⁺release in mammalian 
eggs at physiological basal Ca²⁺i levels and it appears to be very potent at hydrolysing 
PI(4,5)P₂. There are several reasons for this, first is the increased Ca²⁺i sensitivity of PLCζ 
compared to other PLC isoforms (Nomikos et al. 2005). However, this factor is not sufficient 
to account for lack of other PLC activity. For example if this was the case then increasing 
basal level Ca²⁺i would stimulate the activity of other endogenous PLCs however there is no 
evidence for this. PLCδ and PLCγ are able to cause some Ca²⁺release in mouse eggs if these 
are expressed at very high levels far past that physiological (Mehlmann et al. 2001; Yu et al. 
2008).  
Another feature that could ensure PLCζ activity is its localisation in the egg. Chapter 5 
shows that PLCζ localises to small vesicles throughout the cytoplasm. This is different to 
other PLC isoforms which localise to the plasma membrane. They do this mainly through 
binding PI(4,5)P₂ here via a PH domain (Watt et al. 2002). However, as previously stated 
PLCζ does not appear to hydrolyse this source of PI(4,5)P₂ and does not possess a PH 
domain(Saunders et al. 2002; Yu et al. 2012). To compensate for this the results in Chapter 
4 indicate that the XY linker and EF hand domain work in synergy to bind PLCζ to this 
vesicular source of PI(4,5)P₂. In other PLCs for example PLCδ1 the XY linker and EF hand do 
not have a role in PI(4,5)P₂  binding. For example positively charged residues in the EF hand 
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domain of PLCδ play a role in binding anionic phospholipids specifically phosphatidylserine 
(Cai et al. 2013).  Binding of an intracellular source of PI(4,5)P₂ in this way could therefore 
be a unique feature of PLCζ activity. However, PI(4,5)P₂ binding by this region cannot 
discriminate between different pools of PI(4,5)P₂  so doesn’t explain why PLCζ hydrolyses a 
vesicular source of PI(4,5)P₂  over plasma membrane PI(4,5)P₂. It also doesn’t explain why 
PLCζ cannot hydrolyse the PI(4,5)P₂ in the plasma membrane of somatic CHO cells (Phillips 
et al. 2011). This suggests that membrane PI(4,5)P₂ is not available to PLCζ for hydrolysis.  
PI(4,5)P₂  is a negatively charged protein that is exposed on membranes. Positively charged 
MARCKS protein at physiological levels has been found to bind to this PI(4,5)P₂ in order to 
shield it and in turn this inhibits PI(4,5)P₂  hydrolysis by PLCs (Glaser et al. 1996). PI(4,5)P₂  
is released when MARCKS protein is phosphorylated by PKC (Glaser et al. 1996). 
Alternatively CaM binds to MARCKS with a strong affinity which rips it of PI(4,5)P₂  rapidly 
therefore freeing up PI(4,5)P₂  for hydrolysis (Arbuzova et al. 1997). As a result MARCKS 
protein acts as a reversible PI(4,5)P₂ buffer. Interestingly CaM binds to PLCζ via the CaM 
binding domain (Nomikos et al. 2007). PLCδ1 is inhibited by CaM which can be reversed by 
interaction with the small GTPase (Sidhu et al. 2005). 
It is still unclear why PLCδ is able to hydrolyse plasma membrane PI(4,5)P₂  whereas PLCζ 
can’t. This may be because the PH domain of PLCδ has a preference for PI(4,5)P₂  that is 
found in cholesterol rich membranes which may give it an increased affinity to plasma 
membrane PI(4,5)P₂(Rissanen et al. 2017). PLCζ does not contain a PH domain however 
other features of its structure could play a role in discriminating between PI(4,5)P₂  in 
different membranes. Alternatively PLCζ may require an additional targeting protein in 
order to be active that is not present in the plasma membrane. For example the C2 domain 
of PLCζ appears to play a role in enabling Ca²⁺release by ensuring PLCζ membrane 
association (see Chapter 4). However, it is unclear how it does this. The only binding 
partners that the C2 domain of PLCζ has been found to bind with are PI(3)P and PI(5)P 
neither of which are distributed in a vesicular pattern (Kouchi et al. 2005), (Moon and 
Swann 2012 unpublished). It is possible there is an unknown binding partner for the C2 
domain of PLCζ that is yet to be identified. This binding partner could play a role in 
reversing CAM inhibition in the same way Ral does for PLCδ (Sidhu et al. 2005). These 
structural and regulatory properties of PLCζ may explain why it is able to cause Ca²⁺i 
oscillations in mammalian eggs and also may determine the pattern of those oscillations. 
For example oscillations initiated by PLCδ1 in mouse eggs do not follow the same pattern 
as those initiated by PLCζ. This may be because PLCδ1 hydrolyses plasma membrane 
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PI(4,5)P₂  over a vesicular source of PI(4,5)P₂. As a result PLCδ may not stimulate 
Ca²⁺release by Ca²⁺i induced IP₃ formation as this requires hydrolysis of an intracellular 
source of PI(4,5)P₂ . This could explain, for example, why despite high expression levels 
PLCδ in eggs it only causes relatively low frequency oscillations (Coward et al. 2007; Yu et 
al. 2008). It could also explain why PLCδ induced Ca²⁺ release in mouse eggs does not lead 
to down regulation of the IP₃ receptors in the way PLCζ does.  
It has previously been suggested that based on the 3D crystal structure of PLCδ1 (see fig 
7.3) that it may bind to membrane derived PI(4,5)P₂  by a” tether and fix” and fix model 
(Essen et al. 1996). In this model the PH domain of PLCδ1 tethers it to the PI(4,5)P₂  initially 
and then the other domains act help fix it in place so PI(4,5)P₂  is able to come in contact 
with the active site and be hydrolysed. A similar model may be relevant for PLCζ. For 
example the C2 domain may act to tether PLCζ to the membrane by an unknown target 
without which it may not localise at all. The X-Y linker and EF hands domain then bind 
PI(4,5)P₂  by electrostatic interactions which fix PLCζ in place and allow PI(4,5)P₂  to be 
accessible to the active site (see fig 7.4).In this model specific membrane targeting by the 
C2 domain could explain how PLCζ discriminates between vesicular PI(4,5)P₂  and plasmam 
membrane bound PI(4,5)P₂ . 
In most animal groups that release Ca²⁺in response to the activation of egg derived PLCs 
this increase occurs in the form of a single Ca²⁺i increase that crosses the egg as a wave 
front. Mammalian eggs are unique in that they release Ca²⁺as multiple waves that are 
paced to produce low frequency oscillations. Furthermore these Ca²⁺i waves cross the egg 
quickly (Deguchi et al. 2000). This is very different to the single Ca²⁺i wave that takes several 
minutes to cross the egg in sea urchin eggs). In contrast however marine nemertean worms 
release Ca²⁺ in the form of Ca²⁺i oscillations in response to mammalian sperm extracts as 
well as at fertilisation (Stricker 1996; Stricker et al. 2000). Human sperm extracts have also 
been found to cause Ca²⁺i oscillations in ascidian eggs similar to those elicited by sperm 
(Wilding et al. 1997). Interestingly these Ca²⁺I oscillations could not be mimicked solely by 
IP3injection (Wilding et al. 1997). This suggests that the initiationof Ca²⁺i oscillations in eggs 
are dependent on the cellular properties of the egg itself. For example the initiation of Ca²⁺i 
oscillations may be dependent on the rapid re-synthesis of PI(4,5)P₂ . Furthermore the low 
frequency, high amplitude Ca²⁺i oscillations seen in mammalian eggs at fertilisation may 
also be dependent on the unique features of PLCζ induced Ca²⁺ release. This includes PLCζ 
hydrolysis of intracellular PI(4,5)P₂  resulting in Ca²⁺i induced IP₃ formation and the positive 
feedback on PLCζ activity.  
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The Ca²⁺i oscillations in mammalian eggs initiated by PLCζ at fertilisation appear to 
stimulated by a novel IP3 signalling pathway that is different to that of other PLC isoforms. 
This pathway is very likely to depend on the hydrolysis of a vesicular, intracellular source of 
PI(4,5)P₂ . The ability for PLCζ to hydrolyse this PI(4,5)P₂  appears to be a result of structural 
properties of PLCζ itself and the cell biology of a mature egg. Hydrolysis of this vesicular 
source of PI(4,5)P₂  by PLCζ makes it more than possible that Ca²⁺i induced IP3formation is 
responsible for creating the regenerative Ca²⁺i  waves seen in eggs at fertilisation. 
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Figure 7.3 3D structure of PLCδ1 
3D structure of rat derived PLCδ1 without a PH domain as determined by x-ray crystallography (PDB 
ID: 2ISD, Essen et al 1996) 
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Figure 7.4 Schematic showing how PLCζ may bind to PI(4,5)P2by a “tether and fix” model 
The C2 domain may bind to some unknown membrane bound protein (?) which targets and tethers 
PLCζ to the membrane, the EF hand and X-Y linker then bind to PI(4,5)P₂, fixing PLCζ  in place and 
putting the X/Y catalytic domain in close enough contact to hydrolyse PI(4,5)P₂  in the active site.  
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